id,Category,gene,overlapKnown,type,codingConsequence,refGenome,chromosome,genome_position,depth,var_percent,exon_rank,c.DNA,protein,ref,alt,refNum,altNum,refSeq,altSeq,refAA,altAA,tx_name,refSeqId,end,gene_boundaries,filter,hpflags,dbSNP,g1000,esp5400,cg69,LJB_PhyloP,LJB_SIFT,LJB_PolyPhen2,LJB_LRT,LJB_MutationTaster,LJB_GERP,id_cosmic_coding,info_cosmic_coding,id_cosmic_non_coding,info_cosmic_non_coding,gene_strand,ref1,alt1,first1,last1,extId,reason,in_report,seq,comment,reads,clinicsnp_type,pathogenicity_class,cDnaExtra,pos_in_exon,id_clinvar,exon_id,CN,label,status,PLOIDY,screening_id,pred_cat,filterHistoric,reported,occurrences_run,occurrences_account_application,freq_all,freq_all_total,experiment_type,P_COMMENT,PID,false_positived,falsePositive,F_COMMENT,PATHO_DISTRIB,flagged_region_id,ExAC,dist2exon,directScore,disease_clinicaltrial,sameDisease,geneActionable,partientDisease,clinicalTrialID,associationIDS,opID,associationID,CLNREVSTAT,CLNSIG,associationType,effectOnTreatment,PROCESSED_CLNSIG,CLNSIGLAB,LJB_PolyPhen2_HumDiv,OMIM,Other type pathogenicity,IDs of samples in group,Variant frequencies in group,Alternative counts in group,Reference counts in group,Depths in group,VUs in group,Filters in group,consistency_in_group,OP Type,actionability_class,refSeqIdVersion,GnomAD,cds_rank,ACMG value,relative_freq_run,relative_freq_account_application,Relative Frequency in Community,hg38 refGenome,hg38 chromosome,hg38 genome_position,hg38 ref,hg38 alt,OMIM disease,OMIM inheritance modes,OMIM MIM number,pharmvar haplotype,Unique Depth,Unique refNum,Unique altNum,Duplex refNum in group,Duplex altNum in group,Unique refNum in group,Unique altNum in group,Unique Depth in group,Duplex refNum,Duplex altNum,VF% ratio,Variant calling type,Somatic support,Potential secondary finding,variant effect,SampleId
17,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244936,953,44.81,10,c.2612C>T,p.(Pro871Leu),G,A,526,427,CCG,CTG,P,L,NM_007294.3,NM_007294,41244936,within,.,,rs799917,0.5439,0.4932,,4.247,0.0,0.0,0.999,1.0,5.04,,,,,-,G,A,41244936,41244936,A19EA255CA888CE1FE48D08CAD633F1F,,,,,,,1,BRCA1- 458755064,-1485,41812,11,,,,EMPTY,,D,,1,4,17,290862,492662,126000,(eval),,0,0,,"1:4,2:1",,0.41,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.4127,9,3,0.5,0.20731707,0.59038854,GRCh38/hg38,17,43092919,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,17
7,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219780,940,50.53,16,c.4987-68A>G,p.(=),T,C,465,475,,,,,NM_007294.3,NM_007294,41219780,within,.,,rs8176234,0.3546,,,,,,,,,,,,,-,T,C,41219780,41219780,5995ECC305C33150BF3BB2B0C22FCC2A,,,,,,,-1,BRCA1- 458780220,0,125746,17,,,,EMPTY,,D,,0,4,17,234031,492662,126000,,,0,0,,,,,68,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3148,15,1,0.5,0.20731707,0.47503358,GRCh38/hg38,17,43067763,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,17
15,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244000,1088,51.84,10,c.3548A>G,p.(Lys1183Arg),T,C,524,564,AAA,AGA,K,R,NM_007294.3,NM_007294,41244000,within,.,,rs16942,0.3526,0.2952,,-0.319,0.0,0.001,0.924,0.0,-2.35,,,,,-,T,C,41244000,41244000,37A54117EA353BDA677332A1F61FA173,,,,,,,-1,BRCA1- 458756000,-549,41818,11,,,,EMPTY,,D,,0,4,17,272437,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.5,0.20731707,0.55298966,GRCh38/hg38,17,43091983,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,17
11,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41231516,1040,51.25,13,c.4358-2885G>A,p.(=),C,T,507,533,,,,,NM_007294.3,NM_007294,41231516,within,.,,rs8176193,0.3534,,,,,,,,,,,,,-,C,T,41231516,41231516,7F4F80D2D005D34CEA47E4A2C561B172,,,,,,,-1,BRCA1- 458768484,0,209399,14,,,,EMPTY,,D,,0,4,17,190200,492662,126000,,,0,0,,,,,2885,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.317,12,1,0.5,0.20731707,0.3860659,GRCh38/hg38,17,43079499,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,17
16,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244435,1057,50.52,10,c.3113A>G,p.(Glu1038Gly),T,C,523,534,GAA,GGA,E,G,NM_007294.3,NM_007294,41244435,within,.,,rs16941,0.3357,0.279,,-0.149,0.972,0.606,0.922,0.0,-0.974,,,,,-,T,C,41244435,41244435,5D0FF1321BAC3C76DD352C33CC33B93E,,,,,,,-1,BRCA1- 458755565,-984,41815,11,,,,EMPTY,,D,,0,4,17,270861,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,0.936,113705,-1,,,,,,,,,,,3,0.343,9,1,0.5,0.20731707,0.54979074,GRCh38/hg38,17,43092418,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,17
19,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245466,1319,50.34,10,c.2082C>T,p.(Ser694=),G,A,655,664,AGC,AGT,S,S,NM_007294.3,NM_007294,41245466,within,.,,rs1799949,0.3365,0.2957,,,,,,,,,,,,-,G,A,41245466,41245466,3364E3D252EFEDF917C74D44FBC6A381,,,,,,,-1,BRCA1- 458754534,1412,125536,11,,,,EMPTY,,D,,0,4,17,269442,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.5,0.20731707,0.54691046,GRCh38/hg38,17,43093449,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,17
10,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41231335,920,46.63,13,c.4358-2704C>T,p.(=),G,A,491,429,,,,,NM_007294.3,NM_007294,41231335,within,.,,rs562625234,0.0016,,,,,,,,,,,,,-,G,A,41231335,41231335,F655D5B065D85D9E4D96F02B0BB029C2,,,,,,,-1,BRCA1- 458768665,0,136548,14,,,,EMPTY,,D,,0,1,1,115,492662,126000,,,0,0,,,,0.0,2704,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.0,12,3,0.125,0.0121951215,2.3342576E-4,GRCh38/hg38,17,43079318,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,17
9,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41223094,730,50.0,15,c.4837A>G,p.(Ser1613Gly),T,C,365,365,AGT,GGT,S,G,NM_007294.3,NM_007294,41223094,within,.,,rs1799966,0.3558,0.2982,,-0.194,0.968,0.038,0.814,0.0,1.5,,,,,-,T,C,41223094,41223094,E3C52286D31F229973DB3595B052645F,,,,,,,-1,BRCA1- 458776906,-150,41827,16,,,,EMPTY,,D,,0,4,17,273625,492662,126000,,,0,0,,1:1,,0.349,0,,,,,,,,,,,,,,Benign,Benign,0.255,113705,-1,,,,,,,,,,,3,0.35,14,1,0.5,0.20731707,0.5554011,GRCh38/hg38,17,43071077,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,17
13,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41234470,482,47.72,12,c.4308T>C,p.(Ser1436=),A,G,252,230,TCT,TCC,S,S,NM_007294.3,NM_007294,41234470,within,.,,rs1060915,0.3363,0.2796,,,,,,,,,,,,-,A,G,41234470,41234470,B7237055CF1D42F022A050C072B7583B,,,,,,,-1,BRCA1- 458765530,-50,125703,13,,,,EMPTY,,D,,0,4,17,270833,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3433,11,1,0.5,0.20731707,0.5497339,GRCh38/hg38,17,43082453,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,17
8,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219804,940,50.43,16,c.4987-92A>G,p.(=),T,C,466,474,,,,,NM_007294.3,NM_007294,41219804,within,.,,rs8176233,0.3546,,,,,,,,,,,,,-,T,C,41219804,41219804,7341B20C52FFD4B9355840FB9CB56CDA,,,,,,,-1,BRCA1- 458780196,0,125749,17,,,,EMPTY,,D,,0,4,17,225491,492662,126000,,,0,0,,,,,92,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3128,15,1,0.5,0.20731707,0.45769918,GRCh38/hg38,17,43067787,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,17
6,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41215825,79,53.16,17,c.5152+66G>A,p.(=),C,T,37,42,,,,,NM_007294.3,NM_007294,41215825,within,.,,rs3092994,0.3425,,,,,,,,,,,,,-,C,T,41215825,41215825,5BCA8D2E1E3875817F84A3EB582CDFAB,,,,,,,-1,BRCA1- 458784175,0,55428,18,,,,EMPTY,,D,,0,3,15,241843,492662,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3139,16,1,0.375,0.18292683,0.4908903,GRCh38/hg38,17,43063808,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,17
18,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245237,120,50.0,10,c.2311T>C,p.(Leu771=),A,G,60,60,TTG,CTG,L,L,NM_007294.3,NM_007294,41245237,within,.,,rs16940,0.3353,0.2776,,,,,,,,,,,,-,A,G,41245237,41245237,711AF22D84A49E875C2B2A9597A95EE6,,,,,,,-1,BRCA1- 458754763,1641,125554,11,,,,EMPTY,,D,,0,3,16,269517,492662,126000,,,0,0,,1:1,,0.342,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3422,9,1,0.375,0.19512194,0.5470627,GRCh38/hg38,17,43093220,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,17
5,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32953388,1019,48.28,22,c.8755-66T>C,p.(=),T,C,527,492,,,,,NM_000059.3,NM_000059,32953388,within,.,,rs4942486,0.5116,,,,,,,,,,,,,+,T,C,32953388,32953388,97C65B85894EB489F1BFA65897685241,,,,,,,-1,BRCA2-  32953388,0,126190,22,,,,EMPTY,,D,,0,6,19,347826,493217,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5257,21,1,0.75,0.23170732,0.70521903,GRCh38/hg38,13,32379251,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,17
27,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32906980,724,50.55,10,c.1365A>G,p.(Ser455=),A,G,358,366,TCA,TCG,S,S,NM_000059.3,NM_000059,32906980,within,.,,rs1801439,0.0737,0.031,,,,,,,,,,,,+,A,G,32906980,32906980,C76C22E555E869928B452D866988AB4F,,,,,,,-1,BRCA2-  32906980,-545,125943,10,,,,EMPTY,,D,,0,1,4,41480,493217,126000,,,0,0,,"1:4,2:1",,0.051,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0499,9,2,0.125,0.048780486,0.08410091,GRCh38/hg38,13,32332843,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,17
29,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32911463,558,44.98,11,c.2971A>G,p.(Asn991Asp),A,G,307,251,AAC,GAC,N,D,NM_000059.3,NM_000059,32911463,within,.,,rs1799944,0.0801,0.0373,,-0.04,0.0,,0.959,0.0,3.08,,,,,+,A,G,32911463,32911463,36F4F7E6CD788E45B30EA486775D07D6,,,,,,,-1,BRCA2-  32911463,1062,41545,11,,,,EMPTY,,D,,0,1,4,42142,493217,126000,,,0,0,,1:2,,0.053,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0522,10,1,0.125,0.048780486,0.085443124,GRCh38/hg38,13,32337326,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,17
12,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906480,187,57.22,10,c.865A>C,p.(Asn289His),A,C,80,107,AAT,CAT,N,H,NM_000059.3,NM_000059,32906480,within,.,,rs766173,0.0737,0.0312,,0.498,0.998,,0.803,0.0,1.73,,,,,+,A,C,32906480,32906480,EE0CD2A1633CE9FEF0978528634002FE,,,,,,,-1,BRCA2-  32906480,72,41567,10,,,,EMPTY,,D,,0,1,4,41272,493217,126000,,,0,0,,"1:4,2:1",,0.051,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0496,9,2,0.125,0.048780486,0.08367919,GRCh38/hg38,13,32332343,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,17
30,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,235,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,235,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,8,24,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,0.29268292,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,17
1,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32899388,53,32.08,4,c.425+67A>C,p.(=),A,C,36,17,,,,,NM_000059.3,NM_000059,32899388,within,.,,rs11571610,0.0743,,,,,,,,,,,,,+,A,C,32899388,32899388,1AF346DE380A738371905EBFBCED20E1,,,,,,,-1,BRCA2-  32899388,0,126095,4,,,,EMPTY,,D,,0,1,4,39349,493217,126000,,,0,0,,2:1,,,67,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0306,3,3,0.125,0.048780486,0.0797803,GRCh38/hg38,13,32325251,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,17
31,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,1112,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,1112,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,8,24,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,0.29268292,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,17
3,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32930598,67,52.24,15,c.7469T>C,p.(Ile2490Thr),T,C,32,35,ATA,ACA,I,T,NM_000059.3,NM_000059,32930598,within,.,,rs11571707,0.016,0.0016,,0.406,0.895,,0.837,0.0,-5.83,,,,,+,T,C,32930598,32930598,D7CAF30A58440FCA5E8E7BACD8E1EDE4,,,,,,,-1,BRCA2-  32930598,34,96852,15,,,,EMPTY,,D,,0,2,7,6837,493217,126000,,,0,0,,"1:5,2:2",,0.014,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0176,14,2,0.25,0.085365854,0.013862053,GRCh38/hg38,13,32356461,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,17
28,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32910721,976,51.74,11,c.2229T>C,p.(His743=),T,C,471,505,CAT,CAC,H,H,NM_000059.3,NM_000059,32910721,within,.,,rs1801499,0.0735,0.0313,,,,,,,,,,,,+,T,C,32910721,32910721,D39471F16FE6D1F6752C2D4D179996AF,,,,,,,-1,BRCA2-  32910721,320,125979,11,,,,EMPTY,,D,,0,1,4,41536,493217,126000,,,0,0,,1:1,,0.052,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0503,10,1,0.125,0.048780486,0.08421446,GRCh38/hg38,13,32336584,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,17
23,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906729,776,48.07,10,c.1114A>C,p.(Asn372His),A,C,403,373,AAT,CAT,N,H,NM_000059.3,NM_000059,32906729,within,.,,rs144848,0.2494,0.2332,,0.32,0.861,,0.269,0.0,0.396,,,,,+,A,C,32906729,32906729,D514F785F1344AF9F6975E589D47BDF6,,,,,,,-1,BRCA2-  32906729,321,9329,10,,,,EMPTY,,D,,0,7,16,233635,493217,126000,,,0,0,,"1:1,2:1",,0.277,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2733,9,1,0.875,0.19512194,0.47369617,GRCh38/hg38,13,32332592,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,17
32,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,50,100.0,14,c.7397T>C,p.(Val2466Ala),T,C,0,50,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,7,23,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,0.875,0.2804878,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,17
4,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32936646,45,53.33,17,c.7806-14T>C,p.(=),T,C,21,24,,,,,NM_000059.3,NM_000059,32936646,within,.,,rs9534262,0.5316,0.5202,,,,,,,,,,,,+,T,C,32936646,32936646,5803939D8FBB75B042260991F0A62436,,,,,,,-1,BRCA2-  32936646,0,126158,17,,,,EMPTY,,D,,0,5,18,361616,493217,126000,,,0,0,,1:3,2,0.52,14,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5255,16,1,0.625,0.2195122,0.7331783,GRCh38/hg38,13,32362509,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,17
2,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32929478,593,50.93,14,c.7435+53C>T,p.(=),C,T,291,302,,,,,NM_000059.3,NM_000059,32929478,within,.,,rs11147489,0.0725,,,,,,,,,,,,,+,C,T,32929478,32929478,F692B4BE5DCD39FA887FE8D63D296720,,,,,,,-1,BRCA2-  32929478,0,126136,14,,,,EMPTY,,D,,0,1,4,36369,493217,126000,,,0,0,,,,,53,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0301,13,3,0.125,0.048780486,0.07373834,GRCh38/hg38,13,32355341,C,T,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,17
4,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244936,50,50.0,10,c.2612C>T,p.(Pro871Leu),G,A,25,25,CCG,CTG,P,L,NM_007294.3,NM_007294,41244936,within,.,,rs799917,0.5439,0.4932,,4.247,0.0,0.0,0.999,1.0,5.04,,,,,-,G,A,41244936,41244936,A19EA255CA888CE1FE48D08CAD633F1F,,,,,,,1,BRCA1- 458755064,-1485,41812,11,,,,EMPTY,,D,,1,4,17,290862,492662,126000,(eval),,0,0,,"1:4,2:1",,0.41,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.4127,9,3,0.5,0.20731707,0.59038854,GRCh38/hg38,17,43092919,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,18
14,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41231516,73,36.99,13,c.4358-2885G>A,p.(=),C,T,46,27,,,,,NM_007294.3,NM_007294,41231516,within,.,,rs8176193,0.3534,,,,,,,,,,,,,-,C,T,41231516,41231516,7F4F80D2D005D34CEA47E4A2C561B172,,,,,,,-1,BRCA1- 458768484,0,209399,14,,,,EMPTY,,D,,0,4,17,190200,492662,126000,,,0,0,,,,,2885,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.317,12,1,0.5,0.20731707,0.3860659,GRCh38/hg38,17,43079499,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,18
15,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41234470,42,35.71,12,c.4308T>C,p.(Ser1436=),A,G,27,15,TCT,TCC,S,S,NM_007294.3,NM_007294,41234470,within,.,,rs1060915,0.3363,0.2796,,,,,,,,,,,,-,A,G,41234470,41234470,B7237055CF1D42F022A050C072B7583B,,,,,,,-1,BRCA1- 458765530,-50,125703,13,,,,EMPTY,,D,,0,4,17,270833,492662,126000,,,0,0,,1:1,75,0.343,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3433,11,1,0.5,0.20731707,0.5497339,GRCh38/hg38,17,43082453,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,18
3,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244435,50,38.0,10,c.3113A>G,p.(Glu1038Gly),T,C,31,19,GAA,GGA,E,G,NM_007294.3,NM_007294,41244435,within,.,,rs16941,0.3357,0.279,,-0.149,0.972,0.606,0.922,0.0,-0.974,,,,,-,T,C,41244435,41244435,5D0FF1321BAC3C76DD352C33CC33B93E,,,,,,,-1,BRCA1- 458755565,-984,41815,11,,,,EMPTY,,D,,0,4,17,270861,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,0.936,113705,-1,,,,,,,,,,,3,0.343,9,1,0.5,0.20731707,0.54979074,GRCh38/hg38,17,43092418,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,18
13,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41223094,52,44.23,15,c.4837A>G,p.(Ser1613Gly),T,C,29,23,AGT,GGT,S,G,NM_007294.3,NM_007294,41223094,within,.,,rs1799966,0.3558,0.2982,,-0.194,0.968,0.038,0.814,0.0,1.5,,,,,-,T,C,41223094,41223094,E3C52286D31F229973DB3595B052645F,,,,,,,-1,BRCA1- 458776906,-150,41827,16,,,,EMPTY,,D,,0,4,17,273625,492662,126000,,,0,0,,1:1,,0.349,0,,,,,,,,,,,,,,Benign,Benign,0.255,113705,-1,,,,,,,,,,,3,0.35,14,1,0.5,0.20731707,0.5554011,GRCh38/hg38,17,43071077,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,18
12,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219804,82,47.56,16,c.4987-92A>G,p.(=),T,C,43,39,,,,,NM_007294.3,NM_007294,41219804,within,.,,rs8176233,0.3546,,,,,,,,,,,,,-,T,C,41219804,41219804,7341B20C52FFD4B9355840FB9CB56CDA,,,,,,,-1,BRCA1- 458780196,0,125749,17,,,,EMPTY,,D,,0,4,17,225491,492662,126000,,,0,0,,,,,92,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3128,15,1,0.5,0.20731707,0.45769918,GRCh38/hg38,17,43067787,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,18
2,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244000,83,45.78,10,c.3548A>G,p.(Lys1183Arg),T,C,45,38,AAA,AGA,K,R,NM_007294.3,NM_007294,41244000,within,.,,rs16942,0.3526,0.2952,,-0.319,0.0,0.001,0.924,0.0,-2.35,,,,,-,T,C,41244000,41244000,37A54117EA353BDA677332A1F61FA173,,,,,,,-1,BRCA1- 458756000,-549,41818,11,,,,EMPTY,,D,,0,4,17,272437,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.5,0.20731707,0.55298966,GRCh38/hg38,17,43091983,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,18
5,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245466,171,46.2,10,c.2082C>T,p.(Ser694=),G,A,92,79,AGC,AGT,S,S,NM_007294.3,NM_007294,41245466,within,.,,rs1799949,0.3365,0.2957,,,,,,,,,,,,-,G,A,41245466,41245466,3364E3D252EFEDF917C74D44FBC6A381,,,,,,,-1,BRCA1- 458754534,1412,125536,11,,,,EMPTY,,D,,0,4,17,269442,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.5,0.20731707,0.54691046,GRCh38/hg38,17,43093449,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,18
11,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219780,82,47.56,16,c.4987-68A>G,p.(=),T,C,43,39,,,,,NM_007294.3,NM_007294,41219780,within,.,,rs8176234,0.3546,,,,,,,,,,,,,-,T,C,41219780,41219780,5995ECC305C33150BF3BB2B0C22FCC2A,,,,,,,-1,BRCA1- 458780220,0,125746,17,,,,EMPTY,,D,,0,4,17,234031,492662,126000,,,0,0,,,,,68,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3148,15,1,0.5,0.20731707,0.47503358,GRCh38/hg38,17,43067763,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,18
9,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,44,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,44,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,8,24,486661,493217,126000,,,0,0,,"1:3,2:1",20,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,0.29268292,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,18
10,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32953388,117,100.0,22,c.8755-66T>C,p.(=),T,C,0,117,,,,,NM_000059.3,NM_000059,32953388,within,.,,rs4942486,0.5116,,,,,,,,,,,,,+,T,C,32953388,32953388,97C65B85894EB489F1BFA65897685241,,,,,,,-1,BRCA2-  32953388,0,126190,22,,,,EMPTY,,D,,0,6,19,347826,493217,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5257,21,1,0.75,0.23170732,0.70521903,GRCh38/hg38,13,32379251,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,18
1,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32903685,37,100.0,8,c.681+56C>T,p.(=),C,T,0,37,,,,,NM_000059.3,NM_000059,32903685,within,.,,rs2126042,0.1859,,,,,,,,,,,,,+,C,T,32903685,32903685,E9AEF840574909F4761D4EF7950E02CB,,,,,,,-1,BRCA2-  32903685,0,126192,8,,,,EMPTY,,D,,0,5,8,145186,493217,126000,,,0,0,,4:1,7,,56,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2163,7,1,0.625,0.09756097,0.29436535,GRCh38/hg38,13,32329548,C,T,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,18
8,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,34,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,34,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,8,24,487213,493217,126000,,,0,0,,1:3,17,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,0.29268292,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,18
10,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,2202,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,2202,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,8,24,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,0.29268292,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,20
1,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32903685,1917,48.3,8,c.681+56C>T,p.(=),C,T,991,926,,,,,NM_000059.3,NM_000059,32903685,within,.,,rs2126042,0.1859,,,,,,,,,,,,,+,C,T,32903685,32903685,E9AEF840574909F4761D4EF7950E02CB,,,,,,,-1,BRCA2-  32903685,0,126192,8,,,,EMPTY,,D,,0,5,8,145186,493217,126000,,,0,0,,4:1,,,56,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2163,7,1,0.625,0.09756097,0.29436535,GRCh38/hg38,13,32329548,C,T,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,20
11,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,744,99.87,14,c.7397T>C,p.(Val2466Ala),T,C,1,743,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,7,23,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,0.875,0.2804878,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,20
9,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,1232,99.84,11,c.4563A>G,p.(Leu1521=),A,G,2,1230,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,8,24,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,0.29268292,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,20
8,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906729,1118,47.14,10,c.1114A>C,p.(Asn372His),A,C,591,527,AAT,CAT,N,H,NM_000059.3,NM_000059,32906729,within,.,,rs144848,0.2494,0.2332,,0.32,0.861,,0.269,0.0,0.396,,,,,+,A,C,32906729,32906729,D514F785F1344AF9F6975E589D47BDF6,,,,,,,-1,BRCA2-  32906729,321,9329,10,,,,EMPTY,,D,,0,7,16,233635,493217,126000,,,0,0,,"1:1,2:1",,0.277,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2733,9,1,0.875,0.19512194,0.47369617,GRCh38/hg38,13,32332592,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,20
12,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32936646,827,48.37,17,c.7806-14T>C,p.(=),T,C,427,400,,,,,NM_000059.3,NM_000059,32936646,within,.,,rs9534262,0.5316,0.5202,,,,,,,,,,,,+,T,C,32936646,32936646,5803939D8FBB75B042260991F0A62436,,,,,,,-1,BRCA2-  32936646,0,126158,17,,,,EMPTY,,D,,0,5,18,361616,493217,126000,,,0,0,,1:3,,0.52,14,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5255,16,1,0.625,0.2195122,0.7331783,GRCh38/hg38,13,32362509,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,20
13,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32953388,1436,49.23,22,c.8755-66T>C,p.(=),T,C,729,707,,,,,NM_000059.3,NM_000059,32953388,within,.,,rs4942486,0.5116,,,,,,,,,,,,,+,T,C,32953388,32953388,97C65B85894EB489F1BFA65897685241,,,,,,,-1,BRCA2-  32953388,0,126190,22,,,,EMPTY,,D,,0,6,19,347826,493217,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5257,21,1,0.75,0.23170732,0.70521903,GRCh38/hg38,13,32379251,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,20
1,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32903685,1156,53.63,8,c.681+56C>T,p.(=),C,T,536,620,,,,,NM_000059.3,NM_000059,32903685,within,.,,rs2126042,0.1859,,,,,,,,,,,,,+,C,T,32903685,32903685,E9AEF840574909F4761D4EF7950E02CB,,,,,,,-1,BRCA2-  32903685,0,126192,8,,,,EMPTY,,D,,0,5,8,145186,493217,126000,,,0,0,,4:1,,,56,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2163,7,1,0.625,0.09756097,0.29436535,GRCh38/hg38,13,32329548,C,T,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,21
7,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906729,728,47.53,10,c.1114A>C,p.(Asn372His),A,C,382,346,AAT,CAT,N,H,NM_000059.3,NM_000059,32906729,within,.,,rs144848,0.2494,0.2332,,0.32,0.861,,0.269,0.0,0.396,,,,,+,A,C,32906729,32906729,D514F785F1344AF9F6975E589D47BDF6,,,,,,,-1,BRCA2-  32906729,321,9329,10,,,,EMPTY,,D,,0,7,16,233635,493217,126000,,,0,0,,"1:1,2:1",,0.277,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2733,9,1,0.875,0.19512194,0.47369617,GRCh38/hg38,13,32332592,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,21
9,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,1477,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,1477,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,8,24,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,0.29268292,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,21
8,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,847,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,847,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,8,24,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,0.29268292,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,21
12,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32953388,902,54.1,22,c.8755-66T>C,p.(=),T,C,414,488,,,,,NM_000059.3,NM_000059,32953388,within,.,,rs4942486,0.5116,,,,,,,,,,,,,+,T,C,32953388,32953388,97C65B85894EB489F1BFA65897685241,,,,,,,-1,BRCA2-  32953388,0,126190,22,,,,EMPTY,,D,,0,6,19,347826,493217,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5257,21,1,0.75,0.23170732,0.70521903,GRCh38/hg38,13,32379251,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,21
10,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,432,99.77,14,c.7397T>C,p.(Val2466Ala),T,C,1,431,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,7,23,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,0.875,0.2804878,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,21
11,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32936646,455,50.11,17,c.7806-14T>C,p.(=),T,C,227,228,,,,,NM_000059.3,NM_000059,32936646,within,.,,rs9534262,0.5316,0.5202,,,,,,,,,,,,+,T,C,32936646,32936646,5803939D8FBB75B042260991F0A62436,,,,,,,-1,BRCA2-  32936646,0,126158,17,,,,EMPTY,,D,,0,5,18,361616,493217,126000,,,0,0,,1:3,,0.52,14,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5255,16,1,0.625,0.2195122,0.7331783,GRCh38/hg38,13,32362509,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,21
4,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41251931,823,53.95,7,c.442-34C>T,p.(=),G,A,379,444,,,,,NM_007294.3,NM_007294,41251931,within,.,,rs799923,0.0986,0.1757,,,,,,,,,,,,-,G,A,41251931,41251931,A5CCEFE1E7B19A106A59AB89C8776C53,,,,,,,-1,BRCA1- 458748069,0,125864,8,,,,EMPTY,,D,,0,1,6,181678,492662,126000,,,0,0,,,,0.174,34,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.1711,6,1,0.125,0.07317073,0.36876804,GRCh38/hg38,17,43099914,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,22
10,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,1463,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,1463,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,8,24,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,0.29268292,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,22
1,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32903685,1176,51.02,8,c.681+56C>T,p.(=),C,T,576,600,,,,,NM_000059.3,NM_000059,32903685,within,.,,rs2126042,0.1859,,,,,,,,,,,,,+,C,T,32903685,32903685,E9AEF840574909F4761D4EF7950E02CB,,,,,,,-1,BRCA2-  32903685,0,126192,8,,,,EMPTY,,D,,0,5,8,145186,493217,126000,,,0,0,,4:1,,,56,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2163,7,1,0.625,0.09756097,0.29436535,GRCh38/hg38,13,32329548,C,T,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,22
11,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,480,99.79,14,c.7397T>C,p.(Val2466Ala),T,C,1,479,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,7,23,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,0.875,0.2804878,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,22
9,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,670,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,670,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,8,24,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,0.29268292,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,22
8,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906729,708,47.46,10,c.1114A>C,p.(Asn372His),A,C,372,336,AAT,CAT,N,H,NM_000059.3,NM_000059,32906729,within,.,,rs144848,0.2494,0.2332,,0.32,0.861,,0.269,0.0,0.396,,,,,+,A,C,32906729,32906729,D514F785F1344AF9F6975E589D47BDF6,,,,,,,-1,BRCA2-  32906729,321,9329,10,,,,EMPTY,,D,,0,7,16,233635,493217,126000,,,0,0,,"1:1,2:1",,0.277,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2733,9,1,0.875,0.19512194,0.47369617,GRCh38/hg38,13,32332592,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,22
12,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32936646,504,49.4,17,c.7806-14T>C,p.(=),T,C,255,249,,,,,NM_000059.3,NM_000059,32936646,within,.,,rs9534262,0.5316,0.5202,,,,,,,,,,,,+,T,C,32936646,32936646,5803939D8FBB75B042260991F0A62436,,,,,,,-1,BRCA2-  32936646,0,126158,17,,,,EMPTY,,D,,0,5,18,361616,493217,126000,,,0,0,,1:3,,0.52,14,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5255,16,1,0.625,0.2195122,0.7331783,GRCh38/hg38,13,32362509,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,22
13,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32953388,837,48.51,22,c.8755-66T>C,p.(=),T,C,431,406,,,,,NM_000059.3,NM_000059,32953388,within,.,,rs4942486,0.5116,,,,,,,,,,,,,+,T,C,32953388,32953388,97C65B85894EB489F1BFA65897685241,,,,,,,-1,BRCA2-  32953388,0,126190,22,,,,EMPTY,,D,,0,6,19,347826,493217,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5257,21,1,0.75,0.23170732,0.70521903,GRCh38/hg38,13,32379251,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,22
9,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244936,742,47.71,10,c.2612C>T,p.(Pro871Leu),G,A,388,354,CCG,CTG,P,L,NM_007294.3,NM_007294,41244936,within,.,,rs799917,0.5439,0.4932,,4.247,0.0,0.0,0.999,1.0,5.04,,,,,-,G,A,41244936,41244936,A19EA255CA888CE1FE48D08CAD633F1F,,,,,,,1,BRCA1- 458755064,-1485,41812,11,,,,EMPTY,,D,,1,4,17,290862,492662,126000,(eval),,0,0,,"1:4,2:1",,0.41,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.4127,9,3,0.5,0.20731707,0.59038854,GRCh38/hg38,17,43092919,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,23
24,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219804,343,49.85,16,c.4987-92A>G,p.(=),T,C,172,171,,,,,NM_007294.3,NM_007294,41219804,within,.,,rs8176233,0.3546,,,,,,,,,,,,,-,T,C,41219804,41219804,7341B20C52FFD4B9355840FB9CB56CDA,,,,,,,-1,BRCA1- 458780196,0,125749,17,,,,EMPTY,,D,,0,4,17,225491,492662,126000,,,0,0,,,,,92,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3128,15,1,0.5,0.20731707,0.45769918,GRCh38/hg38,17,43067787,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,23
4,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41231516,305,41.31,13,c.4358-2885G>A,p.(=),C,T,179,126,,,,,NM_007294.3,NM_007294,41231516,within,.,,rs8176193,0.3534,,,,,,,,,,,,,-,C,T,41231516,41231516,7F4F80D2D005D34CEA47E4A2C561B172,,,,,,,-1,BRCA1- 458768484,0,209399,14,,,,EMPTY,,D,,0,4,17,190200,492662,126000,,,0,0,,,,,2885,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.317,12,1,0.5,0.20731707,0.3860659,GRCh38/hg38,17,43079499,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,23
11,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245466,934,51.5,10,c.2082C>T,p.(Ser694=),G,A,453,481,AGC,AGT,S,S,NM_007294.3,NM_007294,41245466,within,.,,rs1799949,0.3365,0.2957,,,,,,,,,,,,-,G,A,41245466,41245466,3364E3D252EFEDF917C74D44FBC6A381,,,,,,,-1,BRCA1- 458754534,1412,125536,11,,,,EMPTY,,D,,0,4,17,269442,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.5,0.20731707,0.54691046,GRCh38/hg38,17,43093449,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,23
23,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219780,343,49.56,16,c.4987-68A>G,p.(=),T,C,173,170,,,,,NM_007294.3,NM_007294,41219780,within,.,,rs8176234,0.3546,,,,,,,,,,,,,-,T,C,41219780,41219780,5995ECC305C33150BF3BB2B0C22FCC2A,,,,,,,-1,BRCA1- 458780220,0,125746,17,,,,EMPTY,,D,,0,4,17,234031,492662,126000,,,0,0,,,,,68,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3148,15,1,0.5,0.20731707,0.47503358,GRCh38/hg38,17,43067763,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,23
5,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41234470,187,45.45,12,c.4308T>C,p.(Ser1436=),A,G,102,85,TCT,TCC,S,S,NM_007294.3,NM_007294,41234470,within,.,,rs1060915,0.3363,0.2796,,,,,,,,,,,,-,A,G,41234470,41234470,B7237055CF1D42F022A050C072B7583B,,,,,,,-1,BRCA1- 458765530,-50,125703,13,,,,EMPTY,,D,,0,4,17,270833,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3433,11,1,0.5,0.20731707,0.5497339,GRCh38/hg38,17,43082453,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,23
8,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244435,636,44.5,10,c.3113A>G,p.(Glu1038Gly),T,C,353,283,GAA,GGA,E,G,NM_007294.3,NM_007294,41244435,within,.,,rs16941,0.3357,0.279,,-0.149,0.972,0.606,0.922,0.0,-0.974,,,,,-,T,C,41244435,41244435,5D0FF1321BAC3C76DD352C33CC33B93E,,,,,,,-1,BRCA1- 458755565,-984,41815,11,,,,EMPTY,,D,,0,4,17,270861,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,0.936,113705,-1,,,,,,,,,,,3,0.343,9,1,0.5,0.20731707,0.54979074,GRCh38/hg38,17,43092418,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,23
22,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41215825,170,48.82,17,c.5152+66G>A,p.(=),C,T,87,83,,,,,NM_007294.3,NM_007294,41215825,within,.,,rs3092994,0.3425,,,,,,,,,,,,,-,C,T,41215825,41215825,5BCA8D2E1E3875817F84A3EB582CDFAB,,,,,,,-1,BRCA1- 458784175,0,55428,18,,,,EMPTY,,D,,0,3,15,241843,492662,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3139,16,1,0.375,0.18292683,0.4908903,GRCh38/hg38,17,43063808,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,23
7,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244000,689,48.77,10,c.3548A>G,p.(Lys1183Arg),T,C,353,336,AAA,AGA,K,R,NM_007294.3,NM_007294,41244000,within,.,,rs16942,0.3526,0.2952,,-0.319,0.0,0.001,0.924,0.0,-2.35,,,,,-,T,C,41244000,41244000,37A54117EA353BDA677332A1F61FA173,,,,,,,-1,BRCA1- 458756000,-549,41818,11,,,,EMPTY,,D,,0,4,17,272437,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.5,0.20731707,0.55298966,GRCh38/hg38,17,43091983,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,23
10,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245237,223,48.43,10,c.2311T>C,p.(Leu771=),A,G,115,108,TTG,CTG,L,L,NM_007294.3,NM_007294,41245237,within,.,,rs16940,0.3353,0.2776,,,,,,,,,,,,-,A,G,41245237,41245237,711AF22D84A49E875C2B2A9597A95EE6,,,,,,,-1,BRCA1- 458754763,1641,125554,11,,,,EMPTY,,D,,0,3,16,269517,492662,126000,,,0,0,,1:1,,0.342,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3422,9,1,0.375,0.19512194,0.5470627,GRCh38/hg38,17,43093220,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,23
3,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41223094,578,43.6,15,c.4837A>G,p.(Ser1613Gly),T,C,326,252,AGT,GGT,S,G,NM_007294.3,NM_007294,41223094,within,.,,rs1799966,0.3558,0.2982,,-0.194,0.968,0.038,0.814,0.0,1.5,,,,,-,T,C,41223094,41223094,E3C52286D31F229973DB3595B052645F,,,,,,,-1,BRCA1- 458776906,-150,41827,16,,,,EMPTY,,D,,0,4,17,273625,492662,126000,,,0,0,,1:1,,0.349,0,,,,,,,,,,,,,,Benign,Benign,0.255,113705,-1,,,,,,,,,,,3,0.35,14,1,0.5,0.20731707,0.5554011,GRCh38/hg38,17,43071077,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,23
20,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32930598,253,54.15,15,c.7469T>C,p.(Ile2490Thr),T,C,116,137,ATA,ACA,I,T,NM_000059.3,NM_000059,32930598,within,.,,rs11571707,0.016,0.0016,,0.406,0.895,,0.837,0.0,-5.83,,,,,+,T,C,32930598,32930598,D7CAF30A58440FCA5E8E7BACD8E1EDE4,,,,,,,-1,BRCA2-  32930598,34,96852,15,,,,EMPTY,,D,,0,2,7,6837,493217,126000,,,0,0,,"1:5,2:2",,0.014,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0176,14,2,0.25,0.085365854,0.013862053,GRCh38/hg38,13,32356461,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,23
19,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,188,100.0,14,c.7397T>C,p.(Val2466Ala),T,C,0,188,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,7,23,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,0.875,0.2804878,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,23
12,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,502,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,502,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,8,24,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,0.29268292,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,23
18,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,793,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,793,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,8,24,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,0.29268292,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,23
1,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906729,313,100.0,10,c.1114A>C,p.(Asn372His),A,C,0,313,AAT,CAT,N,H,NM_000059.3,NM_000059,32906729,within,.,,rs144848,0.2494,0.2332,,0.32,0.861,,0.269,0.0,0.396,,,,,+,A,C,32906729,32906729,D514F785F1344AF9F6975E589D47BDF6,,,,,,,-1,BRCA2-  32906729,321,9329,10,,,,EMPTY,,D,,0,7,16,233635,493217,126000,,,0,0,,"1:1,2:1",,0.277,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2733,9,1,0.875,0.19512194,0.47369617,GRCh38/hg38,13,32332592,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,23
23,A,BRCA2,220160,INDEL,frameshift,GRCh37/hg19,13,32913229,847,46.04,11,c.4740_4741dup,p.(Glu1581Valfs*37),A,ATG,456,390,GAG,GTGAGACCATTGAGATCACAGCTGCCCCAAAGTGTAAAGAAATGCAGAATTCTCTCAATAATGATAAAAACCTTGTTTCTATTGAGACTGTGGTGCCACCTAAGCTCTTAA,E,VRPLRSQLPQSVKKCRILSIMIKTLFLLRLWCHLSS*,NM_000059.3,NM_000059,32913229,within,.,,rs864622401,,,,,,,,,,,,,,+,-,TG,32913233,32913234,0E076D63896EAAA67881BF4DED3D9821,,1,,,,,-1,BRCA2-  32913229,-2101,220160,11,,,,EMPTY,,A,,1,1,1,7,493217,126000,,,0,0,,5:1,,,0,,,,,,,,,,,,,,Pathogenic,Pathogenic,,600185,-1,,,,,,,,,,,3,,10,5,0.125,0.0121951215,1.4192536E-5,GRCh38/hg38,13,32339092,A,ATG,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,24
13,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244936,1265,49.09,10,c.2612C>T,p.(Pro871Leu),G,A,643,621,CCG,CTG,P,L,NM_007294.3,NM_007294,41244936,within,.,,rs799917,0.5439,0.4932,,4.247,0.0,0.0,0.999,1.0,5.04,,,,,-,G,A,41244936,41244936,A19EA255CA888CE1FE48D08CAD633F1F,,,,,,,1,BRCA1- 458755064,-1485,41812,11,,,,EMPTY,,D,,1,4,17,290862,492662,126000,(eval),,0,0,,"1:4,2:1",,0.41,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.4127,9,3,0.5,0.20731707,0.59038854,GRCh38/hg38,17,43092919,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,24
10,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244000,1509,51.36,10,c.3548A>G,p.(Lys1183Arg),T,C,733,775,AAA,AGA,K,R,NM_007294.3,NM_007294,41244000,within,.,,rs16942,0.3526,0.2952,,-0.319,0.0,0.001,0.924,0.0,-2.35,,,,,-,T,C,41244000,41244000,37A54117EA353BDA677332A1F61FA173,,,,,,,-1,BRCA1- 458756000,-549,41818,11,,,,EMPTY,,D,,0,4,17,272437,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.5,0.20731707,0.55298966,GRCh38/hg38,17,43091983,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,24
8,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41234470,288,43.4,12,c.4308T>C,p.(Ser1436=),A,G,163,125,TCT,TCC,S,S,NM_007294.3,NM_007294,41234470,within,.,,rs1060915,0.3363,0.2796,,,,,,,,,,,,-,A,G,41234470,41234470,B7237055CF1D42F022A050C072B7583B,,,,,,,-1,BRCA1- 458765530,-50,125703,13,,,,EMPTY,,D,,0,4,17,270833,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3433,11,1,0.5,0.20731707,0.5497339,GRCh38/hg38,17,43082453,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,24
7,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41231516,405,44.2,13,c.4358-2885G>A,p.(=),C,T,226,179,,,,,NM_007294.3,NM_007294,41231516,within,.,,rs8176193,0.3534,,,,,,,,,,,,,-,C,T,41231516,41231516,7F4F80D2D005D34CEA47E4A2C561B172,,,,,,,-1,BRCA1- 458768484,0,209399,14,,,,EMPTY,,D,,0,4,17,190200,492662,126000,,,0,0,,,,,2885,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.317,12,1,0.5,0.20731707,0.3860659,GRCh38/hg38,17,43079499,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,24
11,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244435,1337,50.64,10,c.3113A>G,p.(Glu1038Gly),T,C,660,677,GAA,GGA,E,G,NM_007294.3,NM_007294,41244435,within,.,,rs16941,0.3357,0.279,,-0.149,0.972,0.606,0.922,0.0,-0.974,,,,,-,T,C,41244435,41244435,5D0FF1321BAC3C76DD352C33CC33B93E,,,,,,,-1,BRCA1- 458755565,-984,41815,11,,,,EMPTY,,D,,0,4,17,270861,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,0.936,113705,-1,,,,,,,,,,,3,0.343,9,1,0.5,0.20731707,0.54979074,GRCh38/hg38,17,43092418,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,24
14,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245237,640,48.44,10,c.2311T>C,p.(Leu771=),A,G,330,310,TTG,CTG,L,L,NM_007294.3,NM_007294,41245237,within,.,,rs16940,0.3353,0.2776,,,,,,,,,,,,-,A,G,41245237,41245237,711AF22D84A49E875C2B2A9597A95EE6,,,,,,,-1,BRCA1- 458754763,1641,125554,11,,,,EMPTY,,D,,0,3,16,269517,492662,126000,,,0,0,,1:1,,0.342,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3422,9,1,0.375,0.19512194,0.5470627,GRCh38/hg38,17,43093220,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,24
2,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41215825,346,51.45,17,c.5152+66G>A,p.(=),C,T,168,178,,,,,NM_007294.3,NM_007294,41215825,within,.,,rs3092994,0.3425,,,,,,,,,,,,,-,C,T,41215825,41215825,5BCA8D2E1E3875817F84A3EB582CDFAB,,,,,,,-1,BRCA1- 458784175,0,55428,18,,,,EMPTY,,D,,0,3,15,241843,492662,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3139,16,1,0.375,0.18292683,0.4908903,GRCh38/hg38,17,43063808,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,24
4,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219804,547,47.17,16,c.4987-92A>G,p.(=),T,C,289,258,,,,,NM_007294.3,NM_007294,41219804,within,.,,rs8176233,0.3546,,,,,,,,,,,,,-,T,C,41219804,41219804,7341B20C52FFD4B9355840FB9CB56CDA,,,,,,,-1,BRCA1- 458780196,0,125749,17,,,,EMPTY,,D,,0,4,17,225491,492662,126000,,,0,0,,,,,92,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3128,15,1,0.5,0.20731707,0.45769918,GRCh38/hg38,17,43067787,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,24
3,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219780,545,47.16,16,c.4987-68A>G,p.(=),T,C,288,257,,,,,NM_007294.3,NM_007294,41219780,within,.,,rs8176234,0.3546,,,,,,,,,,,,,-,T,C,41219780,41219780,5995ECC305C33150BF3BB2B0C22FCC2A,,,,,,,-1,BRCA1- 458780220,0,125746,17,,,,EMPTY,,D,,0,4,17,234031,492662,126000,,,0,0,,,,,68,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3148,15,1,0.5,0.20731707,0.47503358,GRCh38/hg38,17,43067763,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,24
6,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41223094,1053,53.47,15,c.4837A>G,p.(Ser1613Gly),T,C,490,563,AGT,GGT,S,G,NM_007294.3,NM_007294,41223094,within,.,,rs1799966,0.3558,0.2982,,-0.194,0.968,0.038,0.814,0.0,1.5,,,,,-,T,C,41223094,41223094,E3C52286D31F229973DB3595B052645F,,,,,,,-1,BRCA1- 458776906,-150,41827,16,,,,EMPTY,,D,,0,4,17,273625,492662,126000,,,0,0,,1:1,,0.349,0,,,,,,,,,,,,,,Benign,Benign,0.255,113705,-1,,,,,,,,,,,3,0.35,14,1,0.5,0.20731707,0.5554011,GRCh38/hg38,17,43071077,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,24
15,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245466,1944,50.36,10,c.2082C>T,p.(Ser694=),G,A,965,979,AGC,AGT,S,S,NM_007294.3,NM_007294,41245466,within,.,,rs1799949,0.3365,0.2957,,,,,,,,,,,,-,G,A,41245466,41245466,3364E3D252EFEDF917C74D44FBC6A381,,,,,,,-1,BRCA1- 458754534,1412,125536,11,,,,EMPTY,,D,,0,4,17,269442,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.5,0.20731707,0.54691046,GRCh38/hg38,17,43093449,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,24
12,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906729,421,52.49,10,c.1114A>C,p.(Asn372His),A,C,200,221,AAT,CAT,N,H,NM_000059.3,NM_000059,32906729,within,.,,rs144848,0.2494,0.2332,,0.32,0.861,,0.269,0.0,0.396,,,,,+,A,C,32906729,32906729,D514F785F1344AF9F6975E589D47BDF6,,,,,,,-1,BRCA2-  32906729,321,9329,10,,,,EMPTY,,D,,0,7,16,233635,493217,126000,,,0,0,,"1:1,2:1",,0.277,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2733,9,1,0.875,0.19512194,0.47369617,GRCh38/hg38,13,32332592,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,24
24,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,1332,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,1332,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,8,24,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,0.29268292,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,24
22,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,994,99.9,11,c.4563A>G,p.(Leu1521=),A,G,1,993,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,8,24,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,0.29268292,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,24
25,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,463,100.0,14,c.7397T>C,p.(Val2466Ala),T,C,0,463,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,7,23,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,0.875,0.2804878,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,24
21,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32912299,600,46.0,11,c.3807T>C,p.(Val1269=),T,C,324,276,GTT,GTC,V,V,NM_000059.3,NM_000059,32912299,within,.,,rs543304,0.1681,0.1911,,,,,,,,,,,,+,T,C,32912299,32912299,F2D3E8FFB3CEE8C1ACEA66738E41BC1E,,,,,,,-1,BRCA2-  32912299,1898,126022,11,,,,EMPTY,,D,,0,1,7,173719,493217,126000,,,0,0,,1:3,,0.176,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.1754,10,1,0.125,0.085365854,0.35221615,GRCh38/hg38,13,32338162,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,24
1,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32903685,995,53.27,8,c.681+56C>T,p.(=),C,T,465,530,,,,,NM_000059.3,NM_000059,32903685,within,.,,rs2126042,0.1859,,,,,,,,,,,,,+,C,T,32903685,32903685,E9AEF840574909F4761D4EF7950E02CB,,,,,,,-1,BRCA2-  32903685,0,126192,8,,,,EMPTY,,D,,0,5,8,145186,493217,126000,,,0,0,,4:1,,,56,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2163,7,1,0.625,0.09756097,0.29436535,GRCh38/hg38,13,32329548,C,T,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,25
7,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,386,99.48,14,c.7397T>C,p.(Val2466Ala),T,C,2,384,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,7,23,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,0.875,0.2804878,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,25
4,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906729,568,51.41,10,c.1114A>C,p.(Asn372His),A,C,276,292,AAT,CAT,N,H,NM_000059.3,NM_000059,32906729,within,.,,rs144848,0.2494,0.2332,,0.32,0.861,,0.269,0.0,0.396,,,,,+,A,C,32906729,32906729,D514F785F1344AF9F6975E589D47BDF6,,,,,,,-1,BRCA2-  32906729,321,9329,10,,,,EMPTY,,D,,0,7,16,233635,493217,126000,,,0,0,,"1:1,2:1",,0.277,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2733,9,1,0.875,0.19512194,0.47369617,GRCh38/hg38,13,32332592,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,25
8,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32936646,488,52.05,17,c.7806-14T>C,p.(=),T,C,234,254,,,,,NM_000059.3,NM_000059,32936646,within,.,,rs9534262,0.5316,0.5202,,,,,,,,,,,,+,T,C,32936646,32936646,5803939D8FBB75B042260991F0A62436,,,,,,,-1,BRCA2-  32936646,0,126158,17,,,,EMPTY,,D,,0,5,18,361616,493217,126000,,,0,0,,1:3,,0.52,14,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5255,16,1,0.625,0.2195122,0.7331783,GRCh38/hg38,13,32362509,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,25
5,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,600,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,600,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,8,24,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,0.29268292,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,25
9,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32953388,590,47.97,22,c.8755-66T>C,p.(=),T,C,307,283,,,,,NM_000059.3,NM_000059,32953388,within,.,,rs4942486,0.5116,,,,,,,,,,,,,+,T,C,32953388,32953388,97C65B85894EB489F1BFA65897685241,,,,,,,-1,BRCA2-  32953388,0,126190,22,,,,EMPTY,,D,,0,6,19,347826,493217,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5257,21,1,0.75,0.23170732,0.70521903,GRCh38/hg38,13,32379251,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,25
6,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,1188,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,1188,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,8,24,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,0.29268292,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,25
22,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244936,1214,50.58,10,c.2612C>T,p.(Pro871Leu),G,A,600,614,CCG,CTG,P,L,NM_007294.3,NM_007294,41244936,within,.,,rs799917,0.5439,0.4932,,4.247,0.0,0.0,0.999,1.0,5.04,,,,,-,G,A,41244936,41244936,A19EA255CA888CE1FE48D08CAD633F1F,,,,,,,1,BRCA1- 458755064,-1485,41812,11,,,,EMPTY,,D,,1,12,29,290862,492662,126000,(eval),,0,0,,"1:4,2:1",,0.41,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.4127,9,3,0.75,0.35365853,0.59038854,GRCh38/hg38,17,43092919,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,26
25,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245466,1708,50.29,10,c.2082C>T,p.(Ser694=),G,A,849,859,AGC,AGT,S,S,NM_007294.3,NM_007294,41245466,within,.,,rs1799949,0.3365,0.2957,,,,,,,,,,,,-,G,A,41245466,41245466,3364E3D252EFEDF917C74D44FBC6A381,,,,,,,-1,BRCA1- 458754534,1412,125536,11,,,,EMPTY,,D,,0,12,29,269442,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.75,0.35365853,0.54691046,GRCh38/hg38,17,43093449,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,26
18,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41234470,431,53.13,12,c.4308T>C,p.(Ser1436=),A,G,202,229,TCT,TCC,S,S,NM_007294.3,NM_007294,41234470,within,.,,rs1060915,0.3363,0.2796,,,,,,,,,,,,-,A,G,41234470,41234470,B7237055CF1D42F022A050C072B7583B,,,,,,,-1,BRCA1- 458765530,-50,125703,13,,,,EMPTY,,D,,0,12,29,270833,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3433,11,1,0.75,0.35365853,0.5497339,GRCh38/hg38,17,43082453,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,26
11,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41215825,211,47.39,17,c.5152+66G>A,p.(=),C,T,111,100,,,,,NM_007294.3,NM_007294,41215825,within,.,,rs3092994,0.3425,,,,,,,,,,,,,-,C,T,41215825,41215825,5BCA8D2E1E3875817F84A3EB582CDFAB,,,,,,,-1,BRCA1- 458784175,0,55428,18,,,,EMPTY,,D,,0,9,24,241843,492662,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3139,16,1,0.5625,0.29268292,0.4908903,GRCh38/hg38,17,43063808,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,26
14,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219804,743,46.7,16,c.4987-92A>G,p.(=),T,C,396,347,,,,,NM_007294.3,NM_007294,41219804,within,.,,rs8176233,0.3546,,,,,,,,,,,,,-,T,C,41219804,41219804,7341B20C52FFD4B9355840FB9CB56CDA,,,,,,,-1,BRCA1- 458780196,0,125749,17,,,,EMPTY,,D,,0,12,29,225491,492662,126000,,,0,0,,,,,92,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3128,15,1,0.75,0.35365853,0.45769918,GRCh38/hg38,17,43067787,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,26
20,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244000,1339,50.34,10,c.3548A>G,p.(Lys1183Arg),T,C,665,674,AAA,AGA,K,R,NM_007294.3,NM_007294,41244000,within,.,,rs16942,0.3526,0.2952,,-0.319,0.0,0.001,0.924,0.0,-2.35,,,,,-,T,C,41244000,41244000,37A54117EA353BDA677332A1F61FA173,,,,,,,-1,BRCA1- 458756000,-549,41818,11,,,,EMPTY,,D,,0,12,29,272437,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.75,0.35365853,0.55298966,GRCh38/hg38,17,43091983,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,26
24,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245237,316,55.7,10,c.2311T>C,p.(Leu771=),A,G,140,176,TTG,CTG,L,L,NM_007294.3,NM_007294,41245237,within,.,,rs16940,0.3353,0.2776,,,,,,,,,,,,-,A,G,41245237,41245237,711AF22D84A49E875C2B2A9597A95EE6,,,,,,,-1,BRCA1- 458754763,1641,125554,11,,,,EMPTY,,D,,0,12,28,269517,492662,126000,,,0,0,,1:1,,0.342,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3422,9,1,0.75,0.34146342,0.5470627,GRCh38/hg38,17,43093220,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,26
27,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41251931,527,50.66,7,c.442-34C>T,p.(=),G,A,260,267,,,,,NM_007294.3,NM_007294,41251931,within,.,,rs799923,0.0986,0.1757,,,,,,,,,,,,-,G,A,41251931,41251931,A5CCEFE1E7B19A106A59AB89C8776C53,,,,,,,-1,BRCA1- 458748069,0,125864,8,,,,EMPTY,,D,,0,3,9,181678,492662,126000,,,0,0,,,,0.174,34,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.1711,6,1,0.1875,0.1097561,0.36876804,GRCh38/hg38,17,43099914,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,26
13,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219780,742,46.77,16,c.4987-68A>G,p.(=),T,C,395,347,,,,,NM_007294.3,NM_007294,41219780,within,.,,rs8176234,0.3546,,,,,,,,,,,,,-,T,C,41219780,41219780,5995ECC305C33150BF3BB2B0C22FCC2A,,,,,,,-1,BRCA1- 458780220,0,125746,17,,,,EMPTY,,D,,0,12,29,234031,492662,126000,,,0,0,,,,,68,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3148,15,1,0.75,0.35365853,0.47503358,GRCh38/hg38,17,43067763,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,26
17,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41231516,734,51.63,13,c.4358-2885G>A,p.(=),C,T,355,379,,,,,NM_007294.3,NM_007294,41231516,within,.,,rs8176193,0.3534,,,,,,,,,,,,,-,C,T,41231516,41231516,7F4F80D2D005D34CEA47E4A2C561B172,,,,,,,-1,BRCA1- 458768484,0,209399,14,,,,EMPTY,,D,,0,12,29,190200,492662,126000,,,0,0,,,,,2885,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.317,12,1,0.75,0.35365853,0.3860659,GRCh38/hg38,17,43079499,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,26
21,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244435,1056,51.23,10,c.3113A>G,p.(Glu1038Gly),T,C,515,541,GAA,GGA,E,G,NM_007294.3,NM_007294,41244435,within,.,,rs16941,0.3357,0.279,,-0.149,0.972,0.606,0.922,0.0,-0.974,,,,,-,T,C,41244435,41244435,5D0FF1321BAC3C76DD352C33CC33B93E,,,,,,,-1,BRCA1- 458755565,-984,41815,11,,,,EMPTY,,D,,0,12,29,270861,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,0.936,113705,-1,,,,,,,,,,,3,0.343,9,1,0.75,0.35365853,0.54979074,GRCh38/hg38,17,43092418,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,26
16,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41223094,908,50.66,15,c.4837A>G,p.(Ser1613Gly),T,C,448,460,AGT,GGT,S,G,NM_007294.3,NM_007294,41223094,within,.,,rs1799966,0.3558,0.2982,,-0.194,0.968,0.038,0.814,0.0,1.5,,,,,-,T,C,41223094,41223094,E3C52286D31F229973DB3595B052645F,,,,,,,-1,BRCA1- 458776906,-150,41827,16,,,,EMPTY,,D,,0,12,29,273625,492662,126000,,,0,0,,1:1,,0.349,0,,,,,,,,,,,,,,Benign,Benign,0.255,113705,-1,,,,,,,,,,,3,0.35,14,1,0.75,0.35365853,0.5554011,GRCh38/hg38,17,43071077,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,26
35,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32911463,418,48.09,11,c.2971A>G,p.(Asn991Asp),A,G,217,201,AAC,GAC,N,D,NM_000059.3,NM_000059,32911463,within,.,,rs1799944,0.0801,0.0373,,-0.04,0.0,,0.959,0.0,3.08,,,,,+,A,G,32911463,32911463,36F4F7E6CD788E45B30EA486775D07D6,,,,,,,-1,BRCA2-  32911463,1062,41545,11,,,,EMPTY,,D,,0,4,8,42142,493217,126000,,,0,0,,1:2,,0.053,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0522,10,1,0.25,0.09756097,0.085443124,GRCh38/hg38,13,32337326,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,26
12,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32899388,266,51.88,4,c.425+67A>C,p.(=),A,C,128,138,,,,,NM_000059.3,NM_000059,32899388,within,.,,rs11571610,0.0743,,,,,,,,,,,,,+,A,C,32899388,32899388,1AF346DE380A738371905EBFBCED20E1,,,,,,,-1,BRCA2-  32899388,0,126095,4,,,,EMPTY,,D,,0,4,8,39349,493217,126000,,,0,0,,2:1,,,67,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0306,3,3,0.25,0.09756097,0.0797803,GRCh38/hg38,13,32325251,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,26
1,D,BRCA2,,SNP,5'UTR,GRCh37/hg19,13,32890572,1196,53.68,2,c.-26G>A,p.(=),G,A,554,642,,,,,NM_000059.3,NM_000059,32890572,within,.,,rs1799943,0.2093,0.2088,,,,,,,,,,,,+,G,A,32890572,32890572,A9C2B39455EF056EDB097A5953EB72EE,,,,,,,-1,BRCA2-  32890572,14,125965,2,,,,EMPTY,,D,,0,8,16,205902,493217,126000,,,0,0,,,,0.243,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2427,1,1,0.5,0.19512194,0.41746736,GRCh38/hg38,13,32316435,G,A,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,26
32,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906480,637,47.25,10,c.865A>C,p.(Asn289His),A,C,336,301,AAT,CAT,N,H,NM_000059.3,NM_000059,32906480,within,.,,rs766173,0.0737,0.0312,,0.498,0.998,,0.803,0.0,1.73,,,,,+,A,C,32906480,32906480,EE0CD2A1633CE9FEF0978528634002FE,,,,,,,-1,BRCA2-  32906480,72,41567,10,,,,EMPTY,,D,,0,4,8,41272,493217,126000,,,0,0,,"1:4,2:1",,0.051,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0496,9,2,0.25,0.09756097,0.08367919,GRCh38/hg38,13,32332343,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,26
8,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32953388,861,100.0,22,c.8755-66T>C,p.(=),T,C,0,861,,,,,NM_000059.3,NM_000059,32953388,within,.,,rs4942486,0.5116,,,,,,,,,,,,,+,T,C,32953388,32953388,97C65B85894EB489F1BFA65897685241,,,,,,,-1,BRCA2-  32953388,0,126190,22,,,,EMPTY,,D,,0,11,30,347826,493217,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5257,21,1,0.6875,0.36585367,0.70521903,GRCh38/hg38,13,32379251,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,26
9,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32953550,589,51.78,22,c.8851G>A,p.(Ala2951Thr),G,A,284,305,GCC,ACC,A,T,NM_000059.3,NM_000059,32953550,within,.,,rs11571769,0.01,0.0044,,7.914,1.0,,1.0,1.0,5.6,,,,,+,G,A,32953550,32953550,D3D6E2E00CDC932E43B7A97E2FA9A9A6,,,,,,,-1,BRCA2-  32953550,97,41570,22,,,,EMPTY,,D,,0,2,3,7101,493217,126000,,,0,0,,"1:8,2:1",,0.0078,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0089,21,3,0.125,0.036585364,0.014397314,GRCh38/hg38,13,32379413,G,A,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,26
33,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32906980,1150,51.48,10,c.1365A>G,p.(Ser455=),A,G,558,592,TCA,TCG,S,S,NM_000059.3,NM_000059,32906980,within,.,,rs1801439,0.0737,0.031,,,,,,,,,,,,+,A,G,32906980,32906980,C76C22E555E869928B452D866988AB4F,,,,,,,-1,BRCA2-  32906980,-545,125943,10,,,,EMPTY,,D,,0,4,8,41480,493217,126000,,,0,0,,"1:4,2:1",,0.051,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0499,9,2,0.25,0.09756097,0.08410091,GRCh38/hg38,13,32332843,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,26
2,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32914236,730,48.63,11,c.5744C>T,p.(Thr1915Met),C,T,375,355,ACG,ATG,T,M,NM_000059.3,NM_000059,32914236,within,.,,rs4987117,0.0086,0.0211,,-1.105,0.674,,0.286,0.0,0.623,,,,,+,C,T,32914236,32914236,9B18380606AE96F8022F8AB5893BFD77,,,,,,,-1,BRCA2-  32914236,-1098,41556,11,,,,EMPTY,,D,,0,3,4,22222,493217,126000,,,0,0,,"1:4,2:1",,0.018,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0179,10,2,0.1875,0.048780486,0.045055218,GRCh38/hg38,13,32340099,C,T,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,26
5,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,236,100.0,14,c.7397T>C,p.(Val2466Ala),T,C,0,236,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,16,39,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.47560975,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,26
37,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,572,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,572,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,16,40,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,0.4878049,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,26
3,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,1250,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,1250,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,16,40,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,0.4878049,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,26
36,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32911888,1064,49.91,11,c.3396A>G,p.(Lys1132=),A,G,533,531,AAA,AAG,K,K,NM_000059.3,NM_000059,32911888,within,.,,rs1801406,0.2668,0.2798,,,,,,,,,,,,+,A,G,32911888,32911888,94F2C0D328C28C466A38A430BBE75D52,,,,,,,-1,BRCA2-  32911888,1487,126010,11,,,,EMPTY,,D,,0,8,16,248687,493217,126000,,,0,0,,1:3,,0.293,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.295,10,1,0.5,0.19512194,0.50421417,GRCh38/hg38,13,32337751,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,26
34,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32910721,1175,53.62,11,c.2229T>C,p.(His743=),T,C,545,630,CAT,CAC,H,H,NM_000059.3,NM_000059,32910721,within,.,,rs1801499,0.0735,0.0313,,,,,,,,,,,,+,T,C,32910721,32910721,D39471F16FE6D1F6752C2D4D179996AF,,,,,,,-1,BRCA2-  32910721,320,125979,11,,,,EMPTY,,D,,0,4,8,41536,493217,126000,,,0,0,,1:1,,0.052,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0503,10,1,0.25,0.09756097,0.08421446,GRCh38/hg38,13,32336584,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,26
7,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32936646,307,100.0,17,c.7806-14T>C,p.(=),T,C,0,307,,,,,NM_000059.3,NM_000059,32936646,within,.,,rs9534262,0.5316,0.5202,,,,,,,,,,,,+,T,C,32936646,32936646,5803939D8FBB75B042260991F0A62436,,,,,,,-1,BRCA2-  32936646,0,126158,17,,,,EMPTY,,D,,0,11,29,361616,493217,126000,,,0,0,,1:3,,0.52,14,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5255,16,1,0.6875,0.35365853,0.7331783,GRCh38/hg38,13,32362509,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,26
6,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32929478,638,57.84,14,c.7435+53C>T,p.(=),C,T,269,369,,,,,NM_000059.3,NM_000059,32929478,within,.,,rs11147489,0.0725,,,,,,,,,,,,,+,C,T,32929478,32929478,F692B4BE5DCD39FA887FE8D63D296720,,,,,,,-1,BRCA2-  32929478,0,126136,14,,,,EMPTY,,D,,0,4,8,36369,493217,126000,,,0,0,,,,,53,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0301,13,3,0.25,0.09756097,0.07373834,GRCh38/hg38,13,32355341,C,T,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,26
4,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32929232,476,46.43,14,c.7242A>G,p.(Ser2414=),A,G,255,221,TCA,TCG,S,S,NM_000059.3,NM_000059,32929232,within,.,,rs1799955,0.2326,0.2114,,,,,,,,,,,,+,A,G,32929232,32929232,6F8D6FF8BC9027D6C0351ADCEF41FD20,,,,,,,-1,BRCA2-  32929232,-194,126133,14,,,,EMPTY,,D,,0,8,16,192923,493217,126000,,,0,0,,"1:3,2:1",,0.224,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2257,13,1,0.5,0.19512194,0.39115238,GRCh38/hg38,13,32355095,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,26
17,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244936,468,51.07,10,c.2612C>T,p.(Pro871Leu),G,A,229,239,CCG,CTG,P,L,NM_007294.3,NM_007294,41244936,within,.,,rs799917,0.5439,0.4932,,4.247,0.0,0.0,0.999,1.0,5.04,,,,,-,G,A,41244936,41244936,A19EA255CA888CE1FE48D08CAD633F1F,,,,,,,1,BRCA1- 458755064,-1485,41812,11,,,,EMPTY,,D,,1,12,29,290862,492662,126000,(eval),,0,0,,"1:4,2:1",,0.41,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.4127,9,3,0.75,0.35365853,0.59038854,GRCh38/hg38,17,43092919,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,27
9,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219804,332,48.19,16,c.4987-92A>G,p.(=),T,C,172,160,,,,,NM_007294.3,NM_007294,41219804,within,.,,rs8176233,0.3546,,,,,,,,,,,,,-,T,C,41219804,41219804,7341B20C52FFD4B9355840FB9CB56CDA,,,,,,,-1,BRCA1- 458780196,0,125749,17,,,,EMPTY,,D,,0,12,29,225491,492662,126000,,,0,0,,,,,92,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3128,15,1,0.75,0.35365853,0.45769918,GRCh38/hg38,17,43067787,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,27
11,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41223094,458,46.94,15,c.4837A>G,p.(Ser1613Gly),T,C,243,215,AGT,GGT,S,G,NM_007294.3,NM_007294,41223094,within,.,,rs1799966,0.3558,0.2982,,-0.194,0.968,0.038,0.814,0.0,1.5,,,,,-,T,C,41223094,41223094,E3C52286D31F229973DB3595B052645F,,,,,,,-1,BRCA1- 458776906,-150,41827,16,,,,EMPTY,,D,,0,12,29,273625,492662,126000,,,0,0,,1:1,,0.349,0,,,,,,,,,,,,,,Benign,Benign,0.255,113705,-1,,,,,,,,,,,3,0.35,14,1,0.75,0.35365853,0.5554011,GRCh38/hg38,17,43071077,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,27
13,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41231516,196,50.0,13,c.4358-2885G>A,p.(=),C,T,98,98,,,,,NM_007294.3,NM_007294,41231516,within,.,,rs8176193,0.3534,,,,,,,,,,,,,-,C,T,41231516,41231516,7F4F80D2D005D34CEA47E4A2C561B172,,,,,,,-1,BRCA1- 458768484,0,209399,14,,,,EMPTY,,D,,0,12,29,190200,492662,126000,,,0,0,,,,,2885,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.317,12,1,0.75,0.35365853,0.3860659,GRCh38/hg38,17,43079499,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,27
15,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244000,618,49.84,10,c.3548A>G,p.(Lys1183Arg),T,C,310,308,AAA,AGA,K,R,NM_007294.3,NM_007294,41244000,within,.,,rs16942,0.3526,0.2952,,-0.319,0.0,0.001,0.924,0.0,-2.35,,,,,-,T,C,41244000,41244000,37A54117EA353BDA677332A1F61FA173,,,,,,,-1,BRCA1- 458756000,-549,41818,11,,,,EMPTY,,D,,0,12,29,272437,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.75,0.35365853,0.55298966,GRCh38/hg38,17,43091983,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,27
14,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41234470,187,54.01,12,c.4308T>C,p.(Ser1436=),A,G,86,101,TCT,TCC,S,S,NM_007294.3,NM_007294,41234470,within,.,,rs1060915,0.3363,0.2796,,,,,,,,,,,,-,A,G,41234470,41234470,B7237055CF1D42F022A050C072B7583B,,,,,,,-1,BRCA1- 458765530,-50,125703,13,,,,EMPTY,,D,,0,12,29,270833,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3433,11,1,0.75,0.35365853,0.5497339,GRCh38/hg38,17,43082453,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,27
8,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219780,332,48.19,16,c.4987-68A>G,p.(=),T,C,172,160,,,,,NM_007294.3,NM_007294,41219780,within,.,,rs8176234,0.3546,,,,,,,,,,,,,-,T,C,41219780,41219780,5995ECC305C33150BF3BB2B0C22FCC2A,,,,,,,-1,BRCA1- 458780220,0,125746,17,,,,EMPTY,,D,,0,12,29,234031,492662,126000,,,0,0,,,,,68,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3148,15,1,0.75,0.35365853,0.47503358,GRCh38/hg38,17,43067763,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,27
16,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244435,498,50.8,10,c.3113A>G,p.(Glu1038Gly),T,C,245,253,GAA,GGA,E,G,NM_007294.3,NM_007294,41244435,within,.,,rs16941,0.3357,0.279,,-0.149,0.972,0.606,0.922,0.0,-0.974,,,,,-,T,C,41244435,41244435,5D0FF1321BAC3C76DD352C33CC33B93E,,,,,,,-1,BRCA1- 458755565,-984,41815,11,,,,EMPTY,,D,,0,12,29,270861,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,0.936,113705,-1,,,,,,,,,,,3,0.343,9,1,0.75,0.35365853,0.54979074,GRCh38/hg38,17,43092418,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,27
19,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245466,726,46.56,10,c.2082C>T,p.(Ser694=),G,A,388,338,AGC,AGT,S,S,NM_007294.3,NM_007294,41245466,within,.,,rs1799949,0.3365,0.2957,,,,,,,,,,,,-,G,A,41245466,41245466,3364E3D252EFEDF917C74D44FBC6A381,,,,,,,-1,BRCA1- 458754534,1412,125536,11,,,,EMPTY,,D,,0,12,29,269442,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.75,0.35365853,0.54691046,GRCh38/hg38,17,43093449,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,27
18,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245237,248,48.39,10,c.2311T>C,p.(Leu771=),A,G,128,120,TTG,CTG,L,L,NM_007294.3,NM_007294,41245237,within,.,,rs16940,0.3353,0.2776,,,,,,,,,,,,-,A,G,41245237,41245237,711AF22D84A49E875C2B2A9597A95EE6,,,,,,,-1,BRCA1- 458754763,1641,125554,11,,,,EMPTY,,D,,0,12,28,269517,492662,126000,,,0,0,,1:1,,0.342,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3422,9,1,0.75,0.34146342,0.5470627,GRCh38/hg38,17,43093220,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,27
27,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32911463,149,57.72,11,c.2971A>G,p.(Asn991Asp),A,G,63,86,AAC,GAC,N,D,NM_000059.3,NM_000059,32911463,within,.,,rs1799944,0.0801,0.0373,,-0.04,0.0,,0.959,0.0,3.08,,,,,+,A,G,32911463,32911463,36F4F7E6CD788E45B30EA486775D07D6,,,,,,,-1,BRCA2-  32911463,1062,41545,11,,,,EMPTY,,D,,0,4,8,42142,493217,126000,,,0,0,,1:2,,0.053,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0522,10,1,0.25,0.09756097,0.085443124,GRCh38/hg38,13,32337326,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,27
12,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32899388,207,51.69,4,c.425+67A>C,p.(=),A,C,100,107,,,,,NM_000059.3,NM_000059,32899388,within,.,,rs11571610,0.0743,,,,,,,,,,,,,+,A,C,32899388,32899388,1AF346DE380A738371905EBFBCED20E1,,,,,,,-1,BRCA2-  32899388,0,126095,4,,,,EMPTY,,D,,0,4,8,39349,493217,126000,,,0,0,,2:1,,,67,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0306,3,3,0.25,0.09756097,0.0797803,GRCh38/hg38,13,32325251,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,27
1,D,BRCA2,,SNP,5'UTR,GRCh37/hg19,13,32890572,628,54.3,2,c.-26G>A,p.(=),G,A,287,341,,,,,NM_000059.3,NM_000059,32890572,within,.,,rs1799943,0.2093,0.2088,,,,,,,,,,,,+,G,A,32890572,32890572,A9C2B39455EF056EDB097A5953EB72EE,,,,,,,-1,BRCA2-  32890572,14,125965,2,,,,EMPTY,,D,,0,8,16,205902,493217,126000,,,0,0,,,,0.243,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2427,1,1,0.5,0.19512194,0.41746736,GRCh38/hg38,13,32316435,G,A,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,27
2,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32929232,284,52.46,14,c.7242A>G,p.(Ser2414=),A,G,135,149,TCA,TCG,S,S,NM_000059.3,NM_000059,32929232,within,.,,rs1799955,0.2326,0.2114,,,,,,,,,,,,+,A,G,32929232,32929232,6F8D6FF8BC9027D6C0351ADCEF41FD20,,,,,,,-1,BRCA2-  32929232,-194,126133,14,,,,EMPTY,,D,,0,8,16,192923,493217,126000,,,0,0,,"1:3,2:1",,0.224,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2257,13,1,0.5,0.19512194,0.39115238,GRCh38/hg38,13,32355095,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,27
26,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32910721,563,52.4,11,c.2229T>C,p.(His743=),T,C,268,295,CAT,CAC,H,H,NM_000059.3,NM_000059,32910721,within,.,,rs1801499,0.0735,0.0313,,,,,,,,,,,,+,T,C,32910721,32910721,D39471F16FE6D1F6752C2D4D179996AF,,,,,,,-1,BRCA2-  32910721,320,125979,11,,,,EMPTY,,D,,0,4,8,41536,493217,126000,,,0,0,,1:1,,0.052,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0503,10,1,0.25,0.09756097,0.08421446,GRCh38/hg38,13,32336584,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,27
23,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906480,296,51.01,10,c.865A>C,p.(Asn289His),A,C,145,151,AAT,CAT,N,H,NM_000059.3,NM_000059,32906480,within,.,,rs766173,0.0737,0.0312,,0.498,0.998,,0.803,0.0,1.73,,,,,+,A,C,32906480,32906480,EE0CD2A1633CE9FEF0978528634002FE,,,,,,,-1,BRCA2-  32906480,72,41567,10,,,,EMPTY,,D,,0,4,8,41272,493217,126000,,,0,0,,"1:4,2:1",,0.051,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0496,9,2,0.25,0.09756097,0.08367919,GRCh38/hg38,13,32332343,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,27
25,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32906980,614,48.86,10,c.1365A>G,p.(Ser455=),A,G,314,300,TCA,TCG,S,S,NM_000059.3,NM_000059,32906980,within,.,,rs1801439,0.0737,0.031,,,,,,,,,,,,+,A,G,32906980,32906980,C76C22E555E869928B452D866988AB4F,,,,,,,-1,BRCA2-  32906980,-545,125943,10,,,,EMPTY,,D,,0,4,8,41480,493217,126000,,,0,0,,"1:4,2:1",,0.051,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0499,9,2,0.25,0.09756097,0.08410091,GRCh38/hg38,13,32332843,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,27
28,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32911888,542,48.52,11,c.3396A>G,p.(Lys1132=),A,G,279,263,AAA,AAG,K,K,NM_000059.3,NM_000059,32911888,within,.,,rs1801406,0.2668,0.2798,,,,,,,,,,,,+,A,G,32911888,32911888,94F2C0D328C28C466A38A430BBE75D52,,,,,,,-1,BRCA2-  32911888,1487,126010,11,,,,EMPTY,,D,,0,8,16,248687,493217,126000,,,0,0,,1:3,,0.293,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.295,10,1,0.5,0.19512194,0.50421417,GRCh38/hg38,13,32337751,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,27
29,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,275,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,275,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,16,40,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,0.4878049,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,27
6,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32953388,309,100.0,22,c.8755-66T>C,p.(=),T,C,0,309,,,,,NM_000059.3,NM_000059,32953388,within,.,,rs4942486,0.5116,,,,,,,,,,,,,+,T,C,32953388,32953388,97C65B85894EB489F1BFA65897685241,,,,,,,-1,BRCA2-  32953388,0,126190,22,,,,EMPTY,,D,,0,11,30,347826,493217,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5257,21,1,0.6875,0.36585367,0.70521903,GRCh38/hg38,13,32379251,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,27
4,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32929478,256,47.27,14,c.7435+53C>T,p.(=),C,T,135,121,,,,,NM_000059.3,NM_000059,32929478,within,.,,rs11147489,0.0725,,,,,,,,,,,,,+,C,T,32929478,32929478,F692B4BE5DCD39FA887FE8D63D296720,,,,,,,-1,BRCA2-  32929478,0,126136,14,,,,EMPTY,,D,,0,4,8,36369,493217,126000,,,0,0,,,,,53,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0301,13,3,0.25,0.09756097,0.07373834,GRCh38/hg38,13,32355341,C,T,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,27
3,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,223,100.0,14,c.7397T>C,p.(Val2466Ala),T,C,0,223,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,16,39,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.47560975,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,27
5,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32936646,206,100.0,17,c.7806-14T>C,p.(=),T,C,0,206,,,,,NM_000059.3,NM_000059,32936646,within,.,,rs9534262,0.5316,0.5202,,,,,,,,,,,,+,T,C,32936646,32936646,5803939D8FBB75B042260991F0A62436,,,,,,,-1,BRCA2-  32936646,0,126158,17,,,,EMPTY,,D,,0,11,29,361616,493217,126000,,,0,0,,1:3,,0.52,14,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5255,16,1,0.6875,0.35365853,0.7331783,GRCh38/hg38,13,32362509,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,27
30,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,530,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,530,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,16,40,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,0.4878049,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,27
12,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906729,636,48.43,10,c.1114A>C,p.(Asn372His),A,C,327,308,AAT,CAT,N,H,NM_000059.3,NM_000059,32906729,within,.,,rs144848,0.2494,0.2332,,0.32,0.861,,0.269,0.0,0.396,,,,,+,A,C,32906729,32906729,D514F785F1344AF9F6975E589D47BDF6,,,,,,,-1,BRCA2-  32906729,321,9329,10,,,,EMPTY,,D,,0,9,25,233635,493217,126000,,,0,0,,"1:1,2:1",,0.277,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2733,9,1,0.5625,0.30487806,0.47369617,GRCh38/hg38,13,32332592,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,28
3,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32953529,623,55.7,22,c.8830A>T,p.(Ile2944Phe),A,T,276,347,ATC,TTC,I,F,NM_000059.3,NM_000059,32953529,within,.,,rs4987047,0.009,0.014,,1.121,0.998,,0.998,0.9984,1.66,,,,,+,A,T,32953529,32953529,0D8ECA84CA3AC164174B10702E8480FA,,,,,,,-1,BRCA2-  32953529,76,41569,22,,,,EMPTY,,D,,0,1,1,1778,493217,126000,,,0,0,,"1:4,2:2",,0.0038,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0039,21,3,0.0625,0.0121951215,0.003604904,GRCh38/hg38,13,32379392,A,T,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,28
17,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,399,100.0,14,c.7397T>C,p.(Val2466Ala),T,C,0,399,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,16,39,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.47560975,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,28
2,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32953388,767,51.24,22,c.8755-66T>C,p.(=),T,C,374,393,,,,,NM_000059.3,NM_000059,32953388,within,.,,rs4942486,0.5116,,,,,,,,,,,,,+,T,C,32953388,32953388,97C65B85894EB489F1BFA65897685241,,,,,,,-1,BRCA2-  32953388,0,126190,22,,,,EMPTY,,D,,0,11,30,347826,493217,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5257,21,1,0.6875,0.36585367,0.70521903,GRCh38/hg38,13,32379251,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,28
16,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32929232,606,51.82,14,c.7242A>G,p.(Ser2414=),A,G,292,314,TCA,TCG,S,S,NM_000059.3,NM_000059,32929232,within,.,,rs1799955,0.2326,0.2114,,,,,,,,,,,,+,A,G,32929232,32929232,6F8D6FF8BC9027D6C0351ADCEF41FD20,,,,,,,-1,BRCA2-  32929232,-194,126133,14,,,,EMPTY,,D,,0,8,16,192923,493217,126000,,,0,0,,"1:3,2:1",,0.224,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2257,13,1,0.5,0.19512194,0.39115238,GRCh38/hg38,13,32355095,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,28
1,D,BRCA2,,SNP,5'UTR,GRCh37/hg19,13,32890572,1297,54.36,2,c.-26G>A,p.(=),G,A,592,705,,,,,NM_000059.3,NM_000059,32890572,within,.,,rs1799943,0.2093,0.2088,,,,,,,,,,,,+,G,A,32890572,32890572,A9C2B39455EF056EDB097A5953EB72EE,,,,,,,-1,BRCA2-  32890572,14,125965,2,,,,EMPTY,,D,,0,8,16,205902,493217,126000,,,0,0,,,,0.243,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2427,1,1,0.5,0.19512194,0.41746736,GRCh38/hg38,13,32316435,G,A,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,28
18,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32936646,449,48.33,17,c.7806-14T>C,p.(=),T,C,232,217,,,,,NM_000059.3,NM_000059,32936646,within,.,,rs9534262,0.5316,0.5202,,,,,,,,,,,,+,T,C,32936646,32936646,5803939D8FBB75B042260991F0A62436,,,,,,,-1,BRCA2-  32936646,0,126158,17,,,,EMPTY,,D,,0,11,29,361616,493217,126000,,,0,0,,1:3,,0.52,14,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5255,16,1,0.6875,0.35365853,0.7331783,GRCh38/hg38,13,32362509,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,28
14,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,618,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,618,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,16,40,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,0.4878049,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,28
13,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32911888,1067,49.77,11,c.3396A>G,p.(Lys1132=),A,G,536,531,AAA,AAG,K,K,NM_000059.3,NM_000059,32911888,within,.,,rs1801406,0.2668,0.2798,,,,,,,,,,,,+,A,G,32911888,32911888,94F2C0D328C28C466A38A430BBE75D52,,,,,,,-1,BRCA2-  32911888,1487,126010,11,,,,EMPTY,,D,,0,8,16,248687,493217,126000,,,0,0,,1:3,,0.293,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.295,10,1,0.5,0.19512194,0.50421417,GRCh38/hg38,13,32337751,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,28
15,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,1277,99.92,11,c.6513G>C,p.(Val2171=),G,C,0,1276,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,16,40,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,0.4878049,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,28
11,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244936,1596,49.75,10,c.2612C>T,p.(Pro871Leu),G,A,802,794,CCG,CTG,P,L,NM_007294.3,NM_007294,41244936,within,.,,rs799917,0.5439,0.4932,,4.247,0.0,0.0,0.999,1.0,5.04,,,,,-,G,A,41244936,41244936,A19EA255CA888CE1FE48D08CAD633F1F,,,,,,,1,BRCA1- 458755064,-1485,41812,11,,,,EMPTY,,D,,1,12,29,290862,492662,126000,(eval),,0,0,,"1:4,2:1",,0.41,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.4127,9,3,0.75,0.35365853,0.59038854,GRCh38/hg38,17,43092919,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,29
2,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219780,1206,46.85,16,c.4987-68A>G,p.(=),T,C,641,565,,,,,NM_007294.3,NM_007294,41219780,within,.,,rs8176234,0.3546,,,,,,,,,,,,,-,T,C,41219780,41219780,5995ECC305C33150BF3BB2B0C22FCC2A,,,,,,,-1,BRCA1- 458780220,0,125746,17,,,,EMPTY,,D,,0,12,29,234031,492662,126000,,,0,0,,,,,68,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3148,15,1,0.75,0.35365853,0.47503358,GRCh38/hg38,17,43067763,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,29
14,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245466,2520,47.98,10,c.2082C>T,p.(Ser694=),G,A,1310,1209,AGC,AGT,S,S,NM_007294.3,NM_007294,41245466,within,.,,rs1799949,0.3365,0.2957,,,,,,,,,,,,-,G,A,41245466,41245466,3364E3D252EFEDF917C74D44FBC6A381,,,,,,,-1,BRCA1- 458754534,1412,125536,11,,,,EMPTY,,D,,0,12,29,269442,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.75,0.35365853,0.54691046,GRCh38/hg38,17,43093449,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,29
3,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219804,1207,46.98,16,c.4987-92A>G,p.(=),T,C,640,567,,,,,NM_007294.3,NM_007294,41219804,within,.,,rs8176233,0.3546,,,,,,,,,,,,,-,T,C,41219804,41219804,7341B20C52FFD4B9355840FB9CB56CDA,,,,,,,-1,BRCA1- 458780196,0,125749,17,,,,EMPTY,,D,,0,12,29,225491,492662,126000,,,0,0,,,,,92,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3128,15,1,0.75,0.35365853,0.45769918,GRCh38/hg38,17,43067787,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,29
10,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244435,1647,51.06,10,c.3113A>G,p.(Glu1038Gly),T,C,806,841,GAA,GGA,E,G,NM_007294.3,NM_007294,41244435,within,.,,rs16941,0.3357,0.279,,-0.149,0.972,0.606,0.922,0.0,-0.974,,,,,-,T,C,41244435,41244435,5D0FF1321BAC3C76DD352C33CC33B93E,,,,,,,-1,BRCA1- 458755565,-984,41815,11,,,,EMPTY,,D,,0,12,29,270861,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,0.936,113705,-1,,,,,,,,,,,3,0.343,9,1,0.75,0.35365853,0.54979074,GRCh38/hg38,17,43092418,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,29
7,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41234470,692,49.57,12,c.4308T>C,p.(Ser1436=),A,G,349,343,TCT,TCC,S,S,NM_007294.3,NM_007294,41234470,within,.,,rs1060915,0.3363,0.2796,,,,,,,,,,,,-,A,G,41234470,41234470,B7237055CF1D42F022A050C072B7583B,,,,,,,-1,BRCA1- 458765530,-50,125703,13,,,,EMPTY,,D,,0,12,29,270833,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3433,11,1,0.75,0.35365853,0.5497339,GRCh38/hg38,17,43082453,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,29
5,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41223094,1500,47.27,15,c.4837A>G,p.(Ser1613Gly),T,C,791,709,AGT,GGT,S,G,NM_007294.3,NM_007294,41223094,within,.,,rs1799966,0.3558,0.2982,,-0.194,0.968,0.038,0.814,0.0,1.5,,,,,-,T,C,41223094,41223094,E3C52286D31F229973DB3595B052645F,,,,,,,-1,BRCA1- 458776906,-150,41827,16,,,,EMPTY,,D,,0,12,29,273625,492662,126000,,,0,0,,1:1,,0.349,0,,,,,,,,,,,,,,Benign,Benign,0.255,113705,-1,,,,,,,,,,,3,0.35,14,1,0.75,0.35365853,0.5554011,GRCh38/hg38,17,43071077,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,29
9,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244000,1790,47.26,10,c.3548A>G,p.(Lys1183Arg),T,C,944,846,AAA,AGA,K,R,NM_007294.3,NM_007294,41244000,within,.,,rs16942,0.3526,0.2952,,-0.319,0.0,0.001,0.924,0.0,-2.35,,,,,-,T,C,41244000,41244000,37A54117EA353BDA677332A1F61FA173,,,,,,,-1,BRCA1- 458756000,-549,41818,11,,,,EMPTY,,D,,0,12,29,272437,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.75,0.35365853,0.55298966,GRCh38/hg38,17,43091983,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,29
28,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41215825,331,50.15,17,c.5152+66G>A,p.(=),C,T,165,166,,,,,NM_007294.3,NM_007294,41215825,within,.,,rs3092994,0.3425,,,,,,,,,,,,,-,C,T,41215825,41215825,5BCA8D2E1E3875817F84A3EB582CDFAB,,,,,,,-1,BRCA1- 458784175,0,55428,18,,,,EMPTY,,D,,0,9,24,241843,492662,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3139,16,1,0.5625,0.29268292,0.4908903,GRCh38/hg38,17,43063808,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,29
6,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41231516,796,52.26,13,c.4358-2885G>A,p.(=),C,T,380,416,,,,,NM_007294.3,NM_007294,41231516,within,.,,rs8176193,0.3534,,,,,,,,,,,,,-,C,T,41231516,41231516,7F4F80D2D005D34CEA47E4A2C561B172,,,,,,,-1,BRCA1- 458768484,0,209399,14,,,,EMPTY,,D,,0,12,29,190200,492662,126000,,,0,0,,,,,2885,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.317,12,1,0.75,0.35365853,0.3860659,GRCh38/hg38,17,43079499,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,29
13,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245237,622,50.0,10,c.2311T>C,p.(Leu771=),A,G,310,311,TTG,CTG,L,L,NM_007294.3,NM_007294,41245237,within,.,,rs16940,0.3353,0.2776,,,,,,,,,,,,-,A,G,41245237,41245237,711AF22D84A49E875C2B2A9597A95EE6,,,,,,,-1,BRCA1- 458754763,1641,125554,11,,,,EMPTY,,D,,0,12,28,269517,492662,126000,,,0,0,,1:1,,0.342,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3422,9,1,0.75,0.34146342,0.5470627,GRCh38/hg38,17,43093220,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,29
12,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906729,1085,99.82,10,c.1114A>C,p.(Asn372His),A,C,2,1083,AAT,CAT,N,H,NM_000059.3,NM_000059,32906729,within,.,,rs144848,0.2494,0.2332,,0.32,0.861,,0.269,0.0,0.396,,,,,+,A,C,32906729,32906729,D514F785F1344AF9F6975E589D47BDF6,,,,,,,-1,BRCA2-  32906729,321,9329,10,,,,EMPTY,,D,,0,9,25,233635,493217,126000,,,0,0,,"1:1,2:1",,0.277,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2733,9,1,0.5625,0.30487806,0.47369617,GRCh38/hg38,13,32332592,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,29
22,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,775,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,775,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,16,40,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,0.4878049,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,29
25,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,632,100.0,14,c.7397T>C,p.(Val2466Ala),T,C,0,632,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,16,39,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.47560975,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,29
23,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,1839,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,1839,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,16,40,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,0.4878049,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,29
16,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32914236,1245,48.43,11,c.5744C>T,p.(Thr1915Met),C,T,642,603,ACG,ATG,T,M,NM_000059.3,NM_000059,32914236,within,.,,rs4987117,0.0086,0.0211,,-1.105,0.674,,0.286,0.0,0.623,,,,,+,C,T,32914236,32914236,9B18380606AE96F8022F8AB5893BFD77,,,,,,,-1,BRCA2-  32914236,-1098,41556,11,,,,EMPTY,,D,,0,3,4,22222,493217,126000,,,0,0,,"1:4,2:1",,0.018,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0179,10,2,0.1875,0.048780486,0.045055218,GRCh38/hg38,13,32340099,C,T,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,30
19,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,626,100.0,14,c.7397T>C,p.(Val2466Ala),T,C,0,626,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,16,39,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.47560975,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,30
3,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32936646,655,49.62,17,c.7806-14T>C,p.(=),T,C,329,325,,,,,NM_000059.3,NM_000059,32936646,within,.,,rs9534262,0.5316,0.5202,,,,,,,,,,,,+,T,C,32936646,32936646,5803939D8FBB75B042260991F0A62436,,,,,,,-1,BRCA2-  32936646,0,126158,17,,,,EMPTY,,D,,0,11,29,361616,493217,126000,,,0,0,,1:3,,0.52,14,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5255,16,1,0.6875,0.35365853,0.7331783,GRCh38/hg38,13,32362509,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,30
13,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906729,612,49.35,10,c.1114A>C,p.(Asn372His),A,C,310,302,AAT,CAT,N,H,NM_000059.3,NM_000059,32906729,within,.,,rs144848,0.2494,0.2332,,0.32,0.861,,0.269,0.0,0.396,,,,,+,A,C,32906729,32906729,D514F785F1344AF9F6975E589D47BDF6,,,,,,,-1,BRCA2-  32906729,321,9329,10,,,,EMPTY,,D,,0,9,25,233635,493217,126000,,,0,0,,"1:1,2:1",,0.277,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2733,9,1,0.5625,0.30487806,0.47369617,GRCh38/hg38,13,32332592,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,30
1,D,BRCA2,,SNP,5'UTR,GRCh37/hg19,13,32890572,1817,51.13,2,c.-26G>A,p.(=),G,A,887,929,,,,,NM_000059.3,NM_000059,32890572,within,.,,rs1799943,0.2093,0.2088,,,,,,,,,,,,+,G,A,32890572,32890572,A9C2B39455EF056EDB097A5953EB72EE,,,,,,,-1,BRCA2-  32890572,14,125965,2,,,,EMPTY,,D,,0,8,16,205902,493217,126000,,,0,0,,,,0.243,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2427,1,1,0.5,0.19512194,0.41746736,GRCh38/hg38,13,32316435,G,A,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,30
17,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,1607,99.88,11,c.6513G>C,p.(Val2171=),G,C,0,1605,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,16,40,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,0.4878049,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,30
2,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32930598,763,52.56,15,c.7469T>C,p.(Ile2490Thr),T,C,362,401,ATA,ACA,I,T,NM_000059.3,NM_000059,32930598,within,.,,rs11571707,0.016,0.0016,,0.406,0.895,,0.837,0.0,-5.83,,,,,+,T,C,32930598,32930598,D7CAF30A58440FCA5E8E7BACD8E1EDE4,,,,,,,-1,BRCA2-  32930598,34,96852,15,,,,EMPTY,,D,,0,4,11,6837,493217,126000,,,0,0,,"1:5,2:2",,0.014,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0176,14,2,0.25,0.13414635,0.013862053,GRCh38/hg38,13,32356461,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,30
14,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32911888,1470,50.82,11,c.3396A>G,p.(Lys1132=),A,G,723,747,AAA,AAG,K,K,NM_000059.3,NM_000059,32911888,within,.,,rs1801406,0.2668,0.2798,,,,,,,,,,,,+,A,G,32911888,32911888,94F2C0D328C28C466A38A430BBE75D52,,,,,,,-1,BRCA2-  32911888,1487,126010,11,,,,EMPTY,,D,,0,8,16,248687,493217,126000,,,0,0,,1:3,,0.293,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.295,10,1,0.5,0.19512194,0.50421417,GRCh38/hg38,13,32337751,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,30
4,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32953388,782,52.43,22,c.8755-66T>C,p.(=),T,C,372,410,,,,,NM_000059.3,NM_000059,32953388,within,.,,rs4942486,0.5116,,,,,,,,,,,,,+,T,C,32953388,32953388,97C65B85894EB489F1BFA65897685241,,,,,,,-1,BRCA2-  32953388,0,126190,22,,,,EMPTY,,D,,0,11,30,347826,493217,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5257,21,1,0.6875,0.36585367,0.70521903,GRCh38/hg38,13,32379251,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,30
15,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,1013,99.9,11,c.4563A>G,p.(Leu1521=),A,G,0,1012,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,16,40,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,0.4878049,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,30
18,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32929232,1056,50.09,14,c.7242A>G,p.(Ser2414=),A,G,527,529,TCA,TCG,S,S,NM_000059.3,NM_000059,32929232,within,.,,rs1799955,0.2326,0.2114,,,,,,,,,,,,+,A,G,32929232,32929232,6F8D6FF8BC9027D6C0351ADCEF41FD20,,,,,,,-1,BRCA2-  32929232,-194,126133,14,,,,EMPTY,,D,,0,8,16,192923,493217,126000,,,0,0,,"1:3,2:1",,0.224,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2257,13,1,0.5,0.19512194,0.39115238,GRCh38/hg38,13,32355095,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,30
20,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244936,1403,50.46,10,c.2612C>T,p.(Pro871Leu),G,A,695,708,CCG,CTG,P,L,NM_007294.3,NM_007294,41244936,within,.,,rs799917,0.5439,0.4932,,4.247,0.0,0.0,0.999,1.0,5.04,,,,,-,G,A,41244936,41244936,A19EA255CA888CE1FE48D08CAD633F1F,,,,,,,1,BRCA1- 458755064,-1485,41812,11,,,,EMPTY,,D,,1,12,29,290862,492662,126000,(eval),,0,0,,"1:4,2:1",,0.41,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.4127,9,3,0.75,0.35365853,0.59038854,GRCh38/hg38,17,43092919,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,31
14,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41223094,1245,50.28,15,c.4837A>G,p.(Ser1613Gly),T,C,619,626,AGT,GGT,S,G,NM_007294.3,NM_007294,41223094,within,.,,rs1799966,0.3558,0.2982,,-0.194,0.968,0.038,0.814,0.0,1.5,,,,,-,T,C,41223094,41223094,E3C52286D31F229973DB3595B052645F,,,,,,,-1,BRCA1- 458776906,-150,41827,16,,,,EMPTY,,D,,0,12,29,273625,492662,126000,,,0,0,,1:1,,0.349,0,,,,,,,,,,,,,,Benign,Benign,0.255,113705,-1,,,,,,,,,,,3,0.35,14,1,0.75,0.35365853,0.5554011,GRCh38/hg38,17,43071077,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,31
15,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41231516,716,46.93,13,c.4358-2885G>A,p.(=),C,T,380,336,,,,,NM_007294.3,NM_007294,41231516,within,.,,rs8176193,0.3534,,,,,,,,,,,,,-,C,T,41231516,41231516,7F4F80D2D005D34CEA47E4A2C561B172,,,,,,,-1,BRCA1- 458768484,0,209399,14,,,,EMPTY,,D,,0,12,29,190200,492662,126000,,,0,0,,,,,2885,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.317,12,1,0.75,0.35365853,0.3860659,GRCh38/hg38,17,43079499,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,31
22,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245466,2085,51.46,10,c.2082C>T,p.(Ser694=),G,A,1012,1073,AGC,AGT,S,S,NM_007294.3,NM_007294,41245466,within,.,,rs1799949,0.3365,0.2957,,,,,,,,,,,,-,G,A,41245466,41245466,3364E3D252EFEDF917C74D44FBC6A381,,,,,,,-1,BRCA1- 458754534,1412,125536,11,,,,EMPTY,,D,,0,12,29,269442,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.75,0.35365853,0.54691046,GRCh38/hg38,17,43093449,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,31
11,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219804,877,51.65,16,c.4987-92A>G,p.(=),T,C,424,453,,,,,NM_007294.3,NM_007294,41219804,within,.,,rs8176233,0.3546,,,,,,,,,,,,,-,T,C,41219804,41219804,7341B20C52FFD4B9355840FB9CB56CDA,,,,,,,-1,BRCA1- 458780196,0,125749,17,,,,EMPTY,,D,,0,12,29,225491,492662,126000,,,0,0,,,,,92,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3128,15,1,0.75,0.35365853,0.45769918,GRCh38/hg38,17,43067787,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,31
18,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244000,1716,51.57,10,c.3548A>G,p.(Lys1183Arg),T,C,831,885,AAA,AGA,K,R,NM_007294.3,NM_007294,41244000,within,.,,rs16942,0.3526,0.2952,,-0.319,0.0,0.001,0.924,0.0,-2.35,,,,,-,T,C,41244000,41244000,37A54117EA353BDA677332A1F61FA173,,,,,,,-1,BRCA1- 458756000,-549,41818,11,,,,EMPTY,,D,,0,12,29,272437,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.75,0.35365853,0.55298966,GRCh38/hg38,17,43091983,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,31
9,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41215825,275,54.91,17,c.5152+66G>A,p.(=),C,T,124,151,,,,,NM_007294.3,NM_007294,41215825,within,.,,rs3092994,0.3425,,,,,,,,,,,,,-,C,T,41215825,41215825,5BCA8D2E1E3875817F84A3EB582CDFAB,,,,,,,-1,BRCA1- 458784175,0,55428,18,,,,EMPTY,,D,,0,9,24,241843,492662,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3139,16,1,0.5625,0.29268292,0.4908903,GRCh38/hg38,17,43063808,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,31
21,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245237,485,50.93,10,c.2311T>C,p.(Leu771=),A,G,238,247,TTG,CTG,L,L,NM_007294.3,NM_007294,41245237,within,.,,rs16940,0.3353,0.2776,,,,,,,,,,,,-,A,G,41245237,41245237,711AF22D84A49E875C2B2A9597A95EE6,,,,,,,-1,BRCA1- 458754763,1641,125554,11,,,,EMPTY,,D,,0,12,28,269517,492662,126000,,,0,0,,1:1,,0.342,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3422,9,1,0.75,0.34146342,0.5470627,GRCh38/hg38,17,43093220,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,31
19,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244435,1425,51.79,10,c.3113A>G,p.(Glu1038Gly),T,C,687,738,GAA,GGA,E,G,NM_007294.3,NM_007294,41244435,within,.,,rs16941,0.3357,0.279,,-0.149,0.972,0.606,0.922,0.0,-0.974,,,,,-,T,C,41244435,41244435,5D0FF1321BAC3C76DD352C33CC33B93E,,,,,,,-1,BRCA1- 458755565,-984,41815,11,,,,EMPTY,,D,,0,12,29,270861,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,0.936,113705,-1,,,,,,,,,,,3,0.343,9,1,0.75,0.35365853,0.54979074,GRCh38/hg38,17,43092418,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,31
10,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219780,877,51.65,16,c.4987-68A>G,p.(=),T,C,424,453,,,,,NM_007294.3,NM_007294,41219780,within,.,,rs8176234,0.3546,,,,,,,,,,,,,-,T,C,41219780,41219780,5995ECC305C33150BF3BB2B0C22FCC2A,,,,,,,-1,BRCA1- 458780220,0,125746,17,,,,EMPTY,,D,,0,12,29,234031,492662,126000,,,0,0,,,,,68,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3148,15,1,0.75,0.35365853,0.47503358,GRCh38/hg38,17,43067763,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,31
16,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41234470,545,48.44,12,c.4308T>C,p.(Ser1436=),A,G,281,264,TCT,TCC,S,S,NM_007294.3,NM_007294,41234470,within,.,,rs1060915,0.3363,0.2796,,,,,,,,,,,,-,A,G,41234470,41234470,B7237055CF1D42F022A050C072B7583B,,,,,,,-1,BRCA1- 458765530,-50,125703,13,,,,EMPTY,,D,,0,12,29,270833,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3433,11,1,0.75,0.35365853,0.5497339,GRCh38/hg38,17,43082453,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,31
3,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32929478,703,49.36,14,c.7435+53C>T,p.(=),C,T,356,347,,,,,NM_000059.3,NM_000059,32929478,within,.,,rs11147489,0.0725,,,,,,,,,,,,,+,C,T,32929478,32929478,F692B4BE5DCD39FA887FE8D63D296720,,,,,,,-1,BRCA2-  32929478,0,126136,14,,,,EMPTY,,D,,0,4,8,36369,493217,126000,,,0,0,,,,,53,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0301,13,3,0.25,0.09756097,0.07373834,GRCh38/hg38,13,32355341,C,T,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,31
32,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32906980,1627,47.94,10,c.1365A>G,p.(Ser455=),A,G,847,780,TCA,TCG,S,S,NM_000059.3,NM_000059,32906980,within,.,,rs1801439,0.0737,0.031,,,,,,,,,,,,+,A,G,32906980,32906980,C76C22E555E869928B452D866988AB4F,,,,,,,-1,BRCA2-  32906980,-545,125943,10,,,,EMPTY,,D,,0,4,8,41480,493217,126000,,,0,0,,"1:4,2:1",,0.051,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0499,9,2,0.25,0.09756097,0.08410091,GRCh38/hg38,13,32332843,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,31
5,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32953388,1012,45.85,22,c.8755-66T>C,p.(=),T,C,548,464,,,,,NM_000059.3,NM_000059,32953388,within,.,,rs4942486,0.5116,,,,,,,,,,,,,+,T,C,32953388,32953388,97C65B85894EB489F1BFA65897685241,,,,,,,-1,BRCA2-  32953388,0,126190,22,,,,EMPTY,,D,,0,11,30,347826,493217,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5257,21,1,0.6875,0.36585367,0.70521903,GRCh38/hg38,13,32379251,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,31
6,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32953550,865,51.33,22,c.8851G>A,p.(Ala2951Thr),G,A,421,444,GCC,ACC,A,T,NM_000059.3,NM_000059,32953550,within,.,,rs11571769,0.01,0.0044,,7.914,1.0,,1.0,1.0,5.6,,,,,+,G,A,32953550,32953550,D3D6E2E00CDC932E43B7A97E2FA9A9A6,,,,,,,-1,BRCA2-  32953550,97,41570,22,,,,EMPTY,,D,,0,2,3,7101,493217,126000,,,0,0,,"1:8,2:1",,0.0078,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0089,21,3,0.125,0.036585364,0.014397314,GRCh38/hg38,13,32379413,G,A,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,31
23,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906480,886,52.6,10,c.865A>C,p.(Asn289His),A,C,419,466,AAT,CAT,N,H,NM_000059.3,NM_000059,32906480,within,.,,rs766173,0.0737,0.0312,,0.498,0.998,,0.803,0.0,1.73,,,,,+,A,C,32906480,32906480,EE0CD2A1633CE9FEF0978528634002FE,,,,,,,-1,BRCA2-  32906480,72,41567,10,,,,EMPTY,,D,,0,4,8,41272,493217,126000,,,0,0,,"1:4,2:1",,0.051,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0496,9,2,0.25,0.09756097,0.08367919,GRCh38/hg38,13,32332343,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,31
34,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32911463,459,49.89,11,c.2971A>G,p.(Asn991Asp),A,G,230,229,AAC,GAC,N,D,NM_000059.3,NM_000059,32911463,within,.,,rs1799944,0.0801,0.0373,,-0.04,0.0,,0.959,0.0,3.08,,,,,+,A,G,32911463,32911463,36F4F7E6CD788E45B30EA486775D07D6,,,,,,,-1,BRCA2-  32911463,1062,41545,11,,,,EMPTY,,D,,0,4,8,42142,493217,126000,,,0,0,,1:2,,0.053,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0522,10,1,0.25,0.09756097,0.085443124,GRCh38/hg38,13,32337326,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,31
33,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32910721,1657,51.48,11,c.2229T>C,p.(His743=),T,C,804,853,CAT,CAC,H,H,NM_000059.3,NM_000059,32910721,within,.,,rs1801499,0.0735,0.0313,,,,,,,,,,,,+,T,C,32910721,32910721,D39471F16FE6D1F6752C2D4D179996AF,,,,,,,-1,BRCA2-  32910721,320,125979,11,,,,EMPTY,,D,,0,4,8,41536,493217,126000,,,0,0,,1:1,,0.052,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0503,10,1,0.25,0.09756097,0.08421446,GRCh38/hg38,13,32336584,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,31
1,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32899388,478,51.46,4,c.425+67A>C,p.(=),A,C,232,246,,,,,NM_000059.3,NM_000059,32899388,within,.,,rs11571610,0.0743,,,,,,,,,,,,,+,A,C,32899388,32899388,1AF346DE380A738371905EBFBCED20E1,,,,,,,-1,BRCA2-  32899388,0,126095,4,,,,EMPTY,,D,,0,4,8,39349,493217,126000,,,0,0,,2:1,,,67,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0306,3,3,0.25,0.09756097,0.0797803,GRCh38/hg38,13,32325251,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,31
2,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,455,100.0,14,c.7397T>C,p.(Val2466Ala),T,C,0,455,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,16,39,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.47560975,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,31
31,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906729,824,51.82,10,c.1114A>C,p.(Asn372His),A,C,397,427,AAT,CAT,N,H,NM_000059.3,NM_000059,32906729,within,.,,rs144848,0.2494,0.2332,,0.32,0.861,,0.269,0.0,0.396,,,,,+,A,C,32906729,32906729,D514F785F1344AF9F6975E589D47BDF6,,,,,,,-1,BRCA2-  32906729,321,9329,10,,,,EMPTY,,D,,0,9,25,233635,493217,126000,,,0,0,,"1:1,2:1",,0.277,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2733,9,1,0.5625,0.30487806,0.47369617,GRCh38/hg38,13,32332592,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,31
4,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32936646,513,48.93,17,c.7806-14T>C,p.(=),T,C,262,251,,,,,NM_000059.3,NM_000059,32936646,within,.,,rs9534262,0.5316,0.5202,,,,,,,,,,,,+,T,C,32936646,32936646,5803939D8FBB75B042260991F0A62436,,,,,,,-1,BRCA2-  32936646,0,126158,17,,,,EMPTY,,D,,0,11,29,361616,493217,126000,,,0,0,,1:3,,0.52,14,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5255,16,1,0.6875,0.35365853,0.7331783,GRCh38/hg38,13,32362509,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,31
35,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,866,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,866,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,16,40,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,0.4878049,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,31
36,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,1691,99.94,11,c.6513G>C,p.(Val2171=),G,C,1,1690,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,16,40,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,0.4878049,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,31
14,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244936,1921,48.15,10,c.2612C>T,p.(Pro871Leu),G,A,995,925,CCG,CTG,P,L,NM_007294.3,NM_007294,41244936,within,.,,rs799917,0.5439,0.4932,,4.247,0.0,0.0,0.999,1.0,5.04,,,,,-,G,A,41244936,41244936,A19EA255CA888CE1FE48D08CAD633F1F,,,,,,,1,BRCA1- 458755064,-1485,41812,11,,,,EMPTY,,D,,1,12,29,290862,492662,126000,(eval),,0,0,,"1:4,2:1",,0.41,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.4127,9,3,0.75,0.35365853,0.59038854,GRCh38/hg38,17,43092919,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,32
7,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41223094,1730,48.15,15,c.4837A>G,p.(Ser1613Gly),T,C,897,833,AGT,GGT,S,G,NM_007294.3,NM_007294,41223094,within,.,,rs1799966,0.3558,0.2982,,-0.194,0.968,0.038,0.814,0.0,1.5,,,,,-,T,C,41223094,41223094,E3C52286D31F229973DB3595B052645F,,,,,,,-1,BRCA1- 458776906,-150,41827,16,,,,EMPTY,,D,,0,12,29,273625,492662,126000,,,0,0,,1:1,,0.349,0,,,,,,,,,,,,,,Benign,Benign,0.255,113705,-1,,,,,,,,,,,3,0.35,14,1,0.75,0.35365853,0.5554011,GRCh38/hg38,17,43071077,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,32
8,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41231516,569,52.72,13,c.4358-2885G>A,p.(=),C,T,269,300,,,,,NM_007294.3,NM_007294,41231516,within,.,,rs8176193,0.3534,,,,,,,,,,,,,-,C,T,41231516,41231516,7F4F80D2D005D34CEA47E4A2C561B172,,,,,,,-1,BRCA1- 458768484,0,209399,14,,,,EMPTY,,D,,0,12,29,190200,492662,126000,,,0,0,,,,,2885,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.317,12,1,0.75,0.35365853,0.3860659,GRCh38/hg38,17,43079499,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,32
11,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244000,2347,53.39,10,c.3548A>G,p.(Lys1183Arg),T,C,1094,1253,AAA,AGA,K,R,NM_007294.3,NM_007294,41244000,within,.,,rs16942,0.3526,0.2952,,-0.319,0.0,0.001,0.924,0.0,-2.35,,,,,-,T,C,41244000,41244000,37A54117EA353BDA677332A1F61FA173,,,,,,,-1,BRCA1- 458756000,-549,41818,11,,,,EMPTY,,D,,0,12,29,272437,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.75,0.35365853,0.55298966,GRCh38/hg38,17,43091983,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,32
16,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245466,3120,49.74,10,c.2082C>T,p.(Ser694=),G,A,1567,1552,AGC,AGT,S,S,NM_007294.3,NM_007294,41245466,within,.,,rs1799949,0.3365,0.2957,,,,,,,,,,,,-,G,A,41245466,41245466,3364E3D252EFEDF917C74D44FBC6A381,,,,,,,-1,BRCA1- 458754534,1412,125536,11,,,,EMPTY,,D,,0,12,29,269442,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.75,0.35365853,0.54691046,GRCh38/hg38,17,43093449,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,32
13,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244435,2001,52.27,10,c.3113A>G,p.(Glu1038Gly),T,C,955,1046,GAA,GGA,E,G,NM_007294.3,NM_007294,41244435,within,.,,rs16941,0.3357,0.279,,-0.149,0.972,0.606,0.922,0.0,-0.974,,,,,-,T,C,41244435,41244435,5D0FF1321BAC3C76DD352C33CC33B93E,,,,,,,-1,BRCA1- 458755565,-984,41815,11,,,,EMPTY,,D,,0,12,29,270861,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,0.936,113705,-1,,,,,,,,,,,3,0.343,9,1,0.75,0.35365853,0.54979074,GRCh38/hg38,17,43092418,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,32
4,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219780,931,47.37,16,c.4987-68A>G,p.(=),T,C,490,441,,,,,NM_007294.3,NM_007294,41219780,within,.,,rs8176234,0.3546,,,,,,,,,,,,,-,T,C,41219780,41219780,5995ECC305C33150BF3BB2B0C22FCC2A,,,,,,,-1,BRCA1- 458780220,0,125746,17,,,,EMPTY,,D,,0,12,29,234031,492662,126000,,,0,0,,,,,68,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3148,15,1,0.75,0.35365853,0.47503358,GRCh38/hg38,17,43067763,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,32
15,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245237,903,51.61,10,c.2311T>C,p.(Leu771=),A,G,437,466,TTG,CTG,L,L,NM_007294.3,NM_007294,41245237,within,.,,rs16940,0.3353,0.2776,,,,,,,,,,,,-,A,G,41245237,41245237,711AF22D84A49E875C2B2A9597A95EE6,,,,,,,-1,BRCA1- 458754763,1641,125554,11,,,,EMPTY,,D,,0,12,28,269517,492662,126000,,,0,0,,1:1,,0.342,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3422,9,1,0.75,0.34146342,0.5470627,GRCh38/hg38,17,43093220,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,32
5,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219804,930,47.96,16,c.4987-92A>G,p.(=),T,C,484,446,,,,,NM_007294.3,NM_007294,41219804,within,.,,rs8176233,0.3546,,,,,,,,,,,,,-,T,C,41219804,41219804,7341B20C52FFD4B9355840FB9CB56CDA,,,,,,,-1,BRCA1- 458780196,0,125749,17,,,,EMPTY,,D,,0,12,29,225491,492662,126000,,,0,0,,,,,92,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3128,15,1,0.75,0.35365853,0.45769918,GRCh38/hg38,17,43067787,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,32
3,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41215825,332,47.59,17,c.5152+66G>A,p.(=),C,T,174,158,,,,,NM_007294.3,NM_007294,41215825,within,.,,rs3092994,0.3425,,,,,,,,,,,,,-,C,T,41215825,41215825,5BCA8D2E1E3875817F84A3EB582CDFAB,,,,,,,-1,BRCA1- 458784175,0,55428,18,,,,EMPTY,,D,,0,9,24,241843,492662,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3139,16,1,0.5625,0.29268292,0.4908903,GRCh38/hg38,17,43063808,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,32
9,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41234470,543,51.75,12,c.4308T>C,p.(Ser1436=),A,G,262,281,TCT,TCC,S,S,NM_007294.3,NM_007294,41234470,within,.,,rs1060915,0.3363,0.2796,,,,,,,,,,,,-,A,G,41234470,41234470,B7237055CF1D42F022A050C072B7583B,,,,,,,-1,BRCA1- 458765530,-50,125703,13,,,,EMPTY,,D,,0,12,29,270833,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3433,11,1,0.75,0.35365853,0.5497339,GRCh38/hg38,17,43082453,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,32
12,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906729,739,56.16,10,c.1114A>C,p.(Asn372His),A,C,324,415,AAT,CAT,N,H,NM_000059.3,NM_000059,32906729,within,.,,rs144848,0.2494,0.2332,,0.32,0.861,,0.269,0.0,0.396,,,,,+,A,C,32906729,32906729,D514F785F1344AF9F6975E589D47BDF6,,,,,,,-1,BRCA2-  32906729,321,9329,10,,,,EMPTY,,D,,0,9,25,233635,493217,126000,,,0,0,,"1:1,2:1",,0.277,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2733,9,1,0.5625,0.30487806,0.47369617,GRCh38/hg38,13,32332592,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,32
23,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32930598,1029,49.37,15,c.7469T>C,p.(Ile2490Thr),T,C,521,508,ATA,ACA,I,T,NM_000059.3,NM_000059,32930598,within,.,,rs11571707,0.016,0.0016,,0.406,0.895,,0.837,0.0,-5.83,,,,,+,T,C,32930598,32930598,D7CAF30A58440FCA5E8E7BACD8E1EDE4,,,,,,,-1,BRCA2-  32930598,34,96852,15,,,,EMPTY,,D,,0,4,11,6837,493217,126000,,,0,0,,"1:5,2:2",,0.014,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0176,14,2,0.25,0.13414635,0.013862053,GRCh38/hg38,13,32356461,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,32
20,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,1340,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,1340,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,16,40,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,0.4878049,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,32
21,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,1927,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,1927,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,16,40,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,0.4878049,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,32
1,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32903685,1828,51.04,8,c.681+56C>T,p.(=),C,T,895,933,,,,,NM_000059.3,NM_000059,32903685,within,.,,rs2126042,0.1859,,,,,,,,,,,,,+,C,T,32903685,32903685,E9AEF840574909F4761D4EF7950E02CB,,,,,,,-1,BRCA2-  32903685,0,126192,8,,,,EMPTY,,D,,0,4,12,145186,493217,126000,,,0,0,,4:1,,,56,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2163,7,1,0.25,0.14634146,0.29436535,GRCh38/hg38,13,32329548,C,T,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,32
22,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,824,99.88,14,c.7397T>C,p.(Val2466Ala),T,C,1,823,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,16,39,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.47560975,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,32
24,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32936646,786,52.04,17,c.7806-14T>C,p.(=),T,C,377,409,,,,,NM_000059.3,NM_000059,32936646,within,.,,rs9534262,0.5316,0.5202,,,,,,,,,,,,+,T,C,32936646,32936646,5803939D8FBB75B042260991F0A62436,,,,,,,-1,BRCA2-  32936646,0,126158,17,,,,EMPTY,,D,,0,11,29,361616,493217,126000,,,0,0,,1:3,,0.52,14,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5255,16,1,0.6875,0.35365853,0.7331783,GRCh38/hg38,13,32362509,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,32
25,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32953388,974,49.38,22,c.8755-66T>C,p.(=),T,C,493,481,,,,,NM_000059.3,NM_000059,32953388,within,.,,rs4942486,0.5116,,,,,,,,,,,,,+,T,C,32953388,32953388,97C65B85894EB489F1BFA65897685241,,,,,,,-1,BRCA2-  32953388,0,126190,22,,,,EMPTY,,D,,0,11,30,347826,493217,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5257,21,1,0.6875,0.36585367,0.70521903,GRCh38/hg38,13,32379251,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,32
14,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244936,2140,99.81,10,c.2612C>T,p.(Pro871Leu),G,A,3,2136,CCG,CTG,P,L,NM_007294.3,NM_007294,41244936,within,.,,rs799917,0.5439,0.4932,,4.247,0.0,0.0,0.999,1.0,5.04,,,,,-,G,A,41244936,41244936,A19EA255CA888CE1FE48D08CAD633F1F,,,,,,,1,BRCA1- 458755064,-1485,41812,11,,,,EMPTY,,D,,1,12,29,290862,492662,126000,(eval),,0,0,,"1:4,2:1",,0.41,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.4127,9,3,0.75,0.35365853,0.59038854,GRCh38/hg38,17,43092919,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,33
7,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41223094,1631,100.0,15,c.4837A>G,p.(Ser1613Gly),T,C,0,1631,AGT,GGT,S,G,NM_007294.3,NM_007294,41223094,within,.,,rs1799966,0.3558,0.2982,,-0.194,0.968,0.038,0.814,0.0,1.5,,,,,-,T,C,41223094,41223094,E3C52286D31F229973DB3595B052645F,,,,,,,-1,BRCA1- 458776906,-150,41827,16,,,,EMPTY,,D,,0,12,29,273625,492662,126000,,,0,0,,1:1,,0.349,0,,,,,,,,,,,,,,Benign,Benign,0.255,113705,-1,,,,,,,,,,,3,0.35,14,1,0.75,0.35365853,0.5554011,GRCh38/hg38,17,43071077,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,33
8,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41231516,796,99.87,13,c.4358-2885G>A,p.(=),C,T,1,795,,,,,NM_007294.3,NM_007294,41231516,within,.,,rs8176193,0.3534,,,,,,,,,,,,,-,C,T,41231516,41231516,7F4F80D2D005D34CEA47E4A2C561B172,,,,,,,-1,BRCA1- 458768484,0,209399,14,,,,EMPTY,,D,,0,12,29,190200,492662,126000,,,0,0,,,,,2885,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.317,12,1,0.75,0.35365853,0.3860659,GRCh38/hg38,17,43079499,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,33
11,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244000,2555,99.65,10,c.3548A>G,p.(Lys1183Arg),T,C,9,2546,AAA,AGA,K,R,NM_007294.3,NM_007294,41244000,within,.,,rs16942,0.3526,0.2952,,-0.319,0.0,0.001,0.924,0.0,-2.35,,,,,-,T,C,41244000,41244000,37A54117EA353BDA677332A1F61FA173,,,,,,,-1,BRCA1- 458756000,-549,41818,11,,,,EMPTY,,D,,0,12,29,272437,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.75,0.35365853,0.55298966,GRCh38/hg38,17,43091983,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,33
16,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245466,3033,99.9,10,c.2082C>T,p.(Ser694=),G,A,3,3030,AGC,AGT,S,S,NM_007294.3,NM_007294,41245466,within,.,,rs1799949,0.3365,0.2957,,,,,,,,,,,,-,G,A,41245466,41245466,3364E3D252EFEDF917C74D44FBC6A381,,,,,,,-1,BRCA1- 458754534,1412,125536,11,,,,EMPTY,,D,,0,12,29,269442,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.75,0.35365853,0.54691046,GRCh38/hg38,17,43093449,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,33
13,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244435,1943,99.85,10,c.3113A>G,p.(Glu1038Gly),T,C,3,1940,GAA,GGA,E,G,NM_007294.3,NM_007294,41244435,within,.,,rs16941,0.3357,0.279,,-0.149,0.972,0.606,0.922,0.0,-0.974,,,,,-,T,C,41244435,41244435,5D0FF1321BAC3C76DD352C33CC33B93E,,,,,,,-1,BRCA1- 458755565,-984,41815,11,,,,EMPTY,,D,,0,12,29,270861,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,0.936,113705,-1,,,,,,,,,,,3,0.343,9,1,0.75,0.35365853,0.54979074,GRCh38/hg38,17,43092418,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,33
4,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219780,1049,100.0,16,c.4987-68A>G,p.(=),T,C,0,1049,,,,,NM_007294.3,NM_007294,41219780,within,.,,rs8176234,0.3546,,,,,,,,,,,,,-,T,C,41219780,41219780,5995ECC305C33150BF3BB2B0C22FCC2A,,,,,,,-1,BRCA1- 458780220,0,125746,17,,,,EMPTY,,D,,0,12,29,234031,492662,126000,,,0,0,,,,,68,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3148,15,1,0.75,0.35365853,0.47503358,GRCh38/hg38,17,43067763,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,33
15,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245237,805,100.0,10,c.2311T>C,p.(Leu771=),A,G,0,805,TTG,CTG,L,L,NM_007294.3,NM_007294,41245237,within,.,,rs16940,0.3353,0.2776,,,,,,,,,,,,-,A,G,41245237,41245237,711AF22D84A49E875C2B2A9597A95EE6,,,,,,,-1,BRCA1- 458754763,1641,125554,11,,,,EMPTY,,D,,0,12,28,269517,492662,126000,,,0,0,,1:1,,0.342,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3422,9,1,0.75,0.34146342,0.5470627,GRCh38/hg38,17,43093220,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,33
5,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219804,1050,100.0,16,c.4987-92A>G,p.(=),T,C,0,1050,,,,,NM_007294.3,NM_007294,41219804,within,.,,rs8176233,0.3546,,,,,,,,,,,,,-,T,C,41219804,41219804,7341B20C52FFD4B9355840FB9CB56CDA,,,,,,,-1,BRCA1- 458780196,0,125749,17,,,,EMPTY,,D,,0,12,29,225491,492662,126000,,,0,0,,,,,92,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3128,15,1,0.75,0.35365853,0.45769918,GRCh38/hg38,17,43067787,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,33
3,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41215825,334,100.0,17,c.5152+66G>A,p.(=),C,T,0,334,,,,,NM_007294.3,NM_007294,41215825,within,.,,rs3092994,0.3425,,,,,,,,,,,,,-,C,T,41215825,41215825,5BCA8D2E1E3875817F84A3EB582CDFAB,,,,,,,-1,BRCA1- 458784175,0,55428,18,,,,EMPTY,,D,,0,9,24,241843,492662,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3139,16,1,0.5625,0.29268292,0.4908903,GRCh38/hg38,17,43063808,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,33
9,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41234470,643,100.0,12,c.4308T>C,p.(Ser1436=),A,G,0,643,TCT,TCC,S,S,NM_007294.3,NM_007294,41234470,within,.,,rs1060915,0.3363,0.2796,,,,,,,,,,,,-,A,G,41234470,41234470,B7237055CF1D42F022A050C072B7583B,,,,,,,-1,BRCA1- 458765530,-50,125703,13,,,,EMPTY,,D,,0,12,29,270833,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3433,11,1,0.75,0.35365853,0.5497339,GRCh38/hg38,17,43082453,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,33
23,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32912299,1111,54.73,11,c.3807T>C,p.(Val1269=),T,C,503,608,GTT,GTC,V,V,NM_000059.3,NM_000059,32912299,within,.,,rs543304,0.1681,0.1911,,,,,,,,,,,,+,T,C,32912299,32912299,F2D3E8FFB3CEE8C1ACEA66738E41BC1E,,,,,,,-1,BRCA2-  32912299,1898,126022,11,,,,EMPTY,,D,,0,3,10,173719,493217,126000,,,0,0,,1:3,,0.176,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.1754,10,1,0.1875,0.12195122,0.35221615,GRCh38/hg38,13,32338162,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,33
29,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32953388,1363,47.25,22,c.8755-66T>C,p.(=),T,C,719,644,,,,,NM_000059.3,NM_000059,32953388,within,.,,rs4942486,0.5116,,,,,,,,,,,,,+,T,C,32953388,32953388,97C65B85894EB489F1BFA65897685241,,,,,,,-1,BRCA2-  32953388,0,126190,22,,,,EMPTY,,D,,0,11,30,347826,493217,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5257,21,1,0.6875,0.36585367,0.70521903,GRCh38/hg38,13,32379251,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,33
27,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,804,99.88,14,c.7397T>C,p.(Val2466Ala),T,C,1,803,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,16,39,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.47560975,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,33
1,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32903685,2215,49.57,8,c.681+56C>T,p.(=),C,T,1117,1098,,,,,NM_000059.3,NM_000059,32903685,within,.,,rs2126042,0.1859,,,,,,,,,,,,,+,C,T,32903685,32903685,E9AEF840574909F4761D4EF7950E02CB,,,,,,,-1,BRCA2-  32903685,0,126192,8,,,,EMPTY,,D,,0,4,12,145186,493217,126000,,,0,0,,4:1,,,56,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2163,7,1,0.25,0.14634146,0.29436535,GRCh38/hg38,13,32329548,C,T,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,33
28,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32936646,765,47.32,17,c.7806-14T>C,p.(=),T,C,403,362,,,,,NM_000059.3,NM_000059,32936646,within,.,,rs9534262,0.5316,0.5202,,,,,,,,,,,,+,T,C,32936646,32936646,5803939D8FBB75B042260991F0A62436,,,,,,,-1,BRCA2-  32936646,0,126158,17,,,,EMPTY,,D,,0,11,29,361616,493217,126000,,,0,0,,1:3,,0.52,14,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5255,16,1,0.6875,0.35365853,0.7331783,GRCh38/hg38,13,32362509,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,33
25,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,1294,99.92,11,c.4563A>G,p.(Leu1521=),A,G,1,1293,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,16,40,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,0.4878049,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,33
26,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,2304,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,2304,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,16,40,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,0.4878049,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,33
15,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244936,2042,99.71,10,c.2612C>T,p.(Pro871Leu),G,A,5,2036,CCG,CTG,P,L,NM_007294.3,NM_007294,41244936,within,.,,rs799917,0.5439,0.4932,,4.247,0.0,0.0,0.999,1.0,5.04,,,,,-,G,A,41244936,41244936,A19EA255CA888CE1FE48D08CAD633F1F,,,,,,,1,BRCA1- 458755064,-1485,41812,11,,,,EMPTY,,D,,1,12,29,290862,492662,126000,(eval),,0,0,,"1:4,2:1",,0.41,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.4127,9,3,0.75,0.35365853,0.59038854,GRCh38/hg38,17,43092919,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,34
17,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245466,3098,99.84,10,c.2082C>T,p.(Ser694=),G,A,4,3093,AGC,AGT,S,S,NM_007294.3,NM_007294,41245466,within,.,,rs1799949,0.3365,0.2957,,,,,,,,,,,,-,G,A,41245466,41245466,3364E3D252EFEDF917C74D44FBC6A381,,,,,,,-1,BRCA1- 458754534,1412,125536,11,,,,EMPTY,,D,,0,12,29,269442,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.75,0.35365853,0.54691046,GRCh38/hg38,17,43093449,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,34
13,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244000,2472,99.88,10,c.3548A>G,p.(Lys1183Arg),T,C,2,2469,AAA,AGA,K,R,NM_007294.3,NM_007294,41244000,within,.,,rs16942,0.3526,0.2952,,-0.319,0.0,0.001,0.924,0.0,-2.35,,,,,-,T,C,41244000,41244000,37A54117EA353BDA677332A1F61FA173,,,,,,,-1,BRCA1- 458756000,-549,41818,11,,,,EMPTY,,D,,0,12,29,272437,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.75,0.35365853,0.55298966,GRCh38/hg38,17,43091983,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,34
9,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41231516,851,100.0,13,c.4358-2885G>A,p.(=),C,T,0,851,,,,,NM_007294.3,NM_007294,41231516,within,.,,rs8176193,0.3534,,,,,,,,,,,,,-,C,T,41231516,41231516,7F4F80D2D005D34CEA47E4A2C561B172,,,,,,,-1,BRCA1- 458768484,0,209399,14,,,,EMPTY,,D,,0,12,29,190200,492662,126000,,,0,0,,,,,2885,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.317,12,1,0.75,0.35365853,0.3860659,GRCh38/hg38,17,43079499,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,34
5,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219780,1171,100.0,16,c.4987-68A>G,p.(=),T,C,0,1171,,,,,NM_007294.3,NM_007294,41219780,within,.,,rs8176234,0.3546,,,,,,,,,,,,,-,T,C,41219780,41219780,5995ECC305C33150BF3BB2B0C22FCC2A,,,,,,,-1,BRCA1- 458780220,0,125746,17,,,,EMPTY,,D,,0,12,29,234031,492662,126000,,,0,0,,,,,68,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3148,15,1,0.75,0.35365853,0.47503358,GRCh38/hg38,17,43067763,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,34
6,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219804,1171,99.91,16,c.4987-92A>G,p.(=),T,C,1,1170,,,,,NM_007294.3,NM_007294,41219804,within,.,,rs8176233,0.3546,,,,,,,,,,,,,-,T,C,41219804,41219804,7341B20C52FFD4B9355840FB9CB56CDA,,,,,,,-1,BRCA1- 458780196,0,125749,17,,,,EMPTY,,D,,0,12,29,225491,492662,126000,,,0,0,,,,,92,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3128,15,1,0.75,0.35365853,0.45769918,GRCh38/hg38,17,43067787,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,34
10,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41234470,703,100.0,12,c.4308T>C,p.(Ser1436=),A,G,0,703,TCT,TCC,S,S,NM_007294.3,NM_007294,41234470,within,.,,rs1060915,0.3363,0.2796,,,,,,,,,,,,-,A,G,41234470,41234470,B7237055CF1D42F022A050C072B7583B,,,,,,,-1,BRCA1- 458765530,-50,125703,13,,,,EMPTY,,D,,0,12,29,270833,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3433,11,1,0.75,0.35365853,0.5497339,GRCh38/hg38,17,43082453,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,34
8,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41223094,1553,99.94,15,c.4837A>G,p.(Ser1613Gly),T,C,1,1552,AGT,GGT,S,G,NM_007294.3,NM_007294,41223094,within,.,,rs1799966,0.3558,0.2982,,-0.194,0.968,0.038,0.814,0.0,1.5,,,,,-,T,C,41223094,41223094,E3C52286D31F229973DB3595B052645F,,,,,,,-1,BRCA1- 458776906,-150,41827,16,,,,EMPTY,,D,,0,12,29,273625,492662,126000,,,0,0,,1:1,,0.349,0,,,,,,,,,,,,,,Benign,Benign,0.255,113705,-1,,,,,,,,,,,3,0.35,14,1,0.75,0.35365853,0.5554011,GRCh38/hg38,17,43071077,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,34
16,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245237,617,99.84,10,c.2311T>C,p.(Leu771=),A,G,1,616,TTG,CTG,L,L,NM_007294.3,NM_007294,41245237,within,.,,rs16940,0.3353,0.2776,,,,,,,,,,,,-,A,G,41245237,41245237,711AF22D84A49E875C2B2A9597A95EE6,,,,,,,-1,BRCA1- 458754763,1641,125554,11,,,,EMPTY,,D,,0,12,28,269517,492662,126000,,,0,0,,1:1,,0.342,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3422,9,1,0.75,0.34146342,0.5470627,GRCh38/hg38,17,43093220,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,34
14,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244435,1804,99.94,10,c.3113A>G,p.(Glu1038Gly),T,C,1,1803,GAA,GGA,E,G,NM_007294.3,NM_007294,41244435,within,.,,rs16941,0.3357,0.279,,-0.149,0.972,0.606,0.922,0.0,-0.974,,,,,-,T,C,41244435,41244435,5D0FF1321BAC3C76DD352C33CC33B93E,,,,,,,-1,BRCA1- 458755565,-984,41815,11,,,,EMPTY,,D,,0,12,29,270861,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,0.936,113705,-1,,,,,,,,,,,3,0.343,9,1,0.75,0.35365853,0.54979074,GRCh38/hg38,17,43092418,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,34
27,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,2282,99.96,11,c.6513G>C,p.(Val2171=),G,C,0,2281,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,16,40,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,0.4878049,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,34
29,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,632,99.84,14,c.7397T>C,p.(Val2466Ala),T,C,1,631,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,16,39,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.47560975,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,34
2,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32953388,1458,99.86,22,c.8755-66T>C,p.(=),T,C,0,1456,,,,,NM_000059.3,NM_000059,32953388,within,.,,rs4942486,0.5116,,,,,,,,,,,,,+,T,C,32953388,32953388,97C65B85894EB489F1BFA65897685241,,,,,,,-1,BRCA2-  32953388,0,126190,22,,,,EMPTY,,D,,0,11,30,347826,493217,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5257,21,1,0.6875,0.36585367,0.70521903,GRCh38/hg38,13,32379251,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,34
28,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32929232,1064,50.47,14,c.7242A>G,p.(Ser2414=),A,G,527,537,TCA,TCG,S,S,NM_000059.3,NM_000059,32929232,within,.,,rs1799955,0.2326,0.2114,,,,,,,,,,,,+,A,G,32929232,32929232,6F8D6FF8BC9027D6C0351ADCEF41FD20,,,,,,,-1,BRCA2-  32929232,-194,126133,14,,,,EMPTY,,D,,0,8,16,192923,493217,126000,,,0,0,,"1:3,2:1",,0.224,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2257,13,1,0.5,0.19512194,0.39115238,GRCh38/hg38,13,32355095,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,34
1,D,BRCA2,,SNP,5'UTR,GRCh37/hg19,13,32890572,2094,53.01,2,c.-26G>A,p.(=),G,A,983,1110,,,,,NM_000059.3,NM_000059,32890572,within,.,,rs1799943,0.2093,0.2088,,,,,,,,,,,,+,G,A,32890572,32890572,A9C2B39455EF056EDB097A5953EB72EE,,,,,,,-1,BRCA2-  32890572,14,125965,2,,,,EMPTY,,D,,0,8,16,205902,493217,126000,,,0,0,,,,0.243,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2427,1,1,0.5,0.19512194,0.41746736,GRCh38/hg38,13,32316435,G,A,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,34
26,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,995,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,995,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,16,40,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,0.4878049,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,34
23,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906729,1167,48.33,10,c.1114A>C,p.(Asn372His),A,C,603,564,AAT,CAT,N,H,NM_000059.3,NM_000059,32906729,within,.,,rs144848,0.2494,0.2332,,0.32,0.861,,0.269,0.0,0.396,,,,,+,A,C,32906729,32906729,D514F785F1344AF9F6975E589D47BDF6,,,,,,,-1,BRCA2-  32906729,321,9329,10,,,,EMPTY,,D,,0,9,25,233635,493217,126000,,,0,0,,"1:1,2:1",,0.277,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2733,9,1,0.5625,0.30487806,0.47369617,GRCh38/hg38,13,32332592,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,34
25,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32911888,1753,50.03,11,c.3396A>G,p.(Lys1132=),A,G,875,877,AAA,AAG,K,K,NM_000059.3,NM_000059,32911888,within,.,,rs1801406,0.2668,0.2798,,,,,,,,,,,,+,A,G,32911888,32911888,94F2C0D328C28C466A38A430BBE75D52,,,,,,,-1,BRCA2-  32911888,1487,126010,11,,,,EMPTY,,D,,0,8,16,248687,493217,126000,,,0,0,,1:3,,0.293,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.295,10,1,0.5,0.19512194,0.50421417,GRCh38/hg38,13,32337751,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,34
30,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32936646,665,100.0,17,c.7806-14T>C,p.(=),T,C,0,665,,,,,NM_000059.3,NM_000059,32936646,within,.,,rs9534262,0.5316,0.5202,,,,,,,,,,,,+,T,C,32936646,32936646,5803939D8FBB75B042260991F0A62436,,,,,,,-1,BRCA2-  32936646,0,126158,17,,,,EMPTY,,D,,0,11,29,361616,493217,126000,,,0,0,,1:3,,0.52,14,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5255,16,1,0.6875,0.35365853,0.7331783,GRCh38/hg38,13,32362509,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,34
14,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244936,1527,49.25,10,c.2612C>T,p.(Pro871Leu),G,A,775,752,CCG,CTG,P,L,NM_007294.3,NM_007294,41244936,within,.,,rs799917,0.5439,0.4932,,4.247,0.0,0.0,0.999,1.0,5.04,,,,,-,G,A,41244936,41244936,A19EA255CA888CE1FE48D08CAD633F1F,,,,,,,1,BRCA1- 458755064,-1485,41812,11,,,,EMPTY,,D,,1,12,29,290862,492662,126000,(eval),,0,0,,"1:4,2:1",,0.41,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.4127,9,3,0.75,0.35365853,0.59038854,GRCh38/hg38,17,43092919,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,35
7,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41223094,1165,50.21,15,c.4837A>G,p.(Ser1613Gly),T,C,580,585,AGT,GGT,S,G,NM_007294.3,NM_007294,41223094,within,.,,rs1799966,0.3558,0.2982,,-0.194,0.968,0.038,0.814,0.0,1.5,,,,,-,T,C,41223094,41223094,E3C52286D31F229973DB3595B052645F,,,,,,,-1,BRCA1- 458776906,-150,41827,16,,,,EMPTY,,D,,0,12,29,273625,492662,126000,,,0,0,,1:1,,0.349,0,,,,,,,,,,,,,,Benign,Benign,0.255,113705,-1,,,,,,,,,,,3,0.35,14,1,0.75,0.35365853,0.5554011,GRCh38/hg38,17,43071077,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,35
8,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41231516,914,47.37,13,c.4358-2885G>A,p.(=),C,T,481,433,,,,,NM_007294.3,NM_007294,41231516,within,.,,rs8176193,0.3534,,,,,,,,,,,,,-,C,T,41231516,41231516,7F4F80D2D005D34CEA47E4A2C561B172,,,,,,,-1,BRCA1- 458768484,0,209399,14,,,,EMPTY,,D,,0,12,29,190200,492662,126000,,,0,0,,,,,2885,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.317,12,1,0.75,0.35365853,0.3860659,GRCh38/hg38,17,43079499,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,35
11,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244000,1714,50.76,10,c.3548A>G,p.(Lys1183Arg),T,C,844,870,AAA,AGA,K,R,NM_007294.3,NM_007294,41244000,within,.,,rs16942,0.3526,0.2952,,-0.319,0.0,0.001,0.924,0.0,-2.35,,,,,-,T,C,41244000,41244000,37A54117EA353BDA677332A1F61FA173,,,,,,,-1,BRCA1- 458756000,-549,41818,11,,,,EMPTY,,D,,0,12,29,272437,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.75,0.35365853,0.55298966,GRCh38/hg38,17,43091983,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,35
16,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245466,2021,49.88,10,c.2082C>T,p.(Ser694=),G,A,1012,1008,AGC,AGT,S,S,NM_007294.3,NM_007294,41245466,within,.,,rs1799949,0.3365,0.2957,,,,,,,,,,,,-,G,A,41245466,41245466,3364E3D252EFEDF917C74D44FBC6A381,,,,,,,-1,BRCA1- 458754534,1412,125536,11,,,,EMPTY,,D,,0,12,29,269442,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.75,0.35365853,0.54691046,GRCh38/hg38,17,43093449,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,35
13,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244435,1430,47.97,10,c.3113A>G,p.(Glu1038Gly),T,C,744,686,GAA,GGA,E,G,NM_007294.3,NM_007294,41244435,within,.,,rs16941,0.3357,0.279,,-0.149,0.972,0.606,0.922,0.0,-0.974,,,,,-,T,C,41244435,41244435,5D0FF1321BAC3C76DD352C33CC33B93E,,,,,,,-1,BRCA1- 458755565,-984,41815,11,,,,EMPTY,,D,,0,12,29,270861,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,0.936,113705,-1,,,,,,,,,,,3,0.343,9,1,0.75,0.35365853,0.54979074,GRCh38/hg38,17,43092418,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,35
4,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219780,853,52.64,16,c.4987-68A>G,p.(=),T,C,404,449,,,,,NM_007294.3,NM_007294,41219780,within,.,,rs8176234,0.3546,,,,,,,,,,,,,-,T,C,41219780,41219780,5995ECC305C33150BF3BB2B0C22FCC2A,,,,,,,-1,BRCA1- 458780220,0,125746,17,,,,EMPTY,,D,,0,12,29,234031,492662,126000,,,0,0,,,,,68,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3148,15,1,0.75,0.35365853,0.47503358,GRCh38/hg38,17,43067763,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,35
15,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245237,375,51.2,10,c.2311T>C,p.(Leu771=),A,G,182,192,TTG,CTG,L,L,NM_007294.3,NM_007294,41245237,within,.,,rs16940,0.3353,0.2776,,,,,,,,,,,,-,A,G,41245237,41245237,711AF22D84A49E875C2B2A9597A95EE6,,,,,,,-1,BRCA1- 458754763,1641,125554,11,,,,EMPTY,,D,,0,12,28,269517,492662,126000,,,0,0,,1:1,,0.342,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3422,9,1,0.75,0.34146342,0.5470627,GRCh38/hg38,17,43093220,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,35
5,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219804,851,52.76,16,c.4987-92A>G,p.(=),T,C,402,449,,,,,NM_007294.3,NM_007294,41219804,within,.,,rs8176233,0.3546,,,,,,,,,,,,,-,T,C,41219804,41219804,7341B20C52FFD4B9355840FB9CB56CDA,,,,,,,-1,BRCA1- 458780196,0,125749,17,,,,EMPTY,,D,,0,12,29,225491,492662,126000,,,0,0,,,,,92,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3128,15,1,0.75,0.35365853,0.45769918,GRCh38/hg38,17,43067787,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,35
9,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41234470,613,43.88,12,c.4308T>C,p.(Ser1436=),A,G,344,269,TCT,TCC,S,S,NM_007294.3,NM_007294,41234470,within,.,,rs1060915,0.3363,0.2796,,,,,,,,,,,,-,A,G,41234470,41234470,B7237055CF1D42F022A050C072B7583B,,,,,,,-1,BRCA1- 458765530,-50,125703,13,,,,EMPTY,,D,,0,12,29,270833,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3433,11,1,0.75,0.35365853,0.5497339,GRCh38/hg38,17,43082453,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,35
2,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32953388,1206,100.0,22,c.8755-66T>C,p.(=),T,C,0,1206,,,,,NM_000059.3,NM_000059,32953388,within,.,,rs4942486,0.5116,,,,,,,,,,,,,+,T,C,32953388,32953388,97C65B85894EB489F1BFA65897685241,,,,,,,-1,BRCA2-  32953388,0,126190,22,,,,EMPTY,,D,,0,11,30,347826,493217,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5257,21,1,0.6875,0.36585367,0.70521903,GRCh38/hg38,13,32379251,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,35
27,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,340,100.0,14,c.7397T>C,p.(Val2466Ala),T,C,0,340,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,16,39,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.47560975,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,35
1,D,BRCA2,,SNP,5'UTR,GRCh37/hg19,13,32890572,1516,54.62,2,c.-26G>A,p.(=),G,A,687,828,,,,,NM_000059.3,NM_000059,32890572,within,.,,rs1799943,0.2093,0.2088,,,,,,,,,,,,+,G,A,32890572,32890572,A9C2B39455EF056EDB097A5953EB72EE,,,,,,,-1,BRCA2-  32890572,14,125965,2,,,,EMPTY,,D,,0,8,16,205902,493217,126000,,,0,0,,,,0.243,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2427,1,1,0.5,0.19512194,0.41746736,GRCh38/hg38,13,32316435,G,A,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,35
23,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32911888,1316,51.98,11,c.3396A>G,p.(Lys1132=),A,G,632,684,AAA,AAG,K,K,NM_000059.3,NM_000059,32911888,within,.,,rs1801406,0.2668,0.2798,,,,,,,,,,,,+,A,G,32911888,32911888,94F2C0D328C28C466A38A430BBE75D52,,,,,,,-1,BRCA2-  32911888,1487,126010,11,,,,EMPTY,,D,,0,8,16,248687,493217,126000,,,0,0,,1:3,,0.293,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.295,10,1,0.5,0.19512194,0.50421417,GRCh38/hg38,13,32337751,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,35
12,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32903685,1272,49.61,8,c.681+56C>T,p.(=),C,T,641,631,,,,,NM_000059.3,NM_000059,32903685,within,.,,rs2126042,0.1859,,,,,,,,,,,,,+,C,T,32903685,32903685,E9AEF840574909F4761D4EF7950E02CB,,,,,,,-1,BRCA2-  32903685,0,126192,8,,,,EMPTY,,D,,0,4,12,145186,493217,126000,,,0,0,,4:1,,,56,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2163,7,1,0.25,0.14634146,0.29436535,GRCh38/hg38,13,32329548,C,T,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,35
26,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32929232,671,57.53,14,c.7242A>G,p.(Ser2414=),A,G,285,386,TCA,TCG,S,S,NM_000059.3,NM_000059,32929232,within,.,,rs1799955,0.2326,0.2114,,,,,,,,,,,,+,A,G,32929232,32929232,6F8D6FF8BC9027D6C0351ADCEF41FD20,,,,,,,-1,BRCA2-  32929232,-194,126133,14,,,,EMPTY,,D,,0,8,16,192923,493217,126000,,,0,0,,"1:3,2:1",,0.224,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2257,13,1,0.5,0.19512194,0.39115238,GRCh38/hg38,13,32355095,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,35
25,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,1708,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,1708,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,16,40,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,0.4878049,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,35
28,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32936646,426,100.0,17,c.7806-14T>C,p.(=),T,C,0,426,,,,,NM_000059.3,NM_000059,32936646,within,.,,rs9534262,0.5316,0.5202,,,,,,,,,,,,+,T,C,32936646,32936646,5803939D8FBB75B042260991F0A62436,,,,,,,-1,BRCA2-  32936646,0,126158,17,,,,EMPTY,,D,,0,11,29,361616,493217,126000,,,0,0,,1:3,,0.52,14,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5255,16,1,0.6875,0.35365853,0.7331783,GRCh38/hg38,13,32362509,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,35
24,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,639,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,639,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,16,40,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,0.4878049,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,35
3,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41251931,1277,52.39,7,c.442-34C>T,p.(=),G,A,608,669,,,,,NM_007294.3,NM_007294,41251931,within,.,,rs799923,0.0986,0.1757,,,,,,,,,,,,-,G,A,41251931,41251931,A5CCEFE1E7B19A106A59AB89C8776C53,,,,,,,-1,BRCA1- 458748069,0,125864,8,,,,EMPTY,,D,,0,3,9,181678,492662,126000,,,0,0,,,,0.174,34,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.1711,6,1,0.1875,0.1097561,0.36876804,GRCh38/hg38,17,43099914,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,36
9,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,898,99.78,14,c.7397T>C,p.(Val2466Ala),T,C,2,896,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,16,39,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.47560975,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,36
8,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,1699,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,1699,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,16,40,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,0.4878049,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,36
7,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,1050,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,1050,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,16,40,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,0.4878049,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,36
10,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32930598,888,46.85,15,c.7469T>C,p.(Ile2490Thr),T,C,472,416,ATA,ACA,I,T,NM_000059.3,NM_000059,32930598,within,.,,rs11571707,0.016,0.0016,,0.406,0.895,,0.837,0.0,-5.83,,,,,+,T,C,32930598,32930598,D7CAF30A58440FCA5E8E7BACD8E1EDE4,,,,,,,-1,BRCA2-  32930598,34,96852,15,,,,EMPTY,,D,,0,4,11,6837,493217,126000,,,0,0,,"1:5,2:2",,0.014,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0176,14,2,0.25,0.13414635,0.013862053,GRCh38/hg38,13,32356461,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,36
6,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906729,559,100.0,10,c.1114A>C,p.(Asn372His),A,C,0,559,AAT,CAT,N,H,NM_000059.3,NM_000059,32906729,within,.,,rs144848,0.2494,0.2332,,0.32,0.861,,0.269,0.0,0.396,,,,,+,A,C,32906729,32906729,D514F785F1344AF9F6975E589D47BDF6,,,,,,,-1,BRCA2-  32906729,321,9329,10,,,,EMPTY,,D,,0,9,25,233635,493217,126000,,,0,0,,"1:1,2:1",,0.277,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2733,9,1,0.5625,0.30487806,0.47369617,GRCh38/hg38,13,32332592,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,36
10,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244936,996,50.3,10,c.2612C>T,p.(Pro871Leu),G,A,495,501,CCG,CTG,P,L,NM_007294.3,NM_007294,41244936,within,.,,rs799917,0.5439,0.4932,,4.247,0.0,0.0,0.999,1.0,5.04,,,,,-,G,A,41244936,41244936,A19EA255CA888CE1FE48D08CAD633F1F,,,,,,,1,BRCA1- 458755064,-1485,41812,11,,,,EMPTY,,D,,1,12,29,290862,492662,126000,(eval),,0,0,,"1:4,2:1",,0.41,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.4127,9,3,0.75,0.35365853,0.59038854,GRCh38/hg38,17,43092919,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,37
4,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41223094,730,50.41,15,c.4837A>G,p.(Ser1613Gly),T,C,362,368,AGT,GGT,S,G,NM_007294.3,NM_007294,41223094,within,.,,rs1799966,0.3558,0.2982,,-0.194,0.968,0.038,0.814,0.0,1.5,,,,,-,T,C,41223094,41223094,E3C52286D31F229973DB3595B052645F,,,,,,,-1,BRCA1- 458776906,-150,41827,16,,,,EMPTY,,D,,0,12,29,273625,492662,126000,,,0,0,,1:1,,0.349,0,,,,,,,,,,,,,,Benign,Benign,0.255,113705,-1,,,,,,,,,,,3,0.35,14,1,0.75,0.35365853,0.5554011,GRCh38/hg38,17,43071077,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,37
11,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245237,450,50.22,10,c.2311T>C,p.(Leu771=),A,G,224,226,TTG,CTG,L,L,NM_007294.3,NM_007294,41245237,within,.,,rs16940,0.3353,0.2776,,,,,,,,,,,,-,A,G,41245237,41245237,711AF22D84A49E875C2B2A9597A95EE6,,,,,,,-1,BRCA1- 458754763,1641,125554,11,,,,EMPTY,,D,,0,12,28,269517,492662,126000,,,0,0,,1:1,,0.342,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3422,9,1,0.75,0.34146342,0.5470627,GRCh38/hg38,17,43093220,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,37
8,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244000,1176,48.47,10,c.3548A>G,p.(Lys1183Arg),T,C,606,570,AAA,AGA,K,R,NM_007294.3,NM_007294,41244000,within,.,,rs16942,0.3526,0.2952,,-0.319,0.0,0.001,0.924,0.0,-2.35,,,,,-,T,C,41244000,41244000,37A54117EA353BDA677332A1F61FA173,,,,,,,-1,BRCA1- 458756000,-549,41818,11,,,,EMPTY,,D,,0,12,29,272437,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.75,0.35365853,0.55298966,GRCh38/hg38,17,43091983,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,37
25,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219780,592,45.1,16,c.4987-68A>G,p.(=),T,C,325,267,,,,,NM_007294.3,NM_007294,41219780,within,.,,rs8176234,0.3546,,,,,,,,,,,,,-,T,C,41219780,41219780,5995ECC305C33150BF3BB2B0C22FCC2A,,,,,,,-1,BRCA1- 458780220,0,125746,17,,,,EMPTY,,D,,0,12,29,234031,492662,126000,,,0,0,,,,,68,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3148,15,1,0.75,0.35365853,0.47503358,GRCh38/hg38,17,43067763,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,37
13,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245466,1491,47.42,10,c.2082C>T,p.(Ser694=),G,A,784,707,AGC,AGT,S,S,NM_007294.3,NM_007294,41245466,within,.,,rs1799949,0.3365,0.2957,,,,,,,,,,,,-,G,A,41245466,41245466,3364E3D252EFEDF917C74D44FBC6A381,,,,,,,-1,BRCA1- 458754534,1412,125536,11,,,,EMPTY,,D,,0,12,29,269442,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.75,0.35365853,0.54691046,GRCh38/hg38,17,43093449,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,37
9,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244435,905,52.93,10,c.3113A>G,p.(Glu1038Gly),T,C,426,479,GAA,GGA,E,G,NM_007294.3,NM_007294,41244435,within,.,,rs16941,0.3357,0.279,,-0.149,0.972,0.606,0.922,0.0,-0.974,,,,,-,T,C,41244435,41244435,5D0FF1321BAC3C76DD352C33CC33B93E,,,,,,,-1,BRCA1- 458755565,-984,41815,11,,,,EMPTY,,D,,0,12,29,270861,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,0.936,113705,-1,,,,,,,,,,,3,0.343,9,1,0.75,0.35365853,0.54979074,GRCh38/hg38,17,43092418,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,37
2,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219804,593,45.53,16,c.4987-92A>G,p.(=),T,C,323,270,,,,,NM_007294.3,NM_007294,41219804,within,.,,rs8176233,0.3546,,,,,,,,,,,,,-,T,C,41219804,41219804,7341B20C52FFD4B9355840FB9CB56CDA,,,,,,,-1,BRCA1- 458780196,0,125749,17,,,,EMPTY,,D,,0,12,29,225491,492662,126000,,,0,0,,,,,92,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3128,15,1,0.75,0.35365853,0.45769918,GRCh38/hg38,17,43067787,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,37
6,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41234470,326,52.15,12,c.4308T>C,p.(Ser1436=),A,G,156,170,TCT,TCC,S,S,NM_007294.3,NM_007294,41234470,within,.,,rs1060915,0.3363,0.2796,,,,,,,,,,,,-,A,G,41234470,41234470,B7237055CF1D42F022A050C072B7583B,,,,,,,-1,BRCA1- 458765530,-50,125703,13,,,,EMPTY,,D,,0,12,29,270833,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3433,11,1,0.75,0.35365853,0.5497339,GRCh38/hg38,17,43082453,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,37
5,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41231516,271,51.29,13,c.4358-2885G>A,p.(=),C,T,132,139,,,,,NM_007294.3,NM_007294,41231516,within,.,,rs8176193,0.3534,,,,,,,,,,,,,-,C,T,41231516,41231516,7F4F80D2D005D34CEA47E4A2C561B172,,,,,,,-1,BRCA1- 458768484,0,209399,14,,,,EMPTY,,D,,0,12,29,190200,492662,126000,,,0,0,,,,,2885,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.317,12,1,0.75,0.35365853,0.3860659,GRCh38/hg38,17,43079499,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,37
24,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41215825,101,52.48,17,c.5152+66G>A,p.(=),C,T,48,53,,,,,NM_007294.3,NM_007294,41215825,within,.,,rs3092994,0.3425,,,,,,,,,,,,,-,C,T,41215825,41215825,5BCA8D2E1E3875817F84A3EB582CDFAB,,,,,,,-1,BRCA1- 458784175,0,55428,18,,,,EMPTY,,D,,0,9,24,241843,492662,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3139,16,1,0.5625,0.29268292,0.4908903,GRCh38/hg38,17,43063808,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,37
20,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,374,100.0,14,c.7397T>C,p.(Val2466Ala),T,C,0,374,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,16,39,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.47560975,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,37
12,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,421,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,421,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,16,40,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,0.4878049,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,37
19,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,915,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,915,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,16,40,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,0.4878049,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,37
21,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32930598,453,52.1,15,c.7469T>C,p.(Ile2490Thr),T,C,217,236,ATA,ACA,I,T,NM_000059.3,NM_000059,32930598,within,.,,rs11571707,0.016,0.0016,,0.406,0.895,,0.837,0.0,-5.83,,,,,+,T,C,32930598,32930598,D7CAF30A58440FCA5E8E7BACD8E1EDE4,,,,,,,-1,BRCA2-  32930598,34,96852,15,,,,EMPTY,,D,,0,4,11,6837,493217,126000,,,0,0,,"1:5,2:2",,0.014,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0176,14,2,0.25,0.13414635,0.013862053,GRCh38/hg38,13,32356461,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,37
1,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906729,463,100.0,10,c.1114A>C,p.(Asn372His),A,C,0,463,AAT,CAT,N,H,NM_000059.3,NM_000059,32906729,within,.,,rs144848,0.2494,0.2332,,0.32,0.861,,0.269,0.0,0.396,,,,,+,A,C,32906729,32906729,D514F785F1344AF9F6975E589D47BDF6,,,,,,,-1,BRCA2-  32906729,321,9329,10,,,,EMPTY,,D,,0,9,25,233635,493217,126000,,,0,0,,"1:1,2:1",,0.277,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2733,9,1,0.5625,0.30487806,0.47369617,GRCh38/hg38,13,32332592,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,37
15,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244936,952,52.1,10,c.2612C>T,p.(Pro871Leu),G,A,456,496,CCG,CTG,P,L,NM_007294.3,NM_007294,41244936,within,.,,rs799917,0.5439,0.4932,,4.247,0.0,0.0,0.999,1.0,5.04,,,,,-,G,A,41244936,41244936,A19EA255CA888CE1FE48D08CAD633F1F,,,,,,,1,BRCA1- 458755064,-1485,41812,11,,,,EMPTY,,D,,1,12,29,290862,492662,126000,(eval),,0,0,,"1:4,2:1",,0.41,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.4127,9,3,0.75,0.35365853,0.59038854,GRCh38/hg38,17,43092919,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,38
17,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245466,1455,49.14,10,c.2082C>T,p.(Ser694=),G,A,740,715,AGC,AGT,S,S,NM_007294.3,NM_007294,41245466,within,.,,rs1799949,0.3365,0.2957,,,,,,,,,,,,-,G,A,41245466,41245466,3364E3D252EFEDF917C74D44FBC6A381,,,,,,,-1,BRCA1- 458754534,1412,125536,11,,,,EMPTY,,D,,0,12,29,269442,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.75,0.35365853,0.54691046,GRCh38/hg38,17,43093449,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,38
13,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244000,1169,53.04,10,c.3548A>G,p.(Lys1183Arg),T,C,549,620,AAA,AGA,K,R,NM_007294.3,NM_007294,41244000,within,.,,rs16942,0.3526,0.2952,,-0.319,0.0,0.001,0.924,0.0,-2.35,,,,,-,T,C,41244000,41244000,37A54117EA353BDA677332A1F61FA173,,,,,,,-1,BRCA1- 458756000,-549,41818,11,,,,EMPTY,,D,,0,12,29,272437,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.75,0.35365853,0.55298966,GRCh38/hg38,17,43091983,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,38
9,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41231516,377,49.34,13,c.4358-2885G>A,p.(=),C,T,191,186,,,,,NM_007294.3,NM_007294,41231516,within,.,,rs8176193,0.3534,,,,,,,,,,,,,-,C,T,41231516,41231516,7F4F80D2D005D34CEA47E4A2C561B172,,,,,,,-1,BRCA1- 458768484,0,209399,14,,,,EMPTY,,D,,0,12,29,190200,492662,126000,,,0,0,,,,,2885,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.317,12,1,0.75,0.35365853,0.3860659,GRCh38/hg38,17,43079499,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,38
5,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219780,698,53.44,16,c.4987-68A>G,p.(=),T,C,325,373,,,,,NM_007294.3,NM_007294,41219780,within,.,,rs8176234,0.3546,,,,,,,,,,,,,-,T,C,41219780,41219780,5995ECC305C33150BF3BB2B0C22FCC2A,,,,,,,-1,BRCA1- 458780220,0,125746,17,,,,EMPTY,,D,,0,12,29,234031,492662,126000,,,0,0,,,,,68,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3148,15,1,0.75,0.35365853,0.47503358,GRCh38/hg38,17,43067763,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,38
10,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41234470,366,50.27,12,c.4308T>C,p.(Ser1436=),A,G,182,184,TCT,TCC,S,S,NM_007294.3,NM_007294,41234470,within,.,,rs1060915,0.3363,0.2796,,,,,,,,,,,,-,A,G,41234470,41234470,B7237055CF1D42F022A050C072B7583B,,,,,,,-1,BRCA1- 458765530,-50,125703,13,,,,EMPTY,,D,,0,12,29,270833,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3433,11,1,0.75,0.35365853,0.5497339,GRCh38/hg38,17,43082453,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,38
6,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219804,696,53.02,16,c.4987-92A>G,p.(=),T,C,327,369,,,,,NM_007294.3,NM_007294,41219804,within,.,,rs8176233,0.3546,,,,,,,,,,,,,-,T,C,41219804,41219804,7341B20C52FFD4B9355840FB9CB56CDA,,,,,,,-1,BRCA1- 458780196,0,125749,17,,,,EMPTY,,D,,0,12,29,225491,492662,126000,,,0,0,,,,,92,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3128,15,1,0.75,0.35365853,0.45769918,GRCh38/hg38,17,43067787,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,38
4,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41215825,81,46.91,17,c.5152+66G>A,p.(=),C,T,43,38,,,,,NM_007294.3,NM_007294,41215825,within,.,,rs3092994,0.3425,,,,,,,,,,,,,-,C,T,41215825,41215825,5BCA8D2E1E3875817F84A3EB582CDFAB,,,,,,,-1,BRCA1- 458784175,0,55428,18,,,,EMPTY,,D,,0,9,24,241843,492662,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3139,16,1,0.5625,0.29268292,0.4908903,GRCh38/hg38,17,43063808,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,38
8,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41223094,651,53.15,15,c.4837A>G,p.(Ser1613Gly),T,C,305,346,AGT,GGT,S,G,NM_007294.3,NM_007294,41223094,within,.,,rs1799966,0.3558,0.2982,,-0.194,0.968,0.038,0.814,0.0,1.5,,,,,-,T,C,41223094,41223094,E3C52286D31F229973DB3595B052645F,,,,,,,-1,BRCA1- 458776906,-150,41827,16,,,,EMPTY,,D,,0,12,29,273625,492662,126000,,,0,0,,1:1,,0.349,0,,,,,,,,,,,,,,Benign,Benign,0.255,113705,-1,,,,,,,,,,,3,0.35,14,1,0.75,0.35365853,0.5554011,GRCh38/hg38,17,43071077,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,38
16,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245237,324,49.07,10,c.2311T>C,p.(Leu771=),A,G,165,159,TTG,CTG,L,L,NM_007294.3,NM_007294,41245237,within,.,,rs16940,0.3353,0.2776,,,,,,,,,,,,-,A,G,41245237,41245237,711AF22D84A49E875C2B2A9597A95EE6,,,,,,,-1,BRCA1- 458754763,1641,125554,11,,,,EMPTY,,D,,0,12,28,269517,492662,126000,,,0,0,,1:1,,0.342,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3422,9,1,0.75,0.34146342,0.5470627,GRCh38/hg38,17,43093220,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,38
14,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244435,901,51.05,10,c.3113A>G,p.(Glu1038Gly),T,C,441,460,GAA,GGA,E,G,NM_007294.3,NM_007294,41244435,within,.,,rs16941,0.3357,0.279,,-0.149,0.972,0.606,0.922,0.0,-0.974,,,,,-,T,C,41244435,41244435,5D0FF1321BAC3C76DD352C33CC33B93E,,,,,,,-1,BRCA1- 458755565,-984,41815,11,,,,EMPTY,,D,,0,12,29,270861,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,0.936,113705,-1,,,,,,,,,,,3,0.343,9,1,0.75,0.35365853,0.54979074,GRCh38/hg38,17,43092418,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,38
2,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32953388,760,100.0,22,c.8755-66T>C,p.(=),T,C,0,760,,,,,NM_000059.3,NM_000059,32953388,within,.,,rs4942486,0.5116,,,,,,,,,,,,,+,T,C,32953388,32953388,97C65B85894EB489F1BFA65897685241,,,,,,,-1,BRCA2-  32953388,0,126190,22,,,,EMPTY,,D,,0,11,30,347826,493217,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5257,21,1,0.6875,0.36585367,0.70521903,GRCh38/hg38,13,32379251,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,38
27,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,284,100.0,14,c.7397T>C,p.(Val2466Ala),T,C,0,284,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,16,39,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.47560975,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,38
1,D,BRCA2,,SNP,5'UTR,GRCh37/hg19,13,32890572,997,55.97,2,c.-26G>A,p.(=),G,A,439,558,,,,,NM_000059.3,NM_000059,32890572,within,.,,rs1799943,0.2093,0.2088,,,,,,,,,,,,+,G,A,32890572,32890572,A9C2B39455EF056EDB097A5953EB72EE,,,,,,,-1,BRCA2-  32890572,14,125965,2,,,,EMPTY,,D,,0,8,16,205902,493217,126000,,,0,0,,,,0.243,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2427,1,1,0.5,0.19512194,0.41746736,GRCh38/hg38,13,32316435,G,A,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,38
23,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32911888,865,48.44,11,c.3396A>G,p.(Lys1132=),A,G,445,419,AAA,AAG,K,K,NM_000059.3,NM_000059,32911888,within,.,,rs1801406,0.2668,0.2798,,,,,,,,,,,,+,A,G,32911888,32911888,94F2C0D328C28C466A38A430BBE75D52,,,,,,,-1,BRCA2-  32911888,1487,126010,11,,,,EMPTY,,D,,0,8,16,248687,493217,126000,,,0,0,,1:3,,0.293,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.295,10,1,0.5,0.19512194,0.50421417,GRCh38/hg38,13,32337751,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,38
12,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32903685,944,50.53,8,c.681+56C>T,p.(=),C,T,467,477,,,,,NM_000059.3,NM_000059,32903685,within,.,,rs2126042,0.1859,,,,,,,,,,,,,+,C,T,32903685,32903685,E9AEF840574909F4761D4EF7950E02CB,,,,,,,-1,BRCA2-  32903685,0,126192,8,,,,EMPTY,,D,,0,4,12,145186,493217,126000,,,0,0,,4:1,,,56,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2163,7,1,0.25,0.14634146,0.29436535,GRCh38/hg38,13,32329548,C,T,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,38
26,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32929232,475,49.05,14,c.7242A>G,p.(Ser2414=),A,G,242,233,TCA,TCG,S,S,NM_000059.3,NM_000059,32929232,within,.,,rs1799955,0.2326,0.2114,,,,,,,,,,,,+,A,G,32929232,32929232,6F8D6FF8BC9027D6C0351ADCEF41FD20,,,,,,,-1,BRCA2-  32929232,-194,126133,14,,,,EMPTY,,D,,0,8,16,192923,493217,126000,,,0,0,,"1:3,2:1",,0.224,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2257,13,1,0.5,0.19512194,0.39115238,GRCh38/hg38,13,32355095,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,38
25,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,1024,99.9,11,c.6513G>C,p.(Val2171=),G,C,0,1023,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,16,40,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,0.4878049,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,38
28,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32936646,335,100.0,17,c.7806-14T>C,p.(=),T,C,0,335,,,,,NM_000059.3,NM_000059,32936646,within,.,,rs9534262,0.5316,0.5202,,,,,,,,,,,,+,T,C,32936646,32936646,5803939D8FBB75B042260991F0A62436,,,,,,,-1,BRCA2-  32936646,0,126158,17,,,,EMPTY,,D,,0,11,29,361616,493217,126000,,,0,0,,1:3,,0.52,14,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5255,16,1,0.6875,0.35365853,0.7331783,GRCh38/hg38,13,32362509,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,38
24,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,460,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,460,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,16,40,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,0.4878049,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,38
11,A,BRCA1,37445,INDEL,frameshift,GRCh37/hg19,17,41245442,917,53.44,10,c.2105dup,p.(Leu702Phefs*10),TAA,TAAA,426,490,TTA,TTTAACAAATGCACCTGGTTCTTTTACTAA,L,FNKCTWFFY*,NM_007294.3,NM_007294,41245442,within,.,,rs80357880,,,,,,,,,,,,,,-,-,A,41245442,41245443,86A74A5E0379B7B5A9A8D8798254ED0C,,1,,,,,5,BRCA1- 458754558,1436,37445,11,,,,EMPTY,,A,,4,1,2,10,492662,126000,"""Patogenica en clinvar  Interpretation:     Pathogenic  Review status:     reviewed by expert panel  Submissions:     12  First in ClinVar:     Apr 1, 2014 Most recent Submission:     Mar 11, 2023 Last evaluated:     Sep 8, 2016 Accession:     VCV000037445.20 Variation ID:     37445 Description:     1bp duplication  """,,0,0,,,,,0,,,,,,,,,,,,,,Pathogenic,Pathogenic,,113705,-1,,,,,,,,,,,3,,9,5,0.0625,0.024390243,2.0297892E-5,GRCh38/hg38,17,43093425,TAA,TAAA,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,39
9,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244936,1321,99.92,10,c.2612C>T,p.(Pro871Leu),G,A,1,1320,CCG,CTG,P,L,NM_007294.3,NM_007294,41244936,within,.,,rs799917,0.5439,0.4932,,4.247,0.0,0.0,0.999,1.0,5.04,,,,,-,G,A,41244936,41244936,A19EA255CA888CE1FE48D08CAD633F1F,,,,,,,1,BRCA1- 458755064,-1485,41812,11,,,,EMPTY,,D,,1,12,29,290862,492662,126000,(eval),,0,0,,"1:4,2:1",,0.41,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.4127,9,3,0.75,0.35365853,0.59038854,GRCh38/hg38,17,43092919,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,39
26,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219780,828,99.88,16,c.4987-68A>G,p.(=),T,C,1,827,,,,,NM_007294.3,NM_007294,41219780,within,.,,rs8176234,0.3546,,,,,,,,,,,,,-,T,C,41219780,41219780,5995ECC305C33150BF3BB2B0C22FCC2A,,,,,,,-1,BRCA1- 458780220,0,125746,17,,,,EMPTY,,D,,0,12,29,234031,492662,126000,,,0,0,,,,,68,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3148,15,1,0.75,0.35365853,0.47503358,GRCh38/hg38,17,43067763,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,39
4,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41231516,513,100.0,13,c.4358-2885G>A,p.(=),C,T,0,513,,,,,NM_007294.3,NM_007294,41231516,within,.,,rs8176193,0.3534,,,,,,,,,,,,,-,C,T,41231516,41231516,7F4F80D2D005D34CEA47E4A2C561B172,,,,,,,-1,BRCA1- 458768484,0,209399,14,,,,EMPTY,,D,,0,12,29,190200,492662,126000,,,0,0,,,,,2885,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.317,12,1,0.75,0.35365853,0.3860659,GRCh38/hg38,17,43079499,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,39
27,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219804,828,100.0,16,c.4987-92A>G,p.(=),T,C,0,828,,,,,NM_007294.3,NM_007294,41219804,within,.,,rs8176233,0.3546,,,,,,,,,,,,,-,T,C,41219804,41219804,7341B20C52FFD4B9355840FB9CB56CDA,,,,,,,-1,BRCA1- 458780196,0,125749,17,,,,EMPTY,,D,,0,12,29,225491,492662,126000,,,0,0,,,,,92,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3128,15,1,0.75,0.35365853,0.45769918,GRCh38/hg38,17,43067787,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,39
5,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41234470,651,99.85,12,c.4308T>C,p.(Ser1436=),A,G,1,650,TCT,TCC,S,S,NM_007294.3,NM_007294,41234470,within,.,,rs1060915,0.3363,0.2796,,,,,,,,,,,,-,A,G,41234470,41234470,B7237055CF1D42F022A050C072B7583B,,,,,,,-1,BRCA1- 458765530,-50,125703,13,,,,EMPTY,,D,,0,12,29,270833,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3433,11,1,0.75,0.35365853,0.5497339,GRCh38/hg38,17,43082453,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,39
8,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244435,1256,99.84,10,c.3113A>G,p.(Glu1038Gly),T,C,2,1254,GAA,GGA,E,G,NM_007294.3,NM_007294,41244435,within,.,,rs16941,0.3357,0.279,,-0.149,0.972,0.606,0.922,0.0,-0.974,,,,,-,T,C,41244435,41244435,5D0FF1321BAC3C76DD352C33CC33B93E,,,,,,,-1,BRCA1- 458755565,-984,41815,11,,,,EMPTY,,D,,0,12,29,270861,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,0.936,113705,-1,,,,,,,,,,,3,0.343,9,1,0.75,0.35365853,0.54979074,GRCh38/hg38,17,43092418,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,39
25,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41215825,159,100.0,17,c.5152+66G>A,p.(=),C,T,0,159,,,,,NM_007294.3,NM_007294,41215825,within,.,,rs3092994,0.3425,,,,,,,,,,,,,-,C,T,41215825,41215825,5BCA8D2E1E3875817F84A3EB582CDFAB,,,,,,,-1,BRCA1- 458784175,0,55428,18,,,,EMPTY,,D,,0,9,24,241843,492662,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3139,16,1,0.5625,0.29268292,0.4908903,GRCh38/hg38,17,43063808,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,39
13,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245466,1900,99.79,10,c.2082C>T,p.(Ser694=),G,A,3,1896,AGC,AGT,S,S,NM_007294.3,NM_007294,41245466,within,.,,rs1799949,0.3365,0.2957,,,,,,,,,,,,-,G,A,41245466,41245466,3364E3D252EFEDF917C74D44FBC6A381,,,,,,,-1,BRCA1- 458754534,1412,125536,11,,,,EMPTY,,D,,0,12,29,269442,492662,126000,,,0,0,,1:2,2,0.348,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.75,0.35365853,0.54691046,GRCh38/hg38,17,43093449,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,39
7,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244000,1657,99.7,10,c.3548A>G,p.(Lys1183Arg),T,C,5,1652,AAA,AGA,K,R,NM_007294.3,NM_007294,41244000,within,.,,rs16942,0.3526,0.2952,,-0.319,0.0,0.001,0.924,0.0,-2.35,,,,,-,T,C,41244000,41244000,37A54117EA353BDA677332A1F61FA173,,,,,,,-1,BRCA1- 458756000,-549,41818,11,,,,EMPTY,,D,,0,12,29,272437,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.75,0.35365853,0.55298966,GRCh38/hg38,17,43091983,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,39
10,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245237,428,100.0,10,c.2311T>C,p.(Leu771=),A,G,0,428,TTG,CTG,L,L,NM_007294.3,NM_007294,41245237,within,.,,rs16940,0.3353,0.2776,,,,,,,,,,,,-,A,G,41245237,41245237,711AF22D84A49E875C2B2A9597A95EE6,,,,,,,-1,BRCA1- 458754763,1641,125554,11,,,,EMPTY,,D,,0,12,28,269517,492662,126000,,,0,0,,1:1,,0.342,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3422,9,1,0.75,0.34146342,0.5470627,GRCh38/hg38,17,43093220,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,39
3,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41223094,973,100.0,15,c.4837A>G,p.(Ser1613Gly),T,C,0,973,AGT,GGT,S,G,NM_007294.3,NM_007294,41223094,within,.,,rs1799966,0.3558,0.2982,,-0.194,0.968,0.038,0.814,0.0,1.5,,,,,-,T,C,41223094,41223094,E3C52286D31F229973DB3595B052645F,,,,,,,-1,BRCA1- 458776906,-150,41827,16,,,,EMPTY,,D,,0,12,29,273625,492662,126000,,,0,0,,1:1,,0.349,0,,,,,,,,,,,,,,Benign,Benign,0.255,113705,-1,,,,,,,,,,,3,0.35,14,1,0.75,0.35365853,0.5554011,GRCh38/hg38,17,43071077,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,39
23,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,480,100.0,14,c.7397T>C,p.(Val2466Ala),T,C,0,480,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,16,39,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.47560975,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,39
21,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,578,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,578,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,16,40,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,0.4878049,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,39
12,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32912299,487,100.0,11,c.3807T>C,p.(Val1269=),T,C,0,487,GTT,GTC,V,V,NM_000059.3,NM_000059,32912299,within,.,,rs543304,0.1681,0.1911,,,,,,,,,,,,+,T,C,32912299,32912299,F2D3E8FFB3CEE8C1ACEA66738E41BC1E,,,,,,,-1,BRCA2-  32912299,1898,126022,11,,,,EMPTY,,D,,0,3,10,173719,493217,126000,,,0,0,,1:3,,0.176,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.1754,10,1,0.1875,0.12195122,0.35221615,GRCh38/hg38,13,32338162,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,39
22,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,1226,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,1226,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,16,40,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,0.4878049,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,39
3,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,2356,99.92,11,c.6513G>C,p.(Val2171=),G,C,0,2354,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,16,40,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,0.4878049,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,42
12,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32899388,557,50.45,4,c.425+67A>C,p.(=),A,C,276,281,,,,,NM_000059.3,NM_000059,32899388,within,.,,rs11571610,0.0743,,,,,,,,,,,,,+,A,C,32899388,32899388,1AF346DE380A738371905EBFBCED20E1,,,,,,,-1,BRCA2-  32899388,0,126095,4,,,,EMPTY,,D,,0,4,8,39349,493217,126000,,,0,0,,2:1,,,67,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0306,3,3,0.25,0.09756097,0.0797803,GRCh38/hg38,13,32325251,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,42
1,D,BRCA2,,SNP,5'UTR,GRCh37/hg19,13,32890572,2468,50.61,2,c.-26G>A,p.(=),G,A,1219,1249,,,,,NM_000059.3,NM_000059,32890572,within,.,,rs1799943,0.2093,0.2088,,,,,,,,,,,,+,G,A,32890572,32890572,A9C2B39455EF056EDB097A5953EB72EE,,,,,,,-1,BRCA2-  32890572,14,125965,2,,,,EMPTY,,D,,0,8,16,205902,493217,126000,,,0,0,,,,0.243,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2427,1,1,0.5,0.19512194,0.41746736,GRCh38/hg38,13,32316435,G,A,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,42
8,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32953388,1494,99.8,22,c.8755-66T>C,p.(=),T,C,3,1491,,,,,NM_000059.3,NM_000059,32953388,within,.,,rs4942486,0.5116,,,,,,,,,,,,,+,T,C,32953388,32953388,97C65B85894EB489F1BFA65897685241,,,,,,,-1,BRCA2-  32953388,0,126190,22,,,,EMPTY,,D,,0,11,30,347826,493217,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5257,21,1,0.6875,0.36585367,0.70521903,GRCh38/hg38,13,32379251,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,42
21,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32911888,1228,53.18,11,c.3396A>G,p.(Lys1132=),A,G,574,653,AAA,AAG,K,K,NM_000059.3,NM_000059,32911888,within,.,,rs1801406,0.2668,0.2798,,,,,,,,,,,,+,A,G,32911888,32911888,94F2C0D328C28C466A38A430BBE75D52,,,,,,,-1,BRCA2-  32911888,1487,126010,11,,,,EMPTY,,D,,0,8,16,248687,493217,126000,,,0,0,,1:3,,0.293,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.295,10,1,0.5,0.19512194,0.50421417,GRCh38/hg38,13,32337751,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,42
18,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32906980,1982,45.16,10,c.1365A>G,p.(Ser455=),A,G,1087,895,TCA,TCG,S,S,NM_000059.3,NM_000059,32906980,within,.,,rs1801439,0.0737,0.031,,,,,,,,,,,,+,A,G,32906980,32906980,C76C22E555E869928B452D866988AB4F,,,,,,,-1,BRCA2-  32906980,-545,125943,10,,,,EMPTY,,D,,0,4,8,41480,493217,126000,,,0,0,,"1:4,2:1",,0.051,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0499,9,2,0.25,0.09756097,0.08410091,GRCh38/hg38,13,32332843,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,42
19,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32910721,1695,48.55,11,c.2229T>C,p.(His743=),T,C,872,823,CAT,CAC,H,H,NM_000059.3,NM_000059,32910721,within,.,,rs1801499,0.0735,0.0313,,,,,,,,,,,,+,T,C,32910721,32910721,D39471F16FE6D1F6752C2D4D179996AF,,,,,,,-1,BRCA2-  32910721,320,125979,11,,,,EMPTY,,D,,0,4,8,41536,493217,126000,,,0,0,,1:1,,0.052,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0503,10,1,0.25,0.09756097,0.08421446,GRCh38/hg38,13,32336584,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,42
22,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,751,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,751,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,16,40,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,0.4878049,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,42
7,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32936646,455,99.78,17,c.7806-14T>C,p.(=),T,C,1,454,,,,,NM_000059.3,NM_000059,32936646,within,.,,rs9534262,0.5316,0.5202,,,,,,,,,,,,+,T,C,32936646,32936646,5803939D8FBB75B042260991F0A62436,,,,,,,-1,BRCA2-  32936646,0,126158,17,,,,EMPTY,,D,,0,11,29,361616,493217,126000,,,0,0,,1:3,,0.52,14,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5255,16,1,0.6875,0.35365853,0.7331783,GRCh38/hg38,13,32362509,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,42
20,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32911463,611,52.86,11,c.2971A>G,p.(Asn991Asp),A,G,288,323,AAC,GAC,N,D,NM_000059.3,NM_000059,32911463,within,.,,rs1799944,0.0801,0.0373,,-0.04,0.0,,0.959,0.0,3.08,,,,,+,A,G,32911463,32911463,36F4F7E6CD788E45B30EA486775D07D6,,,,,,,-1,BRCA2-  32911463,1062,41545,11,,,,EMPTY,,D,,0,4,8,42142,493217,126000,,,0,0,,1:2,,0.053,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0522,10,1,0.25,0.09756097,0.085443124,GRCh38/hg38,13,32337326,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,42
6,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32929478,1070,51.96,14,c.7435+53C>T,p.(=),C,T,514,556,,,,,NM_000059.3,NM_000059,32929478,within,.,,rs11147489,0.0725,,,,,,,,,,,,,+,C,T,32929478,32929478,F692B4BE5DCD39FA887FE8D63D296720,,,,,,,-1,BRCA2-  32929478,0,126136,14,,,,EMPTY,,D,,0,4,8,36369,493217,126000,,,0,0,,,,,53,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0301,13,3,0.25,0.09756097,0.07373834,GRCh38/hg38,13,32355341,C,T,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,42
2,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32914236,1249,51.4,11,c.5744C>T,p.(Thr1915Met),C,T,607,642,ACG,ATG,T,M,NM_000059.3,NM_000059,32914236,within,.,,rs4987117,0.0086,0.0211,,-1.105,0.674,,0.286,0.0,0.623,,,,,+,C,T,32914236,32914236,9B18380606AE96F8022F8AB5893BFD77,,,,,,,-1,BRCA2-  32914236,-1098,41556,11,,,,EMPTY,,D,,0,3,4,22222,493217,126000,,,0,0,,"1:4,2:1",,0.018,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0179,10,2,0.1875,0.048780486,0.045055218,GRCh38/hg38,13,32340099,C,T,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,42
17,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906480,689,44.41,10,c.865A>C,p.(Asn289His),A,C,383,306,AAT,CAT,N,H,NM_000059.3,NM_000059,32906480,within,.,,rs766173,0.0737,0.0312,,0.498,0.998,,0.803,0.0,1.73,,,,,+,A,C,32906480,32906480,EE0CD2A1633CE9FEF0978528634002FE,,,,,,,-1,BRCA2-  32906480,72,41567,10,,,,EMPTY,,D,,0,4,8,41272,493217,126000,,,0,0,,"1:4,2:1",,0.051,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0496,9,2,0.25,0.09756097,0.08367919,GRCh38/hg38,13,32332343,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,42
5,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,454,100.0,14,c.7397T>C,p.(Val2466Ala),T,C,0,454,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,16,39,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.47560975,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,42
4,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32929232,607,51.24,14,c.7242A>G,p.(Ser2414=),A,G,296,311,TCA,TCG,S,S,NM_000059.3,NM_000059,32929232,within,.,,rs1799955,0.2326,0.2114,,,,,,,,,,,,+,A,G,32929232,32929232,6F8D6FF8BC9027D6C0351ADCEF41FD20,,,,,,,-1,BRCA2-  32929232,-194,126133,14,,,,EMPTY,,D,,0,8,16,192923,493217,126000,,,0,0,,"1:3,2:1",,0.224,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2257,13,1,0.5,0.19512194,0.39115238,GRCh38/hg38,13,32355095,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,42
14,A,BRCA1,54583,INDEL,nonsense,GRCh37/hg19,17,41245060,923,49.51,10,c.2486_2487del,p.(Phe829*),TAAA,TA,465,457,TTT,TAA,F,*,NM_007294.3,NM_007294,41245060,within,.,,rs80357658,,,,,,,,,,,,,,-,AA,-,41245061,41245062,2E93618376886C0AB3E241B28BBD9DF6,,1,,,,,-1,BRCA1- 458754940,-1610,54583,11,,,,EMPTY,,A,,2,1,1,5,492662,126000,,,0,0,,,,,0,,,,,,,,,,,,,,Pathogenic,Pathogenic,,113705,-1,,,,,,,,,,,3,,9,5,0.0625,0.0121951215,1.0148946E-5,GRCh38/hg38,17,43093043,TAAA,TA,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,43
13,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244936,1153,44.58,10,c.2612C>T,p.(Pro871Leu),G,A,639,514,CCG,CTG,P,L,NM_007294.3,NM_007294,41244936,within,.,,rs799917,0.5439,0.4932,,4.247,0.0,0.0,0.999,1.0,5.04,,,,,-,G,A,41244936,41244936,A19EA255CA888CE1FE48D08CAD633F1F,,,,,,,1,BRCA1- 458755064,-1485,41812,11,,,,EMPTY,,D,,1,12,29,290862,492662,126000,(eval),,0,0,,"1:4,2:1",2,0.41,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.4127,9,3,0.75,0.35365853,0.59038854,GRCh38/hg38,17,43092919,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,43
10,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244000,1672,50.6,10,c.3548A>G,p.(Lys1183Arg),T,C,826,846,AAA,AGA,K,R,NM_007294.3,NM_007294,41244000,within,.,,rs16942,0.3526,0.2952,,-0.319,0.0,0.001,0.924,0.0,-2.35,,,,,-,T,C,41244000,41244000,37A54117EA353BDA677332A1F61FA173,,,,,,,-1,BRCA1- 458756000,-549,41818,11,,,,EMPTY,,D,,0,12,29,272437,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.75,0.35365853,0.55298966,GRCh38/hg38,17,43091983,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,43
8,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41234470,638,49.53,12,c.4308T>C,p.(Ser1436=),A,G,322,316,TCT,TCC,S,S,NM_007294.3,NM_007294,41234470,within,.,,rs1060915,0.3363,0.2796,,,,,,,,,,,,-,A,G,41234470,41234470,B7237055CF1D42F022A050C072B7583B,,,,,,,-1,BRCA1- 458765530,-50,125703,13,,,,EMPTY,,D,,0,12,29,270833,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3433,11,1,0.75,0.35365853,0.5497339,GRCh38/hg38,17,43082453,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,43
7,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41231516,660,52.12,13,c.4358-2885G>A,p.(=),C,T,316,344,,,,,NM_007294.3,NM_007294,41231516,within,.,,rs8176193,0.3534,,,,,,,,,,,,,-,C,T,41231516,41231516,7F4F80D2D005D34CEA47E4A2C561B172,,,,,,,-1,BRCA1- 458768484,0,209399,14,,,,EMPTY,,D,,0,12,29,190200,492662,126000,,,0,0,,,,,2885,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.317,12,1,0.75,0.35365853,0.3860659,GRCh38/hg38,17,43079499,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,43
11,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244435,1318,46.21,10,c.3113A>G,p.(Glu1038Gly),T,C,709,609,GAA,GGA,E,G,NM_007294.3,NM_007294,41244435,within,.,,rs16941,0.3357,0.279,,-0.149,0.972,0.606,0.922,0.0,-0.974,,,,,-,T,C,41244435,41244435,5D0FF1321BAC3C76DD352C33CC33B93E,,,,,,,-1,BRCA1- 458755565,-984,41815,11,,,,EMPTY,,D,,0,12,29,270861,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,0.936,113705,-1,,,,,,,,,,,3,0.343,9,1,0.75,0.35365853,0.54979074,GRCh38/hg38,17,43092418,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,43
17,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41246481,1680,46.43,10,c.1067A>G,p.(Gln356Arg),T,C,900,780,CAG,CGG,Q,R,NM_007294.3,NM_007294,41246481,within,.,,rs1799950,0.0218,0.0459,,2.371,0.995,0.988,0.992,0.0218,3.71,,,,,-,T,C,41246481,41246481,DE7889D7BF4EEED5C3D165470529DA1E,,,,,,,-1,BRCA1- 458753519,397,41803,11,,,,EMPTY,,D,,0,1,1,61808,492662,126000,,,0,0,,"1:6,2:1",,0.044,0,,,,,,,,,,,,,,Benign,Benign,0.998,113705,-1,,,,,,,,,,,3,0.0471,9,3,0.0625,0.0121951215,0.12545721,GRCh38/hg38,17,43094464,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,43
16,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245466,2207,46.94,10,c.2082C>T,p.(Ser694=),G,A,1170,1036,AGC,AGT,S,S,NM_007294.3,NM_007294,41245466,within,.,,rs1799949,0.3365,0.2957,,,,,,,,,,,,-,G,A,41245466,41245466,3364E3D252EFEDF917C74D44FBC6A381,,,,,,,-1,BRCA1- 458754534,1412,125536,11,,,,EMPTY,,D,,0,12,29,269442,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.75,0.35365853,0.54691046,GRCh38/hg38,17,43093449,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,43
2,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41215825,157,50.96,17,c.5152+66G>A,p.(=),C,T,77,80,,,,,NM_007294.3,NM_007294,41215825,within,.,,rs3092994,0.3425,,,,,,,,,,,,,-,C,T,41215825,41215825,5BCA8D2E1E3875817F84A3EB582CDFAB,,,,,,,-1,BRCA1- 458784175,0,55428,18,,,,EMPTY,,D,,0,9,24,241843,492662,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3139,16,1,0.5625,0.29268292,0.4908903,GRCh38/hg38,17,43063808,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,43
4,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219804,1140,54.56,16,c.4987-92A>G,p.(=),T,C,518,622,,,,,NM_007294.3,NM_007294,41219804,within,.,,rs8176233,0.3546,,,,,,,,,,,,,-,T,C,41219804,41219804,7341B20C52FFD4B9355840FB9CB56CDA,,,,,,,-1,BRCA1- 458780196,0,125749,17,,,,EMPTY,,D,,0,12,29,225491,492662,126000,,,0,0,,,,,92,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3128,15,1,0.75,0.35365853,0.45769918,GRCh38/hg38,17,43067787,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,43
15,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245237,468,47.86,10,c.2311T>C,p.(Leu771=),A,G,244,224,TTG,CTG,L,L,NM_007294.3,NM_007294,41245237,within,.,,rs16940,0.3353,0.2776,,,,,,,,,,,,-,A,G,41245237,41245237,711AF22D84A49E875C2B2A9597A95EE6,,,,,,,-1,BRCA1- 458754763,1641,125554,11,,,,EMPTY,,D,,0,12,28,269517,492662,126000,,,0,0,,1:1,,0.342,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3422,9,1,0.75,0.34146342,0.5470627,GRCh38/hg38,17,43093220,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,43
19,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41251931,658,48.48,7,c.442-34C>T,p.(=),G,A,339,319,,,,,NM_007294.3,NM_007294,41251931,within,.,,rs799923,0.0986,0.1757,,,,,,,,,,,,-,G,A,41251931,41251931,A5CCEFE1E7B19A106A59AB89C8776C53,,,,,,,-1,BRCA1- 458748069,0,125864,8,,,,EMPTY,,D,,0,3,9,181678,492662,126000,,,0,0,,,,0.174,34,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.1711,6,1,0.1875,0.1097561,0.36876804,GRCh38/hg38,17,43099914,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,43
3,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219780,1140,54.56,16,c.4987-68A>G,p.(=),T,C,518,622,,,,,NM_007294.3,NM_007294,41219780,within,.,,rs8176234,0.3546,,,,,,,,,,,,,-,T,C,41219780,41219780,5995ECC305C33150BF3BB2B0C22FCC2A,,,,,,,-1,BRCA1- 458780220,0,125746,17,,,,EMPTY,,D,,0,12,29,234031,492662,126000,,,0,0,,,,,68,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3148,15,1,0.75,0.35365853,0.47503358,GRCh38/hg38,17,43067763,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,43
6,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41223094,1157,50.48,15,c.4837A>G,p.(Ser1613Gly),T,C,573,584,AGT,GGT,S,G,NM_007294.3,NM_007294,41223094,within,.,,rs1799966,0.3558,0.2982,,-0.194,0.968,0.038,0.814,0.0,1.5,,,,,-,T,C,41223094,41223094,E3C52286D31F229973DB3595B052645F,,,,,,,-1,BRCA1- 458776906,-150,41827,16,,,,EMPTY,,D,,0,12,29,273625,492662,126000,,,0,0,,1:1,,0.349,0,,,,,,,,,,,,,,Benign,Benign,0.255,113705,-1,,,,,,,,,,,3,0.35,14,1,0.75,0.35365853,0.5554011,GRCh38/hg38,17,43071077,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,43
23,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32912299,569,49.21,11,c.3807T>C,p.(Val1269=),T,C,289,280,GTT,GTC,V,V,NM_000059.3,NM_000059,32912299,within,.,,rs543304,0.1681,0.1911,,,,,,,,,,,,+,T,C,32912299,32912299,F2D3E8FFB3CEE8C1ACEA66738E41BC1E,,,,,,,-1,BRCA2-  32912299,1898,126022,11,,,,EMPTY,,D,,0,3,10,173719,493217,126000,,,0,0,,1:3,,0.176,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.1754,10,1,0.1875,0.12195122,0.35221615,GRCh38/hg38,13,32338162,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,43
12,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906729,860,48.26,10,c.1114A>C,p.(Asn372His),A,C,445,415,AAT,CAT,N,H,NM_000059.3,NM_000059,32906729,within,.,,rs144848,0.2494,0.2332,,0.32,0.861,,0.269,0.0,0.396,,,,,+,A,C,32906729,32906729,D514F785F1344AF9F6975E589D47BDF6,,,,,,,-1,BRCA2-  32906729,321,9329,10,,,,EMPTY,,D,,0,9,25,233635,493217,126000,,,0,0,,"1:1,2:1",,0.277,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2733,9,1,0.5625,0.30487806,0.47369617,GRCh38/hg38,13,32332592,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,43
25,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,678,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,678,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,16,40,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,0.4878049,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,43
26,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,1503,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,1503,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,16,40,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,0.4878049,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,43
28,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,443,100.0,14,c.7397T>C,p.(Val2466Ala),T,C,0,443,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,16,39,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.47560975,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,43
7,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,126,100.0,14,c.7397T>C,p.(Val2466Ala),T,C,0,126,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,19,81,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.9878049,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,44
5,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,341,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,341,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,19,82,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,1.0,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,44
4,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,142,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,142,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,19,82,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,1.0,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,44
1,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906729,254,51.18,10,c.1114A>C,p.(Asn372His),A,C,124,130,AAT,CAT,N,H,NM_000059.3,NM_000059,32906729,within,.,,rs144848,0.2494,0.2332,,0.32,0.861,,0.269,0.0,0.396,,,,,+,A,C,32906729,32906729,D514F785F1344AF9F6975E589D47BDF6,,,,,,,-1,BRCA2-  32906729,321,9329,10,,,,EMPTY,,D,,0,12,51,233635,493217,126000,,,0,0,,"1:1,2:1",,0.277,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2733,9,1,0.6315789,0.6219512,0.47369617,GRCh38/hg38,13,32332592,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,44
3,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32912299,127,49.61,11,c.3807T>C,p.(Val1269=),T,C,64,63,GTT,GTC,V,V,NM_000059.3,NM_000059,32912299,within,.,,rs543304,0.1681,0.1911,,,,,,,,,,,,+,T,C,32912299,32912299,F2D3E8FFB3CEE8C1ACEA66738E41BC1E,,,,,,,-1,BRCA2-  32912299,1898,126022,11,,,,EMPTY,,D,,0,5,20,173719,493217,126000,,,0,0,,1:3,,0.176,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.1754,10,1,0.2631579,0.24390244,0.35221615,GRCh38/hg38,13,32338162,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,44
1,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32903685,314,47.13,8,c.681+56C>T,p.(=),C,T,166,148,,,,,NM_000059.3,NM_000059,32903685,within,.,,rs2126042,0.1859,,,,,,,,,,,,,+,C,T,32903685,32903685,E9AEF840574909F4761D4EF7950E02CB,,,,,,,-1,BRCA2-  32903685,0,126192,8,,,,EMPTY,,D,,0,3,21,145186,493217,126000,,,0,0,,4:1,,,56,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2163,7,1,0.15789473,0.25609756,0.29436535,GRCh38/hg38,13,32329548,C,T,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,45
6,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,149,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,149,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,19,82,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,1.0,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,45
9,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32936646,127,58.27,17,c.7806-14T>C,p.(=),T,C,53,74,,,,,NM_000059.3,NM_000059,32936646,within,.,,rs9534262,0.5316,0.5202,,,,,,,,,,,,+,T,C,32936646,32936646,5803939D8FBB75B042260991F0A62436,,,,,,,-1,BRCA2-  32936646,0,126158,17,,,,EMPTY,,D,,0,13,61,361616,493217,126000,,,0,0,,1:3,,0.52,14,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5255,16,1,0.68421054,0.74390244,0.7331783,GRCh38/hg38,13,32362509,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,45
12,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32972884,197,49.75,27,c.10234A>G,p.(Ile3412Val),A,G,99,98,ATT,GTT,I,V,NM_000059.3,NM_000059,32972884,within,.,,rs1801426,0.0449,0.0373,,0.556,0.077,,0.019,0.0,-0.286,,,,,+,A,G,32972884,32972884,FD2873D8FA6A6E3D4D35F2ACC4046DA1,,,,,,,-1,BRCA2-  32972884,586,41540,27,,,,EMPTY,,D,,0,2,4,10858,493217,126000,,,0,0,,"1:5,2:2",,0.022,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0248,26,2,0.10526316,0.048780486,0.022014651,GRCh38/hg38,13,32398747,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,45
5,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32912299,165,51.52,11,c.3807T>C,p.(Val1269=),T,C,80,85,GTT,GTC,V,V,NM_000059.3,NM_000059,32912299,within,.,,rs543304,0.1681,0.1911,,,,,,,,,,,,+,T,C,32912299,32912299,F2D3E8FFB3CEE8C1ACEA66738E41BC1E,,,,,,,-1,BRCA2-  32912299,1898,126022,11,,,,EMPTY,,D,,0,5,20,173719,493217,126000,,,0,0,,1:3,,0.176,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.1754,10,1,0.2631579,0.24390244,0.35221615,GRCh38/hg38,13,32338162,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,45
8,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,159,100.0,14,c.7397T>C,p.(Val2466Ala),T,C,0,159,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,19,81,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.9878049,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,45
10,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32953388,226,46.9,22,c.8755-66T>C,p.(=),T,C,120,106,,,,,NM_000059.3,NM_000059,32953388,within,.,,rs4942486,0.5116,,,,,,,,,,,,,+,T,C,32953388,32953388,97C65B85894EB489F1BFA65897685241,,,,,,,-1,BRCA2-  32953388,0,126190,22,,,,EMPTY,,D,,0,13,61,347826,493217,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5257,21,1,0.68421054,0.74390244,0.70521903,GRCh38/hg38,13,32379251,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,45
7,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,326,99.69,11,c.6513G>C,p.(Val2171=),G,C,0,325,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,19,82,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,1.0,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,45
13,A,BRCA2,233359,SNP,nonsense,GRCh37/hg19,13,32929356,218,50.46,14,c.7366C>T,p.(Gln2456*),C,T,108,110,CAG,TAG,Q,*,NM_000059.3,NM_000059,32929356,within,.,,rs397507912,,,,1.379,,,0.511,1.0,4.1,,,,,+,C,T,32929356,32929356,B6CFEE0B37DC7957124AEF4901AA6AEC,,1,,,,,-1,BRCA2-  32929356,-70,233359,14,,,,EMPTY,,A,,1,1,1,3,493217,126000,,,0,0,,,,,0,,,,,,,,,,,,,,Pathogenic,Pathogenic,,600185,-1,,,,,,,,,,,3,,13,5,0.05263158,0.0121951215,6.0825155E-6,GRCh38/hg38,13,32355219,C,T,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,46
14,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,218,100.0,14,c.7397T>C,p.(Val2466Ala),T,C,0,218,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,19,81,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.9878049,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,46
10,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,175,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,175,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,19,82,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,1.0,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,46
12,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32929232,200,52.0,14,c.7242A>G,p.(Ser2414=),A,G,96,104,TCA,TCG,S,S,NM_000059.3,NM_000059,32929232,within,.,,rs1799955,0.2326,0.2114,,,,,,,,,,,,+,A,G,32929232,32929232,6F8D6FF8BC9027D6C0351ADCEF41FD20,,,,,,,-1,BRCA2-  32929232,-194,126133,14,,,,EMPTY,,D,,0,5,31,192923,493217,126000,,,0,0,,"1:3,2:1",,0.224,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2257,13,1,0.2631579,0.37804878,0.39115238,GRCh38/hg38,13,32355095,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,46
8,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906729,296,55.74,10,c.1114A>C,p.(Asn372His),A,C,131,165,AAT,CAT,N,H,NM_000059.3,NM_000059,32906729,within,.,,rs144848,0.2494,0.2332,,0.32,0.861,,0.269,0.0,0.396,,,,,+,A,C,32906729,32906729,D514F785F1344AF9F6975E589D47BDF6,,,,,,,-1,BRCA2-  32906729,321,9329,10,,,,EMPTY,,D,,0,12,51,233635,493217,126000,,,0,0,,"1:1,2:1",,0.277,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2733,9,1,0.6315789,0.6219512,0.47369617,GRCh38/hg38,13,32332592,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,46
2,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32936646,177,48.02,17,c.7806-14T>C,p.(=),T,C,92,85,,,,,NM_000059.3,NM_000059,32936646,within,.,,rs9534262,0.5316,0.5202,,,,,,,,,,,,+,T,C,32936646,32936646,5803939D8FBB75B042260991F0A62436,,,,,,,-1,BRCA2-  32936646,0,126158,17,,,,EMPTY,,D,,0,13,61,361616,493217,126000,,,0,0,,1:3,,0.52,14,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5255,16,1,0.68421054,0.74390244,0.7331783,GRCh38/hg38,13,32362509,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,46
3,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32953388,270,47.41,22,c.8755-66T>C,p.(=),T,C,142,128,,,,,NM_000059.3,NM_000059,32953388,within,.,,rs4942486,0.5116,,,,,,,,,,,,,+,T,C,32953388,32953388,97C65B85894EB489F1BFA65897685241,,,,,,,-1,BRCA2-  32953388,0,126190,22,,,,EMPTY,,D,,0,13,61,347826,493217,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5257,21,1,0.68421054,0.74390244,0.70521903,GRCh38/hg38,13,32379251,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,46
15,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32930598,181,51.38,15,c.7469T>C,p.(Ile2490Thr),T,C,88,93,ATA,ACA,I,T,NM_000059.3,NM_000059,32930598,within,.,,rs11571707,0.016,0.0016,,0.406,0.895,,0.837,0.0,-5.83,,,,,+,T,C,32930598,32930598,D7CAF30A58440FCA5E8E7BACD8E1EDE4,,,,,,,-1,BRCA2-  32930598,34,96852,15,,,,EMPTY,,D,,0,5,22,6837,493217,126000,,,0,0,,"1:5,2:2",,0.014,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0176,14,2,0.2631579,0.2682927,0.013862053,GRCh38/hg38,13,32356461,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,46
9,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32911888,377,48.01,11,c.3396A>G,p.(Lys1132=),A,G,196,181,AAA,AAG,K,K,NM_000059.3,NM_000059,32911888,within,.,,rs1801406,0.2668,0.2798,,,,,,,,,,,,+,A,G,32911888,32911888,94F2C0D328C28C466A38A430BBE75D52,,,,,,,-1,BRCA2-  32911888,1487,126010,11,,,,EMPTY,,D,,0,9,35,248687,493217,126000,,,0,0,,1:3,,0.293,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.295,10,1,0.47368422,0.42682928,0.50421417,GRCh38/hg38,13,32337751,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,46
1,D,BRCA2,,SNP,5'UTR,GRCh37/hg19,13,32890572,587,51.11,2,c.-26G>A,p.(=),G,A,287,300,,,,,NM_000059.3,NM_000059,32890572,within,.,,rs1799943,0.2093,0.2088,,,,,,,,,,,,+,G,A,32890572,32890572,A9C2B39455EF056EDB097A5953EB72EE,,,,,,,-1,BRCA2-  32890572,14,125965,2,,,,EMPTY,,D,,0,8,34,205902,493217,126000,,,0,0,,,,0.243,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2427,1,1,0.42105263,0.41463414,0.41746736,GRCh38/hg38,13,32316435,G,A,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,46
11,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,426,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,426,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,19,82,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,1.0,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,46
2,C,BRCA2,,SNP,missense,GRCh37/hg19,13,32910881,224,53.57,11,c.2389A>C,p.(Lys797Gln),A,C,104,120,AAG,CAG,K,Q,NM_000059.3,NM_000059,32910881,within,.,,rs587782737,,,,-0.112,0.996,,0.965,0.0,-1.64,,,,,+,A,C,32910881,32910881,FCE36A419FDD924E5C700EFC02E78270,,,,,,,-1,BRCA2-  32910881,480,142813,11,,,,EMPTY,,C,,0,1,2,21,493217,126000,,,0,0,,3:1,,,0,,,,,,,,,,,,,,Uncertain_significance,Uncertain significance,,600185,-1,,,,,,,,,,,3,,10,3,0.05263158,0.024390243,4.257761E-5,GRCh38/hg38,13,32336744,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,47
3,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,124,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,124,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,19,82,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,1.0,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,47
4,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,356,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,356,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,19,82,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,1.0,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,47
1,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906729,211,100.0,10,c.1114A>C,p.(Asn372His),A,C,0,211,AAT,CAT,N,H,NM_000059.3,NM_000059,32906729,within,.,,rs144848,0.2494,0.2332,,0.32,0.861,,0.269,0.0,0.396,,,,,+,A,C,32906729,32906729,D514F785F1344AF9F6975E589D47BDF6,,,,,,,-1,BRCA2-  32906729,321,9329,10,,,,EMPTY,,D,,0,12,51,233635,493217,126000,,,0,0,,"1:1,2:1",,0.277,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2733,9,1,0.6315789,0.6219512,0.47369617,GRCh38/hg38,13,32332592,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,47
5,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,188,100.0,14,c.7397T>C,p.(Val2466Ala),T,C,0,188,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,19,81,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.9878049,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,47
18,A,BRCA1,54583,INDEL,nonsense,GRCh37/hg19,17,41245060,259,55.98,10,c.2486_2487del,p.(Phe829*),TAAA,TA,113,145,TTT,TAA,F,*,NM_007294.3,NM_007294,41245060,within,.,,rs80357658,,,,,,,,,,,,,,-,AA,-,41245061,41245062,2E93618376886C0AB3E241B28BBD9DF6,,1,,,,,-1,BRCA1- 458754940,-1610,54583,11,,,,EMPTY,,A,,2,1,2,5,492662,126000,,,0,0,,,,,0,,,,,,,,,,,,,,Pathogenic,Pathogenic,,113705,-1,,,,,,,,,,,3,,9,5,0.05263158,0.024390243,1.0148946E-5,GRCh38/hg38,17,43093043,TAAA,TA,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,48
17,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244936,234,99.57,10,c.2612C>T,p.(Pro871Leu),G,A,1,233,CCG,CTG,P,L,NM_007294.3,NM_007294,41244936,within,.,,rs799917,0.5439,0.4932,,4.247,0.0,0.0,0.999,1.0,5.04,,,,,-,G,A,41244936,41244936,A19EA255CA888CE1FE48D08CAD633F1F,,,,,,,1,BRCA1- 458755064,-1485,41812,11,,,,EMPTY,,D,,1,13,53,290862,492662,126000,(eval),,0,0,,"1:4,2:1",6,0.41,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.4127,9,3,0.68421054,0.64634144,0.59038854,GRCh38/hg38,17,43092919,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,48
7,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219780,235,99.15,16,c.4987-68A>G,p.(=),T,C,2,233,,,,,NM_007294.3,NM_007294,41219780,within,.,,rs8176234,0.3546,,,,,,,,,,,,,-,T,C,41219780,41219780,5995ECC305C33150BF3BB2B0C22FCC2A,,,,,,,-1,BRCA1- 458780220,0,125746,17,,,,EMPTY,,D,,0,13,53,234031,492662,126000,,,0,0,,,,,68,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3148,15,1,0.68421054,0.64634144,0.47503358,GRCh38/hg38,17,43067763,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,48
20,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245466,557,100.0,10,c.2082C>T,p.(Ser694=),G,A,0,557,AGC,AGT,S,S,NM_007294.3,NM_007294,41245466,within,.,,rs1799949,0.3365,0.2957,,,,,,,,,,,,-,G,A,41245466,41245466,3364E3D252EFEDF917C74D44FBC6A381,,,,,,,-1,BRCA1- 458754534,1412,125536,11,,,,EMPTY,,D,,0,13,53,269442,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.68421054,0.64634144,0.54691046,GRCh38/hg38,17,43093449,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,48
19,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245237,144,100.0,10,c.2311T>C,p.(Leu771=),A,G,0,144,TTG,CTG,L,L,NM_007294.3,NM_007294,41245237,within,.,,rs16940,0.3353,0.2776,,,,,,,,,,,,-,A,G,41245237,41245237,711AF22D84A49E875C2B2A9597A95EE6,,,,,,,-1,BRCA1- 458754763,1641,125554,11,,,,EMPTY,,D,,0,12,51,269517,492662,126000,,,0,0,,1:1,,0.342,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3422,9,1,0.6315789,0.6219512,0.5470627,GRCh38/hg38,17,43093220,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,48
15,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244000,404,99.75,10,c.3548A>G,p.(Lys1183Arg),T,C,1,403,AAA,AGA,K,R,NM_007294.3,NM_007294,41244000,within,.,,rs16942,0.3526,0.2952,,-0.319,0.0,0.001,0.924,0.0,-2.35,,,,,-,T,C,41244000,41244000,37A54117EA353BDA677332A1F61FA173,,,,,,,-1,BRCA1- 458756000,-549,41818,11,,,,EMPTY,,D,,0,13,53,272437,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.68421054,0.64634144,0.55298966,GRCh38/hg38,17,43091983,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,48
10,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41223094,336,100.0,15,c.4837A>G,p.(Ser1613Gly),T,C,0,336,AGT,GGT,S,G,NM_007294.3,NM_007294,41223094,within,.,,rs1799966,0.3558,0.2982,,-0.194,0.968,0.038,0.814,0.0,1.5,,,,,-,T,C,41223094,41223094,E3C52286D31F229973DB3595B052645F,,,,,,,-1,BRCA1- 458776906,-150,41827,16,,,,EMPTY,,D,,0,13,53,273625,492662,126000,,,0,0,,1:1,,0.349,0,,,,,,,,,,,,,,Benign,Benign,0.255,113705,-1,,,,,,,,,,,3,0.35,14,1,0.68421054,0.64634144,0.5554011,GRCh38/hg38,17,43071077,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,48
11,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41231516,170,100.0,13,c.4358-2885G>A,p.(=),C,T,0,170,,,,,NM_007294.3,NM_007294,41231516,within,.,,rs8176193,0.3534,,,,,,,,,,,,,-,C,T,41231516,41231516,7F4F80D2D005D34CEA47E4A2C561B172,,,,,,,-1,BRCA1- 458768484,0,209399,14,,,,EMPTY,,D,,0,13,53,190200,492662,126000,,,0,0,,,,,2885,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.317,12,1,0.68421054,0.64634144,0.3860659,GRCh38/hg38,17,43079499,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,48
16,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244435,339,100.0,10,c.3113A>G,p.(Glu1038Gly),T,C,0,339,GAA,GGA,E,G,NM_007294.3,NM_007294,41244435,within,.,,rs16941,0.3357,0.279,,-0.149,0.972,0.606,0.922,0.0,-0.974,,,,,-,T,C,41244435,41244435,5D0FF1321BAC3C76DD352C33CC33B93E,,,,,,,-1,BRCA1- 458755565,-984,41815,11,,,,EMPTY,,D,,0,12,52,270861,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,0.936,113705,-1,,,,,,,,,,,3,0.343,9,1,0.6315789,0.63414633,0.54979074,GRCh38/hg38,17,43092418,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,48
13,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41234470,173,100.0,12,c.4308T>C,p.(Ser1436=),A,G,0,173,TCT,TCC,S,S,NM_007294.3,NM_007294,41234470,within,.,,rs1060915,0.3363,0.2796,,,,,,,,,,,,-,A,G,41234470,41234470,B7237055CF1D42F022A050C072B7583B,,,,,,,-1,BRCA1- 458765530,-50,125703,13,,,,EMPTY,,D,,0,12,52,270833,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3433,11,1,0.6315789,0.63414633,0.5497339,GRCh38/hg38,17,43082453,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,48
8,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219804,235,100.0,16,c.4987-92A>G,p.(=),T,C,0,235,,,,,NM_007294.3,NM_007294,41219804,within,.,,rs8176233,0.3546,,,,,,,,,,,,,-,T,C,41219804,41219804,7341B20C52FFD4B9355840FB9CB56CDA,,,,,,,-1,BRCA1- 458780196,0,125749,17,,,,EMPTY,,D,,0,13,53,225491,492662,126000,,,0,0,,,,,92,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3128,15,1,0.68421054,0.64634144,0.45769918,GRCh38/hg38,17,43067787,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,48
6,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41215825,107,100.0,17,c.5152+66G>A,p.(=),C,T,0,107,,,,,NM_007294.3,NM_007294,41215825,within,.,,rs3092994,0.3425,,,,,,,,,,,,,-,C,T,41215825,41215825,5BCA8D2E1E3875817F84A3EB582CDFAB,,,,,,,-1,BRCA1- 458784175,0,55428,18,,,,EMPTY,,D,,0,8,40,241843,492662,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3139,16,1,0.42105263,0.4878049,0.4908903,GRCh38/hg38,17,43063808,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,48
27,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32911463,123,43.09,11,c.2971A>G,p.(Asn991Asp),A,G,70,53,AAC,GAC,N,D,NM_000059.3,NM_000059,32911463,within,.,,rs1799944,0.0801,0.0373,,-0.04,0.0,,0.959,0.0,3.08,,,,,+,A,G,32911463,32911463,36F4F7E6CD788E45B30EA486775D07D6,,,,,,,-1,BRCA2-  32911463,1062,41545,11,,,,EMPTY,,D,,0,4,17,42142,493217,126000,,,0,0,,1:2,,0.053,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0522,10,1,0.21052632,0.20731707,0.085443124,GRCh38/hg38,13,32337326,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,48
3,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32936646,106,48.11,17,c.7806-14T>C,p.(=),T,C,55,51,,,,,NM_000059.3,NM_000059,32936646,within,.,,rs9534262,0.5316,0.5202,,,,,,,,,,,,+,T,C,32936646,32936646,5803939D8FBB75B042260991F0A62436,,,,,,,-1,BRCA2-  32936646,0,126158,17,,,,EMPTY,,D,,0,13,61,361616,493217,126000,,,0,0,,1:3,,0.52,14,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5255,16,1,0.68421054,0.74390244,0.7331783,GRCh38/hg38,13,32362509,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,48
26,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32910721,364,50.27,11,c.2229T>C,p.(His743=),T,C,181,183,CAT,CAC,H,H,NM_000059.3,NM_000059,32910721,within,.,,rs1801499,0.0735,0.0313,,,,,,,,,,,,+,T,C,32910721,32910721,D39471F16FE6D1F6752C2D4D179996AF,,,,,,,-1,BRCA2-  32910721,320,125979,11,,,,EMPTY,,D,,0,4,17,41536,493217,126000,,,0,0,,1:1,,0.052,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0503,10,1,0.21052632,0.20731707,0.08421446,GRCh38/hg38,13,32336584,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,48
29,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,123,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,123,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,19,82,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,1.0,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,48
5,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32953550,148,49.32,22,c.8851G>A,p.(Ala2951Thr),G,A,75,73,GCC,ACC,A,T,NM_000059.3,NM_000059,32953550,within,.,,rs11571769,0.01,0.0044,,7.914,1.0,,1.0,1.0,5.6,,,,,+,G,A,32953550,32953550,D3D6E2E00CDC932E43B7A97E2FA9A9A6,,,,,,,-1,BRCA2-  32953550,97,41570,22,,,,EMPTY,,D,,0,2,6,7101,493217,126000,,,0,0,,"1:8,2:1",,0.0078,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0089,21,3,0.10526316,0.07317073,0.014397314,GRCh38/hg38,13,32379413,G,A,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,48
31,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,127,100.0,14,c.7397T>C,p.(Val2466Ala),T,C,0,127,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,19,81,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.9878049,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,48
12,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906480,106,46.23,10,c.865A>C,p.(Asn289His),A,C,57,49,AAT,CAT,N,H,NM_000059.3,NM_000059,32906480,within,.,,rs766173,0.0737,0.0312,,0.498,0.998,,0.803,0.0,1.73,,,,,+,A,C,32906480,32906480,EE0CD2A1633CE9FEF0978528634002FE,,,,,,,-1,BRCA2-  32906480,72,41567,10,,,,EMPTY,,D,,0,4,17,41272,493217,126000,,,0,0,,"1:4,2:1",,0.051,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0496,9,2,0.21052632,0.20731707,0.08367919,GRCh38/hg38,13,32332343,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,48
1,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32899388,110,42.73,4,c.425+67A>C,p.(=),A,C,63,47,,,,,NM_000059.3,NM_000059,32899388,within,.,,rs11571610,0.0743,,,,,,,,,,,,,+,A,C,32899388,32899388,1AF346DE380A738371905EBFBCED20E1,,,,,,,-1,BRCA2-  32899388,0,126095,4,,,,EMPTY,,D,,0,4,17,39349,493217,126000,,,0,0,,2:1,,,67,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0306,3,3,0.21052632,0.20731707,0.0797803,GRCh38/hg38,13,32325251,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,48
28,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32912299,128,51.56,11,c.3807T>C,p.(Val1269=),T,C,62,66,GTT,GTC,V,V,NM_000059.3,NM_000059,32912299,within,.,,rs543304,0.1681,0.1911,,,,,,,,,,,,+,T,C,32912299,32912299,F2D3E8FFB3CEE8C1ACEA66738E41BC1E,,,,,,,-1,BRCA2-  32912299,1898,126022,11,,,,EMPTY,,D,,0,5,20,173719,493217,126000,,,0,0,,1:3,,0.176,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.1754,10,1,0.2631579,0.24390244,0.35221615,GRCh38/hg38,13,32338162,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,48
2,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32929478,100,52.0,14,c.7435+53C>T,p.(=),C,T,48,52,,,,,NM_000059.3,NM_000059,32929478,within,.,,rs11147489,0.0725,,,,,,,,,,,,,+,C,T,32929478,32929478,F692B4BE5DCD39FA887FE8D63D296720,,,,,,,-1,BRCA2-  32929478,0,126136,14,,,,EMPTY,,D,,0,4,17,36369,493217,126000,,,0,0,,,,,53,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0301,13,3,0.21052632,0.20731707,0.07373834,GRCh38/hg38,13,32355341,C,T,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,48
30,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,321,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,321,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,19,82,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,1.0,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,48
4,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32953388,247,52.63,22,c.8755-66T>C,p.(=),T,C,117,130,,,,,NM_000059.3,NM_000059,32953388,within,.,,rs4942486,0.5116,,,,,,,,,,,,,+,T,C,32953388,32953388,97C65B85894EB489F1BFA65897685241,,,,,,,-1,BRCA2-  32953388,0,126190,22,,,,EMPTY,,D,,0,13,61,347826,493217,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5257,21,1,0.68421054,0.74390244,0.70521903,GRCh38/hg38,13,32379251,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,48
23,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32906980,352,53.12,10,c.1365A>G,p.(Ser455=),A,G,165,187,TCA,TCG,S,S,NM_000059.3,NM_000059,32906980,within,.,,rs1801439,0.0737,0.031,,,,,,,,,,,,+,A,G,32906980,32906980,C76C22E555E869928B452D866988AB4F,,,,,,,-1,BRCA2-  32906980,-545,125943,10,,,,EMPTY,,D,,0,4,17,41480,493217,126000,,,0,0,,"1:4,2:1",,0.051,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0499,9,2,0.21052632,0.20731707,0.08410091,GRCh38/hg38,13,32332843,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,48
11,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244936,335,43.88,10,c.2612C>T,p.(Pro871Leu),G,A,188,147,CCG,CTG,P,L,NM_007294.3,NM_007294,41244936,within,.,,rs799917,0.5439,0.4932,,4.247,0.0,0.0,0.999,1.0,5.04,,,,,-,G,A,41244936,41244936,A19EA255CA888CE1FE48D08CAD633F1F,,,,,,,1,BRCA1- 458755064,-1485,41812,11,,,,EMPTY,,D,,1,13,53,290862,492662,126000,(eval),,0,0,,"1:4,2:1",,0.41,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.4127,9,3,0.68421054,0.64634144,0.59038854,GRCh38/hg38,17,43092919,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,50
2,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219780,352,46.59,16,c.4987-68A>G,p.(=),T,C,188,164,,,,,NM_007294.3,NM_007294,41219780,within,.,,rs8176234,0.3546,,,,,,,,,,,,,-,T,C,41219780,41219780,5995ECC305C33150BF3BB2B0C22FCC2A,,,,,,,-1,BRCA1- 458780220,0,125746,17,,,,EMPTY,,D,,0,13,53,234031,492662,126000,,,0,0,,,,,68,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3148,15,1,0.68421054,0.64634144,0.47503358,GRCh38/hg38,17,43067763,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,50
14,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245466,609,51.89,10,c.2082C>T,p.(Ser694=),G,A,293,316,AGC,AGT,S,S,NM_007294.3,NM_007294,41245466,within,.,,rs1799949,0.3365,0.2957,,,,,,,,,,,,-,G,A,41245466,41245466,3364E3D252EFEDF917C74D44FBC6A381,,,,,,,-1,BRCA1- 458754534,1412,125536,11,,,,EMPTY,,D,,0,13,53,269442,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.68421054,0.64634144,0.54691046,GRCh38/hg38,17,43093449,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,50
3,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219804,353,46.46,16,c.4987-92A>G,p.(=),T,C,189,164,,,,,NM_007294.3,NM_007294,41219804,within,.,,rs8176233,0.3546,,,,,,,,,,,,,-,T,C,41219804,41219804,7341B20C52FFD4B9355840FB9CB56CDA,,,,,,,-1,BRCA1- 458780196,0,125749,17,,,,EMPTY,,D,,0,13,53,225491,492662,126000,,,0,0,,,,,92,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3128,15,1,0.68421054,0.64634144,0.45769918,GRCh38/hg38,17,43067787,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,50
10,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244435,436,47.02,10,c.3113A>G,p.(Glu1038Gly),T,C,231,205,GAA,GGA,E,G,NM_007294.3,NM_007294,41244435,within,.,,rs16941,0.3357,0.279,,-0.149,0.972,0.606,0.922,0.0,-0.974,,,,,-,T,C,41244435,41244435,5D0FF1321BAC3C76DD352C33CC33B93E,,,,,,,-1,BRCA1- 458755565,-984,41815,11,,,,EMPTY,,D,,0,12,52,270861,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,0.936,113705,-1,,,,,,,,,,,3,0.343,9,1,0.6315789,0.63414633,0.54979074,GRCh38/hg38,17,43092418,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,50
7,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41234470,173,48.55,12,c.4308T>C,p.(Ser1436=),A,G,89,84,TCT,TCC,S,S,NM_007294.3,NM_007294,41234470,within,.,,rs1060915,0.3363,0.2796,,,,,,,,,,,,-,A,G,41234470,41234470,B7237055CF1D42F022A050C072B7583B,,,,,,,-1,BRCA1- 458765530,-50,125703,13,,,,EMPTY,,D,,0,12,52,270833,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3433,11,1,0.6315789,0.63414633,0.5497339,GRCh38/hg38,17,43082453,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,50
5,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41223094,359,48.75,15,c.4837A>G,p.(Ser1613Gly),T,C,184,175,AGT,GGT,S,G,NM_007294.3,NM_007294,41223094,within,.,,rs1799966,0.3558,0.2982,,-0.194,0.968,0.038,0.814,0.0,1.5,,,,,-,T,C,41223094,41223094,E3C52286D31F229973DB3595B052645F,,,,,,,-1,BRCA1- 458776906,-150,41827,16,,,,EMPTY,,D,,0,13,53,273625,492662,126000,,,0,0,,1:1,,0.349,0,,,,,,,,,,,,,,Benign,Benign,0.255,113705,-1,,,,,,,,,,,3,0.35,14,1,0.68421054,0.64634144,0.5554011,GRCh38/hg38,17,43071077,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,50
9,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244000,432,44.44,10,c.3548A>G,p.(Lys1183Arg),T,C,239,192,AAA,AGA,K,R,NM_007294.3,NM_007294,41244000,within,.,,rs16942,0.3526,0.2952,,-0.319,0.0,0.001,0.924,0.0,-2.35,,,,,-,T,C,41244000,41244000,37A54117EA353BDA677332A1F61FA173,,,,,,,-1,BRCA1- 458756000,-549,41818,11,,,,EMPTY,,D,,0,13,53,272437,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.68421054,0.64634144,0.55298966,GRCh38/hg38,17,43091983,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,50
6,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41231516,176,55.11,13,c.4358-2885G>A,p.(=),C,T,79,97,,,,,NM_007294.3,NM_007294,41231516,within,.,,rs8176193,0.3534,,,,,,,,,,,,,-,C,T,41231516,41231516,7F4F80D2D005D34CEA47E4A2C561B172,,,,,,,-1,BRCA1- 458768484,0,209399,14,,,,EMPTY,,D,,0,13,53,190200,492662,126000,,,0,0,,,,,2885,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.317,12,1,0.68421054,0.64634144,0.3860659,GRCh38/hg38,17,43079499,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,50
13,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245237,160,51.25,10,c.2311T>C,p.(Leu771=),A,G,78,82,TTG,CTG,L,L,NM_007294.3,NM_007294,41245237,within,.,,rs16940,0.3353,0.2776,,,,,,,,,,,,-,A,G,41245237,41245237,711AF22D84A49E875C2B2A9597A95EE6,,,,,,,-1,BRCA1- 458754763,1641,125554,11,,,,EMPTY,,D,,0,12,51,269517,492662,126000,,,0,0,,1:1,,0.342,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3422,9,1,0.6315789,0.6219512,0.5470627,GRCh38/hg38,17,43093220,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,50
12,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32911888,358,100.0,11,c.3396A>G,p.(Lys1132=),A,G,0,358,AAA,AAG,K,K,NM_000059.3,NM_000059,32911888,within,.,,rs1801406,0.2668,0.2798,,,,,,,,,,,,+,A,G,32911888,32911888,94F2C0D328C28C466A38A430BBE75D52,,,,,,,-1,BRCA2-  32911888,1487,126010,11,,,,EMPTY,,D,,0,9,35,248687,493217,126000,,,0,0,,1:3,,0.293,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.295,10,1,0.47368422,0.42682928,0.50421417,GRCh38/hg38,13,32337751,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,50
1,D,BRCA2,,SNP,5'UTR,GRCh37/hg19,13,32890572,456,100.0,2,c.-26G>A,p.(=),G,A,0,456,,,,,NM_000059.3,NM_000059,32890572,within,.,,rs1799943,0.2093,0.2088,,,,,,,,,,,,+,G,A,32890572,32890572,A9C2B39455EF056EDB097A5953EB72EE,,,,,,,-1,BRCA2-  32890572,14,125965,2,,,,EMPTY,,D,,0,8,34,205902,493217,126000,,,0,0,,,,0.243,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2427,1,1,0.42105263,0.41463414,0.41746736,GRCh38/hg38,13,32316435,G,A,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,50
21,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32929232,151,99.34,14,c.7242A>G,p.(Ser2414=),A,G,1,150,TCA,TCG,S,S,NM_000059.3,NM_000059,32929232,within,.,,rs1799955,0.2326,0.2114,,,,,,,,,,,,+,A,G,32929232,32929232,6F8D6FF8BC9027D6C0351ADCEF41FD20,,,,,,,-1,BRCA2-  32929232,-194,126133,14,,,,EMPTY,,D,,0,5,31,192923,493217,126000,,,0,0,,"1:3,2:1",,0.224,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2257,13,1,0.2631579,0.37804878,0.39115238,GRCh38/hg38,13,32355095,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,50
23,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32936646,115,100.0,17,c.7806-14T>C,p.(=),T,C,0,115,,,,,NM_000059.3,NM_000059,32936646,within,.,,rs9534262,0.5316,0.5202,,,,,,,,,,,,+,T,C,32936646,32936646,5803939D8FBB75B042260991F0A62436,,,,,,,-1,BRCA2-  32936646,0,126158,17,,,,EMPTY,,D,,0,13,61,361616,493217,126000,,,0,0,,1:3,,0.52,14,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5255,16,1,0.68421054,0.74390244,0.7331783,GRCh38/hg38,13,32362509,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,50
22,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,152,100.0,14,c.7397T>C,p.(Val2466Ala),T,C,0,152,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,19,81,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.9878049,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,50
24,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32953388,291,100.0,22,c.8755-66T>C,p.(=),T,C,0,291,,,,,NM_000059.3,NM_000059,32953388,within,.,,rs4942486,0.5116,,,,,,,,,,,,,+,T,C,32953388,32953388,97C65B85894EB489F1BFA65897685241,,,,,,,-1,BRCA2-  32953388,0,126190,22,,,,EMPTY,,D,,0,13,61,347826,493217,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5257,21,1,0.68421054,0.74390244,0.70521903,GRCh38/hg38,13,32379251,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,50
20,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,426,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,426,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,19,82,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,1.0,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,50
19,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,135,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,135,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,19,82,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,1.0,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,50
11,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244936,341,52.49,10,c.2612C>T,p.(Pro871Leu),G,A,162,179,CCG,CTG,P,L,NM_007294.3,NM_007294,41244936,within,.,,rs799917,0.5439,0.4932,,4.247,0.0,0.0,0.999,1.0,5.04,,,,,-,G,A,41244936,41244936,A19EA255CA888CE1FE48D08CAD633F1F,,,,,,,1,BRCA1- 458755064,-1485,41812,11,,,,EMPTY,,D,,1,13,53,290862,492662,126000,(eval),,0,0,,"1:4,2:1",,0.41,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.4127,9,3,0.68421054,0.64634144,0.59038854,GRCh38/hg38,17,43092919,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,51
14,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245466,588,52.04,10,c.2082C>T,p.(Ser694=),G,A,282,306,AGC,AGT,S,S,NM_007294.3,NM_007294,41245466,within,.,,rs1799949,0.3365,0.2957,,,,,,,,,,,,-,G,A,41245466,41245466,3364E3D252EFEDF917C74D44FBC6A381,,,,,,,-1,BRCA1- 458754534,1412,125536,11,,,,EMPTY,,D,,0,13,53,269442,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.68421054,0.64634144,0.54691046,GRCh38/hg38,17,43093449,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,51
10,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244435,397,51.89,10,c.3113A>G,p.(Glu1038Gly),T,C,191,206,GAA,GGA,E,G,NM_007294.3,NM_007294,41244435,within,.,,rs16941,0.3357,0.279,,-0.149,0.972,0.606,0.922,0.0,-0.974,,,,,-,T,C,41244435,41244435,5D0FF1321BAC3C76DD352C33CC33B93E,,,,,,,-1,BRCA1- 458755565,-984,41815,11,,,,EMPTY,,D,,0,12,52,270861,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,0.936,113705,-1,,,,,,,,,,,3,0.343,9,1,0.6315789,0.63414633,0.54979074,GRCh38/hg38,17,43092418,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,51
8,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41234470,186,47.85,12,c.4308T>C,p.(Ser1436=),A,G,97,89,TCT,TCC,S,S,NM_007294.3,NM_007294,41234470,within,.,,rs1060915,0.3363,0.2796,,,,,,,,,,,,-,A,G,41234470,41234470,B7237055CF1D42F022A050C072B7583B,,,,,,,-1,BRCA1- 458765530,-50,125703,13,,,,EMPTY,,D,,0,12,52,270833,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3433,11,1,0.6315789,0.63414633,0.5497339,GRCh38/hg38,17,43082453,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,51
7,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41231516,166,52.41,13,c.4358-2885G>A,p.(=),C,T,79,87,,,,,NM_007294.3,NM_007294,41231516,within,.,,rs8176193,0.3534,,,,,,,,,,,,,-,C,T,41231516,41231516,7F4F80D2D005D34CEA47E4A2C561B172,,,,,,,-1,BRCA1- 458768484,0,209399,14,,,,EMPTY,,D,,0,13,53,190200,492662,126000,,,0,0,,,,,2885,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.317,12,1,0.68421054,0.64634144,0.3860659,GRCh38/hg38,17,43079499,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,51
9,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244000,429,56.18,10,c.3548A>G,p.(Lys1183Arg),T,C,188,241,AAA,AGA,K,R,NM_007294.3,NM_007294,41244000,within,.,,rs16942,0.3526,0.2952,,-0.319,0.0,0.001,0.924,0.0,-2.35,,,,,-,T,C,41244000,41244000,37A54117EA353BDA677332A1F61FA173,,,,,,,-1,BRCA1- 458756000,-549,41818,11,,,,EMPTY,,D,,0,13,53,272437,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.68421054,0.64634144,0.55298966,GRCh38/hg38,17,43091983,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,51
4,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219804,216,46.76,16,c.4987-92A>G,p.(=),T,C,115,101,,,,,NM_007294.3,NM_007294,41219804,within,.,,rs8176233,0.3546,,,,,,,,,,,,,-,T,C,41219804,41219804,7341B20C52FFD4B9355840FB9CB56CDA,,,,,,,-1,BRCA1- 458780196,0,125749,17,,,,EMPTY,,D,,0,13,53,225491,492662,126000,,,0,0,,,,,92,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3128,15,1,0.68421054,0.64634144,0.45769918,GRCh38/hg38,17,43067787,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,51
13,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245237,176,53.41,10,c.2311T>C,p.(Leu771=),A,G,82,94,TTG,CTG,L,L,NM_007294.3,NM_007294,41245237,within,.,,rs16940,0.3353,0.2776,,,,,,,,,,,,-,A,G,41245237,41245237,711AF22D84A49E875C2B2A9597A95EE6,,,,,,,-1,BRCA1- 458754763,1641,125554,11,,,,EMPTY,,D,,0,12,51,269517,492662,126000,,,0,0,,1:1,,0.342,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3422,9,1,0.6315789,0.6219512,0.5470627,GRCh38/hg38,17,43093220,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,51
3,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219780,216,46.3,16,c.4987-68A>G,p.(=),T,C,115,100,,,,,NM_007294.3,NM_007294,41219780,within,.,,rs8176234,0.3546,,,,,,,,,,,,,-,T,C,41219780,41219780,5995ECC305C33150BF3BB2B0C22FCC2A,,,,,,,-1,BRCA1- 458780220,0,125746,17,,,,EMPTY,,D,,0,13,53,234031,492662,126000,,,0,0,,,,,68,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3148,15,1,0.68421054,0.64634144,0.47503358,GRCh38/hg38,17,43067763,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,51
6,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41223094,364,50.82,15,c.4837A>G,p.(Ser1613Gly),T,C,179,185,AGT,GGT,S,G,NM_007294.3,NM_007294,41223094,within,.,,rs1799966,0.3558,0.2982,,-0.194,0.968,0.038,0.814,0.0,1.5,,,,,-,T,C,41223094,41223094,E3C52286D31F229973DB3595B052645F,,,,,,,-1,BRCA1- 458776906,-150,41827,16,,,,EMPTY,,D,,0,13,53,273625,492662,126000,,,0,0,,1:1,,0.349,0,,,,,,,,,,,,,,Benign,Benign,0.255,113705,-1,,,,,,,,,,,3,0.35,14,1,0.68421054,0.64634144,0.5554011,GRCh38/hg38,17,43071077,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,51
20,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,126,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,126,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,19,82,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,1.0,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,51
21,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,355,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,355,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,19,82,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,1.0,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,51
1,D,BRCA2,,SNP,5'UTR,GRCh37/hg19,13,32890572,473,47.15,2,c.-26G>A,p.(=),G,A,250,223,,,,,NM_000059.3,NM_000059,32890572,within,.,,rs1799943,0.2093,0.2088,,,,,,,,,,,,+,G,A,32890572,32890572,A9C2B39455EF056EDB097A5953EB72EE,,,,,,,-1,BRCA2-  32890572,14,125965,2,,,,EMPTY,,D,,0,8,34,205902,493217,126000,,,0,0,,,,0.243,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2427,1,1,0.42105263,0.41463414,0.41746736,GRCh38/hg38,13,32316435,G,A,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,51
18,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32911888,338,56.51,11,c.3396A>G,p.(Lys1132=),A,G,147,191,AAA,AAG,K,K,NM_000059.3,NM_000059,32911888,within,.,,rs1801406,0.2668,0.2798,,,,,,,,,,,,+,A,G,32911888,32911888,94F2C0D328C28C466A38A430BBE75D52,,,,,,,-1,BRCA2-  32911888,1487,126010,11,,,,EMPTY,,D,,0,9,35,248687,493217,126000,,,0,0,,1:3,,0.293,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.295,10,1,0.47368422,0.42682928,0.50421417,GRCh38/hg38,13,32337751,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,51
12,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32903685,273,50.92,8,c.681+56C>T,p.(=),C,T,134,139,,,,,NM_000059.3,NM_000059,32903685,within,.,,rs2126042,0.1859,,,,,,,,,,,,,+,C,T,32903685,32903685,E9AEF840574909F4761D4EF7950E02CB,,,,,,,-1,BRCA2-  32903685,0,126192,8,,,,EMPTY,,D,,0,3,21,145186,493217,126000,,,0,0,,4:1,,,56,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2163,7,1,0.15789473,0.25609756,0.29436535,GRCh38/hg38,13,32329548,C,T,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,51
23,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32936646,134,49.25,17,c.7806-14T>C,p.(=),T,C,68,66,,,,,NM_000059.3,NM_000059,32936646,within,.,,rs9534262,0.5316,0.5202,,,,,,,,,,,,+,T,C,32936646,32936646,5803939D8FBB75B042260991F0A62436,,,,,,,-1,BRCA2-  32936646,0,126158,17,,,,EMPTY,,D,,0,13,61,361616,493217,126000,,,0,0,,1:3,,0.52,14,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5255,16,1,0.68421054,0.74390244,0.7331783,GRCh38/hg38,13,32362509,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,51
19,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32912560,249,51.41,11,c.4068G>A,p.(Leu1356=),G,A,121,128,TTG,TTA,L,L,NM_000059.3,NM_000059,32912560,within,.,,rs28897724,4.0E-4,0.0032,,,,,,,,,,,,+,G,A,32912560,32912560,86D2C66DC1D349AF38A8161BE983BB19,,,,,,,-1,BRCA2-  32912560,2159,51589,11,,,,EMPTY,,D,,0,1,1,4287,493217,126000,,,0,0,,"1:2,2:2",,0.003,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0029,10,2,0.05263158,0.0121951215,0.008691914,GRCh38/hg38,13,32338423,G,A,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,51
22,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,163,100.0,14,c.7397T>C,p.(Val2466Ala),T,C,0,163,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,19,81,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.9878049,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,51
24,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32953388,231,47.62,22,c.8755-66T>C,p.(=),T,C,121,110,,,,,NM_000059.3,NM_000059,32953388,within,.,,rs4942486,0.5116,,,,,,,,,,,,,+,T,C,32953388,32953388,97C65B85894EB489F1BFA65897685241,,,,,,,-1,BRCA2-  32953388,0,126190,22,,,,EMPTY,,D,,0,13,61,347826,493217,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5257,21,1,0.68421054,0.74390244,0.70521903,GRCh38/hg38,13,32379251,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,51
16,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244936,276,48.91,10,c.2612C>T,p.(Pro871Leu),G,A,141,135,CCG,CTG,P,L,NM_007294.3,NM_007294,41244936,within,.,,rs799917,0.5439,0.4932,,4.247,0.0,0.0,0.999,1.0,5.04,,,,,-,G,A,41244936,41244936,A19EA255CA888CE1FE48D08CAD633F1F,,,,,,,1,BRCA1- 458755064,-1485,41812,11,,,,EMPTY,,D,,1,13,53,290862,492662,126000,(eval),,0,0,,"1:4,2:1",,0.41,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.4127,9,3,0.68421054,0.64634144,0.59038854,GRCh38/hg38,17,43092919,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,52
9,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219804,167,47.9,16,c.4987-92A>G,p.(=),T,C,87,80,,,,,NM_007294.3,NM_007294,41219804,within,.,,rs8176233,0.3546,,,,,,,,,,,,,-,T,C,41219804,41219804,7341B20C52FFD4B9355840FB9CB56CDA,,,,,,,-1,BRCA1- 458780196,0,125749,17,,,,EMPTY,,D,,0,13,53,225491,492662,126000,,,0,0,,,,,92,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3128,15,1,0.68421054,0.64634144,0.45769918,GRCh38/hg38,17,43067787,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,52
17,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245237,125,53.6,10,c.2311T>C,p.(Leu771=),A,G,58,67,TTG,CTG,L,L,NM_007294.3,NM_007294,41245237,within,.,,rs16940,0.3353,0.2776,,,,,,,,,,,,-,A,G,41245237,41245237,711AF22D84A49E875C2B2A9597A95EE6,,,,,,,-1,BRCA1- 458754763,1641,125554,11,,,,EMPTY,,D,,0,12,51,269517,492662,126000,,,0,0,,1:1,,0.342,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3422,9,1,0.6315789,0.6219512,0.5470627,GRCh38/hg38,17,43093220,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,52
7,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41215825,83,57.83,17,c.5152+66G>A,p.(=),C,T,35,48,,,,,NM_007294.3,NM_007294,41215825,within,.,,rs3092994,0.3425,,,,,,,,,,,,,-,C,T,41215825,41215825,5BCA8D2E1E3875817F84A3EB582CDFAB,,,,,,,-1,BRCA1- 458784175,0,55428,18,,,,EMPTY,,D,,0,8,40,241843,492662,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3139,16,1,0.42105263,0.4878049,0.4908903,GRCh38/hg38,17,43063808,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,52
15,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244435,302,45.36,10,c.3113A>G,p.(Glu1038Gly),T,C,165,137,GAA,GGA,E,G,NM_007294.3,NM_007294,41244435,within,.,,rs16941,0.3357,0.279,,-0.149,0.972,0.606,0.922,0.0,-0.974,,,,,-,T,C,41244435,41244435,5D0FF1321BAC3C76DD352C33CC33B93E,,,,,,,-1,BRCA1- 458755565,-984,41815,11,,,,EMPTY,,D,,0,12,52,270861,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,0.936,113705,-1,,,,,,,,,,,3,0.343,9,1,0.6315789,0.63414633,0.54979074,GRCh38/hg38,17,43092418,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,52
24,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41267800,137,43.07,3,c.81-4C>A,p.(=),G,T,78,59,,,,,NM_007294.3,NM_007294,41267800,within,.,,rs1000484532,,,,,,,,,,,,,,-,G,T,41267800,41267800,F4F480521F6C567E3575C6D458460812,,,,,,,-1,BRCA1- 458732200,0,865086,3,,,,EMPTY,,D,,0,1,1,,,126000,,,0,0,,,,,4,,,,,,,,,,,,,,Likely_benign,Likely benign,,113705,-1,,,,,,,,,,,3,,2,3,0.05263158,0.0121951215,,GRCh38/hg38,17,43115783,G,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,52
18,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245466,575,47.48,10,c.2082C>T,p.(Ser694=),G,A,302,273,AGC,AGT,S,S,NM_007294.3,NM_007294,41245466,within,.,,rs1799949,0.3365,0.2957,,,,,,,,,,,,-,G,A,41245466,41245466,3364E3D252EFEDF917C74D44FBC6A381,,,,,,,-1,BRCA1- 458754534,1412,125536,11,,,,EMPTY,,D,,0,13,53,269442,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.68421054,0.64634144,0.54691046,GRCh38/hg38,17,43093449,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,52
8,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219780,167,47.9,16,c.4987-68A>G,p.(=),T,C,87,80,,,,,NM_007294.3,NM_007294,41219780,within,.,,rs8176234,0.3546,,,,,,,,,,,,,-,T,C,41219780,41219780,5995ECC305C33150BF3BB2B0C22FCC2A,,,,,,,-1,BRCA1- 458780220,0,125746,17,,,,EMPTY,,D,,0,13,53,234031,492662,126000,,,0,0,,,,,68,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3148,15,1,0.68421054,0.64634144,0.47503358,GRCh38/hg38,17,43067763,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,52
14,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244000,355,48.73,10,c.3548A>G,p.(Lys1183Arg),T,C,182,173,AAA,AGA,K,R,NM_007294.3,NM_007294,41244000,within,.,,rs16942,0.3526,0.2952,,-0.319,0.0,0.001,0.924,0.0,-2.35,,,,,-,T,C,41244000,41244000,37A54117EA353BDA677332A1F61FA173,,,,,,,-1,BRCA1- 458756000,-549,41818,11,,,,EMPTY,,D,,0,13,53,272437,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.68421054,0.64634144,0.55298966,GRCh38/hg38,17,43091983,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,52
10,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41223094,261,50.96,15,c.4837A>G,p.(Ser1613Gly),T,C,128,133,AGT,GGT,S,G,NM_007294.3,NM_007294,41223094,within,.,,rs1799966,0.3558,0.2982,,-0.194,0.968,0.038,0.814,0.0,1.5,,,,,-,T,C,41223094,41223094,E3C52286D31F229973DB3595B052645F,,,,,,,-1,BRCA1- 458776906,-150,41827,16,,,,EMPTY,,D,,0,13,53,273625,492662,126000,,,0,0,,1:1,,0.349,0,,,,,,,,,,,,,,Benign,Benign,0.255,113705,-1,,,,,,,,,,,3,0.35,14,1,0.68421054,0.64634144,0.5554011,GRCh38/hg38,17,43071077,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,52
11,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41231516,131,41.22,13,c.4358-2885G>A,p.(=),C,T,77,54,,,,,NM_007294.3,NM_007294,41231516,within,.,,rs8176193,0.3534,,,,,,,,,,,,,-,C,T,41231516,41231516,7F4F80D2D005D34CEA47E4A2C561B172,,,,,,,-1,BRCA1- 458768484,0,209399,14,,,,EMPTY,,D,,0,13,53,190200,492662,126000,,,0,0,,,,,2885,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.317,12,1,0.68421054,0.64634144,0.3860659,GRCh38/hg38,17,43079499,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,52
13,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41234470,171,57.31,12,c.4308T>C,p.(Ser1436=),A,G,73,98,TCT,TCC,S,S,NM_007294.3,NM_007294,41234470,within,.,,rs1060915,0.3363,0.2796,,,,,,,,,,,,-,A,G,41234470,41234470,B7237055CF1D42F022A050C072B7583B,,,,,,,-1,BRCA1- 458765530,-50,125703,13,,,,EMPTY,,D,,0,12,52,270833,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3433,11,1,0.6315789,0.63414633,0.5497339,GRCh38/hg38,17,43082453,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,52
19,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41245471,573,47.64,10,c.2077G>A,p.(Asp693Asn),C,T,300,273,GAC,AAC,D,N,NM_007294.3,NM_007294,41245471,within,.,,rs4986850,0.0335,0.0543,,0.205,0.989,0.01,0.597,0.0,1.23,,,,,-,C,T,41245471,41245471,1EA9438AD2460C6CC594B844CD8DC7F6,,,,,,,-1,BRCA1- 458754529,1407,41808,11,,,,EMPTY,,D,,0,1,6,63951,492662,126000,,,0,0,,1:2,,0.057,0,,,,,,,,,,,,,,Benign,Benign,0.001,113705,-1,,,,,,,,,,,3,0.058,9,1,0.05263158,0.07317073,0.12980705,GRCh38/hg38,17,43093454,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,52
30,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,146,100.0,14,c.7397T>C,p.(Val2466Ala),T,C,0,146,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,19,81,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.9878049,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,52
3,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32936646,114,50.88,17,c.7806-14T>C,p.(=),T,C,56,58,,,,,NM_000059.3,NM_000059,32936646,within,.,,rs9534262,0.5316,0.5202,,,,,,,,,,,,+,T,C,32936646,32936646,5803939D8FBB75B042260991F0A62436,,,,,,,-1,BRCA2-  32936646,0,126158,17,,,,EMPTY,,D,,0,13,61,361616,493217,126000,,,0,0,,1:3,,0.52,14,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5255,16,1,0.68421054,0.74390244,0.7331783,GRCh38/hg38,13,32362509,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,52
26,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32911463,117,47.86,11,c.2971A>G,p.(Asn991Asp),A,G,61,56,AAC,GAC,N,D,NM_000059.3,NM_000059,32911463,within,.,,rs1799944,0.0801,0.0373,,-0.04,0.0,,0.959,0.0,3.08,,,,,+,A,G,32911463,32911463,36F4F7E6CD788E45B30EA486775D07D6,,,,,,,-1,BRCA2-  32911463,1062,41545,11,,,,EMPTY,,D,,0,4,17,42142,493217,126000,,,0,0,,1:2,,0.053,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0522,10,1,0.21052632,0.20731707,0.085443124,GRCh38/hg38,13,32337326,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,52
28,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,110,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,110,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,19,82,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,1.0,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,52
5,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32953550,159,51.57,22,c.8851G>A,p.(Ala2951Thr),G,A,77,82,GCC,ACC,A,T,NM_000059.3,NM_000059,32953550,within,.,,rs11571769,0.01,0.0044,,7.914,1.0,,1.0,1.0,5.6,,,,,+,G,A,32953550,32953550,D3D6E2E00CDC932E43B7A97E2FA9A9A6,,,,,,,-1,BRCA2-  32953550,97,41570,22,,,,EMPTY,,D,,0,2,6,7101,493217,126000,,,0,0,,"1:8,2:1",,0.0078,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0089,21,3,0.10526316,0.07317073,0.014397314,GRCh38/hg38,13,32379413,G,A,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,52
12,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906480,105,58.1,10,c.865A>C,p.(Asn289His),A,C,44,61,AAT,CAT,N,H,NM_000059.3,NM_000059,32906480,within,.,,rs766173,0.0737,0.0312,,0.498,0.998,,0.803,0.0,1.73,,,,,+,A,C,32906480,32906480,EE0CD2A1633CE9FEF0978528634002FE,,,,,,,-1,BRCA2-  32906480,72,41567,10,,,,EMPTY,,D,,0,4,17,41272,493217,126000,,,0,0,,"1:4,2:1",,0.051,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0496,9,2,0.21052632,0.20731707,0.08367919,GRCh38/hg38,13,32332343,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,52
1,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32899388,100,52.0,4,c.425+67A>C,p.(=),A,C,48,52,,,,,NM_000059.3,NM_000059,32899388,within,.,,rs11571610,0.0743,,,,,,,,,,,,,+,A,C,32899388,32899388,1AF346DE380A738371905EBFBCED20E1,,,,,,,-1,BRCA2-  32899388,0,126095,4,,,,EMPTY,,D,,0,4,17,39349,493217,126000,,,0,0,,2:1,,,67,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0306,3,3,0.21052632,0.20731707,0.0797803,GRCh38/hg38,13,32325251,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,52
25,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32910721,366,50.55,11,c.2229T>C,p.(His743=),T,C,181,185,CAT,CAC,H,H,NM_000059.3,NM_000059,32910721,within,.,,rs1801499,0.0735,0.0313,,,,,,,,,,,,+,T,C,32910721,32910721,D39471F16FE6D1F6752C2D4D179996AF,,,,,,,-1,BRCA2-  32910721,320,125979,11,,,,EMPTY,,D,,0,4,17,41536,493217,126000,,,0,0,,1:1,,0.052,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0503,10,1,0.21052632,0.20731707,0.08421446,GRCh38/hg38,13,32336584,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,52
29,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,257,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,257,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,19,82,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,1.0,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,52
2,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32929478,118,42.37,14,c.7435+53C>T,p.(=),C,T,68,50,,,,,NM_000059.3,NM_000059,32929478,within,.,,rs11147489,0.0725,,,,,,,,,,,,,+,C,T,32929478,32929478,F692B4BE5DCD39FA887FE8D63D296720,,,,,,,-1,BRCA2-  32929478,0,126136,14,,,,EMPTY,,D,,0,4,17,36369,493217,126000,,,0,0,,,,,53,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0301,13,3,0.21052632,0.20731707,0.07373834,GRCh38/hg38,13,32355341,C,T,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,52
27,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32912299,163,46.63,11,c.3807T>C,p.(Val1269=),T,C,87,76,GTT,GTC,V,V,NM_000059.3,NM_000059,32912299,within,.,,rs543304,0.1681,0.1911,,,,,,,,,,,,+,T,C,32912299,32912299,F2D3E8FFB3CEE8C1ACEA66738E41BC1E,,,,,,,-1,BRCA2-  32912299,1898,126022,11,,,,EMPTY,,D,,0,5,20,173719,493217,126000,,,0,0,,1:3,,0.176,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.1754,10,1,0.2631579,0.24390244,0.35221615,GRCh38/hg38,13,32338162,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,52
4,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32953388,237,50.63,22,c.8755-66T>C,p.(=),T,C,117,120,,,,,NM_000059.3,NM_000059,32953388,within,.,,rs4942486,0.5116,,,,,,,,,,,,,+,T,C,32953388,32953388,97C65B85894EB489F1BFA65897685241,,,,,,,-1,BRCA2-  32953388,0,126190,22,,,,EMPTY,,D,,0,13,61,347826,493217,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5257,21,1,0.68421054,0.74390244,0.70521903,GRCh38/hg38,13,32379251,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,52
23,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32906980,365,45.21,10,c.1365A>G,p.(Ser455=),A,G,200,165,TCA,TCG,S,S,NM_000059.3,NM_000059,32906980,within,.,,rs1801439,0.0737,0.031,,,,,,,,,,,,+,A,G,32906980,32906980,C76C22E555E869928B452D866988AB4F,,,,,,,-1,BRCA2-  32906980,-545,125943,10,,,,EMPTY,,D,,0,4,17,41480,493217,126000,,,0,0,,"1:4,2:1",,0.051,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0499,9,2,0.21052632,0.20731707,0.08410091,GRCh38/hg38,13,32332843,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,52
6,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244936,305,50.49,10,c.2612C>T,p.(Pro871Leu),G,A,151,154,CCG,CTG,P,L,NM_007294.3,NM_007294,41244936,within,.,,rs799917,0.5439,0.4932,,4.247,0.0,0.0,0.999,1.0,5.04,,,,,-,G,A,41244936,41244936,A19EA255CA888CE1FE48D08CAD633F1F,,,,,,,1,BRCA1- 458755064,-1485,41812,11,,,,EMPTY,,D,,1,13,53,290862,492662,126000,(eval),,0,0,,"1:4,2:1",,0.41,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.4127,9,3,0.68421054,0.64634144,0.59038854,GRCh38/hg38,17,43092919,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,53
19,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219804,158,50.63,16,c.4987-92A>G,p.(=),T,C,78,80,,,,,NM_007294.3,NM_007294,41219804,within,.,,rs8176233,0.3546,,,,,,,,,,,,,-,T,C,41219804,41219804,7341B20C52FFD4B9355840FB9CB56CDA,,,,,,,-1,BRCA1- 458780196,0,125749,17,,,,EMPTY,,D,,0,13,53,225491,492662,126000,,,0,0,,,,,92,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3128,15,1,0.68421054,0.64634144,0.45769918,GRCh38/hg38,17,43067787,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,53
7,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245237,188,50.53,10,c.2311T>C,p.(Leu771=),A,G,93,95,TTG,CTG,L,L,NM_007294.3,NM_007294,41245237,within,.,,rs16940,0.3353,0.2776,,,,,,,,,,,,-,A,G,41245237,41245237,711AF22D84A49E875C2B2A9597A95EE6,,,,,,,-1,BRCA1- 458754763,1641,125554,11,,,,EMPTY,,D,,0,12,51,269517,492662,126000,,,0,0,,1:1,,0.342,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3422,9,1,0.6315789,0.6219512,0.5470627,GRCh38/hg38,17,43093220,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,53
2,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41231516,155,47.1,13,c.4358-2885G>A,p.(=),C,T,82,73,,,,,NM_007294.3,NM_007294,41231516,within,.,,rs8176193,0.3534,,,,,,,,,,,,,-,C,T,41231516,41231516,7F4F80D2D005D34CEA47E4A2C561B172,,,,,,,-1,BRCA1- 458768484,0,209399,14,,,,EMPTY,,D,,0,13,53,190200,492662,126000,,,0,0,,,,,2885,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.317,12,1,0.68421054,0.64634144,0.3860659,GRCh38/hg38,17,43079499,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,53
4,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244000,479,49.9,10,c.3548A>G,p.(Lys1183Arg),T,C,240,239,AAA,AGA,K,R,NM_007294.3,NM_007294,41244000,within,.,,rs16942,0.3526,0.2952,,-0.319,0.0,0.001,0.924,0.0,-2.35,,,,,-,T,C,41244000,41244000,37A54117EA353BDA677332A1F61FA173,,,,,,,-1,BRCA1- 458756000,-549,41818,11,,,,EMPTY,,D,,0,13,53,272437,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.68421054,0.64634144,0.55298966,GRCh38/hg38,17,43091983,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,53
18,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219780,159,50.31,16,c.4987-68A>G,p.(=),T,C,79,80,,,,,NM_007294.3,NM_007294,41219780,within,.,,rs8176234,0.3546,,,,,,,,,,,,,-,T,C,41219780,41219780,5995ECC305C33150BF3BB2B0C22FCC2A,,,,,,,-1,BRCA1- 458780220,0,125746,17,,,,EMPTY,,D,,0,13,53,234031,492662,126000,,,0,0,,,,,68,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3148,15,1,0.68421054,0.64634144,0.47503358,GRCh38/hg38,17,43067763,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,53
20,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41223094,353,52.12,15,c.4837A>G,p.(Ser1613Gly),T,C,169,184,AGT,GGT,S,G,NM_007294.3,NM_007294,41223094,within,.,,rs1799966,0.3558,0.2982,,-0.194,0.968,0.038,0.814,0.0,1.5,,,,,-,T,C,41223094,41223094,E3C52286D31F229973DB3595B052645F,,,,,,,-1,BRCA1- 458776906,-150,41827,16,,,,EMPTY,,D,,0,13,53,273625,492662,126000,,,0,0,,1:1,,0.349,0,,,,,,,,,,,,,,Benign,Benign,0.255,113705,-1,,,,,,,,,,,3,0.35,14,1,0.68421054,0.64634144,0.5554011,GRCh38/hg38,17,43071077,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,53
5,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244435,352,50.85,10,c.3113A>G,p.(Glu1038Gly),T,C,173,179,GAA,GGA,E,G,NM_007294.3,NM_007294,41244435,within,.,,rs16941,0.3357,0.279,,-0.149,0.972,0.606,0.922,0.0,-0.974,,,,,-,T,C,41244435,41244435,5D0FF1321BAC3C76DD352C33CC33B93E,,,,,,,-1,BRCA1- 458755565,-984,41815,11,,,,EMPTY,,D,,0,12,52,270861,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,0.936,113705,-1,,,,,,,,,,,3,0.343,9,1,0.6315789,0.63414633,0.54979074,GRCh38/hg38,17,43092418,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,53
8,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245466,581,48.19,10,c.2082C>T,p.(Ser694=),G,A,301,280,AGC,AGT,S,S,NM_007294.3,NM_007294,41245466,within,.,,rs1799949,0.3365,0.2957,,,,,,,,,,,,-,G,A,41245466,41245466,3364E3D252EFEDF917C74D44FBC6A381,,,,,,,-1,BRCA1- 458754534,1412,125536,11,,,,EMPTY,,D,,0,13,53,269442,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.68421054,0.64634144,0.54691046,GRCh38/hg38,17,43093449,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,53
3,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41234470,167,54.49,12,c.4308T>C,p.(Ser1436=),A,G,76,91,TCT,TCC,S,S,NM_007294.3,NM_007294,41234470,within,.,,rs1060915,0.3363,0.2796,,,,,,,,,,,,-,A,G,41234470,41234470,B7237055CF1D42F022A050C072B7583B,,,,,,,-1,BRCA1- 458765530,-50,125703,13,,,,EMPTY,,D,,0,12,52,270833,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3433,11,1,0.6315789,0.63414633,0.5497339,GRCh38/hg38,17,43082453,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,53
9,D,BRCA1,,INDEL,intronic,GRCh37/hg19,17,41249363,84,19.05,8,c.548-58del,p.(=),TAAAAAAA,TAAAAAA,68,16,,,,,NM_007294.3,NM_007294,41249363,within,.,,rs8176144,0.3349,0.2784,,,,,,,,,,,,-,A,-,41249364,41249364,5FE5767CE4FF1F683ED78276A22DFBE8,,,,,,,-1,BRCA1- 458750637,0,125889,9,,,,EMPTY,,D,,0,6,34,238141,492662,126000,,,0,0,,,,,58,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3005,7,1,0.31578946,0.41463414,0.48337603,GRCh38/hg38,17,43097346,TAAAAAAA,TAAAAAA,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,53
16,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32930598,157,100.0,15,c.7469T>C,p.(Ile2490Thr),T,C,0,157,ATA,ACA,I,T,NM_000059.3,NM_000059,32930598,within,.,,rs11571707,0.016,0.0016,,0.406,0.895,,0.837,0.0,-5.83,,,,,+,T,C,32930598,32930598,D7CAF30A58440FCA5E8E7BACD8E1EDE4,,,,,,,-1,BRCA2-  32930598,34,96852,15,,,,EMPTY,,D,,0,5,22,6837,493217,126000,,,0,0,,"1:5,2:2",,0.014,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0176,14,2,0.2631579,0.2682927,0.013862053,GRCh38/hg38,13,32356461,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,53
14,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,285,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,285,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,19,82,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,1.0,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,53
12,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,176,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,176,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,19,82,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,1.0,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,53
15,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,178,100.0,14,c.7397T>C,p.(Val2466Ala),T,C,0,178,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,19,81,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.9878049,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,53
1,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906729,208,99.04,10,c.1114A>C,p.(Asn372His),A,C,0,206,AAT,CAT,N,H,NM_000059.3,NM_000059,32906729,within,.,,rs144848,0.2494,0.2332,,0.32,0.861,,0.269,0.0,0.396,,,,,+,A,C,32906729,32906729,D514F785F1344AF9F6975E589D47BDF6,,,,,,,-1,BRCA2-  32906729,321,9329,10,,,,EMPTY,,D,,0,12,51,233635,493217,126000,,,0,0,,"1:1,2:1",,0.277,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2733,9,1,0.6315789,0.6219512,0.47369617,GRCh38/hg38,13,32332592,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,53
9,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244936,375,47.73,10,c.2612C>T,p.(Pro871Leu),G,A,196,179,CCG,CTG,P,L,NM_007294.3,NM_007294,41244936,within,.,,rs799917,0.5439,0.4932,,4.247,0.0,0.0,0.999,1.0,5.04,,,,,-,G,A,41244936,41244936,A19EA255CA888CE1FE48D08CAD633F1F,,,,,,,1,BRCA1- 458755064,-1485,41812,11,,,,EMPTY,,D,,1,13,53,290862,492662,126000,(eval),,0,0,,"1:4,2:1",,0.41,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.4127,9,3,0.68421054,0.64634144,0.59038854,GRCh38/hg38,17,43092919,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,54
4,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41223094,421,49.17,15,c.4837A>G,p.(Ser1613Gly),T,C,214,207,AGT,GGT,S,G,NM_007294.3,NM_007294,41223094,within,.,,rs1799966,0.3558,0.2982,,-0.194,0.968,0.038,0.814,0.0,1.5,,,,,-,T,C,41223094,41223094,E3C52286D31F229973DB3595B052645F,,,,,,,-1,BRCA1- 458776906,-150,41827,16,,,,EMPTY,,D,,0,13,53,273625,492662,126000,,,0,0,,1:1,,0.349,0,,,,,,,,,,,,,,Benign,Benign,0.255,113705,-1,,,,,,,,,,,3,0.35,14,1,0.68421054,0.64634144,0.5554011,GRCh38/hg38,17,43071077,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,54
23,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41215825,117,47.86,17,c.5152+66G>A,p.(=),C,T,61,56,,,,,NM_007294.3,NM_007294,41215825,within,.,,rs3092994,0.3425,,,,,,,,,,,,,-,C,T,41215825,41215825,5BCA8D2E1E3875817F84A3EB582CDFAB,,,,,,,-1,BRCA1- 458784175,0,55428,18,,,,EMPTY,,D,,0,8,40,241843,492662,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3139,16,1,0.42105263,0.4878049,0.4908903,GRCh38/hg38,17,43063808,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,54
11,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245466,664,47.59,10,c.2082C>T,p.(Ser694=),G,A,348,316,AGC,AGT,S,S,NM_007294.3,NM_007294,41245466,within,.,,rs1799949,0.3365,0.2957,,,,,,,,,,,,-,G,A,41245466,41245466,3364E3D252EFEDF917C74D44FBC6A381,,,,,,,-1,BRCA1- 458754534,1412,125536,11,,,,EMPTY,,D,,0,13,53,269442,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.68421054,0.64634144,0.54691046,GRCh38/hg38,17,43093449,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,54
8,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244435,400,51.5,10,c.3113A>G,p.(Glu1038Gly),T,C,194,206,GAA,GGA,E,G,NM_007294.3,NM_007294,41244435,within,.,,rs16941,0.3357,0.279,,-0.149,0.972,0.606,0.922,0.0,-0.974,,,,,-,T,C,41244435,41244435,5D0FF1321BAC3C76DD352C33CC33B93E,,,,,,,-1,BRCA1- 458755565,-984,41815,11,,,,EMPTY,,D,,0,12,52,270861,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,0.936,113705,-1,,,,,,,,,,,3,0.343,9,1,0.6315789,0.63414633,0.54979074,GRCh38/hg38,17,43092418,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,54
24,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219780,262,58.02,16,c.4987-68A>G,p.(=),T,C,110,152,,,,,NM_007294.3,NM_007294,41219780,within,.,,rs8176234,0.3546,,,,,,,,,,,,,-,T,C,41219780,41219780,5995ECC305C33150BF3BB2B0C22FCC2A,,,,,,,-1,BRCA1- 458780220,0,125746,17,,,,EMPTY,,D,,0,13,53,234031,492662,126000,,,0,0,,,,,68,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3148,15,1,0.68421054,0.64634144,0.47503358,GRCh38/hg38,17,43067763,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,54
13,D,BRCA1,,INDEL,intronic,GRCh37/hg19,17,41249363,81,16.05,8,c.548-58del,p.(=),TAAAAAAA,TAAAAAA,68,13,,,,,NM_007294.3,NM_007294,41249363,within,.,,rs8176144,0.3349,0.2784,,,,,,,,,,,,-,A,-,41249364,41249364,5FE5767CE4FF1F683ED78276A22DFBE8,,,,,,,-1,BRCA1- 458750637,0,125889,9,,,,EMPTY,,D,,0,6,34,238141,492662,126000,,,0,0,,,,,58,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3005,7,1,0.31578946,0.41463414,0.48337603,GRCh38/hg38,17,43097346,TAAAAAAA,TAAAAAA,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,54
2,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219804,262,58.4,16,c.4987-92A>G,p.(=),T,C,109,153,,,,,NM_007294.3,NM_007294,41219804,within,.,,rs8176233,0.3546,,,,,,,,,,,,,-,T,C,41219804,41219804,7341B20C52FFD4B9355840FB9CB56CDA,,,,,,,-1,BRCA1- 458780196,0,125749,17,,,,EMPTY,,D,,0,13,53,225491,492662,126000,,,0,0,,,,,92,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3128,15,1,0.68421054,0.64634144,0.45769918,GRCh38/hg38,17,43067787,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,54
7,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244000,519,48.55,10,c.3548A>G,p.(Lys1183Arg),T,C,267,252,AAA,AGA,K,R,NM_007294.3,NM_007294,41244000,within,.,,rs16942,0.3526,0.2952,,-0.319,0.0,0.001,0.924,0.0,-2.35,,,,,-,T,C,41244000,41244000,37A54117EA353BDA677332A1F61FA173,,,,,,,-1,BRCA1- 458756000,-549,41818,11,,,,EMPTY,,D,,0,13,53,272437,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.68421054,0.64634144,0.55298966,GRCh38/hg38,17,43091983,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,54
10,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245237,176,47.73,10,c.2311T>C,p.(Leu771=),A,G,92,84,TTG,CTG,L,L,NM_007294.3,NM_007294,41245237,within,.,,rs16940,0.3353,0.2776,,,,,,,,,,,,-,A,G,41245237,41245237,711AF22D84A49E875C2B2A9597A95EE6,,,,,,,-1,BRCA1- 458754763,1641,125554,11,,,,EMPTY,,D,,0,12,51,269517,492662,126000,,,0,0,,1:1,,0.342,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3422,9,1,0.6315789,0.6219512,0.5470627,GRCh38/hg38,17,43093220,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,54
6,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41234470,205,50.24,12,c.4308T>C,p.(Ser1436=),A,G,102,103,TCT,TCC,S,S,NM_007294.3,NM_007294,41234470,within,.,,rs1060915,0.3363,0.2796,,,,,,,,,,,,-,A,G,41234470,41234470,B7237055CF1D42F022A050C072B7583B,,,,,,,-1,BRCA1- 458765530,-50,125703,13,,,,EMPTY,,D,,0,12,52,270833,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3433,11,1,0.6315789,0.63414633,0.5497339,GRCh38/hg38,17,43082453,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,54
5,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41231516,212,47.17,13,c.4358-2885G>A,p.(=),C,T,112,100,,,,,NM_007294.3,NM_007294,41231516,within,.,,rs8176193,0.3534,,,,,,,,,,,,,-,C,T,41231516,41231516,7F4F80D2D005D34CEA47E4A2C561B172,,,,,,,-1,BRCA1- 458768484,0,209399,14,,,,EMPTY,,D,,0,13,53,190200,492662,126000,,,0,0,,,,,2885,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.317,12,1,0.68421054,0.64634144,0.3860659,GRCh38/hg38,17,43079499,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,54
20,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32936646,137,52.55,17,c.7806-14T>C,p.(=),T,C,65,72,,,,,NM_000059.3,NM_000059,32936646,within,.,,rs9534262,0.5316,0.5202,,,,,,,,,,,,+,T,C,32936646,32936646,5803939D8FBB75B042260991F0A62436,,,,,,,-1,BRCA2-  32936646,0,126158,17,,,,EMPTY,,D,,0,13,61,361616,493217,126000,,,0,0,,1:3,,0.52,14,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5255,16,1,0.68421054,0.74390244,0.7331783,GRCh38/hg38,13,32362509,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,54
19,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,180,100.0,14,c.7397T>C,p.(Val2466Ala),T,C,0,180,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,19,81,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.9878049,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,54
12,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,190,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,190,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,19,82,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,1.0,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,54
18,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,464,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,464,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,19,82,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,1.0,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,54
21,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32953388,294,51.36,22,c.8755-66T>C,p.(=),T,C,143,151,,,,,NM_000059.3,NM_000059,32953388,within,.,,rs4942486,0.5116,,,,,,,,,,,,,+,T,C,32953388,32953388,97C65B85894EB489F1BFA65897685241,,,,,,,-1,BRCA2-  32953388,0,126190,22,,,,EMPTY,,D,,0,13,61,347826,493217,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5257,21,1,0.68421054,0.74390244,0.70521903,GRCh38/hg38,13,32379251,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,54
1,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906729,277,100.0,10,c.1114A>C,p.(Asn372His),A,C,0,277,AAT,CAT,N,H,NM_000059.3,NM_000059,32906729,within,.,,rs144848,0.2494,0.2332,,0.32,0.861,,0.269,0.0,0.396,,,,,+,A,C,32906729,32906729,D514F785F1344AF9F6975E589D47BDF6,,,,,,,-1,BRCA2-  32906729,321,9329,10,,,,EMPTY,,D,,0,12,51,233635,493217,126000,,,0,0,,"1:1,2:1",,0.277,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2733,9,1,0.6315789,0.6219512,0.47369617,GRCh38/hg38,13,32332592,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,54
11,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244936,301,51.83,10,c.2612C>T,p.(Pro871Leu),G,A,145,156,CCG,CTG,P,L,NM_007294.3,NM_007294,41244936,within,.,,rs799917,0.5439,0.4932,,4.247,0.0,0.0,0.999,1.0,5.04,,,,,-,G,A,41244936,41244936,A19EA255CA888CE1FE48D08CAD633F1F,,,,,,,1,BRCA1- 458755064,-1485,41812,11,,,,EMPTY,,D,,1,13,53,290862,492662,126000,(eval),,0,0,,"1:4,2:1",,0.41,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.4127,9,3,0.68421054,0.64634144,0.59038854,GRCh38/hg38,17,43092919,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,55
14,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245466,506,47.83,10,c.2082C>T,p.(Ser694=),G,A,264,242,AGC,AGT,S,S,NM_007294.3,NM_007294,41245466,within,.,,rs1799949,0.3365,0.2957,,,,,,,,,,,,-,G,A,41245466,41245466,3364E3D252EFEDF917C74D44FBC6A381,,,,,,,-1,BRCA1- 458754534,1412,125536,11,,,,EMPTY,,D,,0,13,53,269442,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.68421054,0.64634144,0.54691046,GRCh38/hg38,17,43093449,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,55
10,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244435,352,51.42,10,c.3113A>G,p.(Glu1038Gly),T,C,171,181,GAA,GGA,E,G,NM_007294.3,NM_007294,41244435,within,.,,rs16941,0.3357,0.279,,-0.149,0.972,0.606,0.922,0.0,-0.974,,,,,-,T,C,41244435,41244435,5D0FF1321BAC3C76DD352C33CC33B93E,,,,,,,-1,BRCA1- 458755565,-984,41815,11,,,,EMPTY,,D,,0,12,52,270861,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,0.936,113705,-1,,,,,,,,,,,3,0.343,9,1,0.6315789,0.63414633,0.54979074,GRCh38/hg38,17,43092418,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,55
7,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41234470,150,53.33,12,c.4308T>C,p.(Ser1436=),A,G,70,80,TCT,TCC,S,S,NM_007294.3,NM_007294,41234470,within,.,,rs1060915,0.3363,0.2796,,,,,,,,,,,,-,A,G,41234470,41234470,B7237055CF1D42F022A050C072B7583B,,,,,,,-1,BRCA1- 458765530,-50,125703,13,,,,EMPTY,,D,,0,12,52,270833,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3433,11,1,0.6315789,0.63414633,0.5497339,GRCh38/hg38,17,43082453,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,55
5,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41223094,327,46.79,15,c.4837A>G,p.(Ser1613Gly),T,C,174,153,AGT,GGT,S,G,NM_007294.3,NM_007294,41223094,within,.,,rs1799966,0.3558,0.2982,,-0.194,0.968,0.038,0.814,0.0,1.5,,,,,-,T,C,41223094,41223094,E3C52286D31F229973DB3595B052645F,,,,,,,-1,BRCA1- 458776906,-150,41827,16,,,,EMPTY,,D,,0,13,53,273625,492662,126000,,,0,0,,1:1,,0.349,0,,,,,,,,,,,,,,Benign,Benign,0.255,113705,-1,,,,,,,,,,,3,0.35,14,1,0.68421054,0.64634144,0.5554011,GRCh38/hg38,17,43071077,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,55
16,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41251931,155,42.58,7,c.442-34C>T,p.(=),G,A,89,66,,,,,NM_007294.3,NM_007294,41251931,within,.,,rs799923,0.0986,0.1757,,,,,,,,,,,,-,G,A,41251931,41251931,A5CCEFE1E7B19A106A59AB89C8776C53,,,,,,,-1,BRCA1- 458748069,0,125864,8,,,,EMPTY,,D,,0,1,15,181678,492662,126000,,,0,0,,,,0.174,34,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.1711,6,1,0.05263158,0.18292683,0.36876804,GRCh38/hg38,17,43099914,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,55
9,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244000,511,50.1,10,c.3548A>G,p.(Lys1183Arg),T,C,255,256,AAA,AGA,K,R,NM_007294.3,NM_007294,41244000,within,.,,rs16942,0.3526,0.2952,,-0.319,0.0,0.001,0.924,0.0,-2.35,,,,,-,T,C,41244000,41244000,37A54117EA353BDA677332A1F61FA173,,,,,,,-1,BRCA1- 458756000,-549,41818,11,,,,EMPTY,,D,,0,13,53,272437,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.68421054,0.64634144,0.55298966,GRCh38/hg38,17,43091983,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,55
2,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41215825,99,55.56,17,c.5152+66G>A,p.(=),C,T,44,55,,,,,NM_007294.3,NM_007294,41215825,within,.,,rs3092994,0.3425,,,,,,,,,,,,,-,C,T,41215825,41215825,5BCA8D2E1E3875817F84A3EB582CDFAB,,,,,,,-1,BRCA1- 458784175,0,55428,18,,,,EMPTY,,D,,0,8,40,241843,492662,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3139,16,1,0.42105263,0.4878049,0.4908903,GRCh38/hg38,17,43063808,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,55
4,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219804,220,47.73,16,c.4987-92A>G,p.(=),T,C,115,105,,,,,NM_007294.3,NM_007294,41219804,within,.,,rs8176233,0.3546,,,,,,,,,,,,,-,T,C,41219804,41219804,7341B20C52FFD4B9355840FB9CB56CDA,,,,,,,-1,BRCA1- 458780196,0,125749,17,,,,EMPTY,,D,,0,13,53,225491,492662,126000,,,0,0,,,,,92,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3128,15,1,0.68421054,0.64634144,0.45769918,GRCh38/hg38,17,43067787,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,55
6,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41231516,148,56.08,13,c.4358-2885G>A,p.(=),C,T,65,83,,,,,NM_007294.3,NM_007294,41231516,within,.,,rs8176193,0.3534,,,,,,,,,,,,,-,C,T,41231516,41231516,7F4F80D2D005D34CEA47E4A2C561B172,,,,,,,-1,BRCA1- 458768484,0,209399,14,,,,EMPTY,,D,,0,13,53,190200,492662,126000,,,0,0,,,,,2885,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.317,12,1,0.68421054,0.64634144,0.3860659,GRCh38/hg38,17,43079499,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,55
15,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41246481,503,45.73,10,c.1067A>G,p.(Gln356Arg),T,C,273,230,CAG,CGG,Q,R,NM_007294.3,NM_007294,41246481,within,.,,rs1799950,0.0218,0.0459,,2.371,0.995,0.988,0.992,0.0218,3.71,,,,,-,T,C,41246481,41246481,DE7889D7BF4EEED5C3D165470529DA1E,,,,,,,-1,BRCA1- 458753519,397,41803,11,,,,EMPTY,,D,,0,1,3,61808,492662,126000,,,0,0,,"1:6,2:1",,0.044,0,,,,,,,,,,,,,,Benign,Benign,0.998,113705,-1,,,,,,,,,,,3,0.0471,9,3,0.05263158,0.036585364,0.12545721,GRCh38/hg38,17,43094464,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,55
13,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245237,154,42.86,10,c.2311T>C,p.(Leu771=),A,G,88,66,TTG,CTG,L,L,NM_007294.3,NM_007294,41245237,within,.,,rs16940,0.3353,0.2776,,,,,,,,,,,,-,A,G,41245237,41245237,711AF22D84A49E875C2B2A9597A95EE6,,,,,,,-1,BRCA1- 458754763,1641,125554,11,,,,EMPTY,,D,,0,12,51,269517,492662,126000,,,0,0,,1:1,,0.342,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3422,9,1,0.6315789,0.6219512,0.5470627,GRCh38/hg38,17,43093220,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,55
3,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219780,220,47.73,16,c.4987-68A>G,p.(=),T,C,115,105,,,,,NM_007294.3,NM_007294,41219780,within,.,,rs8176234,0.3546,,,,,,,,,,,,,-,T,C,41219780,41219780,5995ECC305C33150BF3BB2B0C22FCC2A,,,,,,,-1,BRCA1- 458780220,0,125746,17,,,,EMPTY,,D,,0,13,53,234031,492662,126000,,,0,0,,,,,68,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3148,15,1,0.68421054,0.64634144,0.47503358,GRCh38/hg38,17,43067763,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,55
1,D,BRCA2,,SNP,5'UTR,GRCh37/hg19,13,32890572,366,53.55,2,c.-26G>A,p.(=),G,A,170,196,,,,,NM_000059.3,NM_000059,32890572,within,.,,rs1799943,0.2093,0.2088,,,,,,,,,,,,+,G,A,32890572,32890572,A9C2B39455EF056EDB097A5953EB72EE,,,,,,,-1,BRCA2-  32890572,14,125965,2,,,,EMPTY,,D,,0,8,34,205902,493217,126000,,,0,0,,,,0.243,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2427,1,1,0.42105263,0.41463414,0.41746736,GRCh38/hg38,13,32316435,G,A,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,55
24,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,120,100.0,14,c.7397T>C,p.(Val2466Ala),T,C,0,120,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,19,81,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.9878049,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,55
12,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32903685,256,44.92,8,c.681+56C>T,p.(=),C,T,141,115,,,,,NM_000059.3,NM_000059,32903685,within,.,,rs2126042,0.1859,,,,,,,,,,,,,+,C,T,32903685,32903685,E9AEF840574909F4761D4EF7950E02CB,,,,,,,-1,BRCA2-  32903685,0,126192,8,,,,EMPTY,,D,,0,3,21,145186,493217,126000,,,0,0,,4:1,,,56,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2163,7,1,0.15789473,0.25609756,0.29436535,GRCh38/hg38,13,32329548,C,T,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,55
26,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32953388,245,46.94,22,c.8755-66T>C,p.(=),T,C,130,115,,,,,NM_000059.3,NM_000059,32953388,within,.,,rs4942486,0.5116,,,,,,,,,,,,,+,T,C,32953388,32953388,97C65B85894EB489F1BFA65897685241,,,,,,,-1,BRCA2-  32953388,0,126190,22,,,,EMPTY,,D,,0,13,61,347826,493217,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5257,21,1,0.68421054,0.74390244,0.70521903,GRCh38/hg38,13,32379251,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,55
21,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32911888,296,54.05,11,c.3396A>G,p.(Lys1132=),A,G,136,160,AAA,AAG,K,K,NM_000059.3,NM_000059,32911888,within,.,,rs1801406,0.2668,0.2798,,,,,,,,,,,,+,A,G,32911888,32911888,94F2C0D328C28C466A38A430BBE75D52,,,,,,,-1,BRCA2-  32911888,1487,126010,11,,,,EMPTY,,D,,0,9,35,248687,493217,126000,,,0,0,,1:3,,0.293,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.295,10,1,0.47368422,0.42682928,0.50421417,GRCh38/hg38,13,32337751,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,55
22,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,158,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,158,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,19,82,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,1.0,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,55
25,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32936646,114,46.49,17,c.7806-14T>C,p.(=),T,C,61,53,,,,,NM_000059.3,NM_000059,32936646,within,.,,rs9534262,0.5316,0.5202,,,,,,,,,,,,+,T,C,32936646,32936646,5803939D8FBB75B042260991F0A62436,,,,,,,-1,BRCA2-  32936646,0,126158,17,,,,EMPTY,,D,,0,13,61,361616,493217,126000,,,0,0,,1:3,,0.52,14,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5255,16,1,0.68421054,0.74390244,0.7331783,GRCh38/hg38,13,32362509,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,55
23,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,311,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,311,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,19,82,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,1.0,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,55
11,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244936,327,48.62,10,c.2612C>T,p.(Pro871Leu),G,A,168,159,CCG,CTG,P,L,NM_007294.3,NM_007294,41244936,within,.,,rs799917,0.5439,0.4932,,4.247,0.0,0.0,0.999,1.0,5.04,,,,,-,G,A,41244936,41244936,A19EA255CA888CE1FE48D08CAD633F1F,,,,,,,1,BRCA1- 458755064,-1485,41812,11,,,,EMPTY,,D,,1,13,53,290862,492662,126000,(eval),,0,0,,"1:4,2:1",,0.41,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.4127,9,3,0.68421054,0.64634144,0.59038854,GRCh38/hg38,17,43092919,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,56
14,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245466,553,47.56,10,c.2082C>T,p.(Ser694=),G,A,290,263,AGC,AGT,S,S,NM_007294.3,NM_007294,41245466,within,.,,rs1799949,0.3365,0.2957,,,,,,,,,,,,-,G,A,41245466,41245466,3364E3D252EFEDF917C74D44FBC6A381,,,,,,,-1,BRCA1- 458754534,1412,125536,11,,,,EMPTY,,D,,0,13,53,269442,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.68421054,0.64634144,0.54691046,GRCh38/hg38,17,43093449,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,56
10,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244435,297,51.85,10,c.3113A>G,p.(Glu1038Gly),T,C,143,154,GAA,GGA,E,G,NM_007294.3,NM_007294,41244435,within,.,,rs16941,0.3357,0.279,,-0.149,0.972,0.606,0.922,0.0,-0.974,,,,,-,T,C,41244435,41244435,5D0FF1321BAC3C76DD352C33CC33B93E,,,,,,,-1,BRCA1- 458755565,-984,41815,11,,,,EMPTY,,D,,0,12,52,270861,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,0.936,113705,-1,,,,,,,,,,,3,0.343,9,1,0.6315789,0.63414633,0.54979074,GRCh38/hg38,17,43092418,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,56
8,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41234470,87,47.13,12,c.4308T>C,p.(Ser1436=),A,G,46,41,TCT,TCC,S,S,NM_007294.3,NM_007294,41234470,within,.,,rs1060915,0.3363,0.2796,,,,,,,,,,,,-,A,G,41234470,41234470,B7237055CF1D42F022A050C072B7583B,,,,,,,-1,BRCA1- 458765530,-50,125703,13,,,,EMPTY,,D,,0,12,52,270833,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3433,11,1,0.6315789,0.63414633,0.5497339,GRCh38/hg38,17,43082453,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,56
7,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41231516,114,43.86,13,c.4358-2885G>A,p.(=),C,T,64,50,,,,,NM_007294.3,NM_007294,41231516,within,.,,rs8176193,0.3534,,,,,,,,,,,,,-,C,T,41231516,41231516,7F4F80D2D005D34CEA47E4A2C561B172,,,,,,,-1,BRCA1- 458768484,0,209399,14,,,,EMPTY,,D,,0,13,53,190200,492662,126000,,,0,0,,,,,2885,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.317,12,1,0.68421054,0.64634144,0.3860659,GRCh38/hg38,17,43079499,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,56
9,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244000,362,45.3,10,c.3548A>G,p.(Lys1183Arg),T,C,198,164,AAA,AGA,K,R,NM_007294.3,NM_007294,41244000,within,.,,rs16942,0.3526,0.2952,,-0.319,0.0,0.001,0.924,0.0,-2.35,,,,,-,T,C,41244000,41244000,37A54117EA353BDA677332A1F61FA173,,,,,,,-1,BRCA1- 458756000,-549,41818,11,,,,EMPTY,,D,,0,13,53,272437,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.68421054,0.64634144,0.55298966,GRCh38/hg38,17,43091983,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,56
4,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219780,158,43.67,16,c.4987-68A>G,p.(=),T,C,89,69,,,,,NM_007294.3,NM_007294,41219780,within,.,,rs8176234,0.3546,,,,,,,,,,,,,-,T,C,41219780,41219780,5995ECC305C33150BF3BB2B0C22FCC2A,,,,,,,-1,BRCA1- 458780220,0,125746,17,,,,EMPTY,,D,,0,13,53,234031,492662,126000,,,0,0,,,,,68,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3148,15,1,0.68421054,0.64634144,0.47503358,GRCh38/hg38,17,43067763,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,56
13,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245237,165,43.03,10,c.2311T>C,p.(Leu771=),A,G,94,71,TTG,CTG,L,L,NM_007294.3,NM_007294,41245237,within,.,,rs16940,0.3353,0.2776,,,,,,,,,,,,-,A,G,41245237,41245237,711AF22D84A49E875C2B2A9597A95EE6,,,,,,,-1,BRCA1- 458754763,1641,125554,11,,,,EMPTY,,D,,0,12,51,269517,492662,126000,,,0,0,,1:1,,0.342,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3422,9,1,0.6315789,0.6219512,0.5470627,GRCh38/hg38,17,43093220,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,56
5,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219804,158,43.67,16,c.4987-92A>G,p.(=),T,C,89,69,,,,,NM_007294.3,NM_007294,41219804,within,.,,rs8176233,0.3546,,,,,,,,,,,,,-,T,C,41219804,41219804,7341B20C52FFD4B9355840FB9CB56CDA,,,,,,,-1,BRCA1- 458780196,0,125749,17,,,,EMPTY,,D,,0,13,53,225491,492662,126000,,,0,0,,,,,92,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3128,15,1,0.68421054,0.64634144,0.45769918,GRCh38/hg38,17,43067787,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,56
3,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41215825,89,43.82,17,c.5152+66G>A,p.(=),C,T,50,39,,,,,NM_007294.3,NM_007294,41215825,within,.,,rs3092994,0.3425,,,,,,,,,,,,,-,C,T,41215825,41215825,5BCA8D2E1E3875817F84A3EB582CDFAB,,,,,,,-1,BRCA1- 458784175,0,55428,18,,,,EMPTY,,D,,0,8,40,241843,492662,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3139,16,1,0.42105263,0.4878049,0.4908903,GRCh38/hg38,17,43063808,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,56
6,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41223094,307,50.49,15,c.4837A>G,p.(Ser1613Gly),T,C,152,155,AGT,GGT,S,G,NM_007294.3,NM_007294,41223094,within,.,,rs1799966,0.3558,0.2982,,-0.194,0.968,0.038,0.814,0.0,1.5,,,,,-,T,C,41223094,41223094,E3C52286D31F229973DB3595B052645F,,,,,,,-1,BRCA1- 458776906,-150,41827,16,,,,EMPTY,,D,,0,13,53,273625,492662,126000,,,0,0,,1:1,,0.349,0,,,,,,,,,,,,,,Benign,Benign,0.255,113705,-1,,,,,,,,,,,3,0.35,14,1,0.68421054,0.64634144,0.5554011,GRCh38/hg38,17,43071077,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,56
12,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906729,86,45.35,10,c.1114A>C,p.(Asn372His),A,C,47,39,AAT,CAT,N,H,NM_000059.3,NM_000059,32906729,within,.,,rs144848,0.2494,0.2332,,0.32,0.861,,0.269,0.0,0.396,,,,,+,A,C,32906729,32906729,D514F785F1344AF9F6975E589D47BDF6,,,,,,,-1,BRCA2-  32906729,321,9329,10,,,,EMPTY,,D,,0,12,51,233635,493217,126000,,,0,0,,"1:1,2:1",,0.277,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2733,9,1,0.6315789,0.6219512,0.47369617,GRCh38/hg38,13,32332592,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,56
23,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,129,100.0,14,c.7397T>C,p.(Val2466Ala),T,C,0,129,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,19,81,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.9878049,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,56
20,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,152,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,152,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,19,82,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,1.0,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,56
21,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,242,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,242,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,19,82,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,1.0,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,56
2,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32953388,124,52.42,22,c.8755-66T>C,p.(=),T,C,59,65,,,,,NM_000059.3,NM_000059,32953388,within,.,,rs4942486,0.5116,,,,,,,,,,,,,+,T,C,32953388,32953388,97C65B85894EB489F1BFA65897685241,,,,,,,-1,BRCA2-  32953388,0,126190,22,,,,EMPTY,,D,,0,13,61,347826,493217,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5257,21,1,0.68421054,0.74390244,0.70521903,GRCh38/hg38,13,32379251,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,56
1,D,BRCA2,,SNP,5'UTR,GRCh37/hg19,13,32890572,348,49.14,2,c.-26G>A,p.(=),G,A,177,171,,,,,NM_000059.3,NM_000059,32890572,within,.,,rs1799943,0.2093,0.2088,,,,,,,,,,,,+,G,A,32890572,32890572,A9C2B39455EF056EDB097A5953EB72EE,,,,,,,-1,BRCA2-  32890572,14,125965,2,,,,EMPTY,,D,,0,8,34,205902,493217,126000,,,0,0,,,,0.243,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2427,1,1,0.42105263,0.41463414,0.41746736,GRCh38/hg38,13,32316435,G,A,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,56
25,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32936646,137,42.34,17,c.7806-14T>C,p.(=),T,C,79,58,,,,,NM_000059.3,NM_000059,32936646,within,.,,rs9534262,0.5316,0.5202,,,,,,,,,,,,+,T,C,32936646,32936646,5803939D8FBB75B042260991F0A62436,,,,,,,-1,BRCA2-  32936646,0,126158,17,,,,EMPTY,,D,,0,13,61,361616,493217,126000,,,0,0,,1:3,,0.52,14,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5255,16,1,0.68421054,0.74390244,0.7331783,GRCh38/hg38,13,32362509,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,56
19,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32911888,242,52.07,11,c.3396A>G,p.(Lys1132=),A,G,116,126,AAA,AAG,K,K,NM_000059.3,NM_000059,32911888,within,.,,rs1801406,0.2668,0.2798,,,,,,,,,,,,+,A,G,32911888,32911888,94F2C0D328C28C466A38A430BBE75D52,,,,,,,-1,BRCA2-  32911888,1487,126010,11,,,,EMPTY,,D,,0,9,35,248687,493217,126000,,,0,0,,1:3,,0.293,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.295,10,1,0.47368422,0.42682928,0.50421417,GRCh38/hg38,13,32337751,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,56
24,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32930598,128,61.72,15,c.7469T>C,p.(Ile2490Thr),T,C,49,79,ATA,ACA,I,T,NM_000059.3,NM_000059,32930598,within,.,,rs11571707,0.016,0.0016,,0.406,0.895,,0.837,0.0,-5.83,,,,,+,T,C,32930598,32930598,D7CAF30A58440FCA5E8E7BACD8E1EDE4,,,,,,,-1,BRCA2-  32930598,34,96852,15,,,,EMPTY,,D,,0,5,22,6837,493217,126000,,,0,0,,"1:5,2:2",,0.014,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0176,14,2,0.2631579,0.2682927,0.013862053,GRCh38/hg38,13,32356461,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,56
22,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32929232,187,51.87,14,c.7242A>G,p.(Ser2414=),A,G,90,97,TCA,TCG,S,S,NM_000059.3,NM_000059,32929232,within,.,,rs1799955,0.2326,0.2114,,,,,,,,,,,,+,A,G,32929232,32929232,6F8D6FF8BC9027D6C0351ADCEF41FD20,,,,,,,-1,BRCA2-  32929232,-194,126133,14,,,,EMPTY,,D,,0,5,31,192923,493217,126000,,,0,0,,"1:3,2:1",,0.224,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2257,13,1,0.2631579,0.37804878,0.39115238,GRCh38/hg38,13,32355095,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,56
13,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244936,185,100.0,10,c.2612C>T,p.(Pro871Leu),G,A,0,185,CCG,CTG,P,L,NM_007294.3,NM_007294,41244936,within,.,,rs799917,0.5439,0.4932,,4.247,0.0,0.0,0.999,1.0,5.04,,,,,-,G,A,41244936,41244936,A19EA255CA888CE1FE48D08CAD633F1F,,,,,,,1,BRCA1- 458755064,-1485,41812,11,,,,EMPTY,,D,,1,13,53,290862,492662,126000,(eval),,0,0,,"1:4,2:1",,0.41,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.4127,9,3,0.68421054,0.64634144,0.59038854,GRCh38/hg38,17,43092919,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,57
10,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244000,354,51.69,10,c.3548A>G,p.(Lys1183Arg),T,C,171,183,AAA,AGA,K,R,NM_007294.3,NM_007294,41244000,within,.,,rs16942,0.3526,0.2952,,-0.319,0.0,0.001,0.924,0.0,-2.35,,,,,-,T,C,41244000,41244000,37A54117EA353BDA677332A1F61FA173,,,,,,,-1,BRCA1- 458756000,-549,41818,11,,,,EMPTY,,D,,0,13,53,272437,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.68421054,0.64634144,0.55298966,GRCh38/hg38,17,43091983,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,57
8,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41231516,104,54.81,13,c.4358-2885G>A,p.(=),C,T,47,57,,,,,NM_007294.3,NM_007294,41231516,within,.,,rs8176193,0.3534,,,,,,,,,,,,,-,C,T,41231516,41231516,7F4F80D2D005D34CEA47E4A2C561B172,,,,,,,-1,BRCA1- 458768484,0,209399,14,,,,EMPTY,,D,,0,13,53,190200,492662,126000,,,0,0,,,,,2885,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.317,12,1,0.68421054,0.64634144,0.3860659,GRCh38/hg38,17,43079499,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,57
7,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41223094,222,50.9,15,c.4837A>G,p.(Ser1613Gly),T,C,109,113,AGT,GGT,S,G,NM_007294.3,NM_007294,41223094,within,.,,rs1799966,0.3558,0.2982,,-0.194,0.968,0.038,0.814,0.0,1.5,,,,,-,T,C,41223094,41223094,E3C52286D31F229973DB3595B052645F,,,,,,,-1,BRCA1- 458776906,-150,41827,16,,,,EMPTY,,D,,0,13,53,273625,492662,126000,,,0,0,,1:1,,0.349,0,,,,,,,,,,,,,,Benign,Benign,0.255,113705,-1,,,,,,,,,,,3,0.35,14,1,0.68421054,0.64634144,0.5554011,GRCh38/hg38,17,43071077,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,57
11,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244435,212,55.19,10,c.3113A>G,p.(Glu1038Gly),T,C,95,117,GAA,GGA,E,G,NM_007294.3,NM_007294,41244435,within,.,,rs16941,0.3357,0.279,,-0.149,0.972,0.606,0.922,0.0,-0.974,,,,,-,T,C,41244435,41244435,5D0FF1321BAC3C76DD352C33CC33B93E,,,,,,,-1,BRCA1- 458755565,-984,41815,11,,,,EMPTY,,D,,0,12,52,270861,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,0.936,113705,-1,,,,,,,,,,,3,0.343,9,1,0.6315789,0.63414633,0.54979074,GRCh38/hg38,17,43092418,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,57
14,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245237,115,46.96,10,c.2311T>C,p.(Leu771=),A,G,61,54,TTG,CTG,L,L,NM_007294.3,NM_007294,41245237,within,.,,rs16940,0.3353,0.2776,,,,,,,,,,,,-,A,G,41245237,41245237,711AF22D84A49E875C2B2A9597A95EE6,,,,,,,-1,BRCA1- 458754763,1641,125554,11,,,,EMPTY,,D,,0,12,51,269517,492662,126000,,,0,0,,1:1,,0.342,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3422,9,1,0.6315789,0.6219512,0.5470627,GRCh38/hg38,17,43093220,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,57
4,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219780,168,42.26,16,c.4987-68A>G,p.(=),T,C,97,71,,,,,NM_007294.3,NM_007294,41219780,within,.,,rs8176234,0.3546,,,,,,,,,,,,,-,T,C,41219780,41219780,5995ECC305C33150BF3BB2B0C22FCC2A,,,,,,,-1,BRCA1- 458780220,0,125746,17,,,,EMPTY,,D,,0,13,53,234031,492662,126000,,,0,0,,,,,68,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3148,15,1,0.68421054,0.64634144,0.47503358,GRCh38/hg38,17,43067763,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,57
5,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219804,168,42.26,16,c.4987-92A>G,p.(=),T,C,97,71,,,,,NM_007294.3,NM_007294,41219804,within,.,,rs8176233,0.3546,,,,,,,,,,,,,-,T,C,41219804,41219804,7341B20C52FFD4B9355840FB9CB56CDA,,,,,,,-1,BRCA1- 458780196,0,125749,17,,,,EMPTY,,D,,0,13,53,225491,492662,126000,,,0,0,,,,,92,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3128,15,1,0.68421054,0.64634144,0.45769918,GRCh38/hg38,17,43067787,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,57
3,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41215825,34,47.06,17,c.5152+66G>A,p.(=),C,T,18,16,,,,,NM_007294.3,NM_007294,41215825,within,.,,rs3092994,0.3425,,,,,,,,,,,,,-,C,T,41215825,41215825,5BCA8D2E1E3875817F84A3EB582CDFAB,,,,,,,-1,BRCA1- 458784175,0,55428,18,,,,EMPTY,,D,,0,8,40,241843,492662,126000,,,0,0,,,14,,66,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3139,16,1,0.42105263,0.4878049,0.4908903,GRCh38/hg38,17,43063808,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,57
9,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41234470,120,46.67,12,c.4308T>C,p.(Ser1436=),A,G,64,56,TCT,TCC,S,S,NM_007294.3,NM_007294,41234470,within,.,,rs1060915,0.3363,0.2796,,,,,,,,,,,,-,A,G,41234470,41234470,B7237055CF1D42F022A050C072B7583B,,,,,,,-1,BRCA1- 458765530,-50,125703,13,,,,EMPTY,,D,,0,12,52,270833,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3433,11,1,0.6315789,0.63414633,0.5497339,GRCh38/hg38,17,43082453,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,57
15,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245466,381,51.97,10,c.2082C>T,p.(Ser694=),G,A,183,198,AGC,AGT,S,S,NM_007294.3,NM_007294,41245466,within,.,,rs1799949,0.3365,0.2957,,,,,,,,,,,,-,G,A,41245466,41245466,3364E3D252EFEDF917C74D44FBC6A381,,,,,,,-1,BRCA1- 458754534,1412,125536,11,,,,EMPTY,,D,,0,13,53,269442,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.68421054,0.64634144,0.54691046,GRCh38/hg38,17,43093449,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,57
12,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32911888,110,50.0,11,c.3396A>G,p.(Lys1132=),A,G,55,55,AAA,AAG,K,K,NM_000059.3,NM_000059,32911888,within,.,,rs1801406,0.2668,0.2798,,,,,,,,,,,,+,A,G,32911888,32911888,94F2C0D328C28C466A38A430BBE75D52,,,,,,,-1,BRCA2-  32911888,1487,126010,11,,,,EMPTY,,D,,0,9,35,248687,493217,126000,,,0,0,,1:3,,0.293,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.295,10,1,0.47368422,0.42682928,0.50421417,GRCh38/hg38,13,32337751,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,57
2,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32972884,122,51.64,27,c.10234A>G,p.(Ile3412Val),A,G,59,63,ATT,GTT,I,V,NM_000059.3,NM_000059,32972884,within,.,,rs1801426,0.0449,0.0373,,0.556,0.077,,0.019,0.0,-0.286,,,,,+,A,G,32972884,32972884,FD2873D8FA6A6E3D4D35F2ACC4046DA1,,,,,,,-1,BRCA2-  32972884,586,41540,27,,,,EMPTY,,D,,0,2,4,10858,493217,126000,,,0,0,,"1:5,2:2",,0.022,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0248,26,2,0.10526316,0.048780486,0.022014651,GRCh38/hg38,13,32398747,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,57
1,D,BRCA2,,SNP,5'UTR,GRCh37/hg19,13,32890572,219,46.58,2,c.-26G>A,p.(=),G,A,117,102,,,,,NM_000059.3,NM_000059,32890572,within,.,,rs1799943,0.2093,0.2088,,,,,,,,,,,,+,G,A,32890572,32890572,A9C2B39455EF056EDB097A5953EB72EE,,,,,,,-1,BRCA2-  32890572,14,125965,2,,,,EMPTY,,D,,0,8,34,205902,493217,126000,,,0,0,,,,0.243,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2427,1,1,0.42105263,0.41463414,0.41746736,GRCh38/hg38,13,32316435,G,A,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,57
21,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32929232,135,54.81,14,c.7242A>G,p.(Ser2414=),A,G,61,74,TCA,TCG,S,S,NM_000059.3,NM_000059,32929232,within,.,,rs1799955,0.2326,0.2114,,,,,,,,,,,,+,A,G,32929232,32929232,6F8D6FF8BC9027D6C0351ADCEF41FD20,,,,,,,-1,BRCA2-  32929232,-194,126133,14,,,,EMPTY,,D,,0,5,31,192923,493217,126000,,,0,0,,"1:3,2:1",,0.224,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2257,13,1,0.2631579,0.37804878,0.39115238,GRCh38/hg38,13,32355095,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,57
23,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32936646,87,62.07,17,c.7806-14T>C,p.(=),T,C,33,54,,,,,NM_000059.3,NM_000059,32936646,within,.,,rs9534262,0.5316,0.5202,,,,,,,,,,,,+,T,C,32936646,32936646,5803939D8FBB75B042260991F0A62436,,,,,,,-1,BRCA2-  32936646,0,126158,17,,,,EMPTY,,D,,0,13,61,361616,493217,126000,,,0,0,,1:3,,0.52,14,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5255,16,1,0.68421054,0.74390244,0.7331783,GRCh38/hg38,13,32362509,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,57
22,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,96,100.0,14,c.7397T>C,p.(Val2466Ala),T,C,0,96,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,19,81,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.9878049,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,57
24,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32953388,186,43.55,22,c.8755-66T>C,p.(=),T,C,105,81,,,,,NM_000059.3,NM_000059,32953388,within,.,,rs4942486,0.5116,,,,,,,,,,,,,+,T,C,32953388,32953388,97C65B85894EB489F1BFA65897685241,,,,,,,-1,BRCA2-  32953388,0,126190,22,,,,EMPTY,,D,,0,13,61,347826,493217,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5257,21,1,0.68421054,0.74390244,0.70521903,GRCh38/hg38,13,32379251,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,57
18,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32912299,95,47.37,11,c.3807T>C,p.(Val1269=),T,C,50,45,GTT,GTC,V,V,NM_000059.3,NM_000059,32912299,within,.,,rs543304,0.1681,0.1911,,,,,,,,,,,,+,T,C,32912299,32912299,F2D3E8FFB3CEE8C1ACEA66738E41BC1E,,,,,,,-1,BRCA2-  32912299,1898,126022,11,,,,EMPTY,,D,,0,5,20,173719,493217,126000,,,0,0,,1:3,,0.176,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.1754,10,1,0.2631579,0.24390244,0.35221615,GRCh38/hg38,13,32338162,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,57
20,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,193,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,193,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,19,82,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,1.0,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,57
19,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,116,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,116,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,19,82,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,1.0,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,57
11,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244936,399,53.63,10,c.2612C>T,p.(Pro871Leu),G,A,185,214,CCG,CTG,P,L,NM_007294.3,NM_007294,41244936,within,.,,rs799917,0.5439,0.4932,,4.247,0.0,0.0,0.999,1.0,5.04,,,,,-,G,A,41244936,41244936,A19EA255CA888CE1FE48D08CAD633F1F,,,,,,,1,BRCA1- 458755064,-1485,41812,11,,,,EMPTY,,D,,1,13,53,290862,492662,126000,(eval),,0,0,,"1:4,2:1",,0.41,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.4127,9,3,0.68421054,0.64634144,0.59038854,GRCh38/hg38,17,43092919,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,58
14,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245466,795,50.57,10,c.2082C>T,p.(Ser694=),G,A,393,402,AGC,AGT,S,S,NM_007294.3,NM_007294,41245466,within,.,,rs1799949,0.3365,0.2957,,,,,,,,,,,,-,G,A,41245466,41245466,3364E3D252EFEDF917C74D44FBC6A381,,,,,,,-1,BRCA1- 458754534,1412,125536,11,,,,EMPTY,,D,,0,13,53,269442,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.68421054,0.64634144,0.54691046,GRCh38/hg38,17,43093449,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,58
10,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244435,445,54.16,10,c.3113A>G,p.(Glu1038Gly),T,C,204,241,GAA,GGA,E,G,NM_007294.3,NM_007294,41244435,within,.,,rs16941,0.3357,0.279,,-0.149,0.972,0.606,0.922,0.0,-0.974,,,,,-,T,C,41244435,41244435,5D0FF1321BAC3C76DD352C33CC33B93E,,,,,,,-1,BRCA1- 458755565,-984,41815,11,,,,EMPTY,,D,,0,12,52,270861,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,0.936,113705,-1,,,,,,,,,,,3,0.343,9,1,0.6315789,0.63414633,0.54979074,GRCh38/hg38,17,43092418,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,58
8,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41234470,200,50.0,12,c.4308T>C,p.(Ser1436=),A,G,100,100,TCT,TCC,S,S,NM_007294.3,NM_007294,41234470,within,.,,rs1060915,0.3363,0.2796,,,,,,,,,,,,-,A,G,41234470,41234470,B7237055CF1D42F022A050C072B7583B,,,,,,,-1,BRCA1- 458765530,-50,125703,13,,,,EMPTY,,D,,0,12,52,270833,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3433,11,1,0.6315789,0.63414633,0.5497339,GRCh38/hg38,17,43082453,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,58
7,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41231516,216,50.46,13,c.4358-2885G>A,p.(=),C,T,107,109,,,,,NM_007294.3,NM_007294,41231516,within,.,,rs8176193,0.3534,,,,,,,,,,,,,-,C,T,41231516,41231516,7F4F80D2D005D34CEA47E4A2C561B172,,,,,,,-1,BRCA1- 458768484,0,209399,14,,,,EMPTY,,D,,0,13,53,190200,492662,126000,,,0,0,,,,,2885,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.317,12,1,0.68421054,0.64634144,0.3860659,GRCh38/hg38,17,43079499,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,58
9,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244000,655,52.52,10,c.3548A>G,p.(Lys1183Arg),T,C,311,344,AAA,AGA,K,R,NM_007294.3,NM_007294,41244000,within,.,,rs16942,0.3526,0.2952,,-0.319,0.0,0.001,0.924,0.0,-2.35,,,,,-,T,C,41244000,41244000,37A54117EA353BDA677332A1F61FA173,,,,,,,-1,BRCA1- 458756000,-549,41818,11,,,,EMPTY,,D,,0,13,53,272437,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.68421054,0.64634144,0.55298966,GRCh38/hg38,17,43091983,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,58
2,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41215825,72,41.67,17,c.5152+66G>A,p.(=),C,T,42,30,,,,,NM_007294.3,NM_007294,41215825,within,.,,rs3092994,0.3425,,,,,,,,,,,,,-,C,T,41215825,41215825,5BCA8D2E1E3875817F84A3EB582CDFAB,,,,,,,-1,BRCA1- 458784175,0,55428,18,,,,EMPTY,,D,,0,8,40,241843,492662,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3139,16,1,0.42105263,0.4878049,0.4908903,GRCh38/hg38,17,43063808,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,58
4,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219804,324,56.79,16,c.4987-92A>G,p.(=),T,C,140,184,,,,,NM_007294.3,NM_007294,41219804,within,.,,rs8176233,0.3546,,,,,,,,,,,,,-,T,C,41219804,41219804,7341B20C52FFD4B9355840FB9CB56CDA,,,,,,,-1,BRCA1- 458780196,0,125749,17,,,,EMPTY,,D,,0,13,53,225491,492662,126000,,,0,0,,,,,92,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3128,15,1,0.68421054,0.64634144,0.45769918,GRCh38/hg38,17,43067787,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,58
13,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245237,189,43.92,10,c.2311T>C,p.(Leu771=),A,G,106,83,TTG,CTG,L,L,NM_007294.3,NM_007294,41245237,within,.,,rs16940,0.3353,0.2776,,,,,,,,,,,,-,A,G,41245237,41245237,711AF22D84A49E875C2B2A9597A95EE6,,,,,,,-1,BRCA1- 458754763,1641,125554,11,,,,EMPTY,,D,,0,12,51,269517,492662,126000,,,0,0,,1:1,,0.342,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3422,9,1,0.6315789,0.6219512,0.5470627,GRCh38/hg38,17,43093220,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,58
3,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219780,325,56.62,16,c.4987-68A>G,p.(=),T,C,141,184,,,,,NM_007294.3,NM_007294,41219780,within,.,,rs8176234,0.3546,,,,,,,,,,,,,-,T,C,41219780,41219780,5995ECC305C33150BF3BB2B0C22FCC2A,,,,,,,-1,BRCA1- 458780220,0,125746,17,,,,EMPTY,,D,,0,13,53,234031,492662,126000,,,0,0,,,,,68,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3148,15,1,0.68421054,0.64634144,0.47503358,GRCh38/hg38,17,43067763,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,58
6,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41223094,387,50.39,15,c.4837A>G,p.(Ser1613Gly),T,C,192,195,AGT,GGT,S,G,NM_007294.3,NM_007294,41223094,within,.,,rs1799966,0.3558,0.2982,,-0.194,0.968,0.038,0.814,0.0,1.5,,,,,-,T,C,41223094,41223094,E3C52286D31F229973DB3595B052645F,,,,,,,-1,BRCA1- 458776906,-150,41827,16,,,,EMPTY,,D,,0,13,53,273625,492662,126000,,,0,0,,1:1,,0.349,0,,,,,,,,,,,,,,Benign,Benign,0.255,113705,-1,,,,,,,,,,,3,0.35,14,1,0.68421054,0.64634144,0.5554011,GRCh38/hg38,17,43071077,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,58
12,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32911888,382,50.52,11,c.3396A>G,p.(Lys1132=),A,G,189,193,AAA,AAG,K,K,NM_000059.3,NM_000059,32911888,within,.,,rs1801406,0.2668,0.2798,,,,,,,,,,,,+,A,G,32911888,32911888,94F2C0D328C28C466A38A430BBE75D52,,,,,,,-1,BRCA2-  32911888,1487,126010,11,,,,EMPTY,,D,,0,9,35,248687,493217,126000,,,0,0,,1:3,,0.293,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.295,10,1,0.47368422,0.42682928,0.50421417,GRCh38/hg38,13,32337751,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,58
23,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32953388,350,50.57,22,c.8755-66T>C,p.(=),T,C,173,177,,,,,NM_000059.3,NM_000059,32953388,within,.,,rs4942486,0.5116,,,,,,,,,,,,,+,T,C,32953388,32953388,97C65B85894EB489F1BFA65897685241,,,,,,,-1,BRCA2-  32953388,0,126190,22,,,,EMPTY,,D,,0,13,61,347826,493217,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5257,21,1,0.68421054,0.74390244,0.70521903,GRCh38/hg38,13,32379251,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,58
19,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,418,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,418,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,19,82,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,1.0,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,58
22,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32936646,252,50.4,17,c.7806-14T>C,p.(=),T,C,125,127,,,,,NM_000059.3,NM_000059,32936646,within,.,,rs9534262,0.5316,0.5202,,,,,,,,,,,,+,T,C,32936646,32936646,5803939D8FBB75B042260991F0A62436,,,,,,,-1,BRCA2-  32936646,0,126158,17,,,,EMPTY,,D,,0,13,61,361616,493217,126000,,,0,0,,1:3,,0.52,14,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5255,16,1,0.68421054,0.74390244,0.7331783,GRCh38/hg38,13,32362509,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,58
18,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,180,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,180,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,19,82,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,1.0,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,58
21,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,225,100.0,14,c.7397T>C,p.(Val2466Ala),T,C,0,225,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,19,81,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.9878049,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,58
20,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32929232,273,48.72,14,c.7242A>G,p.(Ser2414=),A,G,140,133,TCA,TCG,S,S,NM_000059.3,NM_000059,32929232,within,.,,rs1799955,0.2326,0.2114,,,,,,,,,,,,+,A,G,32929232,32929232,6F8D6FF8BC9027D6C0351ADCEF41FD20,,,,,,,-1,BRCA2-  32929232,-194,126133,14,,,,EMPTY,,D,,0,5,31,192923,493217,126000,,,0,0,,"1:3,2:1",,0.224,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2257,13,1,0.2631579,0.37804878,0.39115238,GRCh38/hg38,13,32355095,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,58
1,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906729,290,46.55,10,c.1114A>C,p.(Asn372His),A,C,155,135,AAT,CAT,N,H,NM_000059.3,NM_000059,32906729,within,.,,rs144848,0.2494,0.2332,,0.32,0.861,,0.269,0.0,0.396,,,,,+,A,C,32906729,32906729,D514F785F1344AF9F6975E589D47BDF6,,,,,,,-1,BRCA2-  32906729,321,9329,10,,,,EMPTY,,D,,0,12,51,233635,493217,126000,,,0,0,,"1:1,2:1",,0.277,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2733,9,1,0.6315789,0.6219512,0.47369617,GRCh38/hg38,13,32332592,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,58
14,C,BRCA2,,SNP,missense,GRCh37/hg19,13,32930633,122,45.08,15,c.7504C>T,p.(Arg2502Cys),C,T,67,55,CGC,TGC,R,C,NM_000059.3,NM_000059,32930633,within,.,,rs55716624,4.0E-4,0.0012,,0.109,0.88,,0.297,0.0,0.574,,,,,+,C,T,32930633,32930633,6FDBFAA3D62085B357A51882F7AD5CFF,,,,,,,-1,BRCA2-  32930633,69,41563,15,,,,EMPTY,,C,,0,1,1,276,493217,126000,,,0,0,,2:4,,3.0E-4,0,,,,,,,,,,,,,,Conflicting_interpretations_of_pathogenicity,Conflicting interpretations of pathogenicity,,600185,-1,,,,,,,,,,,3,3.0E-4,14,3,0.05263158,0.0121951215,5.595914E-4,GRCh38/hg38,13,32356496,C,T,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,59
15,C,BRCA2,,SNP,missense,GRCh37/hg19,13,32937492,132,48.48,18,c.8153T>C,p.(Ile2718Thr),T,C,68,64,ATT,ACT,I,T,NM_000059.3,NM_000059,32937492,within,.,,rs80359060,,,,2.634,0.497,,0.755,0.0,0.238,,,,,+,T,C,32937492,32937492,03A9A85637E6B0CA77A5C2BBC542C1F4,,,,,,,-1,BRCA2-  32937492,177,38140,18,,,,EMPTY,,C,,0,1,3,9,493217,126000,,,0,0,,3:1,,0.0,0,,,,,,,,,,,,,,Conflicting_interpretations_of_pathogenicity,Conflicting interpretations of pathogenicity,,600185,-1,,,,,,,,,,,3,0.0,17,3,0.05263158,0.036585364,1.8247547E-5,GRCh38/hg38,13,32363355,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,59
7,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41267763,429,46.85,3,c.114G>A,p.(Lys38=),C,T,227,201,AAG,AAA,K,K,NM_007294.3,NM_007294,41267763,within,.,,rs1800062,0.0126,,,,,,,,,,,,,-,C,T,41267763,41267763,53F8A9FB4D1CBF9D8C698B41A0E52E7F,,,,,,,-1,BRCA1- 458732237,-21,54146,3,,,,EMPTY,,D,,0,1,1,1408,492662,126000,,,0,0,,"1:1,2:3",,0.0039,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.0042,2,2,0.05263158,0.0121951215,0.002857943,GRCh38/hg38,17,43115746,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,59
10,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,174,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,174,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,19,82,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,1.0,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,59
13,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32930598,122,54.92,15,c.7469T>C,p.(Ile2490Thr),T,C,55,67,ATA,ACA,I,T,NM_000059.3,NM_000059,32930598,within,.,,rs11571707,0.016,0.0016,,0.406,0.895,,0.837,0.0,-5.83,,,,,+,T,C,32930598,32930598,D7CAF30A58440FCA5E8E7BACD8E1EDE4,,,,,,,-1,BRCA2-  32930598,34,96852,15,,,,EMPTY,,D,,0,5,22,6837,493217,126000,,,0,0,,"1:5,2:2",,0.014,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0176,14,2,0.2631579,0.2682927,0.013862053,GRCh38/hg38,13,32356461,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,59
9,D,BRCA2,,INDEL,intronic,GRCh37/hg19,13,32907531,119,40.34,10,c.1909+9_1909+10del,p.(=),CTG,C,66,48,,,,,NM_000059.3,NM_000059,32907531,within,.,,rs527732001,0.001,0.0024,,,,,,,,,,,,+,GT,-,32907533,32907534,9F6019F72A4BAFBE318BC8AD4E938ECC,,,,,,,-1,BRCA2-  32907531,0,182282,10,,,,EMPTY,,D,,0,1,1,150,493217,126000,,,0,0,,2:2,,5.0E-4,9,,,,,,,,,,,,,,Benign/Likely_benign,Benign/Likely benign,,600185,-1,,,,,,,,,,,3,5.0E-4,9,3,0.05263158,0.0121951215,3.0412577E-4,GRCh38/hg38,13,32333394,CTG,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,59
1,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906729,224,54.02,10,c.1114A>C,p.(Asn372His),A,C,103,121,AAT,CAT,N,H,NM_000059.3,NM_000059,32906729,within,.,,rs144848,0.2494,0.2332,,0.32,0.861,,0.269,0.0,0.396,,,,,+,A,C,32906729,32906729,D514F785F1344AF9F6975E589D47BDF6,,,,,,,-1,BRCA2-  32906729,321,9329,10,,,,EMPTY,,D,,0,12,51,233635,493217,126000,,,0,0,,"1:1,2:1",,0.277,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2733,9,1,0.6315789,0.6219512,0.47369617,GRCh38/hg38,13,32332592,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,59
2,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32944713,182,47.25,19,c.8487+19A>G,p.(=),A,G,96,86,,,,,NM_000059.3,NM_000059,32944713,within,.,,rs11571743,0.0102,0.0128,,,,,,,,,,,,+,A,G,32944713,32944713,823D212785806406EEEAFA70BE56340C,,,,,,,-1,BRCA2-  32944713,0,126178,19,,,,EMPTY,,D,,0,1,1,1237,493217,126000,,,0,0,,"1:1,2:2",,0.0032,19,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0034,18,3,0.05263158,0.0121951215,0.0025080238,GRCh38/hg38,13,32370576,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,59
8,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32907413,251,49.4,10,c.1798T>C,p.(Tyr600His),T,C,127,124,TAT,CAT,Y,H,NM_000059.3,NM_000059,32907413,within,.,,rs75419644,0.001,0.0018,,0.395,0.745,,0.871,0.0,0.0747,,,,,+,T,C,32907413,32907413,AE4BC8A41E8D892C9754A08D634BBD18,,,,,,,-1,BRCA2-  32907413,-112,51197,10,,,,EMPTY,,D,,0,1,1,171,493217,126000,,,0,0,,"1:1,2:3",,5.0E-4,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,5.0E-4,9,2,0.05263158,0.0121951215,3.4670337E-4,GRCh38/hg38,13,32333276,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,59
12,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,162,100.0,14,c.7397T>C,p.(Val2466Ala),T,C,0,162,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,19,81,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.9878049,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,59
11,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,372,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,372,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,19,82,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,1.0,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,59
2,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906729,250,53.2,10,c.1114A>C,p.(Asn372His),A,C,117,133,AAT,CAT,N,H,NM_000059.3,NM_000059,32906729,within,.,,rs144848,0.2494,0.2332,,0.32,0.861,,0.269,0.0,0.396,,,,,+,A,C,32906729,32906729,D514F785F1344AF9F6975E589D47BDF6,,,,,,,-1,BRCA2-  32906729,321,9329,10,,,,EMPTY,,D,,0,12,51,233635,493217,126000,,,0,0,,"1:1,2:1",,0.277,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2733,9,1,0.6315789,0.6219512,0.47369617,GRCh38/hg38,13,32332592,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,60
5,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,388,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,388,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,19,82,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,1.0,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,60
4,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,166,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,166,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,19,82,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,1.0,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,60
7,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32930598,158,50.0,15,c.7469T>C,p.(Ile2490Thr),T,C,79,79,ATA,ACA,I,T,NM_000059.3,NM_000059,32930598,within,.,,rs11571707,0.016,0.0016,,0.406,0.895,,0.837,0.0,-5.83,,,,,+,T,C,32930598,32930598,D7CAF30A58440FCA5E8E7BACD8E1EDE4,,,,,,,-1,BRCA2-  32930598,34,96852,15,,,,EMPTY,,D,,0,5,22,6837,493217,126000,,,0,0,,"1:5,2:2",,0.014,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0176,14,2,0.2631579,0.2682927,0.013862053,GRCh38/hg38,13,32356461,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,60
1,D,BRCA2,,SNP,5'UTR,GRCh37/hg19,13,32890572,512,54.49,2,c.-26G>A,p.(=),G,A,233,279,,,,,NM_000059.3,NM_000059,32890572,within,.,,rs1799943,0.2093,0.2088,,,,,,,,,,,,+,G,A,32890572,32890572,A9C2B39455EF056EDB097A5953EB72EE,,,,,,,-1,BRCA2-  32890572,14,125965,2,,,,EMPTY,,D,,0,8,34,205902,493217,126000,,,0,0,,,,0.243,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2427,1,1,0.42105263,0.41463414,0.41746736,GRCh38/hg38,13,32316435,G,A,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,60
3,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32911888,259,49.03,11,c.3396A>G,p.(Lys1132=),A,G,132,127,AAA,AAG,K,K,NM_000059.3,NM_000059,32911888,within,.,,rs1801406,0.2668,0.2798,,,,,,,,,,,,+,A,G,32911888,32911888,94F2C0D328C28C466A38A430BBE75D52,,,,,,,-1,BRCA2-  32911888,1487,126010,11,,,,EMPTY,,D,,0,9,35,248687,493217,126000,,,0,0,,1:3,,0.293,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.295,10,1,0.47368422,0.42682928,0.50421417,GRCh38/hg38,13,32337751,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,60
6,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,173,100.0,14,c.7397T>C,p.(Val2466Ala),T,C,0,173,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,19,81,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.9878049,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,60
15,C,BRCA2,,SNP,missense,GRCh37/hg19,13,32910599,129,57.36,11,c.2107A>G,p.(Thr703Ala),A,G,55,74,ACC,GCC,T,A,NM_000059.3,NM_000059,32910599,within,.,,rs2072450524,,,,-0.034,0.697,,0.777,0.0,-4.72,,,,,+,A,G,32910599,32910599,8FF732C6C09D4069D93D4960836C10F2,,,,,,,-1,BRCA2-  32910599,198,836747,11,,,,EMPTY,,C,,0,1,1,,,126000,,,0,0,,,,,0,,,,,,,,,,,,,,Uncertain_significance,Uncertain significance,,600185,-1,,,,,,,,,,,3,,10,3,0.05263158,0.0121951215,,GRCh38/hg38,13,32336462,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,62
9,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244936,153,47.71,10,c.2612C>T,p.(Pro871Leu),G,A,79,73,CCG,CTG,P,L,NM_007294.3,NM_007294,41244936,within,.,,rs799917,0.5439,0.4932,,4.247,0.0,0.0,0.999,1.0,5.04,,,,,-,G,A,41244936,41244936,A19EA255CA888CE1FE48D08CAD633F1F,,,,,,,1,BRCA1- 458755064,-1485,41812,11,,,,EMPTY,,D,,1,13,53,290862,492662,126000,(eval),,0,0,,"1:4,2:1",,0.41,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.4127,9,3,0.68421054,0.64634144,0.59038854,GRCh38/hg38,17,43092919,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,62
4,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41223094,238,45.8,15,c.4837A>G,p.(Ser1613Gly),T,C,129,109,AGT,GGT,S,G,NM_007294.3,NM_007294,41223094,within,.,,rs1799966,0.3558,0.2982,,-0.194,0.968,0.038,0.814,0.0,1.5,,,,,-,T,C,41223094,41223094,E3C52286D31F229973DB3595B052645F,,,,,,,-1,BRCA1- 458776906,-150,41827,16,,,,EMPTY,,D,,0,13,53,273625,492662,126000,,,0,0,,1:1,,0.349,0,,,,,,,,,,,,,,Benign,Benign,0.255,113705,-1,,,,,,,,,,,3,0.35,14,1,0.68421054,0.64634144,0.5554011,GRCh38/hg38,17,43071077,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,62
2,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219780,100,49.0,16,c.4987-68A>G,p.(=),T,C,51,49,,,,,NM_007294.3,NM_007294,41219780,within,.,,rs8176234,0.3546,,,,,,,,,,,,,-,T,C,41219780,41219780,5995ECC305C33150BF3BB2B0C22FCC2A,,,,,,,-1,BRCA1- 458780220,0,125746,17,,,,EMPTY,,D,,0,13,53,234031,492662,126000,,,0,0,,,,,68,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3148,15,1,0.68421054,0.64634144,0.47503358,GRCh38/hg38,17,43067763,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,62
7,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244524,180,46.11,10,c.3024G>A,p.(Met1008Ile),C,T,97,83,ATG,ATA,M,I,NM_007294.3,NM_007294,41244524,within,.,,rs1800704,6.0E-4,5.0E-4,,-0.569,0.581,0.002,0.002,0.0,-4.11,,,,,-,C,T,41244524,41244524,1893B29D4EED5180B84E604D61B2843A,,,,,,,-1,BRCA1- 458755476,-1073,41814,11,,,,EMPTY,,D,,0,1,1,1112,492662,126000,,,0,0,,"1:1,2:3",,9.0E-4,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,9.0E-4,9,2,0.05263158,0.0121951215,0.0022571257,GRCh38/hg38,17,43092507,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,62
3,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219804,100,50.0,16,c.4987-92A>G,p.(=),T,C,50,50,,,,,NM_007294.3,NM_007294,41219804,within,.,,rs8176233,0.3546,,,,,,,,,,,,,-,T,C,41219804,41219804,7341B20C52FFD4B9355840FB9CB56CDA,,,,,,,-1,BRCA1- 458780196,0,125749,17,,,,EMPTY,,D,,0,13,53,225491,492662,126000,,,0,0,,,,,92,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3128,15,1,0.68421054,0.64634144,0.45769918,GRCh38/hg38,17,43067787,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,62
8,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41244815,108,50.0,10,c.2733A>G,p.(Gly911=),T,C,54,54,GGA,GGG,G,G,NM_007294.3,NM_007294,41244815,within,.,,rs1800740,6.0E-4,5.0E-4,,,,,,,,,,,,-,T,C,41244815,41244815,3E4F34FD4356DE564F52FC508676F88F,,,,,,,-1,BRCA1- 458755185,-1364,54664,11,,,,EMPTY,,D,,0,1,1,1113,492662,126000,,,0,0,,2:4,,8.0E-4,0,,,,,,,,,,,,,,Likely_benign,Likely benign,,113705,-1,,,,,,,,,,,3,9.0E-4,9,2,0.05263158,0.0121951215,0.0022591553,GRCh38/hg38,17,43092798,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,62
6,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244000,264,49.62,10,c.3548A>G,p.(Lys1183Arg),T,C,133,131,AAA,AGA,K,R,NM_007294.3,NM_007294,41244000,within,.,,rs16942,0.3526,0.2952,,-0.319,0.0,0.001,0.924,0.0,-2.35,,,,,-,T,C,41244000,41244000,37A54117EA353BDA677332A1F61FA173,,,,,,,-1,BRCA1- 458756000,-549,41818,11,,,,EMPTY,,D,,0,13,53,272437,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.68421054,0.64634144,0.55298966,GRCh38/hg38,17,43091983,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,62
11,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41246567,112,59.82,10,c.981A>G,p.(Thr327=),T,C,45,67,ACA,ACG,T,T,NM_007294.3,NM_007294,41246567,within,.,,rs1800063,6.0E-4,5.0E-4,,,,,,,,,,,,-,T,C,41246567,41246567,48AF28AFFD8166B347ABE52D4EFB1258,,,,,,,-1,BRCA1- 458753433,311,55771,11,,,,EMPTY,,D,,0,1,1,1112,492662,126000,,,0,0,,"1:1,2:2",,8.0E-4,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,9.0E-4,9,2,0.05263158,0.0121951215,0.0022571257,GRCh38/hg38,17,43094550,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,62
10,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245466,259,47.1,10,c.2082C>T,p.(Ser694=),G,A,137,122,AGC,AGT,S,S,NM_007294.3,NM_007294,41245466,within,.,,rs1799949,0.3365,0.2957,,,,,,,,,,,,-,G,A,41245466,41245466,3364E3D252EFEDF917C74D44FBC6A381,,,,,,,-1,BRCA1- 458754534,1412,125536,11,,,,EMPTY,,D,,0,13,53,269442,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.68421054,0.64634144,0.54691046,GRCh38/hg38,17,43093449,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,62
5,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41231516,90,57.78,13,c.4358-2885G>A,p.(=),C,T,38,52,,,,,NM_007294.3,NM_007294,41231516,within,.,,rs8176193,0.3534,,,,,,,,,,,,,-,C,T,41231516,41231516,7F4F80D2D005D34CEA47E4A2C561B172,,,,,,,-1,BRCA1- 458768484,0,209399,14,,,,EMPTY,,D,,0,13,53,190200,492662,126000,,,0,0,,,,,2885,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.317,12,1,0.68421054,0.64634144,0.3860659,GRCh38/hg38,17,43079499,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,62
12,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906729,126,46.83,10,c.1114A>C,p.(Asn372His),A,C,67,59,AAT,CAT,N,H,NM_000059.3,NM_000059,32906729,within,.,,rs144848,0.2494,0.2332,,0.32,0.861,,0.269,0.0,0.396,,,,,+,A,C,32906729,32906729,D514F785F1344AF9F6975E589D47BDF6,,,,,,,-1,BRCA2-  32906729,321,9329,10,,,,EMPTY,,D,,0,12,51,233635,493217,126000,,,0,0,,"1:1,2:1",,0.277,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2733,9,1,0.6315789,0.6219512,0.47369617,GRCh38/hg38,13,32332592,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,62
19,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,91,100.0,14,c.7397T>C,p.(Val2466Ala),T,C,0,91,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,19,81,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.9878049,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,62
1,D,BRCA2,,SNP,5'UTR,GRCh37/hg19,13,32890572,208,54.81,2,c.-26G>A,p.(=),G,A,94,114,,,,,NM_000059.3,NM_000059,32890572,within,.,,rs1799943,0.2093,0.2088,,,,,,,,,,,,+,G,A,32890572,32890572,A9C2B39455EF056EDB097A5953EB72EE,,,,,,,-1,BRCA2-  32890572,14,125965,2,,,,EMPTY,,D,,0,8,34,205902,493217,126000,,,0,0,,,,0.243,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2427,1,1,0.42105263,0.41463414,0.41746736,GRCh38/hg38,13,32316435,G,A,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,62
16,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32911888,93,52.69,11,c.3396A>G,p.(Lys1132=),A,G,44,49,AAA,AAG,K,K,NM_000059.3,NM_000059,32911888,within,.,,rs1801406,0.2668,0.2798,,,,,,,,,,,,+,A,G,32911888,32911888,94F2C0D328C28C466A38A430BBE75D52,,,,,,,-1,BRCA2-  32911888,1487,126010,11,,,,EMPTY,,D,,0,9,35,248687,493217,126000,,,0,0,,1:3,,0.293,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.295,10,1,0.47368422,0.42682928,0.50421417,GRCh38/hg38,13,32337751,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,62
18,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,160,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,160,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,19,82,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,1.0,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,62
17,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,87,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,87,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,19,82,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,1.0,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,62
16,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244936,320,45.94,10,c.2612C>T,p.(Pro871Leu),G,A,173,147,CCG,CTG,P,L,NM_007294.3,NM_007294,41244936,within,.,,rs799917,0.5439,0.4932,,4.247,0.0,0.0,0.999,1.0,5.04,,,,,-,G,A,41244936,41244936,A19EA255CA888CE1FE48D08CAD633F1F,,,,,,,1,BRCA1- 458755064,-1485,41812,11,,,,EMPTY,,D,,1,13,53,290862,492662,126000,(eval),,0,0,,"1:4,2:1",,0.41,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.4127,9,3,0.68421054,0.64634144,0.59038854,GRCh38/hg38,17,43092919,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,63
17,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245237,162,52.47,10,c.2311T>C,p.(Leu771=),A,G,77,85,TTG,CTG,L,L,NM_007294.3,NM_007294,41245237,within,.,,rs16940,0.3353,0.2776,,,,,,,,,,,,-,A,G,41245237,41245237,711AF22D84A49E875C2B2A9597A95EE6,,,,,,,-1,BRCA1- 458754763,1641,125554,11,,,,EMPTY,,D,,0,12,51,269517,492662,126000,,,0,0,,1:1,,0.342,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3422,9,1,0.6315789,0.6219512,0.5470627,GRCh38/hg38,17,43093220,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,63
11,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41234470,199,55.78,12,c.4308T>C,p.(Ser1436=),A,G,88,111,TCT,TCC,S,S,NM_007294.3,NM_007294,41234470,within,.,,rs1060915,0.3363,0.2796,,,,,,,,,,,,-,A,G,41234470,41234470,B7237055CF1D42F022A050C072B7583B,,,,,,,-1,BRCA1- 458765530,-50,125703,13,,,,EMPTY,,D,,0,12,52,270833,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3433,11,1,0.6315789,0.63414633,0.5497339,GRCh38/hg38,17,43082453,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,63
14,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244000,496,50.0,10,c.3548A>G,p.(Lys1183Arg),T,C,248,248,AAA,AGA,K,R,NM_007294.3,NM_007294,41244000,within,.,,rs16942,0.3526,0.2952,,-0.319,0.0,0.001,0.924,0.0,-2.35,,,,,-,T,C,41244000,41244000,37A54117EA353BDA677332A1F61FA173,,,,,,,-1,BRCA1- 458756000,-549,41818,11,,,,EMPTY,,D,,0,13,53,272437,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.68421054,0.64634144,0.55298966,GRCh38/hg38,17,43091983,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,63
10,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41231516,179,51.4,13,c.4358-2885G>A,p.(=),C,T,87,92,,,,,NM_007294.3,NM_007294,41231516,within,.,,rs8176193,0.3534,,,,,,,,,,,,,-,C,T,41231516,41231516,7F4F80D2D005D34CEA47E4A2C561B172,,,,,,,-1,BRCA1- 458768484,0,209399,14,,,,EMPTY,,D,,0,13,53,190200,492662,126000,,,0,0,,,,,2885,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.317,12,1,0.68421054,0.64634144,0.3860659,GRCh38/hg38,17,43079499,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,63
15,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244435,357,47.9,10,c.3113A>G,p.(Glu1038Gly),T,C,186,171,GAA,GGA,E,G,NM_007294.3,NM_007294,41244435,within,.,,rs16941,0.3357,0.279,,-0.149,0.972,0.606,0.922,0.0,-0.974,,,,,-,T,C,41244435,41244435,5D0FF1321BAC3C76DD352C33CC33B93E,,,,,,,-1,BRCA1- 458755565,-984,41815,11,,,,EMPTY,,D,,0,12,52,270861,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,0.936,113705,-1,,,,,,,,,,,3,0.343,9,1,0.6315789,0.63414633,0.54979074,GRCh38/hg38,17,43092418,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,63
7,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219804,276,48.91,16,c.4987-92A>G,p.(=),T,C,141,135,,,,,NM_007294.3,NM_007294,41219804,within,.,,rs8176233,0.3546,,,,,,,,,,,,,-,T,C,41219804,41219804,7341B20C52FFD4B9355840FB9CB56CDA,,,,,,,-1,BRCA1- 458780196,0,125749,17,,,,EMPTY,,D,,0,13,53,225491,492662,126000,,,0,0,,,,,92,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3128,15,1,0.68421054,0.64634144,0.45769918,GRCh38/hg38,17,43067787,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,63
9,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41223094,278,45.32,15,c.4837A>G,p.(Ser1613Gly),T,C,152,126,AGT,GGT,S,G,NM_007294.3,NM_007294,41223094,within,.,,rs1799966,0.3558,0.2982,,-0.194,0.968,0.038,0.814,0.0,1.5,,,,,-,T,C,41223094,41223094,E3C52286D31F229973DB3595B052645F,,,,,,,-1,BRCA1- 458776906,-150,41827,16,,,,EMPTY,,D,,0,13,53,273625,492662,126000,,,0,0,,1:1,,0.349,0,,,,,,,,,,,,,,Benign,Benign,0.255,113705,-1,,,,,,,,,,,3,0.35,14,1,0.68421054,0.64634144,0.5554011,GRCh38/hg38,17,43071077,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,63
6,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219780,275,48.36,16,c.4987-68A>G,p.(=),T,C,142,133,,,,,NM_007294.3,NM_007294,41219780,within,.,,rs8176234,0.3546,,,,,,,,,,,,,-,T,C,41219780,41219780,5995ECC305C33150BF3BB2B0C22FCC2A,,,,,,,-1,BRCA1- 458780220,0,125746,17,,,,EMPTY,,D,,0,13,53,234031,492662,126000,,,0,0,,,,,68,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3148,15,1,0.68421054,0.64634144,0.47503358,GRCh38/hg38,17,43067763,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,63
18,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245466,539,53.06,10,c.2082C>T,p.(Ser694=),G,A,253,286,AGC,AGT,S,S,NM_007294.3,NM_007294,41245466,within,.,,rs1799949,0.3365,0.2957,,,,,,,,,,,,-,G,A,41245466,41245466,3364E3D252EFEDF917C74D44FBC6A381,,,,,,,-1,BRCA1- 458754534,1412,125536,11,,,,EMPTY,,D,,0,13,53,269442,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.68421054,0.64634144,0.54691046,GRCh38/hg38,17,43093449,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,63
24,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32906980,442,47.51,10,c.1365A>G,p.(Ser455=),A,G,232,210,TCA,TCG,S,S,NM_000059.3,NM_000059,32906980,within,.,,rs1801439,0.0737,0.031,,,,,,,,,,,,+,A,G,32906980,32906980,C76C22E555E869928B452D866988AB4F,,,,,,,-1,BRCA2-  32906980,-545,125943,10,,,,EMPTY,,D,,0,4,17,41480,493217,126000,,,0,0,,"1:4,2:1",,0.051,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0499,9,2,0.21052632,0.20731707,0.08410091,GRCh38/hg38,13,32332843,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,63
25,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32910721,394,46.7,11,c.2229T>C,p.(His743=),T,C,210,184,CAT,CAC,H,H,NM_000059.3,NM_000059,32910721,within,.,,rs1801499,0.0735,0.0313,,,,,,,,,,,,+,T,C,32910721,32910721,D39471F16FE6D1F6752C2D4D179996AF,,,,,,,-1,BRCA2-  32910721,320,125979,11,,,,EMPTY,,D,,0,4,17,41536,493217,126000,,,0,0,,1:1,,0.052,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0503,10,1,0.21052632,0.20731707,0.08421446,GRCh38/hg38,13,32336584,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,63
29,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,162,100.0,14,c.7397T>C,p.(Val2466Ala),T,C,0,162,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,19,81,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.9878049,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,63
3,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32936646,122,100.0,17,c.7806-14T>C,p.(=),T,C,0,122,,,,,NM_000059.3,NM_000059,32936646,within,.,,rs9534262,0.5316,0.5202,,,,,,,,,,,,+,T,C,32936646,32936646,5803939D8FBB75B042260991F0A62436,,,,,,,-1,BRCA2-  32936646,0,126158,17,,,,EMPTY,,D,,0,13,61,361616,493217,126000,,,0,0,,1:3,,0.52,14,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5255,16,1,0.68421054,0.74390244,0.7331783,GRCh38/hg38,13,32362509,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,63
23,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906729,232,43.53,10,c.1114A>C,p.(Asn372His),A,C,131,101,AAT,CAT,N,H,NM_000059.3,NM_000059,32906729,within,.,,rs144848,0.2494,0.2332,,0.32,0.861,,0.269,0.0,0.396,,,,,+,A,C,32906729,32906729,D514F785F1344AF9F6975E589D47BDF6,,,,,,,-1,BRCA2-  32906729,321,9329,10,,,,EMPTY,,D,,0,12,51,233635,493217,126000,,,0,0,,"1:1,2:1",,0.277,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2733,9,1,0.6315789,0.6219512,0.47369617,GRCh38/hg38,13,32332592,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,63
26,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32911463,137,42.34,11,c.2971A>G,p.(Asn991Asp),A,G,79,58,AAC,GAC,N,D,NM_000059.3,NM_000059,32911463,within,.,,rs1799944,0.0801,0.0373,,-0.04,0.0,,0.959,0.0,3.08,,,,,+,A,G,32911463,32911463,36F4F7E6CD788E45B30EA486775D07D6,,,,,,,-1,BRCA2-  32911463,1062,41545,11,,,,EMPTY,,D,,0,4,17,42142,493217,126000,,,0,0,,1:2,,0.053,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0522,10,1,0.21052632,0.20731707,0.085443124,GRCh38/hg38,13,32337326,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,63
2,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32929478,134,44.78,14,c.7435+53C>T,p.(=),C,T,74,60,,,,,NM_000059.3,NM_000059,32929478,within,.,,rs11147489,0.0725,,,,,,,,,,,,,+,C,T,32929478,32929478,F692B4BE5DCD39FA887FE8D63D296720,,,,,,,-1,BRCA2-  32929478,0,126136,14,,,,EMPTY,,D,,0,4,17,36369,493217,126000,,,0,0,,,,,53,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0301,13,3,0.21052632,0.20731707,0.07373834,GRCh38/hg38,13,32355341,C,T,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,63
12,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906480,98,52.04,10,c.865A>C,p.(Asn289His),A,C,47,51,AAT,CAT,N,H,NM_000059.3,NM_000059,32906480,within,.,,rs766173,0.0737,0.0312,,0.498,0.998,,0.803,0.0,1.73,,,,,+,A,C,32906480,32906480,EE0CD2A1633CE9FEF0978528634002FE,,,,,,,-1,BRCA2-  32906480,72,41567,10,,,,EMPTY,,D,,0,4,17,41272,493217,126000,,,0,0,,"1:4,2:1",,0.051,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0496,9,2,0.21052632,0.20731707,0.08367919,GRCh38/hg38,13,32332343,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,63
27,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,157,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,157,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,19,82,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,1.0,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,63
28,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,354,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,354,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,19,82,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,1.0,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,63
1,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32899388,108,51.85,4,c.425+67A>C,p.(=),A,C,52,56,,,,,NM_000059.3,NM_000059,32899388,within,.,,rs11571610,0.0743,,,,,,,,,,,,,+,A,C,32899388,32899388,1AF346DE380A738371905EBFBCED20E1,,,,,,,-1,BRCA2-  32899388,0,126095,4,,,,EMPTY,,D,,0,4,17,39349,493217,126000,,,0,0,,2:1,,,67,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0306,3,3,0.21052632,0.20731707,0.0797803,GRCh38/hg38,13,32325251,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,63
4,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32953388,265,100.0,22,c.8755-66T>C,p.(=),T,C,0,265,,,,,NM_000059.3,NM_000059,32953388,within,.,,rs4942486,0.5116,,,,,,,,,,,,,+,T,C,32953388,32953388,97C65B85894EB489F1BFA65897685241,,,,,,,-1,BRCA2-  32953388,0,126190,22,,,,EMPTY,,D,,0,13,61,347826,493217,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5257,21,1,0.68421054,0.74390244,0.70521903,GRCh38/hg38,13,32379251,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,63
14,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244936,269,99.63,10,c.2612C>T,p.(Pro871Leu),G,A,1,268,CCG,CTG,P,L,NM_007294.3,NM_007294,41244936,within,.,,rs799917,0.5439,0.4932,,4.247,0.0,0.0,0.999,1.0,5.04,,,,,-,G,A,41244936,41244936,A19EA255CA888CE1FE48D08CAD633F1F,,,,,,,1,BRCA1- 458755064,-1485,41812,11,,,,EMPTY,,D,,1,13,53,290862,492662,126000,(eval),,0,0,,"1:4,2:1",,0.41,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.4127,9,3,0.68421054,0.64634144,0.59038854,GRCh38/hg38,17,43092919,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,64
11,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244000,403,100.0,10,c.3548A>G,p.(Lys1183Arg),T,C,0,403,AAA,AGA,K,R,NM_007294.3,NM_007294,41244000,within,.,,rs16942,0.3526,0.2952,,-0.319,0.0,0.001,0.924,0.0,-2.35,,,,,-,T,C,41244000,41244000,37A54117EA353BDA677332A1F61FA173,,,,,,,-1,BRCA1- 458756000,-549,41818,11,,,,EMPTY,,D,,0,13,53,272437,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.68421054,0.64634144,0.55298966,GRCh38/hg38,17,43091983,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,64
16,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245466,476,99.79,10,c.2082C>T,p.(Ser694=),G,A,1,475,AGC,AGT,S,S,NM_007294.3,NM_007294,41245466,within,.,,rs1799949,0.3365,0.2957,,,,,,,,,,,,-,G,A,41245466,41245466,3364E3D252EFEDF917C74D44FBC6A381,,,,,,,-1,BRCA1- 458754534,1412,125536,11,,,,EMPTY,,D,,0,13,53,269442,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.68421054,0.64634144,0.54691046,GRCh38/hg38,17,43093449,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,64
13,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244435,292,100.0,10,c.3113A>G,p.(Glu1038Gly),T,C,0,292,GAA,GGA,E,G,NM_007294.3,NM_007294,41244435,within,.,,rs16941,0.3357,0.279,,-0.149,0.972,0.606,0.922,0.0,-0.974,,,,,-,T,C,41244435,41244435,5D0FF1321BAC3C76DD352C33CC33B93E,,,,,,,-1,BRCA1- 458755565,-984,41815,11,,,,EMPTY,,D,,0,12,52,270861,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,0.936,113705,-1,,,,,,,,,,,3,0.343,9,1,0.6315789,0.63414633,0.54979074,GRCh38/hg38,17,43092418,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,64
9,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41231516,103,100.0,13,c.4358-2885G>A,p.(=),C,T,0,103,,,,,NM_007294.3,NM_007294,41231516,within,.,,rs8176193,0.3534,,,,,,,,,,,,,-,C,T,41231516,41231516,7F4F80D2D005D34CEA47E4A2C561B172,,,,,,,-1,BRCA1- 458768484,0,209399,14,,,,EMPTY,,D,,0,13,53,190200,492662,126000,,,0,0,,,,,2885,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.317,12,1,0.68421054,0.64634144,0.3860659,GRCh38/hg38,17,43079499,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,64
5,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219780,169,100.0,16,c.4987-68A>G,p.(=),T,C,0,169,,,,,NM_007294.3,NM_007294,41219780,within,.,,rs8176234,0.3546,,,,,,,,,,,,,-,T,C,41219780,41219780,5995ECC305C33150BF3BB2B0C22FCC2A,,,,,,,-1,BRCA1- 458780220,0,125746,17,,,,EMPTY,,D,,0,13,53,234031,492662,126000,,,0,0,,,,,68,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3148,15,1,0.68421054,0.64634144,0.47503358,GRCh38/hg38,17,43067763,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,64
10,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41234470,113,100.0,12,c.4308T>C,p.(Ser1436=),A,G,0,113,TCT,TCC,S,S,NM_007294.3,NM_007294,41234470,within,.,,rs1060915,0.3363,0.2796,,,,,,,,,,,,-,A,G,41234470,41234470,B7237055CF1D42F022A050C072B7583B,,,,,,,-1,BRCA1- 458765530,-50,125703,13,,,,EMPTY,,D,,0,12,52,270833,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3433,11,1,0.6315789,0.63414633,0.5497339,GRCh38/hg38,17,43082453,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,64
6,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219804,169,100.0,16,c.4987-92A>G,p.(=),T,C,0,169,,,,,NM_007294.3,NM_007294,41219804,within,.,,rs8176233,0.3546,,,,,,,,,,,,,-,T,C,41219804,41219804,7341B20C52FFD4B9355840FB9CB56CDA,,,,,,,-1,BRCA1- 458780196,0,125749,17,,,,EMPTY,,D,,0,13,53,225491,492662,126000,,,0,0,,,,,92,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3128,15,1,0.68421054,0.64634144,0.45769918,GRCh38/hg38,17,43067787,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,64
15,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245237,129,99.22,10,c.2311T>C,p.(Leu771=),A,G,1,128,TTG,CTG,L,L,NM_007294.3,NM_007294,41245237,within,.,,rs16940,0.3353,0.2776,,,,,,,,,,,,-,A,G,41245237,41245237,711AF22D84A49E875C2B2A9597A95EE6,,,,,,,-1,BRCA1- 458754763,1641,125554,11,,,,EMPTY,,D,,0,12,51,269517,492662,126000,,,0,0,,1:1,,0.342,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3422,9,1,0.6315789,0.6219512,0.5470627,GRCh38/hg38,17,43093220,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,64
17,D,BRCA1,,INDEL,intronic,GRCh37/hg19,17,41249363,62,30.65,8,c.548-58del,p.(=),TAAAAAAA,TAAAAAA,43,19,,,,,NM_007294.3,NM_007294,41249363,within,.,,rs8176144,0.3349,0.2784,,,,,,,,,,,,-,A,-,41249364,41249364,5FE5767CE4FF1F683ED78276A22DFBE8,,,,,,,-1,BRCA1- 458750637,0,125889,9,,,,EMPTY,,D,,0,6,34,238141,492662,126000,,,0,0,,,,,58,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3005,7,1,0.31578946,0.41463414,0.48337603,GRCh38/hg38,17,43097346,TAAAAAAA,TAAAAAA,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,64
8,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41223094,235,100.0,15,c.4837A>G,p.(Ser1613Gly),T,C,0,235,AGT,GGT,S,G,NM_007294.3,NM_007294,41223094,within,.,,rs1799966,0.3558,0.2982,,-0.194,0.968,0.038,0.814,0.0,1.5,,,,,-,T,C,41223094,41223094,E3C52286D31F229973DB3595B052645F,,,,,,,-1,BRCA1- 458776906,-150,41827,16,,,,EMPTY,,D,,0,13,53,273625,492662,126000,,,0,0,,1:1,,0.349,0,,,,,,,,,,,,,,Benign,Benign,0.255,113705,-1,,,,,,,,,,,3,0.35,14,1,0.68421054,0.64634144,0.5554011,GRCh38/hg38,17,43071077,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,64
27,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,309,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,309,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,19,82,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,1.0,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,64
22,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906729,181,58.56,10,c.1114A>C,p.(Asn372His),A,C,75,106,AAT,CAT,N,H,NM_000059.3,NM_000059,32906729,within,.,,rs144848,0.2494,0.2332,,0.32,0.861,,0.269,0.0,0.396,,,,,+,A,C,32906729,32906729,D514F785F1344AF9F6975E589D47BDF6,,,,,,,-1,BRCA2-  32906729,321,9329,10,,,,EMPTY,,D,,0,12,51,233635,493217,126000,,,0,0,,"1:1,2:1",,0.277,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2733,9,1,0.6315789,0.6219512,0.47369617,GRCh38/hg38,13,32332592,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,64
3,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32936646,90,44.44,17,c.7806-14T>C,p.(=),T,C,50,40,,,,,NM_000059.3,NM_000059,32936646,within,.,,rs9534262,0.5316,0.5202,,,,,,,,,,,,+,T,C,32936646,32936646,5803939D8FBB75B042260991F0A62436,,,,,,,-1,BRCA2-  32936646,0,126158,17,,,,EMPTY,,D,,0,13,61,361616,493217,126000,,,0,0,,1:3,,0.52,14,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5255,16,1,0.68421054,0.74390244,0.7331783,GRCh38/hg38,13,32362509,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,64
25,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32911463,122,44.26,11,c.2971A>G,p.(Asn991Asp),A,G,68,54,AAC,GAC,N,D,NM_000059.3,NM_000059,32911463,within,.,,rs1799944,0.0801,0.0373,,-0.04,0.0,,0.959,0.0,3.08,,,,,+,A,G,32911463,32911463,36F4F7E6CD788E45B30EA486775D07D6,,,,,,,-1,BRCA2-  32911463,1062,41545,11,,,,EMPTY,,D,,0,4,17,42142,493217,126000,,,0,0,,1:2,,0.053,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0522,10,1,0.21052632,0.20731707,0.085443124,GRCh38/hg38,13,32337326,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,64
26,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,122,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,122,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,19,82,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,1.0,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,64
2,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32929478,111,51.35,14,c.7435+53C>T,p.(=),C,T,54,57,,,,,NM_000059.3,NM_000059,32929478,within,.,,rs11147489,0.0725,,,,,,,,,,,,,+,C,T,32929478,32929478,F692B4BE5DCD39FA887FE8D63D296720,,,,,,,-1,BRCA2-  32929478,0,126136,14,,,,EMPTY,,D,,0,4,17,36369,493217,126000,,,0,0,,,,,53,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0301,13,3,0.21052632,0.20731707,0.07373834,GRCh38/hg38,13,32355341,C,T,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,64
24,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32910721,372,45.97,11,c.2229T>C,p.(His743=),T,C,201,171,CAT,CAC,H,H,NM_000059.3,NM_000059,32910721,within,.,,rs1801499,0.0735,0.0313,,,,,,,,,,,,+,T,C,32910721,32910721,D39471F16FE6D1F6752C2D4D179996AF,,,,,,,-1,BRCA2-  32910721,320,125979,11,,,,EMPTY,,D,,0,4,17,41536,493217,126000,,,0,0,,1:1,,0.052,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0503,10,1,0.21052632,0.20731707,0.08421446,GRCh38/hg38,13,32336584,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,64
12,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906480,90,50.0,10,c.865A>C,p.(Asn289His),A,C,45,45,AAT,CAT,N,H,NM_000059.3,NM_000059,32906480,within,.,,rs766173,0.0737,0.0312,,0.498,0.998,,0.803,0.0,1.73,,,,,+,A,C,32906480,32906480,EE0CD2A1633CE9FEF0978528634002FE,,,,,,,-1,BRCA2-  32906480,72,41567,10,,,,EMPTY,,D,,0,4,17,41272,493217,126000,,,0,0,,"1:4,2:1",,0.051,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0496,9,2,0.21052632,0.20731707,0.08367919,GRCh38/hg38,13,32332343,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,64
1,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32899388,116,55.17,4,c.425+67A>C,p.(=),A,C,52,64,,,,,NM_000059.3,NM_000059,32899388,within,.,,rs11571610,0.0743,,,,,,,,,,,,,+,A,C,32899388,32899388,1AF346DE380A738371905EBFBCED20E1,,,,,,,-1,BRCA2-  32899388,0,126095,4,,,,EMPTY,,D,,0,4,17,39349,493217,126000,,,0,0,,2:1,,,67,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0306,3,3,0.21052632,0.20731707,0.0797803,GRCh38/hg38,13,32325251,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,64
4,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32953388,219,52.51,22,c.8755-66T>C,p.(=),T,C,104,115,,,,,NM_000059.3,NM_000059,32953388,within,.,,rs4942486,0.5116,,,,,,,,,,,,,+,T,C,32953388,32953388,97C65B85894EB489F1BFA65897685241,,,,,,,-1,BRCA2-  32953388,0,126190,22,,,,EMPTY,,D,,0,13,61,347826,493217,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5257,21,1,0.68421054,0.74390244,0.70521903,GRCh38/hg38,13,32379251,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,64
23,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32906980,331,45.32,10,c.1365A>G,p.(Ser455=),A,G,181,150,TCA,TCG,S,S,NM_000059.3,NM_000059,32906980,within,.,,rs1801439,0.0737,0.031,,,,,,,,,,,,+,A,G,32906980,32906980,C76C22E555E869928B452D866988AB4F,,,,,,,-1,BRCA2-  32906980,-545,125943,10,,,,EMPTY,,D,,0,4,17,41480,493217,126000,,,0,0,,"1:4,2:1",,0.051,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0499,9,2,0.21052632,0.20731707,0.08410091,GRCh38/hg38,13,32332843,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,64
28,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,120,100.0,14,c.7397T>C,p.(Val2466Ala),T,C,0,120,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,19,81,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.9878049,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,64
13,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244936,262,48.09,10,c.2612C>T,p.(Pro871Leu),G,A,136,126,CCG,CTG,P,L,NM_007294.3,NM_007294,41244936,within,.,,rs799917,0.5439,0.4932,,4.247,0.0,0.0,0.999,1.0,5.04,,,,,-,G,A,41244936,41244936,A19EA255CA888CE1FE48D08CAD633F1F,,,,,,,1,BRCA1- 458755064,-1485,41812,11,,,,EMPTY,,D,,1,11,40,290862,492662,126000,(eval),,0,0,,"1:4,2:1",,0.41,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.4127,9,3,0.47826087,0.4878049,0.59038854,GRCh38/hg38,17,43092919,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,65
10,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244000,452,51.33,10,c.3548A>G,p.(Lys1183Arg),T,C,220,232,AAA,AGA,K,R,NM_007294.3,NM_007294,41244000,within,.,,rs16942,0.3526,0.2952,,-0.319,0.0,0.001,0.924,0.0,-2.35,,,,,-,T,C,41244000,41244000,37A54117EA353BDA677332A1F61FA173,,,,,,,-1,BRCA1- 458756000,-549,41818,11,,,,EMPTY,,D,,0,11,40,272437,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.47826087,0.4878049,0.55298966,GRCh38/hg38,17,43091983,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,65
8,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41234470,182,52.75,12,c.4308T>C,p.(Ser1436=),A,G,86,96,TCT,TCC,S,S,NM_007294.3,NM_007294,41234470,within,.,,rs1060915,0.3363,0.2796,,,,,,,,,,,,-,A,G,41234470,41234470,B7237055CF1D42F022A050C072B7583B,,,,,,,-1,BRCA1- 458765530,-50,125703,13,,,,EMPTY,,D,,0,11,40,270833,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3433,11,1,0.47826087,0.4878049,0.5497339,GRCh38/hg38,17,43082453,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,65
7,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41231516,142,54.93,13,c.4358-2885G>A,p.(=),C,T,64,78,,,,,NM_007294.3,NM_007294,41231516,within,.,,rs8176193,0.3534,,,,,,,,,,,,,-,C,T,41231516,41231516,7F4F80D2D005D34CEA47E4A2C561B172,,,,,,,-1,BRCA1- 458768484,0,209399,14,,,,EMPTY,,D,,0,11,40,190200,492662,126000,,,0,0,,,,,2885,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.317,12,1,0.47826087,0.4878049,0.3860659,GRCh38/hg38,17,43079499,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,65
11,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244435,301,46.18,10,c.3113A>G,p.(Glu1038Gly),T,C,162,139,GAA,GGA,E,G,NM_007294.3,NM_007294,41244435,within,.,,rs16941,0.3357,0.279,,-0.149,0.972,0.606,0.922,0.0,-0.974,,,,,-,T,C,41244435,41244435,5D0FF1321BAC3C76DD352C33CC33B93E,,,,,,,-1,BRCA1- 458755565,-984,41815,11,,,,EMPTY,,D,,0,11,40,270861,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,0.936,113705,-1,,,,,,,,,,,3,0.343,9,1,0.47826087,0.4878049,0.54979074,GRCh38/hg38,17,43092418,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,65
14,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245237,142,59.15,10,c.2311T>C,p.(Leu771=),A,G,58,84,TTG,CTG,L,L,NM_007294.3,NM_007294,41245237,within,.,,rs16940,0.3353,0.2776,,,,,,,,,,,,-,A,G,41245237,41245237,711AF22D84A49E875C2B2A9597A95EE6,,,,,,,-1,BRCA1- 458754763,1641,125554,11,,,,EMPTY,,D,,0,11,39,269517,492662,126000,,,0,0,,1:1,,0.342,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3422,9,1,0.47826087,0.47560975,0.5470627,GRCh38/hg38,17,43093220,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,65
4,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219804,193,48.19,16,c.4987-92A>G,p.(=),T,C,100,93,,,,,NM_007294.3,NM_007294,41219804,within,.,,rs8176233,0.3546,,,,,,,,,,,,,-,T,C,41219804,41219804,7341B20C52FFD4B9355840FB9CB56CDA,,,,,,,-1,BRCA1- 458780196,0,125749,17,,,,EMPTY,,D,,0,11,40,225491,492662,126000,,,0,0,,,,,92,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3128,15,1,0.47826087,0.4878049,0.45769918,GRCh38/hg38,17,43067787,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,65
3,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219780,193,48.7,16,c.4987-68A>G,p.(=),T,C,99,94,,,,,NM_007294.3,NM_007294,41219780,within,.,,rs8176234,0.3546,,,,,,,,,,,,,-,T,C,41219780,41219780,5995ECC305C33150BF3BB2B0C22FCC2A,,,,,,,-1,BRCA1- 458780220,0,125746,17,,,,EMPTY,,D,,0,11,40,234031,492662,126000,,,0,0,,,,,68,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3148,15,1,0.47826087,0.4878049,0.47503358,GRCh38/hg38,17,43067763,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,65
6,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41223094,287,54.7,15,c.4837A>G,p.(Ser1613Gly),T,C,130,157,AGT,GGT,S,G,NM_007294.3,NM_007294,41223094,within,.,,rs1799966,0.3558,0.2982,,-0.194,0.968,0.038,0.814,0.0,1.5,,,,,-,T,C,41223094,41223094,E3C52286D31F229973DB3595B052645F,,,,,,,-1,BRCA1- 458776906,-150,41827,16,,,,EMPTY,,D,,0,11,40,273625,492662,126000,,,0,0,,1:1,,0.349,0,,,,,,,,,,,,,,Benign,Benign,0.255,113705,-1,,,,,,,,,,,3,0.35,14,1,0.47826087,0.4878049,0.5554011,GRCh38/hg38,17,43071077,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,65
15,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245466,479,48.85,10,c.2082C>T,p.(Ser694=),G,A,245,234,AGC,AGT,S,S,NM_007294.3,NM_007294,41245466,within,.,,rs1799949,0.3365,0.2957,,,,,,,,,,,,-,G,A,41245466,41245466,3364E3D252EFEDF917C74D44FBC6A381,,,,,,,-1,BRCA1- 458754534,1412,125536,11,,,,EMPTY,,D,,0,11,40,269442,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.47826087,0.4878049,0.54691046,GRCh38/hg38,17,43093449,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,65
12,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906729,219,50.68,10,c.1114A>C,p.(Asn372His),A,C,108,111,AAT,CAT,N,H,NM_000059.3,NM_000059,32906729,within,.,,rs144848,0.2494,0.2332,,0.32,0.861,,0.269,0.0,0.396,,,,,+,A,C,32906729,32906729,D514F785F1344AF9F6975E589D47BDF6,,,,,,,-1,BRCA2-  32906729,321,9329,10,,,,EMPTY,,D,,0,14,39,233635,493217,126000,,,0,0,,"1:1,2:1",,0.277,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2733,9,1,0.6086956,0.47560975,0.47369617,GRCh38/hg38,13,32332592,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,65
23,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,141,100.0,14,c.7397T>C,p.(Val2466Ala),T,C,0,141,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,23,62,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.75609756,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,65
20,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,132,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,132,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,23,63,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,0.76829267,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,65
21,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,320,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,320,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,23,63,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,0.76829267,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,65
1,D,BRCA2,,SNP,5'UTR,GRCh37/hg19,13,32890572,351,49.86,2,c.-26G>A,p.(=),G,A,176,175,,,,,NM_000059.3,NM_000059,32890572,within,.,,rs1799943,0.2093,0.2088,,,,,,,,,,,,+,G,A,32890572,32890572,A9C2B39455EF056EDB097A5953EB72EE,,,,,,,-1,BRCA2-  32890572,14,125965,2,,,,EMPTY,,D,,0,10,26,205902,493217,126000,,,0,0,,,,0.243,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2427,1,1,0.4347826,0.31707317,0.41746736,GRCh38/hg38,13,32316435,G,A,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,65
19,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32911888,212,49.53,11,c.3396A>G,p.(Lys1132=),A,G,107,105,AAA,AAG,K,K,NM_000059.3,NM_000059,32911888,within,.,,rs1801406,0.2668,0.2798,,,,,,,,,,,,+,A,G,32911888,32911888,94F2C0D328C28C466A38A430BBE75D52,,,,,,,-1,BRCA2-  32911888,1487,126010,11,,,,EMPTY,,D,,0,10,26,248687,493217,126000,,,0,0,,1:3,,0.293,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.295,10,1,0.4347826,0.31707317,0.50421417,GRCh38/hg38,13,32337751,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,65
24,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32936646,136,100.0,17,c.7806-14T>C,p.(=),T,C,0,136,,,,,NM_000059.3,NM_000059,32936646,within,.,,rs9534262,0.5316,0.5202,,,,,,,,,,,,+,T,C,32936646,32936646,5803939D8FBB75B042260991F0A62436,,,,,,,-1,BRCA2-  32936646,0,126158,17,,,,EMPTY,,D,,0,19,48,361616,493217,126000,,,0,0,,1:3,,0.52,14,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5255,16,1,0.82608694,0.58536583,0.7331783,GRCh38/hg38,13,32362509,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,65
25,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32953388,246,100.0,22,c.8755-66T>C,p.(=),T,C,0,246,,,,,NM_000059.3,NM_000059,32953388,within,.,,rs4942486,0.5116,,,,,,,,,,,,,+,T,C,32953388,32953388,97C65B85894EB489F1BFA65897685241,,,,,,,-1,BRCA2-  32953388,0,126190,22,,,,EMPTY,,D,,0,18,48,347826,493217,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5257,21,1,0.7826087,0.58536583,0.70521903,GRCh38/hg38,13,32379251,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,65
22,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32929232,173,53.76,14,c.7242A>G,p.(Ser2414=),A,G,80,93,TCA,TCG,S,S,NM_000059.3,NM_000059,32929232,within,.,,rs1799955,0.2326,0.2114,,,,,,,,,,,,+,A,G,32929232,32929232,6F8D6FF8BC9027D6C0351ADCEF41FD20,,,,,,,-1,BRCA2-  32929232,-194,126133,14,,,,EMPTY,,D,,0,10,26,192923,493217,126000,,,0,0,,"1:3,2:1",,0.224,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2257,13,1,0.4347826,0.31707317,0.39115238,GRCh38/hg38,13,32355095,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,65
10,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41251931,190,49.47,7,c.442-34C>T,p.(=),G,A,96,94,,,,,NM_007294.3,NM_007294,41251931,within,.,,rs799923,0.0986,0.1757,,,,,,,,,,,,-,G,A,41251931,41251931,A5CCEFE1E7B19A106A59AB89C8776C53,,,,,,,-1,BRCA1- 458748069,0,125864,8,,,,EMPTY,,D,,0,5,14,181678,492662,126000,,,0,0,,,,0.174,34,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.1711,6,1,0.2173913,0.17073171,0.36876804,GRCh38/hg38,17,43099914,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,66
8,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41226548,178,48.31,14,c.4485-10A>G,p.(=),T,C,92,86,,,,,NM_007294.3,NM_007294,41226548,within,.,,rs863224420,,,,,,,,,,,,,,-,T,C,41226548,41226548,030BC2752C19B58D2A3DB67F0C94E955,,,,,,,-1,BRCA1- 458773452,0,215874,15,,,,EMPTY,,D,,0,1,1,42,492662,126000,,,0,0,,2:1,,,10,,,,,,,,,,,,,,Conflicting_interpretations_of_pathogenicity,Conflicting interpretations of pathogenicity,,113705,-1,,,,,,,,,,,3,0.0,13,3,0.04347826,0.0121951215,8.5251144E-5,GRCh38/hg38,17,43074531,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,66
14,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32911463,147,44.22,11,c.2971A>G,p.(Asn991Asp),A,G,82,65,AAC,GAC,N,D,NM_000059.3,NM_000059,32911463,within,.,,rs1799944,0.0801,0.0373,,-0.04,0.0,,0.959,0.0,3.08,,,,,+,A,G,32911463,32911463,36F4F7E6CD788E45B30EA486775D07D6,,,,,,,-1,BRCA2-  32911463,1062,41545,11,,,,EMPTY,,D,,0,5,13,42142,493217,126000,,,0,0,,1:2,,0.053,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0522,10,1,0.2173913,0.15853658,0.085443124,GRCh38/hg38,13,32337326,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,66
16,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,157,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,157,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,23,63,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,0.76829267,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,66
3,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32936646,138,52.9,17,c.7806-14T>C,p.(=),T,C,65,73,,,,,NM_000059.3,NM_000059,32936646,within,.,,rs9534262,0.5316,0.5202,,,,,,,,,,,,+,T,C,32936646,32936646,5803939D8FBB75B042260991F0A62436,,,,,,,-1,BRCA2-  32936646,0,126158,17,,,,EMPTY,,D,,0,19,48,361616,493217,126000,,,0,0,,1:3,,0.52,14,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5255,16,1,0.82608694,0.58536583,0.7331783,GRCh38/hg38,13,32362509,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,66
11,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906480,140,49.29,10,c.865A>C,p.(Asn289His),A,C,71,69,AAT,CAT,N,H,NM_000059.3,NM_000059,32906480,within,.,,rs766173,0.0737,0.0312,,0.498,0.998,,0.803,0.0,1.73,,,,,+,A,C,32906480,32906480,EE0CD2A1633CE9FEF0978528634002FE,,,,,,,-1,BRCA2-  32906480,72,41567,10,,,,EMPTY,,D,,0,5,13,41272,493217,126000,,,0,0,,"1:4,2:1",,0.051,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0496,9,2,0.2173913,0.15853658,0.08367919,GRCh38/hg38,13,32332343,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,66
15,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32912299,187,48.13,11,c.3807T>C,p.(Val1269=),T,C,97,90,GTT,GTC,V,V,NM_000059.3,NM_000059,32912299,within,.,,rs543304,0.1681,0.1911,,,,,,,,,,,,+,T,C,32912299,32912299,F2D3E8FFB3CEE8C1ACEA66738E41BC1E,,,,,,,-1,BRCA2-  32912299,1898,126022,11,,,,EMPTY,,D,,0,5,15,173719,493217,126000,,,0,0,,1:3,,0.176,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.1754,10,1,0.2173913,0.18292683,0.35221615,GRCh38/hg38,13,32338162,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,66
12,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32906980,446,53.59,10,c.1365A>G,p.(Ser455=),A,G,207,239,TCA,TCG,S,S,NM_000059.3,NM_000059,32906980,within,.,,rs1801439,0.0737,0.031,,,,,,,,,,,,+,A,G,32906980,32906980,C76C22E555E869928B452D866988AB4F,,,,,,,-1,BRCA2-  32906980,-545,125943,10,,,,EMPTY,,D,,0,5,13,41480,493217,126000,,,0,0,,"1:4,2:1",,0.051,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0499,9,2,0.2173913,0.15853658,0.08410091,GRCh38/hg38,13,32332843,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,66
13,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32910721,446,50.67,11,c.2229T>C,p.(His743=),T,C,220,226,CAT,CAC,H,H,NM_000059.3,NM_000059,32910721,within,.,,rs1801499,0.0735,0.0313,,,,,,,,,,,,+,T,C,32910721,32910721,D39471F16FE6D1F6752C2D4D179996AF,,,,,,,-1,BRCA2-  32910721,320,125979,11,,,,EMPTY,,D,,0,5,13,41536,493217,126000,,,0,0,,1:1,,0.052,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0503,10,1,0.2173913,0.15853658,0.08421446,GRCh38/hg38,13,32336584,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,66
2,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32929478,137,47.45,14,c.7435+53C>T,p.(=),C,T,72,65,,,,,NM_000059.3,NM_000059,32929478,within,.,,rs11147489,0.0725,,,,,,,,,,,,,+,C,T,32929478,32929478,F692B4BE5DCD39FA887FE8D63D296720,,,,,,,-1,BRCA2-  32929478,0,126136,14,,,,EMPTY,,D,,0,5,13,36369,493217,126000,,,0,0,,,,,53,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0301,13,3,0.2173913,0.15853658,0.07373834,GRCh38/hg38,13,32355341,C,T,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,66
17,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,445,99.78,11,c.6513G>C,p.(Val2171=),G,C,0,444,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,23,63,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,0.76829267,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,66
18,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,228,100.0,14,c.7397T>C,p.(Val2466Ala),T,C,0,228,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,23,62,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.75609756,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,66
1,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32899388,138,48.55,4,c.425+67A>C,p.(=),A,C,71,67,,,,,NM_000059.3,NM_000059,32899388,within,.,,rs11571610,0.0743,,,,,,,,,,,,,+,A,C,32899388,32899388,1AF346DE380A738371905EBFBCED20E1,,,,,,,-1,BRCA2-  32899388,0,126095,4,,,,EMPTY,,D,,0,5,13,39349,493217,126000,,,0,0,,2:1,,,67,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0306,3,3,0.2173913,0.15853658,0.0797803,GRCh38/hg38,13,32325251,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,66
4,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32953388,309,47.25,22,c.8755-66T>C,p.(=),T,C,163,146,,,,,NM_000059.3,NM_000059,32953388,within,.,,rs4942486,0.5116,,,,,,,,,,,,,+,T,C,32953388,32953388,97C65B85894EB489F1BFA65897685241,,,,,,,-1,BRCA2-  32953388,0,126190,22,,,,EMPTY,,D,,0,18,48,347826,493217,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5257,21,1,0.7826087,0.58536583,0.70521903,GRCh38/hg38,13,32379251,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,66
5,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32911888,248,61.29,11,c.3396A>G,p.(Lys1132=),A,G,96,152,AAA,AAG,K,K,NM_000059.3,NM_000059,32911888,within,.,,rs1801406,0.2668,0.2798,,,,,,,,,,,,+,A,G,32911888,32911888,94F2C0D328C28C466A38A430BBE75D52,,,,,,,-1,BRCA2-  32911888,1487,126010,11,,,,EMPTY,,D,,0,10,26,248687,493217,126000,,,0,0,,1:3,,0.293,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.295,10,1,0.4347826,0.31707317,0.50421417,GRCh38/hg38,13,32337751,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,67
6,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,170,99.41,11,c.4563A>G,p.(Leu1521=),A,G,1,169,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,23,63,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,0.76829267,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,67
9,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,181,100.0,14,c.7397T>C,p.(Val2466Ala),T,C,0,181,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,23,62,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.75609756,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,67
4,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906729,255,47.06,10,c.1114A>C,p.(Asn372His),A,C,135,120,AAT,CAT,N,H,NM_000059.3,NM_000059,32906729,within,.,,rs144848,0.2494,0.2332,,0.32,0.861,,0.269,0.0,0.396,,,,,+,A,C,32906729,32906729,D514F785F1344AF9F6975E589D47BDF6,,,,,,,-1,BRCA2-  32906729,321,9329,10,,,,EMPTY,,D,,0,14,39,233635,493217,126000,,,0,0,,"1:1,2:1",,0.277,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2733,9,1,0.6086956,0.47560975,0.47369617,GRCh38/hg38,13,32332592,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,67
11,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32953388,258,46.9,22,c.8755-66T>C,p.(=),T,C,137,121,,,,,NM_000059.3,NM_000059,32953388,within,.,,rs4942486,0.5116,,,,,,,,,,,,,+,T,C,32953388,32953388,97C65B85894EB489F1BFA65897685241,,,,,,,-1,BRCA2-  32953388,0,126190,22,,,,EMPTY,,D,,0,18,48,347826,493217,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5257,21,1,0.7826087,0.58536583,0.70521903,GRCh38/hg38,13,32379251,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,67
1,D,BRCA2,,SNP,5'UTR,GRCh37/hg19,13,32890572,415,48.92,2,c.-26G>A,p.(=),G,A,212,203,,,,,NM_000059.3,NM_000059,32890572,within,.,,rs1799943,0.2093,0.2088,,,,,,,,,,,,+,G,A,32890572,32890572,A9C2B39455EF056EDB097A5953EB72EE,,,,,,,-1,BRCA2-  32890572,14,125965,2,,,,EMPTY,,D,,0,10,26,205902,493217,126000,,,0,0,,,,0.243,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2427,1,1,0.4347826,0.31707317,0.41746736,GRCh38/hg38,13,32316435,G,A,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,67
7,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,307,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,307,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,23,63,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,0.76829267,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,67
8,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32929232,203,47.29,14,c.7242A>G,p.(Ser2414=),A,G,107,96,TCA,TCG,S,S,NM_000059.3,NM_000059,32929232,within,.,,rs1799955,0.2326,0.2114,,,,,,,,,,,,+,A,G,32929232,32929232,6F8D6FF8BC9027D6C0351ADCEF41FD20,,,,,,,-1,BRCA2-  32929232,-194,126133,14,,,,EMPTY,,D,,0,10,26,192923,493217,126000,,,0,0,,"1:3,2:1",,0.224,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2257,13,1,0.4347826,0.31707317,0.39115238,GRCh38/hg38,13,32355095,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,67
10,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32936646,146,54.11,17,c.7806-14T>C,p.(=),T,C,67,79,,,,,NM_000059.3,NM_000059,32936646,within,.,,rs9534262,0.5316,0.5202,,,,,,,,,,,,+,T,C,32936646,32936646,5803939D8FBB75B042260991F0A62436,,,,,,,-1,BRCA2-  32936646,0,126158,17,,,,EMPTY,,D,,0,19,48,361616,493217,126000,,,0,0,,1:3,,0.52,14,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5255,16,1,0.82608694,0.58536583,0.7331783,GRCh38/hg38,13,32362509,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,67
11,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32930598,146,54.11,15,c.7469T>C,p.(Ile2490Thr),T,C,67,79,ATA,ACA,I,T,NM_000059.3,NM_000059,32930598,within,.,,rs11571707,0.016,0.0016,,0.406,0.895,,0.837,0.0,-5.83,,,,,+,T,C,32930598,32930598,D7CAF30A58440FCA5E8E7BACD8E1EDE4,,,,,,,-1,BRCA2-  32930598,34,96852,15,,,,EMPTY,,D,,0,6,17,6837,493217,126000,,,0,0,,"1:5,2:2",,0.014,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0176,14,2,0.26086956,0.20731707,0.013862053,GRCh38/hg38,13,32356461,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,68
5,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906729,197,40.61,10,c.1114A>C,p.(Asn372His),A,C,117,80,AAT,CAT,N,H,NM_000059.3,NM_000059,32906729,within,.,,rs144848,0.2494,0.2332,,0.32,0.861,,0.269,0.0,0.396,,,,,+,A,C,32906729,32906729,D514F785F1344AF9F6975E589D47BDF6,,,,,,,-1,BRCA2-  32906729,321,9329,10,,,,EMPTY,,D,,0,14,39,233635,493217,126000,,,0,0,,"1:1,2:1",,0.277,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2733,9,1,0.6086956,0.47560975,0.47369617,GRCh38/hg38,13,32332592,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,68
2,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32953388,242,53.72,22,c.8755-66T>C,p.(=),T,C,112,130,,,,,NM_000059.3,NM_000059,32953388,within,.,,rs4942486,0.5116,,,,,,,,,,,,,+,T,C,32953388,32953388,97C65B85894EB489F1BFA65897685241,,,,,,,-1,BRCA2-  32953388,0,126190,22,,,,EMPTY,,D,,0,18,48,347826,493217,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5257,21,1,0.7826087,0.58536583,0.70521903,GRCh38/hg38,13,32379251,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,68
6,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32911888,208,53.85,11,c.3396A>G,p.(Lys1132=),A,G,96,112,AAA,AAG,K,K,NM_000059.3,NM_000059,32911888,within,.,,rs1801406,0.2668,0.2798,,,,,,,,,,,,+,A,G,32911888,32911888,94F2C0D328C28C466A38A430BBE75D52,,,,,,,-1,BRCA2-  32911888,1487,126010,11,,,,EMPTY,,D,,0,10,26,248687,493217,126000,,,0,0,,1:3,,0.293,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.295,10,1,0.4347826,0.31707317,0.50421417,GRCh38/hg38,13,32337751,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,68
8,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,309,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,309,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,23,63,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,0.76829267,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,68
12,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32936646,133,51.13,17,c.7806-14T>C,p.(=),T,C,65,68,,,,,NM_000059.3,NM_000059,32936646,within,.,,rs9534262,0.5316,0.5202,,,,,,,,,,,,+,T,C,32936646,32936646,5803939D8FBB75B042260991F0A62436,,,,,,,-1,BRCA2-  32936646,0,126158,17,,,,EMPTY,,D,,0,19,48,361616,493217,126000,,,0,0,,1:3,,0.52,14,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5255,16,1,0.82608694,0.58536583,0.7331783,GRCh38/hg38,13,32362509,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,68
1,D,BRCA2,,SNP,5'UTR,GRCh37/hg19,13,32890572,409,53.3,2,c.-26G>A,p.(=),G,A,191,218,,,,,NM_000059.3,NM_000059,32890572,within,.,,rs1799943,0.2093,0.2088,,,,,,,,,,,,+,G,A,32890572,32890572,A9C2B39455EF056EDB097A5953EB72EE,,,,,,,-1,BRCA2-  32890572,14,125965,2,,,,EMPTY,,D,,0,10,26,205902,493217,126000,,,0,0,,,,0.243,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2427,1,1,0.4347826,0.31707317,0.41746736,GRCh38/hg38,13,32316435,G,A,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,68
7,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,126,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,126,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,23,63,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,0.76829267,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,68
10,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,144,100.0,14,c.7397T>C,p.(Val2466Ala),T,C,0,144,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,23,62,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.75609756,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,68
9,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32929232,182,50.0,14,c.7242A>G,p.(Ser2414=),A,G,91,91,TCA,TCG,S,S,NM_000059.3,NM_000059,32929232,within,.,,rs1799955,0.2326,0.2114,,,,,,,,,,,,+,A,G,32929232,32929232,6F8D6FF8BC9027D6C0351ADCEF41FD20,,,,,,,-1,BRCA2-  32929232,-194,126133,14,,,,EMPTY,,D,,0,10,26,192923,493217,126000,,,0,0,,"1:3,2:1",,0.224,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2257,13,1,0.4347826,0.31707317,0.39115238,GRCh38/hg38,13,32355095,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,68
3,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41251931,184,44.57,7,c.442-34C>T,p.(=),G,A,102,82,,,,,NM_007294.3,NM_007294,41251931,within,.,,rs799923,0.0986,0.1757,,,,,,,,,,,,-,G,A,41251931,41251931,A5CCEFE1E7B19A106A59AB89C8776C53,,,,,,,-1,BRCA1- 458748069,0,125864,8,,,,EMPTY,,D,,0,5,14,181678,492662,126000,,,0,0,,,,0.174,34,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.1711,6,1,0.2173913,0.17073171,0.36876804,GRCh38/hg38,17,43099914,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,69
9,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32936646,144,100.0,17,c.7806-14T>C,p.(=),T,C,0,144,,,,,NM_000059.3,NM_000059,32936646,within,.,,rs9534262,0.5316,0.5202,,,,,,,,,,,,+,T,C,32936646,32936646,5803939D8FBB75B042260991F0A62436,,,,,,,-1,BRCA2-  32936646,0,126158,17,,,,EMPTY,,D,,0,19,48,361616,493217,126000,,,0,0,,1:3,,0.52,14,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5255,16,1,0.82608694,0.58536583,0.7331783,GRCh38/hg38,13,32362509,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,69
8,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,165,100.0,14,c.7397T>C,p.(Val2466Ala),T,C,0,165,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,23,62,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.75609756,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,69
1,D,BRCA2,,SNP,5'UTR,GRCh37/hg19,13,32890572,343,49.27,2,c.-26G>A,p.(=),G,A,174,169,,,,,NM_000059.3,NM_000059,32890572,within,.,,rs1799943,0.2093,0.2088,,,,,,,,,,,,+,G,A,32890572,32890572,A9C2B39455EF056EDB097A5953EB72EE,,,,,,,-1,BRCA2-  32890572,14,125965,2,,,,EMPTY,,D,,0,10,26,205902,493217,126000,,,0,0,,,,0.243,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2427,1,1,0.4347826,0.31707317,0.41746736,GRCh38/hg38,13,32316435,G,A,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,69
10,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32953388,254,100.0,22,c.8755-66T>C,p.(=),T,C,0,254,,,,,NM_000059.3,NM_000059,32953388,within,.,,rs4942486,0.5116,,,,,,,,,,,,,+,T,C,32953388,32953388,97C65B85894EB489F1BFA65897685241,,,,,,,-1,BRCA2-  32953388,0,126190,22,,,,EMPTY,,D,,0,18,48,347826,493217,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5257,21,1,0.7826087,0.58536583,0.70521903,GRCh38/hg38,13,32379251,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,69
7,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32929232,199,100.0,14,c.7242A>G,p.(Ser2414=),A,G,0,199,TCA,TCG,S,S,NM_000059.3,NM_000059,32929232,within,.,,rs1799955,0.2326,0.2114,,,,,,,,,,,,+,A,G,32929232,32929232,6F8D6FF8BC9027D6C0351ADCEF41FD20,,,,,,,-1,BRCA2-  32929232,-194,126133,14,,,,EMPTY,,D,,0,10,26,192923,493217,126000,,,0,0,,"1:3,2:1",,0.224,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2257,13,1,0.4347826,0.31707317,0.39115238,GRCh38/hg38,13,32355095,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,69
5,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,149,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,149,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,23,63,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,0.76829267,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,69
6,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,354,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,354,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,23,63,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,0.76829267,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,69
4,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32911888,347,100.0,11,c.3396A>G,p.(Lys1132=),A,G,0,347,AAA,AAG,K,K,NM_000059.3,NM_000059,32911888,within,.,,rs1801406,0.2668,0.2798,,,,,,,,,,,,+,A,G,32911888,32911888,94F2C0D328C28C466A38A430BBE75D52,,,,,,,-1,BRCA2-  32911888,1487,126010,11,,,,EMPTY,,D,,0,10,26,248687,493217,126000,,,0,0,,1:3,,0.293,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.295,10,1,0.4347826,0.31707317,0.50421417,GRCh38/hg38,13,32337751,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,69
1,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32903685,314,51.91,8,c.681+56C>T,p.(=),C,T,151,163,,,,,NM_000059.3,NM_000059,32903685,within,.,,rs2126042,0.1859,,,,,,,,,,,,,+,C,T,32903685,32903685,E9AEF840574909F4761D4EF7950E02CB,,,,,,,-1,BRCA2-  32903685,0,126192,8,,,,EMPTY,,D,,0,6,18,145186,493217,126000,,,0,0,,4:1,,,56,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2163,7,1,0.26086956,0.2195122,0.29436535,GRCh38/hg38,13,32329548,C,T,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,70
5,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,349,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,349,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,23,63,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,0.76829267,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,70
4,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,135,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,135,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,23,63,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,0.76829267,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,70
7,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32936646,136,49.26,17,c.7806-14T>C,p.(=),T,C,69,67,,,,,NM_000059.3,NM_000059,32936646,within,.,,rs9534262,0.5316,0.5202,,,,,,,,,,,,+,T,C,32936646,32936646,5803939D8FBB75B042260991F0A62436,,,,,,,-1,BRCA2-  32936646,0,126158,17,,,,EMPTY,,D,,0,19,48,361616,493217,126000,,,0,0,,1:3,,0.52,14,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5255,16,1,0.82608694,0.58536583,0.7331783,GRCh38/hg38,13,32362509,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,70
3,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906729,196,55.61,10,c.1114A>C,p.(Asn372His),A,C,87,109,AAT,CAT,N,H,NM_000059.3,NM_000059,32906729,within,.,,rs144848,0.2494,0.2332,,0.32,0.861,,0.269,0.0,0.396,,,,,+,A,C,32906729,32906729,D514F785F1344AF9F6975E589D47BDF6,,,,,,,-1,BRCA2-  32906729,321,9329,10,,,,EMPTY,,D,,0,14,39,233635,493217,126000,,,0,0,,"1:1,2:1",,0.277,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2733,9,1,0.6086956,0.47560975,0.47369617,GRCh38/hg38,13,32332592,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,70
6,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,127,100.0,14,c.7397T>C,p.(Val2466Ala),T,C,0,127,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,23,62,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.75609756,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,70
8,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32953388,226,47.79,22,c.8755-66T>C,p.(=),T,C,118,108,,,,,NM_000059.3,NM_000059,32953388,within,.,,rs4942486,0.5116,,,,,,,,,,,,,+,T,C,32953388,32953388,97C65B85894EB489F1BFA65897685241,,,,,,,-1,BRCA2-  32953388,0,126190,22,,,,EMPTY,,D,,0,18,48,347826,493217,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5257,21,1,0.7826087,0.58536583,0.70521903,GRCh38/hg38,13,32379251,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,70
11,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244936,254,99.61,10,c.2612C>T,p.(Pro871Leu),G,A,1,253,CCG,CTG,P,L,NM_007294.3,NM_007294,41244936,within,.,,rs799917,0.5439,0.4932,,4.247,0.0,0.0,0.999,1.0,5.04,,,,,-,G,A,41244936,41244936,A19EA255CA888CE1FE48D08CAD633F1F,,,,,,,1,BRCA1- 458755064,-1485,41812,11,,,,EMPTY,,D,,1,11,40,290862,492662,126000,(eval),,0,0,,"1:4,2:1",,0.41,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.4127,9,3,0.47826087,0.4878049,0.59038854,GRCh38/hg38,17,43092919,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,71
14,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245466,333,99.4,10,c.2082C>T,p.(Ser694=),G,A,2,331,AGC,AGT,S,S,NM_007294.3,NM_007294,41245466,within,.,,rs1799949,0.3365,0.2957,,,,,,,,,,,,-,G,A,41245466,41245466,3364E3D252EFEDF917C74D44FBC6A381,,,,,,,-1,BRCA1- 458754534,1412,125536,11,,,,EMPTY,,D,,0,11,40,269442,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.47826087,0.4878049,0.54691046,GRCh38/hg38,17,43093449,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,71
10,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244435,267,100.0,10,c.3113A>G,p.(Glu1038Gly),T,C,0,267,GAA,GGA,E,G,NM_007294.3,NM_007294,41244435,within,.,,rs16941,0.3357,0.279,,-0.149,0.972,0.606,0.922,0.0,-0.974,,,,,-,T,C,41244435,41244435,5D0FF1321BAC3C76DD352C33CC33B93E,,,,,,,-1,BRCA1- 458755565,-984,41815,11,,,,EMPTY,,D,,0,11,40,270861,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,0.936,113705,-1,,,,,,,,,,,3,0.343,9,1,0.47826087,0.4878049,0.54979074,GRCh38/hg38,17,43092418,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,71
8,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41234470,104,100.0,12,c.4308T>C,p.(Ser1436=),A,G,0,104,TCT,TCC,S,S,NM_007294.3,NM_007294,41234470,within,.,,rs1060915,0.3363,0.2796,,,,,,,,,,,,-,A,G,41234470,41234470,B7237055CF1D42F022A050C072B7583B,,,,,,,-1,BRCA1- 458765530,-50,125703,13,,,,EMPTY,,D,,0,11,40,270833,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3433,11,1,0.47826087,0.4878049,0.5497339,GRCh38/hg38,17,43082453,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,71
7,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41231516,146,100.0,13,c.4358-2885G>A,p.(=),C,T,0,146,,,,,NM_007294.3,NM_007294,41231516,within,.,,rs8176193,0.3534,,,,,,,,,,,,,-,C,T,41231516,41231516,7F4F80D2D005D34CEA47E4A2C561B172,,,,,,,-1,BRCA1- 458768484,0,209399,14,,,,EMPTY,,D,,0,11,40,190200,492662,126000,,,0,0,,,,,2885,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.317,12,1,0.47826087,0.4878049,0.3860659,GRCh38/hg38,17,43079499,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,71
9,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244000,378,99.74,10,c.3548A>G,p.(Lys1183Arg),T,C,1,377,AAA,AGA,K,R,NM_007294.3,NM_007294,41244000,within,.,,rs16942,0.3526,0.2952,,-0.319,0.0,0.001,0.924,0.0,-2.35,,,,,-,T,C,41244000,41244000,37A54117EA353BDA677332A1F61FA173,,,,,,,-1,BRCA1- 458756000,-549,41818,11,,,,EMPTY,,D,,0,11,40,272437,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.47826087,0.4878049,0.55298966,GRCh38/hg38,17,43091983,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,71
2,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41215825,74,50.0,17,c.5152+66G>A,p.(=),C,T,36,37,,,,,NM_007294.3,NM_007294,41215825,within,.,,rs3092994,0.3425,,,,,,,,,,,,,-,C,T,41215825,41215825,5BCA8D2E1E3875817F84A3EB582CDFAB,,,,,,,-1,BRCA1- 458784175,0,55428,18,,,,EMPTY,,D,,0,8,32,241843,492662,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3139,16,1,0.3478261,0.3902439,0.4908903,GRCh38/hg38,17,43063808,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,71
15,D,BRCA1,,INDEL,intronic,GRCh37/hg19,17,41249363,92,19.57,8,c.548-58del,p.(=),TAAAAAAA,TAAAAAA,74,18,,,,,NM_007294.3,NM_007294,41249363,within,.,,rs8176144,0.3349,0.2784,,,,,,,,,,,,-,A,-,41249364,41249364,5FE5767CE4FF1F683ED78276A22DFBE8,,,,,,,-1,BRCA1- 458750637,0,125889,9,,,,EMPTY,,D,,0,4,28,238141,492662,126000,,,0,0,,,,,58,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3005,7,1,0.17391305,0.34146342,0.48337603,GRCh38/hg38,17,43097346,TAAAAAAA,TAAAAAA,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,71
4,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219804,174,100.0,16,c.4987-92A>G,p.(=),T,C,0,174,,,,,NM_007294.3,NM_007294,41219804,within,.,,rs8176233,0.3546,,,,,,,,,,,,,-,T,C,41219804,41219804,7341B20C52FFD4B9355840FB9CB56CDA,,,,,,,-1,BRCA1- 458780196,0,125749,17,,,,EMPTY,,D,,0,11,40,225491,492662,126000,,,0,0,,,,,92,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3128,15,1,0.47826087,0.4878049,0.45769918,GRCh38/hg38,17,43067787,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,71
13,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245237,132,100.0,10,c.2311T>C,p.(Leu771=),A,G,0,132,TTG,CTG,L,L,NM_007294.3,NM_007294,41245237,within,.,,rs16940,0.3353,0.2776,,,,,,,,,,,,-,A,G,41245237,41245237,711AF22D84A49E875C2B2A9597A95EE6,,,,,,,-1,BRCA1- 458754763,1641,125554,11,,,,EMPTY,,D,,0,11,39,269517,492662,126000,,,0,0,,1:1,,0.342,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3422,9,1,0.47826087,0.47560975,0.5470627,GRCh38/hg38,17,43093220,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,71
3,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219780,174,100.0,16,c.4987-68A>G,p.(=),T,C,0,174,,,,,NM_007294.3,NM_007294,41219780,within,.,,rs8176234,0.3546,,,,,,,,,,,,,-,T,C,41219780,41219780,5995ECC305C33150BF3BB2B0C22FCC2A,,,,,,,-1,BRCA1- 458780220,0,125746,17,,,,EMPTY,,D,,0,11,40,234031,492662,126000,,,0,0,,,,,68,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3148,15,1,0.47826087,0.4878049,0.47503358,GRCh38/hg38,17,43067763,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,71
6,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41223094,291,100.0,15,c.4837A>G,p.(Ser1613Gly),T,C,0,291,AGT,GGT,S,G,NM_007294.3,NM_007294,41223094,within,.,,rs1799966,0.3558,0.2982,,-0.194,0.968,0.038,0.814,0.0,1.5,,,,,-,T,C,41223094,41223094,E3C52286D31F229973DB3595B052645F,,,,,,,-1,BRCA1- 458776906,-150,41827,16,,,,EMPTY,,D,,0,11,40,273625,492662,126000,,,0,0,,1:1,,0.349,0,,,,,,,,,,,,,,Benign,Benign,0.255,113705,-1,,,,,,,,,,,3,0.35,14,1,0.47826087,0.4878049,0.5554011,GRCh38/hg38,17,43071077,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,71
23,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,115,100.0,14,c.7397T>C,p.(Val2466Ala),T,C,0,115,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,23,62,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.75609756,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,71
20,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,139,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,139,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,23,63,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,0.76829267,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,71
12,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32912299,145,51.72,11,c.3807T>C,p.(Val1269=),T,C,70,75,GTT,GTC,V,V,NM_000059.3,NM_000059,32912299,within,.,,rs543304,0.1681,0.1911,,,,,,,,,,,,+,T,C,32912299,32912299,F2D3E8FFB3CEE8C1ACEA66738E41BC1E,,,,,,,-1,BRCA2-  32912299,1898,126022,11,,,,EMPTY,,D,,0,5,15,173719,493217,126000,,,0,0,,1:3,,0.176,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.1754,10,1,0.2173913,0.18292683,0.35221615,GRCh38/hg38,13,32338162,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,71
1,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32903685,289,50.52,8,c.681+56C>T,p.(=),C,T,143,146,,,,,NM_000059.3,NM_000059,32903685,within,.,,rs2126042,0.1859,,,,,,,,,,,,,+,C,T,32903685,32903685,E9AEF840574909F4761D4EF7950E02CB,,,,,,,-1,BRCA2-  32903685,0,126192,8,,,,EMPTY,,D,,0,6,18,145186,493217,126000,,,0,0,,4:1,,,56,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2163,7,1,0.26086956,0.2195122,0.29436535,GRCh38/hg38,13,32329548,C,T,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,71
22,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,353,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,353,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,23,63,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,0.76829267,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,71
24,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32936646,134,50.0,17,c.7806-14T>C,p.(=),T,C,67,67,,,,,NM_000059.3,NM_000059,32936646,within,.,,rs9534262,0.5316,0.5202,,,,,,,,,,,,+,T,C,32936646,32936646,5803939D8FBB75B042260991F0A62436,,,,,,,-1,BRCA2-  32936646,0,126158,17,,,,EMPTY,,D,,0,19,48,361616,493217,126000,,,0,0,,1:3,,0.52,14,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5255,16,1,0.82608694,0.58536583,0.7331783,GRCh38/hg38,13,32362509,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,71
25,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32953388,215,47.91,22,c.8755-66T>C,p.(=),T,C,112,103,,,,,NM_000059.3,NM_000059,32953388,within,.,,rs4942486,0.5116,,,,,,,,,,,,,+,T,C,32953388,32953388,97C65B85894EB489F1BFA65897685241,,,,,,,-1,BRCA2-  32953388,0,126190,22,,,,EMPTY,,D,,0,18,48,347826,493217,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5257,21,1,0.7826087,0.58536583,0.70521903,GRCh38/hg38,13,32379251,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,71
21,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32913804,212,48.58,11,c.5312G>A,p.(Gly1771Asp),G,A,109,103,GGT,GAT,G,D,NM_000059.3,NM_000059,32913804,within,.,,rs80358755,2.0E-4,4.0E-4,,-0.53,0.574,,0.611,0.0,-0.338,,,,,+,G,A,32913804,32913804,BC26819C286393C4A8B4C12A74635CA2,,,,,,,-1,BRCA2-  32913804,-1530,37958,11,,,,EMPTY,,D,,0,1,1,936,493217,126000,,,0,0,,"1:1,2:4",,3.0E-4,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,3.0E-4,10,2,0.04347826,0.0121951215,0.0018977448,GRCh38/hg38,13,32339667,G,A,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,71
5,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906729,167,53.29,10,c.1114A>C,p.(Asn372His),A,C,78,89,AAT,CAT,N,H,NM_000059.3,NM_000059,32906729,within,.,,rs144848,0.2494,0.2332,,0.32,0.861,,0.269,0.0,0.396,,,,,+,A,C,32906729,32906729,D514F785F1344AF9F6975E589D47BDF6,,,,,,,-1,BRCA2-  32906729,321,9329,10,,,,EMPTY,,D,,0,14,39,233635,493217,126000,,,0,0,,"1:1,2:1",,0.277,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2733,9,1,0.6086956,0.47560975,0.47369617,GRCh38/hg38,13,32332592,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,72
6,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32911888,249,50.2,11,c.3396A>G,p.(Lys1132=),A,G,124,125,AAA,AAG,K,K,NM_000059.3,NM_000059,32911888,within,.,,rs1801406,0.2668,0.2798,,,,,,,,,,,,+,A,G,32911888,32911888,94F2C0D328C28C466A38A430BBE75D52,,,,,,,-1,BRCA2-  32911888,1487,126010,11,,,,EMPTY,,D,,0,10,26,248687,493217,126000,,,0,0,,1:3,,0.293,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.295,10,1,0.4347826,0.31707317,0.50421417,GRCh38/hg38,13,32337751,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,72
8,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,340,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,340,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,23,63,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,0.76829267,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,72
1,D,BRCA2,,SNP,5'UTR,GRCh37/hg19,13,32890572,383,48.56,2,c.-26G>A,p.(=),G,A,197,186,,,,,NM_000059.3,NM_000059,32890572,within,.,,rs1799943,0.2093,0.2088,,,,,,,,,,,,+,G,A,32890572,32890572,A9C2B39455EF056EDB097A5953EB72EE,,,,,,,-1,BRCA2-  32890572,14,125965,2,,,,EMPTY,,D,,0,10,26,205902,493217,126000,,,0,0,,,,0.243,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2427,1,1,0.4347826,0.31707317,0.41746736,GRCh38/hg38,13,32316435,G,A,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,72
7,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,102,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,102,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,23,63,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,0.76829267,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,72
10,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,113,100.0,14,c.7397T>C,p.(Val2466Ala),T,C,0,113,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,23,62,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.75609756,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,72
3,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32972884,170,38.24,27,c.10234A>G,p.(Ile3412Val),A,G,105,65,ATT,GTT,I,V,NM_000059.3,NM_000059,32972884,within,.,,rs1801426,0.0449,0.0373,,0.556,0.077,,0.019,0.0,-0.286,,,,,+,A,G,32972884,32972884,FD2873D8FA6A6E3D4D35F2ACC4046DA1,,,,,,,-1,BRCA2-  32972884,586,41540,27,,,,EMPTY,,D,,0,2,2,10858,493217,126000,,,0,0,,"1:5,2:2",,0.022,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0248,26,2,0.08695652,0.024390243,0.022014651,GRCh38/hg38,13,32398747,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,72
12,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32944667,108,49.07,19,c.8460A>C,p.(Val2820=),A,C,55,53,GTA,GTC,V,V,NM_000059.3,NM_000059,32944667,within,.,,rs9590940,0.0144,0.013,,,,,,,,,,,,+,A,C,32944667,32944667,E956DD757CA55036791307691F1BAD19,,,,,,,-1,BRCA2-  32944667,-28,52594,19,,,,EMPTY,,D,,0,1,1,1423,493217,126000,,,0,0,,"1:1,2:3",,0.0037,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.004,18,2,0.04347826,0.0121951215,0.0028851398,GRCh38/hg38,13,32370530,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,72
9,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32929232,109,51.38,14,c.7242A>G,p.(Ser2414=),A,G,53,56,TCA,TCG,S,S,NM_000059.3,NM_000059,32929232,within,.,,rs1799955,0.2326,0.2114,,,,,,,,,,,,+,A,G,32929232,32929232,6F8D6FF8BC9027D6C0351ADCEF41FD20,,,,,,,-1,BRCA2-  32929232,-194,126133,14,,,,EMPTY,,D,,0,10,26,192923,493217,126000,,,0,0,,"1:3,2:1",,0.224,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2257,13,1,0.4347826,0.31707317,0.39115238,GRCh38/hg38,13,32355095,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,72
11,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32936646,104,48.08,17,c.7806-14T>C,p.(=),T,C,54,50,,,,,NM_000059.3,NM_000059,32936646,within,.,,rs9534262,0.5316,0.5202,,,,,,,,,,,,+,T,C,32936646,32936646,5803939D8FBB75B042260991F0A62436,,,,,,,-1,BRCA2-  32936646,0,126158,17,,,,EMPTY,,D,,0,19,48,361616,493217,126000,,,0,0,,1:3,,0.52,14,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5255,16,1,0.82608694,0.58536583,0.7331783,GRCh38/hg38,13,32362509,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,72
14,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244936,322,48.14,10,c.2612C>T,p.(Pro871Leu),G,A,167,155,CCG,CTG,P,L,NM_007294.3,NM_007294,41244936,within,.,,rs799917,0.5439,0.4932,,4.247,0.0,0.0,0.999,1.0,5.04,,,,,-,G,A,41244936,41244936,A19EA255CA888CE1FE48D08CAD633F1F,,,,,,,1,BRCA1- 458755064,-1485,41812,11,,,,EMPTY,,D,,1,11,40,290862,492662,126000,(eval),,0,0,,"1:4,2:1",,0.41,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.4127,9,3,0.47826087,0.4878049,0.59038854,GRCh38/hg38,17,43092919,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,73
11,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244000,367,49.59,10,c.3548A>G,p.(Lys1183Arg),T,C,185,182,AAA,AGA,K,R,NM_007294.3,NM_007294,41244000,within,.,,rs16942,0.3526,0.2952,,-0.319,0.0,0.001,0.924,0.0,-2.35,,,,,-,T,C,41244000,41244000,37A54117EA353BDA677332A1F61FA173,,,,,,,-1,BRCA1- 458756000,-549,41818,11,,,,EMPTY,,D,,0,11,40,272437,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.47826087,0.4878049,0.55298966,GRCh38/hg38,17,43091983,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,73
16,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245466,400,49.0,10,c.2082C>T,p.(Ser694=),G,A,204,196,AGC,AGT,S,S,NM_007294.3,NM_007294,41245466,within,.,,rs1799949,0.3365,0.2957,,,,,,,,,,,,-,G,A,41245466,41245466,3364E3D252EFEDF917C74D44FBC6A381,,,,,,,-1,BRCA1- 458754534,1412,125536,11,,,,EMPTY,,D,,0,11,40,269442,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.47826087,0.4878049,0.54691046,GRCh38/hg38,17,43093449,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,73
13,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244435,317,50.79,10,c.3113A>G,p.(Glu1038Gly),T,C,156,161,GAA,GGA,E,G,NM_007294.3,NM_007294,41244435,within,.,,rs16941,0.3357,0.279,,-0.149,0.972,0.606,0.922,0.0,-0.974,,,,,-,T,C,41244435,41244435,5D0FF1321BAC3C76DD352C33CC33B93E,,,,,,,-1,BRCA1- 458755565,-984,41815,11,,,,EMPTY,,D,,0,11,40,270861,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,0.936,113705,-1,,,,,,,,,,,3,0.343,9,1,0.47826087,0.4878049,0.54979074,GRCh38/hg38,17,43092418,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,73
9,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41231516,166,44.58,13,c.4358-2885G>A,p.(=),C,T,92,74,,,,,NM_007294.3,NM_007294,41231516,within,.,,rs8176193,0.3534,,,,,,,,,,,,,-,C,T,41231516,41231516,7F4F80D2D005D34CEA47E4A2C561B172,,,,,,,-1,BRCA1- 458768484,0,209399,14,,,,EMPTY,,D,,0,11,40,190200,492662,126000,,,0,0,,,,,2885,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.317,12,1,0.47826087,0.4878049,0.3860659,GRCh38/hg38,17,43079499,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,73
5,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219780,194,46.39,16,c.4987-68A>G,p.(=),T,C,104,90,,,,,NM_007294.3,NM_007294,41219780,within,.,,rs8176234,0.3546,,,,,,,,,,,,,-,T,C,41219780,41219780,5995ECC305C33150BF3BB2B0C22FCC2A,,,,,,,-1,BRCA1- 458780220,0,125746,17,,,,EMPTY,,D,,0,11,40,234031,492662,126000,,,0,0,,,,,68,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3148,15,1,0.47826087,0.4878049,0.47503358,GRCh38/hg38,17,43067763,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,73
6,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219804,194,46.39,16,c.4987-92A>G,p.(=),T,C,104,90,,,,,NM_007294.3,NM_007294,41219804,within,.,,rs8176233,0.3546,,,,,,,,,,,,,-,T,C,41219804,41219804,7341B20C52FFD4B9355840FB9CB56CDA,,,,,,,-1,BRCA1- 458780196,0,125749,17,,,,EMPTY,,D,,0,11,40,225491,492662,126000,,,0,0,,,,,92,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3128,15,1,0.47826087,0.4878049,0.45769918,GRCh38/hg38,17,43067787,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,73
10,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41234470,161,44.72,12,c.4308T>C,p.(Ser1436=),A,G,89,72,TCT,TCC,S,S,NM_007294.3,NM_007294,41234470,within,.,,rs1060915,0.3363,0.2796,,,,,,,,,,,,-,A,G,41234470,41234470,B7237055CF1D42F022A050C072B7583B,,,,,,,-1,BRCA1- 458765530,-50,125703,13,,,,EMPTY,,D,,0,11,40,270833,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3433,11,1,0.47826087,0.4878049,0.5497339,GRCh38/hg38,17,43082453,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,73
15,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245237,143,45.45,10,c.2311T>C,p.(Leu771=),A,G,78,65,TTG,CTG,L,L,NM_007294.3,NM_007294,41245237,within,.,,rs16940,0.3353,0.2776,,,,,,,,,,,,-,A,G,41245237,41245237,711AF22D84A49E875C2B2A9597A95EE6,,,,,,,-1,BRCA1- 458754763,1641,125554,11,,,,EMPTY,,D,,0,11,39,269517,492662,126000,,,0,0,,1:1,,0.342,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3422,9,1,0.47826087,0.47560975,0.5470627,GRCh38/hg38,17,43093220,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,73
4,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41215825,78,50.0,17,c.5152+66G>A,p.(=),C,T,39,39,,,,,NM_007294.3,NM_007294,41215825,within,.,,rs3092994,0.3425,,,,,,,,,,,,,-,C,T,41215825,41215825,5BCA8D2E1E3875817F84A3EB582CDFAB,,,,,,,-1,BRCA1- 458784175,0,55428,18,,,,EMPTY,,D,,0,8,32,241843,492662,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3139,16,1,0.3478261,0.3902439,0.4908903,GRCh38/hg38,17,43063808,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,73
8,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41223094,303,49.83,15,c.4837A>G,p.(Ser1613Gly),T,C,152,151,AGT,GGT,S,G,NM_007294.3,NM_007294,41223094,within,.,,rs1799966,0.3558,0.2982,,-0.194,0.968,0.038,0.814,0.0,1.5,,,,,-,T,C,41223094,41223094,E3C52286D31F229973DB3595B052645F,,,,,,,-1,BRCA1- 458776906,-150,41827,16,,,,EMPTY,,D,,0,11,40,273625,492662,126000,,,0,0,,1:1,,0.349,0,,,,,,,,,,,,,,Benign,Benign,0.255,113705,-1,,,,,,,,,,,3,0.35,14,1,0.47826087,0.4878049,0.5554011,GRCh38/hg38,17,43071077,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,73
25,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32929232,189,48.15,14,c.7242A>G,p.(Ser2414=),A,G,98,91,TCA,TCG,S,S,NM_000059.3,NM_000059,32929232,within,.,,rs1799955,0.2326,0.2114,,,,,,,,,,,,+,A,G,32929232,32929232,6F8D6FF8BC9027D6C0351ADCEF41FD20,,,,,,,-1,BRCA2-  32929232,-194,126133,14,,,,EMPTY,,D,,0,10,26,192923,493217,126000,,,0,0,,"1:3,2:1",,0.224,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2257,13,1,0.4347826,0.31707317,0.39115238,GRCh38/hg38,13,32355095,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,73
12,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906729,197,54.82,10,c.1114A>C,p.(Asn372His),A,C,88,108,AAT,CAT,N,H,NM_000059.3,NM_000059,32906729,within,.,,rs144848,0.2494,0.2332,,0.32,0.861,,0.269,0.0,0.396,,,,,+,A,C,32906729,32906729,D514F785F1344AF9F6975E589D47BDF6,,,,,,,-1,BRCA2-  32906729,321,9329,10,,,,EMPTY,,D,,0,14,39,233635,493217,126000,,,0,0,,"1:1,2:1",,0.277,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2733,9,1,0.6086956,0.47560975,0.47369617,GRCh38/hg38,13,32332592,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,73
2,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32953388,222,49.55,22,c.8755-66T>C,p.(=),T,C,112,110,,,,,NM_000059.3,NM_000059,32953388,within,.,,rs4942486,0.5116,,,,,,,,,,,,,+,T,C,32953388,32953388,97C65B85894EB489F1BFA65897685241,,,,,,,-1,BRCA2-  32953388,0,126190,22,,,,EMPTY,,D,,0,18,48,347826,493217,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5257,21,1,0.7826087,0.58536583,0.70521903,GRCh38/hg38,13,32379251,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,73
26,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,141,100.0,14,c.7397T>C,p.(Val2466Ala),T,C,0,141,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,23,62,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.75609756,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,73
1,D,BRCA2,,SNP,5'UTR,GRCh37/hg19,13,32890572,377,50.4,2,c.-26G>A,p.(=),G,A,187,190,,,,,NM_000059.3,NM_000059,32890572,within,.,,rs1799943,0.2093,0.2088,,,,,,,,,,,,+,G,A,32890572,32890572,A9C2B39455EF056EDB097A5953EB72EE,,,,,,,-1,BRCA2-  32890572,14,125965,2,,,,EMPTY,,D,,0,10,26,205902,493217,126000,,,0,0,,,,0.243,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2427,1,1,0.4347826,0.31707317,0.41746736,GRCh38/hg38,13,32316435,G,A,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,73
24,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,369,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,369,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,23,63,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,0.76829267,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,73
23,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,118,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,118,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,23,63,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,0.76829267,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,73
28,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32936646,115,52.17,17,c.7806-14T>C,p.(=),T,C,55,60,,,,,NM_000059.3,NM_000059,32936646,within,.,,rs9534262,0.5316,0.5202,,,,,,,,,,,,+,T,C,32936646,32936646,5803939D8FBB75B042260991F0A62436,,,,,,,-1,BRCA2-  32936646,0,126158,17,,,,EMPTY,,D,,0,19,48,361616,493217,126000,,,0,0,,1:3,,0.52,14,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5255,16,1,0.82608694,0.58536583,0.7331783,GRCh38/hg38,13,32362509,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,73
27,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32930598,147,50.34,15,c.7469T>C,p.(Ile2490Thr),T,C,73,74,ATA,ACA,I,T,NM_000059.3,NM_000059,32930598,within,.,,rs11571707,0.016,0.0016,,0.406,0.895,,0.837,0.0,-5.83,,,,,+,T,C,32930598,32930598,D7CAF30A58440FCA5E8E7BACD8E1EDE4,,,,,,,-1,BRCA2-  32930598,34,96852,15,,,,EMPTY,,D,,0,6,17,6837,493217,126000,,,0,0,,"1:5,2:2",,0.014,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0176,14,2,0.26086956,0.20731707,0.013862053,GRCh38/hg38,13,32356461,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,73
22,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32911888,305,52.79,11,c.3396A>G,p.(Lys1132=),A,G,144,161,AAA,AAG,K,K,NM_000059.3,NM_000059,32911888,within,.,,rs1801406,0.2668,0.2798,,,,,,,,,,,,+,A,G,32911888,32911888,94F2C0D328C28C466A38A430BBE75D52,,,,,,,-1,BRCA2-  32911888,1487,126010,11,,,,EMPTY,,D,,0,10,26,248687,493217,126000,,,0,0,,1:3,,0.293,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.295,10,1,0.4347826,0.31707317,0.50421417,GRCh38/hg38,13,32337751,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,73
3,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41251931,107,49.53,7,c.442-34C>T,p.(=),G,A,54,53,,,,,NM_007294.3,NM_007294,41251931,within,.,,rs799923,0.0986,0.1757,,,,,,,,,,,,-,G,A,41251931,41251931,A5CCEFE1E7B19A106A59AB89C8776C53,,,,,,,-1,BRCA1- 458748069,0,125864,8,,,,EMPTY,,D,,0,5,14,181678,492662,126000,,,0,0,,,,0.174,34,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.1711,6,1,0.2173913,0.17073171,0.36876804,GRCh38/hg38,17,43099914,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,74
5,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32911888,171,100.0,11,c.3396A>G,p.(Lys1132=),A,G,0,171,AAA,AAG,K,K,NM_000059.3,NM_000059,32911888,within,.,,rs1801406,0.2668,0.2798,,,,,,,,,,,,+,A,G,32911888,32911888,94F2C0D328C28C466A38A430BBE75D52,,,,,,,-1,BRCA2-  32911888,1487,126010,11,,,,EMPTY,,D,,0,10,26,248687,493217,126000,,,0,0,,1:3,,0.293,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.295,10,1,0.4347826,0.31707317,0.50421417,GRCh38/hg38,13,32337751,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,74
6,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,108,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,108,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,23,63,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,0.76829267,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,74
7,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32914236,185,43.78,11,c.5744C>T,p.(Thr1915Met),C,T,104,81,ACG,ATG,T,M,NM_000059.3,NM_000059,32914236,within,.,,rs4987117,0.0086,0.0211,,-1.105,0.674,,0.286,0.0,0.623,,,,,+,C,T,32914236,32914236,9B18380606AE96F8022F8AB5893BFD77,,,,,,,-1,BRCA2-  32914236,-1098,41556,11,,,,EMPTY,,D,,0,2,6,22222,493217,126000,,,0,0,,"1:4,2:1",,0.018,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0179,10,2,0.08695652,0.07317073,0.045055218,GRCh38/hg38,13,32340099,C,T,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,74
12,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32953388,142,100.0,22,c.8755-66T>C,p.(=),T,C,0,142,,,,,NM_000059.3,NM_000059,32953388,within,.,,rs4942486,0.5116,,,,,,,,,,,,,+,T,C,32953388,32953388,97C65B85894EB489F1BFA65897685241,,,,,,,-1,BRCA2-  32953388,0,126190,22,,,,EMPTY,,D,,0,18,48,347826,493217,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5257,21,1,0.7826087,0.58536583,0.70521903,GRCh38/hg38,13,32379251,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,74
8,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,294,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,294,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,23,63,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,0.76829267,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,74
1,D,BRCA2,,SNP,5'UTR,GRCh37/hg19,13,32890572,245,99.59,2,c.-26G>A,p.(=),G,A,1,244,,,,,NM_000059.3,NM_000059,32890572,within,.,,rs1799943,0.2093,0.2088,,,,,,,,,,,,+,G,A,32890572,32890572,A9C2B39455EF056EDB097A5953EB72EE,,,,,,,-1,BRCA2-  32890572,14,125965,2,,,,EMPTY,,D,,0,10,26,205902,493217,126000,,,0,0,,,,0.243,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2427,1,1,0.4347826,0.31707317,0.41746736,GRCh38/hg38,13,32316435,G,A,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,74
10,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,104,99.04,14,c.7397T>C,p.(Val2466Ala),T,C,1,103,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,23,62,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.75609756,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,74
9,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32929232,137,100.0,14,c.7242A>G,p.(Ser2414=),A,G,0,137,TCA,TCG,S,S,NM_000059.3,NM_000059,32929232,within,.,,rs1799955,0.2326,0.2114,,,,,,,,,,,,+,A,G,32929232,32929232,6F8D6FF8BC9027D6C0351ADCEF41FD20,,,,,,,-1,BRCA2-  32929232,-194,126133,14,,,,EMPTY,,D,,0,10,26,192923,493217,126000,,,0,0,,"1:3,2:1",,0.224,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2257,13,1,0.4347826,0.31707317,0.39115238,GRCh38/hg38,13,32355095,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,74
11,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32936646,71,100.0,17,c.7806-14T>C,p.(=),T,C,0,71,,,,,NM_000059.3,NM_000059,32936646,within,.,,rs9534262,0.5316,0.5202,,,,,,,,,,,,+,T,C,32936646,32936646,5803939D8FBB75B042260991F0A62436,,,,,,,-1,BRCA2-  32936646,0,126158,17,,,,EMPTY,,D,,0,19,48,361616,493217,126000,,,0,0,,1:3,,0.52,14,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5255,16,1,0.82608694,0.58536583,0.7331783,GRCh38/hg38,13,32362509,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,74
6,C,BRCA2,,SNP,missense,GRCh37/hg19,13,32937492,112,41.07,18,c.8153T>C,p.(Ile2718Thr),T,C,66,46,ATT,ACT,I,T,NM_000059.3,NM_000059,32937492,within,.,,rs80359060,,,,2.634,0.497,,0.755,0.0,0.238,,,,,+,T,C,32937492,32937492,03A9A85637E6B0CA77A5C2BBC542C1F4,,,,,,,-1,BRCA2-  32937492,177,38140,18,,,,EMPTY,,C,,0,2,2,9,493217,126000,,,0,0,,3:1,,0.0,0,,,,,,,,,,,,,,Conflicting_interpretations_of_pathogenicity,Conflicting interpretations of pathogenicity,,600185,-1,,,,,,,,,,,3,0.0,17,3,0.08695652,0.024390243,1.8247547E-5,GRCh38/hg38,13,32363355,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,75
3,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,334,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,334,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,23,63,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,0.76829267,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,75
4,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,149,100.0,14,c.7397T>C,p.(Val2466Ala),T,C,0,149,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,23,62,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.75609756,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,75
2,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,145,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,145,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,23,63,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,0.76829267,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,75
1,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906729,170,100.0,10,c.1114A>C,p.(Asn372His),A,C,0,170,AAT,CAT,N,H,NM_000059.3,NM_000059,32906729,within,.,,rs144848,0.2494,0.2332,,0.32,0.861,,0.269,0.0,0.396,,,,,+,A,C,32906729,32906729,D514F785F1344AF9F6975E589D47BDF6,,,,,,,-1,BRCA2-  32906729,321,9329,10,,,,EMPTY,,D,,0,14,39,233635,493217,126000,,,0,0,,"1:1,2:1",,0.277,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2733,9,1,0.6086956,0.47560975,0.47369617,GRCh38/hg38,13,32332592,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,75
5,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32930598,149,100.0,15,c.7469T>C,p.(Ile2490Thr),T,C,0,149,ATA,ACA,I,T,NM_000059.3,NM_000059,32930598,within,.,,rs11571707,0.016,0.0016,,0.406,0.895,,0.837,0.0,-5.83,,,,,+,T,C,32930598,32930598,D7CAF30A58440FCA5E8E7BACD8E1EDE4,,,,,,,-1,BRCA2-  32930598,34,96852,15,,,,EMPTY,,D,,0,6,17,6837,493217,126000,,,0,0,,"1:5,2:2",,0.014,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0176,14,2,0.26086956,0.20731707,0.013862053,GRCh38/hg38,13,32356461,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,75
2,A,BRCA1,37553,INDEL,frameshift,GRCh37/hg19,17,41243686,212,50.47,10,c.3858_3861del,p.(Ser1286Argfs*20),CCTCA,C,104,107,AGTGAG,AGGAAACAAAATGTTCTGCTAGCTTGTTTTCTTCACAGTGCAGTGAATTGGAAGACTTGA,SE,RKQNVLLACFLHSAVNWKT*,NM_007294.3,NM_007294,41243686,within,.,,rs80357842,,,,,,,,,,,,,,-,CTCA,-,41243687,41243690,C5E4D108684430EB657F552244521B7C,,1,,,,,-1,BRCA1- 458756314,-236,37553,11,,,,EMPTY,,A,,1,1,1,15,492662,126000,,,0,0,,5:1,,,0,,,,,,,,,,,,,,Pathogenic,Pathogenic,,113705,-1,,,,,,,,,,,3,0.0,9,5,0.04347826,0.0121951215,3.0446838E-5,GRCh38/hg38,17,43091669,CCTCA,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,76
11,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41203084,148,44.59,20,c.5328C>T,p.(Pro1776=),G,A,82,66,CCC,CCT,P,P,NM_007294.3,NM_007294,41203084,within,.,,rs759867616,,,,,,,,,,,,,,-,G,A,41203084,41203084,A962EBF50261177EE9FA798792328C9A,,,,,,,-1,BRCA1- 458796916,-5,185660,21,,,,EMPTY,,D,,0,1,1,12,492662,126000,,,0,0,,,,0.0,0,,,,,,,,,,,,,,Likely_benign,Likely benign,,113705,-1,,,,,,,,,,,3,0.0,19,3,0.04347826,0.0121951215,2.435747E-5,GRCh38/hg38,17,43051067,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,76
1,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32903685,346,48.84,8,c.681+56C>T,p.(=),C,T,177,169,,,,,NM_000059.3,NM_000059,32903685,within,.,,rs2126042,0.1859,,,,,,,,,,,,,+,C,T,32903685,32903685,E9AEF840574909F4761D4EF7950E02CB,,,,,,,-1,BRCA2-  32903685,0,126192,8,,,,EMPTY,,D,,0,6,18,145186,493217,126000,,,0,0,,4:1,,,56,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2163,7,1,0.26086956,0.2195122,0.29436535,GRCh38/hg38,13,32329548,C,T,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,76
7,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,154,100.0,14,c.7397T>C,p.(Val2466Ala),T,C,0,154,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,23,62,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.75609756,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,76
4,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906729,206,41.75,10,c.1114A>C,p.(Asn372His),A,C,120,86,AAT,CAT,N,H,NM_000059.3,NM_000059,32906729,within,.,,rs144848,0.2494,0.2332,,0.32,0.861,,0.269,0.0,0.396,,,,,+,A,C,32906729,32906729,D514F785F1344AF9F6975E589D47BDF6,,,,,,,-1,BRCA2-  32906729,321,9329,10,,,,EMPTY,,D,,0,14,39,233635,493217,126000,,,0,0,,"1:1,2:1",,0.277,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2733,9,1,0.6086956,0.47560975,0.47369617,GRCh38/hg38,13,32332592,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,76
8,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32936646,170,51.18,17,c.7806-14T>C,p.(=),T,C,83,87,,,,,NM_000059.3,NM_000059,32936646,within,.,,rs9534262,0.5316,0.5202,,,,,,,,,,,,+,T,C,32936646,32936646,5803939D8FBB75B042260991F0A62436,,,,,,,-1,BRCA2-  32936646,0,126158,17,,,,EMPTY,,D,,0,19,48,361616,493217,126000,,,0,0,,1:3,,0.52,14,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5255,16,1,0.82608694,0.58536583,0.7331783,GRCh38/hg38,13,32362509,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,76
5,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,182,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,182,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,23,63,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,0.76829267,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,76
9,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32953388,239,50.21,22,c.8755-66T>C,p.(=),T,C,119,120,,,,,NM_000059.3,NM_000059,32953388,within,.,,rs4942486,0.5116,,,,,,,,,,,,,+,T,C,32953388,32953388,97C65B85894EB489F1BFA65897685241,,,,,,,-1,BRCA2-  32953388,0,126190,22,,,,EMPTY,,D,,0,18,48,347826,493217,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5257,21,1,0.7826087,0.58536583,0.70521903,GRCh38/hg38,13,32379251,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,76
6,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,388,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,388,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,23,63,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,0.76829267,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,76
11,A,BRCA1,37445,INDEL,frameshift,GRCh37/hg19,17,41245442,251,54.98,10,c.2105dup,p.(Leu702Phefs*10),TAA,TAAA,112,138,TTA,TTTAACAAATGCACCTGGTTCTTTTACTAA,L,FNKCTWFFY*,NM_007294.3,NM_007294,41245442,within,.,,rs80357880,,,,,,,,,,,,,,-,-,A,41245442,41245443,86A74A5E0379B7B5A9A8D8798254ED0C,,1,,,,,5,BRCA1- 458754558,1436,37445,11,,,,EMPTY,,A,,4,1,3,10,492662,126000,"""Patogenica en clinvar  Interpretation:     Pathogenic  Review status:     reviewed by expert panel  Submissions:     12  First in ClinVar:     Apr 1, 2014 Most recent Submission:     Mar 11, 2023 Last evaluated:     Sep 8, 2016 Accession:     VCV000037445.20 Variation ID:     37445 Description:     1bp duplication  """,,0,0,,,,,0,,,,,,,,,,,,,,Pathogenic,Pathogenic,,113705,-1,,,,,,,,,,,3,,9,5,0.04347826,0.036585364,2.0297892E-5,GRCh38/hg38,17,43093425,TAA,TAAA,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,77
9,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244936,305,43.93,10,c.2612C>T,p.(Pro871Leu),G,A,171,134,CCG,CTG,P,L,NM_007294.3,NM_007294,41244936,within,.,,rs799917,0.5439,0.4932,,4.247,0.0,0.0,0.999,1.0,5.04,,,,,-,G,A,41244936,41244936,A19EA255CA888CE1FE48D08CAD633F1F,,,,,,,1,BRCA1- 458755064,-1485,41812,11,,,,EMPTY,,D,,1,11,40,290862,492662,126000,(eval),,0,0,,"1:4,2:1",,0.41,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.4127,9,3,0.47826087,0.4878049,0.59038854,GRCh38/hg38,17,43092919,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,77
14,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41251931,198,38.89,7,c.442-34C>T,p.(=),G,A,121,77,,,,,NM_007294.3,NM_007294,41251931,within,.,,rs799923,0.0986,0.1757,,,,,,,,,,,,-,G,A,41251931,41251931,A5CCEFE1E7B19A106A59AB89C8776C53,,,,,,,-1,BRCA1- 458748069,0,125864,8,,,,EMPTY,,D,,0,5,14,181678,492662,126000,,,0,0,,,,0.174,34,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.1711,6,1,0.2173913,0.17073171,0.36876804,GRCh38/hg38,17,43099914,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,77
23,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41215825,82,56.1,17,c.5152+66G>A,p.(=),C,T,36,46,,,,,NM_007294.3,NM_007294,41215825,within,.,,rs3092994,0.3425,,,,,,,,,,,,,-,C,T,41215825,41215825,5BCA8D2E1E3875817F84A3EB582CDFAB,,,,,,,-1,BRCA1- 458784175,0,55428,18,,,,EMPTY,,D,,0,8,32,241843,492662,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3139,16,1,0.3478261,0.3902439,0.4908903,GRCh38/hg38,17,43063808,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,77
4,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41231516,136,44.85,13,c.4358-2885G>A,p.(=),C,T,75,61,,,,,NM_007294.3,NM_007294,41231516,within,.,,rs8176193,0.3534,,,,,,,,,,,,,-,C,T,41231516,41231516,7F4F80D2D005D34CEA47E4A2C561B172,,,,,,,-1,BRCA1- 458768484,0,209399,14,,,,EMPTY,,D,,0,11,40,190200,492662,126000,,,0,0,,,,,2885,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.317,12,1,0.47826087,0.4878049,0.3860659,GRCh38/hg38,17,43079499,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,77
5,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41234470,120,51.67,12,c.4308T>C,p.(Ser1436=),A,G,57,62,TCT,TCC,S,S,NM_007294.3,NM_007294,41234470,within,.,,rs1060915,0.3363,0.2796,,,,,,,,,,,,-,A,G,41234470,41234470,B7237055CF1D42F022A050C072B7583B,,,,,,,-1,BRCA1- 458765530,-50,125703,13,,,,EMPTY,,D,,0,11,40,270833,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3433,11,1,0.47826087,0.4878049,0.5497339,GRCh38/hg38,17,43082453,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,77
8,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244435,311,51.77,10,c.3113A>G,p.(Glu1038Gly),T,C,150,161,GAA,GGA,E,G,NM_007294.3,NM_007294,41244435,within,.,,rs16941,0.3357,0.279,,-0.149,0.972,0.606,0.922,0.0,-0.974,,,,,-,T,C,41244435,41244435,5D0FF1321BAC3C76DD352C33CC33B93E,,,,,,,-1,BRCA1- 458755565,-984,41815,11,,,,EMPTY,,D,,0,11,40,270861,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,0.936,113705,-1,,,,,,,,,,,3,0.343,9,1,0.47826087,0.4878049,0.54979074,GRCh38/hg38,17,43092418,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,77
24,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219780,177,41.81,16,c.4987-68A>G,p.(=),T,C,103,74,,,,,NM_007294.3,NM_007294,41219780,within,.,,rs8176234,0.3546,,,,,,,,,,,,,-,T,C,41219780,41219780,5995ECC305C33150BF3BB2B0C22FCC2A,,,,,,,-1,BRCA1- 458780220,0,125746,17,,,,EMPTY,,D,,0,11,40,234031,492662,126000,,,0,0,,,,,68,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3148,15,1,0.47826087,0.4878049,0.47503358,GRCh38/hg38,17,43067763,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,77
25,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219804,177,41.81,16,c.4987-92A>G,p.(=),T,C,103,74,,,,,NM_007294.3,NM_007294,41219804,within,.,,rs8176233,0.3546,,,,,,,,,,,,,-,T,C,41219804,41219804,7341B20C52FFD4B9355840FB9CB56CDA,,,,,,,-1,BRCA1- 458780196,0,125749,17,,,,EMPTY,,D,,0,11,40,225491,492662,126000,,,0,0,,,,,92,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3128,15,1,0.47826087,0.4878049,0.45769918,GRCh38/hg38,17,43067787,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,77
13,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245466,455,52.53,10,c.2082C>T,p.(Ser694=),G,A,216,239,AGC,AGT,S,S,NM_007294.3,NM_007294,41245466,within,.,,rs1799949,0.3365,0.2957,,,,,,,,,,,,-,G,A,41245466,41245466,3364E3D252EFEDF917C74D44FBC6A381,,,,,,,-1,BRCA1- 458754534,1412,125536,11,,,,EMPTY,,D,,0,11,40,269442,492662,126000,,,0,0,,1:2,3,0.348,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.47826087,0.4878049,0.54691046,GRCh38/hg38,17,43093449,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,77
7,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244000,372,51.08,10,c.3548A>G,p.(Lys1183Arg),T,C,182,190,AAA,AGA,K,R,NM_007294.3,NM_007294,41244000,within,.,,rs16942,0.3526,0.2952,,-0.319,0.0,0.001,0.924,0.0,-2.35,,,,,-,T,C,41244000,41244000,37A54117EA353BDA677332A1F61FA173,,,,,,,-1,BRCA1- 458756000,-549,41818,11,,,,EMPTY,,D,,0,11,40,272437,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.47826087,0.4878049,0.55298966,GRCh38/hg38,17,43091983,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,77
10,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245237,145,53.79,10,c.2311T>C,p.(Leu771=),A,G,67,78,TTG,CTG,L,L,NM_007294.3,NM_007294,41245237,within,.,,rs16940,0.3353,0.2776,,,,,,,,,,,,-,A,G,41245237,41245237,711AF22D84A49E875C2B2A9597A95EE6,,,,,,,-1,BRCA1- 458754763,1641,125554,11,,,,EMPTY,,D,,0,11,39,269517,492662,126000,,,0,0,,1:1,,0.342,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3422,9,1,0.47826087,0.47560975,0.5470627,GRCh38/hg38,17,43093220,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,77
3,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41223094,292,52.05,15,c.4837A>G,p.(Ser1613Gly),T,C,140,152,AGT,GGT,S,G,NM_007294.3,NM_007294,41223094,within,.,,rs1799966,0.3558,0.2982,,-0.194,0.968,0.038,0.814,0.0,1.5,,,,,-,T,C,41223094,41223094,E3C52286D31F229973DB3595B052645F,,,,,,,-1,BRCA1- 458776906,-150,41827,16,,,,EMPTY,,D,,0,11,40,273625,492662,126000,,,0,0,,1:1,,0.349,0,,,,,,,,,,,,,,Benign,Benign,0.255,113705,-1,,,,,,,,,,,3,0.35,14,1,0.47826087,0.4878049,0.5554011,GRCh38/hg38,17,43071077,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,77
12,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,153,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,153,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,23,63,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,0.76829267,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,77
19,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,284,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,284,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,23,63,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,0.76829267,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,77
1,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32912299,137,100.0,11,c.3807T>C,p.(Val1269=),T,C,0,137,GTT,GTC,V,V,NM_000059.3,NM_000059,32912299,within,.,,rs543304,0.1681,0.1911,,,,,,,,,,,,+,T,C,32912299,32912299,F2D3E8FFB3CEE8C1ACEA66738E41BC1E,,,,,,,-1,BRCA2-  32912299,1898,126022,11,,,,EMPTY,,D,,0,5,15,173719,493217,126000,,,0,0,,1:3,,0.176,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.1754,10,1,0.2173913,0.18292683,0.35221615,GRCh38/hg38,13,32338162,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,77
21,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,130,100.0,14,c.7397T>C,p.(Val2466Ala),T,C,0,130,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,23,62,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.75609756,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,77
22,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32944741,118,38.14,19,c.8487+47C>T,p.(=),C,T,73,45,,,,,NM_000059.3,NM_000059,32944741,within,.,,rs11571744,0.0162,0.0152,,,,,,,,,,,,+,C,T,32944741,32944741,CCFA6A67453503D5A2ABA9EA2FE12152,,,,,,,-1,BRCA2-  32944741,0,126179,19,,,,EMPTY,,D,,0,1,1,22639,493217,126000,,,0,0,,2:1,,0.0041,47,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0047,18,3,0.04347826,0.0121951215,0.045900688,GRCh38/hg38,13,32370604,C,T,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,77
14,C,BRCA2,,SNP,missense,GRCh37/hg19,13,32913702,381,52.49,11,c.5210A>T,p.(Asp1737Val),A,T,179,200,GAT,GTT,D,V,NM_000059.3,NM_000059,32913702,within,.,,rs587778120,,,,-0.241,0.992,,0.592,0.0025,-2.47,,,,,+,A,T,32913702,32913702,3C8B4F923DB98AAC177706C92C73C816,,,,,,,-1,BRCA2-  32913702,-1632,133729,11,,,,EMPTY,,C,,0,1,1,6,493217,126000,,,0,0,,,,,0,,,,,,,,,,,,,,Uncertain_significance,Uncertain significance,,600185,-1,,,,,,,,,,,3,,10,3,0.04347826,0.0121951215,1.2165031E-5,GRCh38/hg38,13,32339565,A,T,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,78
7,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244936,351,44.73,10,c.2612C>T,p.(Pro871Leu),G,A,194,157,CCG,CTG,P,L,NM_007294.3,NM_007294,41244936,within,.,,rs799917,0.5439,0.4932,,4.247,0.0,0.0,0.999,1.0,5.04,,,,,-,G,A,41244936,41244936,A19EA255CA888CE1FE48D08CAD633F1F,,,,,,,1,BRCA1- 458755064,-1485,41812,11,,,,EMPTY,,D,,1,11,40,290862,492662,126000,(eval),,0,0,,"1:4,2:1",,0.41,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.4127,9,3,0.47826087,0.4878049,0.59038854,GRCh38/hg38,17,43092919,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,78
19,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219804,191,45.55,16,c.4987-92A>G,p.(=),T,C,104,87,,,,,NM_007294.3,NM_007294,41219804,within,.,,rs8176233,0.3546,,,,,,,,,,,,,-,T,C,41219804,41219804,7341B20C52FFD4B9355840FB9CB56CDA,,,,,,,-1,BRCA1- 458780196,0,125749,17,,,,EMPTY,,D,,0,11,40,225491,492662,126000,,,0,0,,,,,92,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3128,15,1,0.47826087,0.4878049,0.45769918,GRCh38/hg38,17,43067787,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,78
2,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41231516,141,44.68,13,c.4358-2885G>A,p.(=),C,T,78,63,,,,,NM_007294.3,NM_007294,41231516,within,.,,rs8176193,0.3534,,,,,,,,,,,,,-,C,T,41231516,41231516,7F4F80D2D005D34CEA47E4A2C561B172,,,,,,,-1,BRCA1- 458768484,0,209399,14,,,,EMPTY,,D,,0,11,40,190200,492662,126000,,,0,0,,,,,2885,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.317,12,1,0.47826087,0.4878049,0.3860659,GRCh38/hg38,17,43079499,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,78
6,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244435,397,50.88,10,c.3113A>G,p.(Glu1038Gly),T,C,195,202,GAA,GGA,E,G,NM_007294.3,NM_007294,41244435,within,.,,rs16941,0.3357,0.279,,-0.149,0.972,0.606,0.922,0.0,-0.974,,,,,-,T,C,41244435,41244435,5D0FF1321BAC3C76DD352C33CC33B93E,,,,,,,-1,BRCA1- 458755565,-984,41815,11,,,,EMPTY,,D,,0,11,40,270861,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,0.936,113705,-1,,,,,,,,,,,3,0.343,9,1,0.47826087,0.4878049,0.54979074,GRCh38/hg38,17,43092418,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,78
18,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219780,192,45.83,16,c.4987-68A>G,p.(=),T,C,104,88,,,,,NM_007294.3,NM_007294,41219780,within,.,,rs8176234,0.3546,,,,,,,,,,,,,-,T,C,41219780,41219780,5995ECC305C33150BF3BB2B0C22FCC2A,,,,,,,-1,BRCA1- 458780220,0,125746,17,,,,EMPTY,,D,,0,11,40,234031,492662,126000,,,0,0,,,,,68,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3148,15,1,0.47826087,0.4878049,0.47503358,GRCh38/hg38,17,43067763,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,78
9,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245466,541,49.17,10,c.2082C>T,p.(Ser694=),G,A,275,266,AGC,AGT,S,S,NM_007294.3,NM_007294,41245466,within,.,,rs1799949,0.3365,0.2957,,,,,,,,,,,,-,G,A,41245466,41245466,3364E3D252EFEDF917C74D44FBC6A381,,,,,,,-1,BRCA1- 458754534,1412,125536,11,,,,EMPTY,,D,,0,11,40,269442,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.47826087,0.4878049,0.54691046,GRCh38/hg38,17,43093449,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,78
20,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41223094,365,44.93,15,c.4837A>G,p.(Ser1613Gly),T,C,201,164,AGT,GGT,S,G,NM_007294.3,NM_007294,41223094,within,.,,rs1799966,0.3558,0.2982,,-0.194,0.968,0.038,0.814,0.0,1.5,,,,,-,T,C,41223094,41223094,E3C52286D31F229973DB3595B052645F,,,,,,,-1,BRCA1- 458776906,-150,41827,16,,,,EMPTY,,D,,0,11,40,273625,492662,126000,,,0,0,,1:1,,0.349,0,,,,,,,,,,,,,,Benign,Benign,0.255,113705,-1,,,,,,,,,,,3,0.35,14,1,0.47826087,0.4878049,0.5554011,GRCh38/hg38,17,43071077,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,78
3,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41234470,150,58.0,12,c.4308T>C,p.(Ser1436=),A,G,63,87,TCT,TCC,S,S,NM_007294.3,NM_007294,41234470,within,.,,rs1060915,0.3363,0.2796,,,,,,,,,,,,-,A,G,41234470,41234470,B7237055CF1D42F022A050C072B7583B,,,,,,,-1,BRCA1- 458765530,-50,125703,13,,,,EMPTY,,D,,0,11,40,270833,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3433,11,1,0.47826087,0.4878049,0.5497339,GRCh38/hg38,17,43082453,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,78
8,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245237,201,45.27,10,c.2311T>C,p.(Leu771=),A,G,110,91,TTG,CTG,L,L,NM_007294.3,NM_007294,41245237,within,.,,rs16940,0.3353,0.2776,,,,,,,,,,,,-,A,G,41245237,41245237,711AF22D84A49E875C2B2A9597A95EE6,,,,,,,-1,BRCA1- 458754763,1641,125554,11,,,,EMPTY,,D,,0,11,39,269517,492662,126000,,,0,0,,1:1,,0.342,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3422,9,1,0.47826087,0.47560975,0.5470627,GRCh38/hg38,17,43093220,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,78
5,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244000,435,53.79,10,c.3548A>G,p.(Lys1183Arg),T,C,201,234,AAA,AGA,K,R,NM_007294.3,NM_007294,41244000,within,.,,rs16942,0.3526,0.2952,,-0.319,0.0,0.001,0.924,0.0,-2.35,,,,,-,T,C,41244000,41244000,37A54117EA353BDA677332A1F61FA173,,,,,,,-1,BRCA1- 458756000,-549,41818,11,,,,EMPTY,,D,,0,11,40,272437,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.47826087,0.4878049,0.55298966,GRCh38/hg38,17,43091983,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,78
12,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,205,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,205,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,23,63,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,0.76829267,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,78
16,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,141,100.0,14,c.7397T>C,p.(Val2466Ala),T,C,0,141,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,23,62,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.75609756,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,78
17,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32930598,155,40.65,15,c.7469T>C,p.(Ile2490Thr),T,C,92,63,ATA,ACA,I,T,NM_000059.3,NM_000059,32930598,within,.,,rs11571707,0.016,0.0016,,0.406,0.895,,0.837,0.0,-5.83,,,,,+,T,C,32930598,32930598,D7CAF30A58440FCA5E8E7BACD8E1EDE4,,,,,,,-1,BRCA2-  32930598,34,96852,15,,,,EMPTY,,D,,0,6,17,6837,493217,126000,,,0,0,,"1:5,2:2",,0.014,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0176,14,2,0.26086956,0.20731707,0.013862053,GRCh38/hg38,13,32356461,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,78
1,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906729,186,100.0,10,c.1114A>C,p.(Asn372His),A,C,0,186,AAT,CAT,N,H,NM_000059.3,NM_000059,32906729,within,.,,rs144848,0.2494,0.2332,,0.32,0.861,,0.269,0.0,0.396,,,,,+,A,C,32906729,32906729,D514F785F1344AF9F6975E589D47BDF6,,,,,,,-1,BRCA2-  32906729,321,9329,10,,,,EMPTY,,D,,0,14,39,233635,493217,126000,,,0,0,,"1:1,2:1",,0.277,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2733,9,1,0.6086956,0.47560975,0.47369617,GRCh38/hg38,13,32332592,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,78
15,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,372,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,372,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,23,63,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,0.76829267,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,78
18,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244936,265,100.0,10,c.2612C>T,p.(Pro871Leu),G,A,0,265,CCG,CTG,P,L,NM_007294.3,NM_007294,41244936,within,.,,rs799917,0.5439,0.4932,,4.247,0.0,0.0,0.999,1.0,5.04,,,,,-,G,A,41244936,41244936,A19EA255CA888CE1FE48D08CAD633F1F,,,,,,,1,BRCA1- 458755064,-1485,41812,11,,,,EMPTY,,D,,1,11,40,290862,492662,126000,(eval),,0,0,,"1:4,2:1",,0.41,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.4127,9,3,0.47826087,0.4878049,0.59038854,GRCh38/hg38,17,43092919,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,79
11,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41223094,272,100.0,15,c.4837A>G,p.(Ser1613Gly),T,C,0,272,AGT,GGT,S,G,NM_007294.3,NM_007294,41223094,within,.,,rs1799966,0.3558,0.2982,,-0.194,0.968,0.038,0.814,0.0,1.5,,,,,-,T,C,41223094,41223094,E3C52286D31F229973DB3595B052645F,,,,,,,-1,BRCA1- 458776906,-150,41827,16,,,,EMPTY,,D,,0,11,40,273625,492662,126000,,,0,0,,1:1,,0.349,0,,,,,,,,,,,,,,Benign,Benign,0.255,113705,-1,,,,,,,,,,,3,0.35,14,1,0.47826087,0.4878049,0.5554011,GRCh38/hg38,17,43071077,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,79
16,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244000,324,100.0,10,c.3548A>G,p.(Lys1183Arg),T,C,0,324,AAA,AGA,K,R,NM_007294.3,NM_007294,41244000,within,.,,rs16942,0.3526,0.2952,,-0.319,0.0,0.001,0.924,0.0,-2.35,,,,,-,T,C,41244000,41244000,37A54117EA353BDA677332A1F61FA173,,,,,,,-1,BRCA1- 458756000,-549,41818,11,,,,EMPTY,,D,,0,11,40,272437,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.47826087,0.4878049,0.55298966,GRCh38/hg38,17,43091983,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,79
13,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41231516,126,100.0,13,c.4358-2885G>A,p.(=),C,T,0,126,,,,,NM_007294.3,NM_007294,41231516,within,.,,rs8176193,0.3534,,,,,,,,,,,,,-,C,T,41231516,41231516,7F4F80D2D005D34CEA47E4A2C561B172,,,,,,,-1,BRCA1- 458768484,0,209399,14,,,,EMPTY,,D,,0,11,40,190200,492662,126000,,,0,0,,,,,2885,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.317,12,1,0.47826087,0.4878049,0.3860659,GRCh38/hg38,17,43079499,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,79
20,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245466,391,99.49,10,c.2082C>T,p.(Ser694=),G,A,1,389,AGC,AGT,S,S,NM_007294.3,NM_007294,41245466,within,.,,rs1799949,0.3365,0.2957,,,,,,,,,,,,-,G,A,41245466,41245466,3364E3D252EFEDF917C74D44FBC6A381,,,,,,,-1,BRCA1- 458754534,1412,125536,11,,,,EMPTY,,D,,0,11,40,269442,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.47826087,0.4878049,0.54691046,GRCh38/hg38,17,43093449,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,79
19,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245237,157,99.36,10,c.2311T>C,p.(Leu771=),A,G,0,156,TTG,CTG,L,L,NM_007294.3,NM_007294,41245237,within,.,,rs16940,0.3353,0.2776,,,,,,,,,,,,-,A,G,41245237,41245237,711AF22D84A49E875C2B2A9597A95EE6,,,,,,,-1,BRCA1- 458754763,1641,125554,11,,,,EMPTY,,D,,0,11,39,269517,492662,126000,,,0,0,,1:1,,0.342,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3422,9,1,0.47826087,0.47560975,0.5470627,GRCh38/hg38,17,43093220,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,79
8,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41215825,52,100.0,17,c.5152+66G>A,p.(=),C,T,0,52,,,,,NM_007294.3,NM_007294,41215825,within,.,,rs3092994,0.3425,,,,,,,,,,,,,-,C,T,41215825,41215825,5BCA8D2E1E3875817F84A3EB582CDFAB,,,,,,,-1,BRCA1- 458784175,0,55428,18,,,,EMPTY,,D,,0,8,32,241843,492662,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3139,16,1,0.3478261,0.3902439,0.4908903,GRCh38/hg38,17,43063808,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,79
10,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219804,146,100.0,16,c.4987-92A>G,p.(=),T,C,0,146,,,,,NM_007294.3,NM_007294,41219804,within,.,,rs8176233,0.3546,,,,,,,,,,,,,-,T,C,41219804,41219804,7341B20C52FFD4B9355840FB9CB56CDA,,,,,,,-1,BRCA1- 458780196,0,125749,17,,,,EMPTY,,D,,0,11,40,225491,492662,126000,,,0,0,,,,,92,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3128,15,1,0.47826087,0.4878049,0.45769918,GRCh38/hg38,17,43067787,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,79
14,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41234470,146,100.0,12,c.4308T>C,p.(Ser1436=),A,G,0,146,TCT,TCC,S,S,NM_007294.3,NM_007294,41234470,within,.,,rs1060915,0.3363,0.2796,,,,,,,,,,,,-,A,G,41234470,41234470,B7237055CF1D42F022A050C072B7583B,,,,,,,-1,BRCA1- 458765530,-50,125703,13,,,,EMPTY,,D,,0,11,40,270833,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3433,11,1,0.47826087,0.4878049,0.5497339,GRCh38/hg38,17,43082453,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,79
21,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41245471,392,49.49,10,c.2077G>A,p.(Asp693Asn),C,T,197,194,GAC,AAC,D,N,NM_007294.3,NM_007294,41245471,within,.,,rs4986850,0.0335,0.0543,,0.205,0.989,0.01,0.597,0.0,1.23,,,,,-,C,T,41245471,41245471,1EA9438AD2460C6CC594B844CD8DC7F6,,,,,,,-1,BRCA1- 458754529,1407,41808,11,,,,EMPTY,,D,,0,1,5,63951,492662,126000,,,0,0,,1:2,,0.057,0,,,,,,,,,,,,,,Benign,Benign,0.001,113705,-1,,,,,,,,,,,3,0.058,9,1,0.04347826,0.06097561,0.12980705,GRCh38/hg38,17,43093454,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,79
9,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219780,146,100.0,16,c.4987-68A>G,p.(=),T,C,0,146,,,,,NM_007294.3,NM_007294,41219780,within,.,,rs8176234,0.3546,,,,,,,,,,,,,-,T,C,41219780,41219780,5995ECC305C33150BF3BB2B0C22FCC2A,,,,,,,-1,BRCA1- 458780220,0,125746,17,,,,EMPTY,,D,,0,11,40,234031,492662,126000,,,0,0,,,,,68,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3148,15,1,0.47826087,0.4878049,0.47503358,GRCh38/hg38,17,43067763,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,79
17,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244435,319,100.0,10,c.3113A>G,p.(Glu1038Gly),T,C,0,319,GAA,GGA,E,G,NM_007294.3,NM_007294,41244435,within,.,,rs16941,0.3357,0.279,,-0.149,0.972,0.606,0.922,0.0,-0.974,,,,,-,T,C,41244435,41244435,5D0FF1321BAC3C76DD352C33CC33B93E,,,,,,,-1,BRCA1- 458755565,-984,41815,11,,,,EMPTY,,D,,0,11,40,270861,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,0.936,113705,-1,,,,,,,,,,,3,0.343,9,1,0.47826087,0.4878049,0.54979074,GRCh38/hg38,17,43092418,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,79
12,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32899388,134,56.72,4,c.425+67A>C,p.(=),A,C,58,76,,,,,NM_000059.3,NM_000059,32899388,within,.,,rs11571610,0.0743,,,,,,,,,,,,,+,A,C,32899388,32899388,1AF346DE380A738371905EBFBCED20E1,,,,,,,-1,BRCA2-  32899388,0,126095,4,,,,EMPTY,,D,,0,5,13,39349,493217,126000,,,0,0,,2:1,,,67,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0306,3,3,0.2173913,0.15853658,0.0797803,GRCh38/hg38,13,32325251,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,79
1,D,BRCA2,,SNP,5'UTR,GRCh37/hg19,13,32890572,390,46.41,2,c.-26G>A,p.(=),G,A,209,181,,,,,NM_000059.3,NM_000059,32890572,within,.,,rs1799943,0.2093,0.2088,,,,,,,,,,,,+,G,A,32890572,32890572,A9C2B39455EF056EDB097A5953EB72EE,,,,,,,-1,BRCA2-  32890572,14,125965,2,,,,EMPTY,,D,,0,10,26,205902,493217,126000,,,0,0,,,,0.243,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2427,1,1,0.4347826,0.31707317,0.41746736,GRCh38/hg38,13,32316435,G,A,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,79
2,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32929232,189,53.97,14,c.7242A>G,p.(Ser2414=),A,G,87,102,TCA,TCG,S,S,NM_000059.3,NM_000059,32929232,within,.,,rs1799955,0.2326,0.2114,,,,,,,,,,,,+,A,G,32929232,32929232,6F8D6FF8BC9027D6C0351ADCEF41FD20,,,,,,,-1,BRCA2-  32929232,-194,126133,14,,,,EMPTY,,D,,0,10,26,192923,493217,126000,,,0,0,,"1:3,2:1",,0.224,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2257,13,1,0.4347826,0.31707317,0.39115238,GRCh38/hg38,13,32355095,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,79
32,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,283,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,283,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,23,63,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,0.76829267,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,79
27,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32906980,347,46.69,10,c.1365A>G,p.(Ser455=),A,G,185,162,TCA,TCG,S,S,NM_000059.3,NM_000059,32906980,within,.,,rs1801439,0.0737,0.031,,,,,,,,,,,,+,A,G,32906980,32906980,C76C22E555E869928B452D866988AB4F,,,,,,,-1,BRCA2-  32906980,-545,125943,10,,,,EMPTY,,D,,0,5,13,41480,493217,126000,,,0,0,,"1:4,2:1",,0.051,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0499,9,2,0.2173913,0.15853658,0.08410091,GRCh38/hg38,13,32332843,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,79
29,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32911463,95,35.79,11,c.2971A>G,p.(Asn991Asp),A,G,61,34,AAC,GAC,N,D,NM_000059.3,NM_000059,32911463,within,.,,rs1799944,0.0801,0.0373,,-0.04,0.0,,0.959,0.0,3.08,,,,,+,A,G,32911463,32911463,36F4F7E6CD788E45B30EA486775D07D6,,,,,,,-1,BRCA2-  32911463,1062,41545,11,,,,EMPTY,,D,,0,5,13,42142,493217,126000,,,0,0,,1:2,,0.053,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0522,10,1,0.2173913,0.15853658,0.085443124,GRCh38/hg38,13,32337326,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,79
23,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906480,216,49.07,10,c.865A>C,p.(Asn289His),A,C,110,106,AAT,CAT,N,H,NM_000059.3,NM_000059,32906480,within,.,,rs766173,0.0737,0.0312,,0.498,0.998,,0.803,0.0,1.73,,,,,+,A,C,32906480,32906480,EE0CD2A1633CE9FEF0978528634002FE,,,,,,,-1,BRCA2-  32906480,72,41567,10,,,,EMPTY,,D,,0,5,13,41272,493217,126000,,,0,0,,"1:4,2:1",,0.051,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0496,9,2,0.2173913,0.15853658,0.08367919,GRCh38/hg38,13,32332343,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,79
6,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32953388,169,100.0,22,c.8755-66T>C,p.(=),T,C,0,169,,,,,NM_000059.3,NM_000059,32953388,within,.,,rs4942486,0.5116,,,,,,,,,,,,,+,T,C,32953388,32953388,97C65B85894EB489F1BFA65897685241,,,,,,,-1,BRCA2-  32953388,0,126190,22,,,,EMPTY,,D,,0,18,48,347826,493217,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5257,21,1,0.7826087,0.58536583,0.70521903,GRCh38/hg38,13,32379251,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,79
4,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32929478,82,37.8,14,c.7435+53C>T,p.(=),C,T,51,31,,,,,NM_000059.3,NM_000059,32929478,within,.,,rs11147489,0.0725,,,,,,,,,,,,,+,C,T,32929478,32929478,F692B4BE5DCD39FA887FE8D63D296720,,,,,,,-1,BRCA2-  32929478,0,126136,14,,,,EMPTY,,D,,0,5,13,36369,493217,126000,,,0,0,,,,,53,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0301,13,3,0.2173913,0.15853658,0.07373834,GRCh38/hg38,13,32355341,C,T,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,79
30,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32911888,268,55.6,11,c.3396A>G,p.(Lys1132=),A,G,119,149,AAA,AAG,K,K,NM_000059.3,NM_000059,32911888,within,.,,rs1801406,0.2668,0.2798,,,,,,,,,,,,+,A,G,32911888,32911888,94F2C0D328C28C466A38A430BBE75D52,,,,,,,-1,BRCA2-  32911888,1487,126010,11,,,,EMPTY,,D,,0,10,26,248687,493217,126000,,,0,0,,1:3,,0.293,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.295,10,1,0.4347826,0.31707317,0.50421417,GRCh38/hg38,13,32337751,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,79
28,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32910721,350,48.0,11,c.2229T>C,p.(His743=),T,C,182,168,CAT,CAC,H,H,NM_000059.3,NM_000059,32910721,within,.,,rs1801499,0.0735,0.0313,,,,,,,,,,,,+,T,C,32910721,32910721,D39471F16FE6D1F6752C2D4D179996AF,,,,,,,-1,BRCA2-  32910721,320,125979,11,,,,EMPTY,,D,,0,5,13,41536,493217,126000,,,0,0,,1:1,,0.052,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0503,10,1,0.2173913,0.15853658,0.08421446,GRCh38/hg38,13,32336584,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,79
3,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,135,100.0,14,c.7397T>C,p.(Val2466Ala),T,C,0,135,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,23,62,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.75609756,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,79
5,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32936646,129,100.0,17,c.7806-14T>C,p.(=),T,C,0,129,,,,,NM_000059.3,NM_000059,32936646,within,.,,rs9534262,0.5316,0.5202,,,,,,,,,,,,+,T,C,32936646,32936646,5803939D8FBB75B042260991F0A62436,,,,,,,-1,BRCA2-  32936646,0,126158,17,,,,EMPTY,,D,,0,19,48,361616,493217,126000,,,0,0,,1:3,,0.52,14,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5255,16,1,0.82608694,0.58536583,0.7331783,GRCh38/hg38,13,32362509,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,79
31,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,184,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,184,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,23,63,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,0.76829267,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,79
5,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32911888,273,56.78,11,c.3396A>G,p.(Lys1132=),A,G,118,155,AAA,AAG,K,K,NM_000059.3,NM_000059,32911888,within,.,,rs1801406,0.2668,0.2798,,,,,,,,,,,,+,A,G,32911888,32911888,94F2C0D328C28C466A38A430BBE75D52,,,,,,,-1,BRCA2-  32911888,1487,126010,11,,,,EMPTY,,D,,0,10,26,248687,493217,126000,,,0,0,,1:3,,0.293,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.295,10,1,0.4347826,0.31707317,0.50421417,GRCh38/hg38,13,32337751,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,80
6,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,200,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,200,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,23,63,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,0.76829267,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,80
9,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,115,100.0,14,c.7397T>C,p.(Val2466Ala),T,C,0,115,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,23,62,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.75609756,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,80
4,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906729,173,42.2,10,c.1114A>C,p.(Asn372His),A,C,100,73,AAT,CAT,N,H,NM_000059.3,NM_000059,32906729,within,.,,rs144848,0.2494,0.2332,,0.32,0.861,,0.269,0.0,0.396,,,,,+,A,C,32906729,32906729,D514F785F1344AF9F6975E589D47BDF6,,,,,,,-1,BRCA2-  32906729,321,9329,10,,,,EMPTY,,D,,0,14,39,233635,493217,126000,,,0,0,,"1:1,2:1",,0.277,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2733,9,1,0.6086956,0.47560975,0.47369617,GRCh38/hg38,13,32332592,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,80
11,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32953388,177,100.0,22,c.8755-66T>C,p.(=),T,C,0,177,,,,,NM_000059.3,NM_000059,32953388,within,.,,rs4942486,0.5116,,,,,,,,,,,,,+,T,C,32953388,32953388,97C65B85894EB489F1BFA65897685241,,,,,,,-1,BRCA2-  32953388,0,126190,22,,,,EMPTY,,D,,0,18,48,347826,493217,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5257,21,1,0.7826087,0.58536583,0.70521903,GRCh38/hg38,13,32379251,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,80
1,D,BRCA2,,SNP,5'UTR,GRCh37/hg19,13,32890572,384,48.44,2,c.-26G>A,p.(=),G,A,198,186,,,,,NM_000059.3,NM_000059,32890572,within,.,,rs1799943,0.2093,0.2088,,,,,,,,,,,,+,G,A,32890572,32890572,A9C2B39455EF056EDB097A5953EB72EE,,,,,,,-1,BRCA2-  32890572,14,125965,2,,,,EMPTY,,D,,0,10,26,205902,493217,126000,,,0,0,,,,0.243,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2427,1,1,0.4347826,0.31707317,0.41746736,GRCh38/hg38,13,32316435,G,A,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,80
7,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,315,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,315,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,23,63,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,0.76829267,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,80
8,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32929232,151,53.64,14,c.7242A>G,p.(Ser2414=),A,G,70,81,TCA,TCG,S,S,NM_000059.3,NM_000059,32929232,within,.,,rs1799955,0.2326,0.2114,,,,,,,,,,,,+,A,G,32929232,32929232,6F8D6FF8BC9027D6C0351ADCEF41FD20,,,,,,,-1,BRCA2-  32929232,-194,126133,14,,,,EMPTY,,D,,0,10,26,192923,493217,126000,,,0,0,,"1:3,2:1",,0.224,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2257,13,1,0.4347826,0.31707317,0.39115238,GRCh38/hg38,13,32355095,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,80
10,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32936646,114,100.0,17,c.7806-14T>C,p.(=),T,C,0,114,,,,,NM_000059.3,NM_000059,32936646,within,.,,rs9534262,0.5316,0.5202,,,,,,,,,,,,+,T,C,32936646,32936646,5803939D8FBB75B042260991F0A62436,,,,,,,-1,BRCA2-  32936646,0,126158,17,,,,EMPTY,,D,,0,19,48,361616,493217,126000,,,0,0,,1:3,,0.52,14,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5255,16,1,0.82608694,0.58536583,0.7331783,GRCh38/hg38,13,32362509,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,80
15,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32911888,385,52.99,11,c.3396A>G,p.(Lys1132=),A,G,181,204,AAA,AAG,K,K,NM_000059.3,NM_000059,32911888,within,.,,rs1801406,0.2668,0.2798,,,,,,,,,,,,+,A,G,32911888,32911888,94F2C0D328C28C466A38A430BBE75D52,,,,,,,-1,BRCA2-  32911888,1487,126010,11,,,,EMPTY,,D,,0,10,26,248687,493217,126000,,,0,0,,1:3,,0.293,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.295,10,1,0.4347826,0.31707317,0.50421417,GRCh38/hg38,13,32337751,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,81
6,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32936646,193,100.0,17,c.7806-14T>C,p.(=),T,C,0,193,,,,,NM_000059.3,NM_000059,32936646,within,.,,rs9534262,0.5316,0.5202,,,,,,,,,,,,+,T,C,32936646,32936646,5803939D8FBB75B042260991F0A62436,,,,,,,-1,BRCA2-  32936646,0,126158,17,,,,EMPTY,,D,,0,19,48,361616,493217,126000,,,0,0,,1:3,,0.52,14,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5255,16,1,0.82608694,0.58536583,0.7331783,GRCh38/hg38,13,32362509,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,81
14,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32911463,141,58.16,11,c.2971A>G,p.(Asn991Asp),A,G,59,82,AAC,GAC,N,D,NM_000059.3,NM_000059,32911463,within,.,,rs1799944,0.0801,0.0373,,-0.04,0.0,,0.959,0.0,3.08,,,,,+,A,G,32911463,32911463,36F4F7E6CD788E45B30EA486775D07D6,,,,,,,-1,BRCA2-  32911463,1062,41545,11,,,,EMPTY,,D,,0,5,13,42142,493217,126000,,,0,0,,1:2,,0.053,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0522,10,1,0.2173913,0.15853658,0.085443124,GRCh38/hg38,13,32337326,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,81
16,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,243,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,243,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,23,63,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,0.76829267,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,81
11,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906480,277,48.74,10,c.865A>C,p.(Asn289His),A,C,142,135,AAT,CAT,N,H,NM_000059.3,NM_000059,32906480,within,.,,rs766173,0.0737,0.0312,,0.498,0.998,,0.803,0.0,1.73,,,,,+,A,C,32906480,32906480,EE0CD2A1633CE9FEF0978528634002FE,,,,,,,-1,BRCA2-  32906480,72,41567,10,,,,EMPTY,,D,,0,5,13,41272,493217,126000,,,0,0,,"1:4,2:1",,0.051,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0496,9,2,0.2173913,0.15853658,0.08367919,GRCh38/hg38,13,32332343,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,81
1,D,BRCA2,,SNP,5'UTR,GRCh37/hg19,13,32890572,498,55.02,2,c.-26G>A,p.(=),G,A,224,274,,,,,NM_000059.3,NM_000059,32890572,within,.,,rs1799943,0.2093,0.2088,,,,,,,,,,,,+,G,A,32890572,32890572,A9C2B39455EF056EDB097A5953EB72EE,,,,,,,-1,BRCA2-  32890572,14,125965,2,,,,EMPTY,,D,,0,10,26,205902,493217,126000,,,0,0,,,,0.243,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2427,1,1,0.4347826,0.31707317,0.41746736,GRCh38/hg38,13,32316435,G,A,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,81
10,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32899388,243,53.91,4,c.425+67A>C,p.(=),A,C,112,131,,,,,NM_000059.3,NM_000059,32899388,within,.,,rs11571610,0.0743,,,,,,,,,,,,,+,A,C,32899388,32899388,1AF346DE380A738371905EBFBCED20E1,,,,,,,-1,BRCA2-  32899388,0,126095,4,,,,EMPTY,,D,,0,5,13,39349,493217,126000,,,0,0,,2:1,,,67,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0306,3,3,0.2173913,0.15853658,0.0797803,GRCh38/hg38,13,32325251,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,81
3,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32929232,264,48.48,14,c.7242A>G,p.(Ser2414=),A,G,136,128,TCA,TCG,S,S,NM_000059.3,NM_000059,32929232,within,.,,rs1799955,0.2326,0.2114,,,,,,,,,,,,+,A,G,32929232,32929232,6F8D6FF8BC9027D6C0351ADCEF41FD20,,,,,,,-1,BRCA2-  32929232,-194,126133,14,,,,EMPTY,,D,,0,10,26,192923,493217,126000,,,0,0,,"1:3,2:1",,0.224,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2257,13,1,0.4347826,0.31707317,0.39115238,GRCh38/hg38,13,32355095,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,81
7,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32953388,269,100.0,22,c.8755-66T>C,p.(=),T,C,0,269,,,,,NM_000059.3,NM_000059,32953388,within,.,,rs4942486,0.5116,,,,,,,,,,,,,+,T,C,32953388,32953388,97C65B85894EB489F1BFA65897685241,,,,,,,-1,BRCA2-  32953388,0,126190,22,,,,EMPTY,,D,,0,18,48,347826,493217,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5257,21,1,0.7826087,0.58536583,0.70521903,GRCh38/hg38,13,32379251,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,81
12,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32906980,526,50.57,10,c.1365A>G,p.(Ser455=),A,G,260,266,TCA,TCG,S,S,NM_000059.3,NM_000059,32906980,within,.,,rs1801439,0.0737,0.031,,,,,,,,,,,,+,A,G,32906980,32906980,C76C22E555E869928B452D866988AB4F,,,,,,,-1,BRCA2-  32906980,-545,125943,10,,,,EMPTY,,D,,0,5,13,41480,493217,126000,,,0,0,,"1:4,2:1",,0.051,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0499,9,2,0.2173913,0.15853658,0.08410091,GRCh38/hg38,13,32332843,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,81
13,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32910721,534,50.0,11,c.2229T>C,p.(His743=),T,C,267,267,CAT,CAC,H,H,NM_000059.3,NM_000059,32910721,within,.,,rs1801499,0.0735,0.0313,,,,,,,,,,,,+,T,C,32910721,32910721,D39471F16FE6D1F6752C2D4D179996AF,,,,,,,-1,BRCA2-  32910721,320,125979,11,,,,EMPTY,,D,,0,5,13,41536,493217,126000,,,0,0,,1:1,,0.052,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0503,10,1,0.2173913,0.15853658,0.08421446,GRCh38/hg38,13,32336584,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,81
5,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32929478,116,57.76,14,c.7435+53C>T,p.(=),C,T,49,67,,,,,NM_000059.3,NM_000059,32929478,within,.,,rs11147489,0.0725,,,,,,,,,,,,,+,C,T,32929478,32929478,F692B4BE5DCD39FA887FE8D63D296720,,,,,,,-1,BRCA2-  32929478,0,126136,14,,,,EMPTY,,D,,0,5,13,36369,493217,126000,,,0,0,,,,,53,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0301,13,3,0.2173913,0.15853658,0.07373834,GRCh38/hg38,13,32355341,C,T,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,81
4,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,218,100.0,14,c.7397T>C,p.(Val2466Ala),T,C,0,218,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,23,62,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.75609756,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,81
17,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32914236,324,51.85,11,c.5744C>T,p.(Thr1915Met),C,T,156,168,ACG,ATG,T,M,NM_000059.3,NM_000059,32914236,within,.,,rs4987117,0.0086,0.0211,,-1.105,0.674,,0.286,0.0,0.623,,,,,+,C,T,32914236,32914236,9B18380606AE96F8022F8AB5893BFD77,,,,,,,-1,BRCA2-  32914236,-1098,41556,11,,,,EMPTY,,D,,0,2,6,22222,493217,126000,,,0,0,,"1:4,2:1",,0.018,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0179,10,2,0.08695652,0.07317073,0.045055218,GRCh38/hg38,13,32340099,C,T,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,81
2,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,472,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,472,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,23,63,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,0.76829267,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,81
13,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244936,339,99.71,10,c.2612C>T,p.(Pro871Leu),G,A,1,338,CCG,CTG,P,L,NM_007294.3,NM_007294,41244936,within,.,,rs799917,0.5439,0.4932,,4.247,0.0,0.0,0.999,1.0,5.04,,,,,-,G,A,41244936,41244936,A19EA255CA888CE1FE48D08CAD633F1F,,,,,,,1,BRCA1- 458755064,-1485,41812,11,,,,EMPTY,,D,,1,11,40,290862,492662,126000,(eval),,0,0,,"1:4,2:1",,0.41,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.4127,9,3,0.47826087,0.4878049,0.59038854,GRCh38/hg38,17,43092919,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,82
10,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244000,467,99.57,10,c.3548A>G,p.(Lys1183Arg),T,C,1,465,AAA,AGA,K,R,NM_007294.3,NM_007294,41244000,within,.,,rs16942,0.3526,0.2952,,-0.319,0.0,0.001,0.924,0.0,-2.35,,,,,-,T,C,41244000,41244000,37A54117EA353BDA677332A1F61FA173,,,,,,,-1,BRCA1- 458756000,-549,41818,11,,,,EMPTY,,D,,0,11,40,272437,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.47826087,0.4878049,0.55298966,GRCh38/hg38,17,43091983,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,82
8,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41231516,136,100.0,13,c.4358-2885G>A,p.(=),C,T,0,136,,,,,NM_007294.3,NM_007294,41231516,within,.,,rs8176193,0.3534,,,,,,,,,,,,,-,C,T,41231516,41231516,7F4F80D2D005D34CEA47E4A2C561B172,,,,,,,-1,BRCA1- 458768484,0,209399,14,,,,EMPTY,,D,,0,11,40,190200,492662,126000,,,0,0,,,,,2885,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.317,12,1,0.47826087,0.4878049,0.3860659,GRCh38/hg38,17,43079499,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,82
7,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41223094,304,100.0,15,c.4837A>G,p.(Ser1613Gly),T,C,0,304,AGT,GGT,S,G,NM_007294.3,NM_007294,41223094,within,.,,rs1799966,0.3558,0.2982,,-0.194,0.968,0.038,0.814,0.0,1.5,,,,,-,T,C,41223094,41223094,E3C52286D31F229973DB3595B052645F,,,,,,,-1,BRCA1- 458776906,-150,41827,16,,,,EMPTY,,D,,0,11,40,273625,492662,126000,,,0,0,,1:1,,0.349,0,,,,,,,,,,,,,,Benign,Benign,0.255,113705,-1,,,,,,,,,,,3,0.35,14,1,0.47826087,0.4878049,0.5554011,GRCh38/hg38,17,43071077,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,82
11,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244435,325,100.0,10,c.3113A>G,p.(Glu1038Gly),T,C,0,325,GAA,GGA,E,G,NM_007294.3,NM_007294,41244435,within,.,,rs16941,0.3357,0.279,,-0.149,0.972,0.606,0.922,0.0,-0.974,,,,,-,T,C,41244435,41244435,5D0FF1321BAC3C76DD352C33CC33B93E,,,,,,,-1,BRCA1- 458755565,-984,41815,11,,,,EMPTY,,D,,0,11,40,270861,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,0.936,113705,-1,,,,,,,,,,,3,0.343,9,1,0.47826087,0.4878049,0.54979074,GRCh38/hg38,17,43092418,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,82
14,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245237,163,100.0,10,c.2311T>C,p.(Leu771=),A,G,0,163,TTG,CTG,L,L,NM_007294.3,NM_007294,41245237,within,.,,rs16940,0.3353,0.2776,,,,,,,,,,,,-,A,G,41245237,41245237,711AF22D84A49E875C2B2A9597A95EE6,,,,,,,-1,BRCA1- 458754763,1641,125554,11,,,,EMPTY,,D,,0,11,39,269517,492662,126000,,,0,0,,1:1,,0.342,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3422,9,1,0.47826087,0.47560975,0.5470627,GRCh38/hg38,17,43093220,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,82
5,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219780,173,100.0,16,c.4987-68A>G,p.(=),T,C,0,173,,,,,NM_007294.3,NM_007294,41219780,within,.,,rs8176234,0.3546,,,,,,,,,,,,,-,T,C,41219780,41219780,5995ECC305C33150BF3BB2B0C22FCC2A,,,,,,,-1,BRCA1- 458780220,0,125746,17,,,,EMPTY,,D,,0,11,40,234031,492662,126000,,,0,0,,,,,68,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3148,15,1,0.47826087,0.4878049,0.47503358,GRCh38/hg38,17,43067763,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,82
6,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219804,173,100.0,16,c.4987-92A>G,p.(=),T,C,0,173,,,,,NM_007294.3,NM_007294,41219804,within,.,,rs8176233,0.3546,,,,,,,,,,,,,-,T,C,41219804,41219804,7341B20C52FFD4B9355840FB9CB56CDA,,,,,,,-1,BRCA1- 458780196,0,125749,17,,,,EMPTY,,D,,0,11,40,225491,492662,126000,,,0,0,,,,,92,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3128,15,1,0.47826087,0.4878049,0.45769918,GRCh38/hg38,17,43067787,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,82
9,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41234470,145,100.0,12,c.4308T>C,p.(Ser1436=),A,G,0,145,TCT,TCC,S,S,NM_007294.3,NM_007294,41234470,within,.,,rs1060915,0.3363,0.2796,,,,,,,,,,,,-,A,G,41234470,41234470,B7237055CF1D42F022A050C072B7583B,,,,,,,-1,BRCA1- 458765530,-50,125703,13,,,,EMPTY,,D,,0,11,40,270833,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3433,11,1,0.47826087,0.4878049,0.5497339,GRCh38/hg38,17,43082453,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,82
15,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245466,439,99.77,10,c.2082C>T,p.(Ser694=),G,A,1,438,AGC,AGT,S,S,NM_007294.3,NM_007294,41245466,within,.,,rs1799949,0.3365,0.2957,,,,,,,,,,,,-,G,A,41245466,41245466,3364E3D252EFEDF917C74D44FBC6A381,,,,,,,-1,BRCA1- 458754534,1412,125536,11,,,,EMPTY,,D,,0,11,40,269442,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.47826087,0.4878049,0.54691046,GRCh38/hg38,17,43093449,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,82
3,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32936646,138,47.1,17,c.7806-14T>C,p.(=),T,C,73,65,,,,,NM_000059.3,NM_000059,32936646,within,.,,rs9534262,0.5316,0.5202,,,,,,,,,,,,+,T,C,32936646,32936646,5803939D8FBB75B042260991F0A62436,,,,,,,-1,BRCA2-  32936646,0,126158,17,,,,EMPTY,,D,,0,19,48,361616,493217,126000,,,0,0,,1:3,,0.52,14,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5255,16,1,0.82608694,0.58536583,0.7331783,GRCh38/hg38,13,32362509,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,82
21,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32906980,387,52.45,10,c.1365A>G,p.(Ser455=),A,G,184,203,TCA,TCG,S,S,NM_000059.3,NM_000059,32906980,within,.,,rs1801439,0.0737,0.031,,,,,,,,,,,,+,A,G,32906980,32906980,C76C22E555E869928B452D866988AB4F,,,,,,,-1,BRCA2-  32906980,-545,125943,10,,,,EMPTY,,D,,0,5,13,41480,493217,126000,,,0,0,,"1:4,2:1",,0.051,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0499,9,2,0.2173913,0.15853658,0.08410091,GRCh38/hg38,13,32332843,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,82
26,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,134,100.0,14,c.7397T>C,p.(Val2466Ala),T,C,0,134,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,23,62,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.75609756,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,82
20,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906729,196,53.06,10,c.1114A>C,p.(Asn372His),A,C,92,104,AAT,CAT,N,H,NM_000059.3,NM_000059,32906729,within,.,,rs144848,0.2494,0.2332,,0.32,0.861,,0.269,0.0,0.396,,,,,+,A,C,32906729,32906729,D514F785F1344AF9F6975E589D47BDF6,,,,,,,-1,BRCA2-  32906729,321,9329,10,,,,EMPTY,,D,,0,14,39,233635,493217,126000,,,0,0,,"1:1,2:1",,0.277,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2733,9,1,0.6086956,0.47560975,0.47369617,GRCh38/hg38,13,32332592,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,82
25,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,326,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,326,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,23,63,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,0.76829267,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,82
23,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32911463,126,54.76,11,c.2971A>G,p.(Asn991Asp),A,G,57,69,AAC,GAC,N,D,NM_000059.3,NM_000059,32911463,within,.,,rs1799944,0.0801,0.0373,,-0.04,0.0,,0.959,0.0,3.08,,,,,+,A,G,32911463,32911463,36F4F7E6CD788E45B30EA486775D07D6,,,,,,,-1,BRCA2-  32911463,1062,41545,11,,,,EMPTY,,D,,0,5,13,42142,493217,126000,,,0,0,,1:2,,0.053,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0522,10,1,0.2173913,0.15853658,0.085443124,GRCh38/hg38,13,32337326,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,82
2,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32929478,80,45.0,14,c.7435+53C>T,p.(=),C,T,44,36,,,,,NM_000059.3,NM_000059,32929478,within,.,,rs11147489,0.0725,,,,,,,,,,,,,+,C,T,32929478,32929478,F692B4BE5DCD39FA887FE8D63D296720,,,,,,,-1,BRCA2-  32929478,0,126136,14,,,,EMPTY,,D,,0,5,13,36369,493217,126000,,,0,0,,,,,53,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0301,13,3,0.2173913,0.15853658,0.07373834,GRCh38/hg38,13,32355341,C,T,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,82
12,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906480,211,47.87,10,c.865A>C,p.(Asn289His),A,C,110,101,AAT,CAT,N,H,NM_000059.3,NM_000059,32906480,within,.,,rs766173,0.0737,0.0312,,0.498,0.998,,0.803,0.0,1.73,,,,,+,A,C,32906480,32906480,EE0CD2A1633CE9FEF0978528634002FE,,,,,,,-1,BRCA2-  32906480,72,41567,10,,,,EMPTY,,D,,0,5,13,41272,493217,126000,,,0,0,,"1:4,2:1",,0.051,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0496,9,2,0.2173913,0.15853658,0.08367919,GRCh38/hg38,13,32332343,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,82
24,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,188,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,188,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,23,63,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,0.76829267,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,82
1,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32899388,180,51.11,4,c.425+67A>C,p.(=),A,C,88,92,,,,,NM_000059.3,NM_000059,32899388,within,.,,rs11571610,0.0743,,,,,,,,,,,,,+,A,C,32899388,32899388,1AF346DE380A738371905EBFBCED20E1,,,,,,,-1,BRCA2-  32899388,0,126095,4,,,,EMPTY,,D,,0,5,13,39349,493217,126000,,,0,0,,2:1,,,67,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0306,3,3,0.2173913,0.15853658,0.0797803,GRCh38/hg38,13,32325251,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,82
22,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32910721,355,48.45,11,c.2229T>C,p.(His743=),T,C,183,172,CAT,CAC,H,H,NM_000059.3,NM_000059,32910721,within,.,,rs1801499,0.0735,0.0313,,,,,,,,,,,,+,T,C,32910721,32910721,D39471F16FE6D1F6752C2D4D179996AF,,,,,,,-1,BRCA2-  32910721,320,125979,11,,,,EMPTY,,D,,0,5,13,41536,493217,126000,,,0,0,,1:1,,0.052,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0503,10,1,0.2173913,0.15853658,0.08421446,GRCh38/hg38,13,32336584,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,82
4,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32953388,196,47.45,22,c.8755-66T>C,p.(=),T,C,103,93,,,,,NM_000059.3,NM_000059,32953388,within,.,,rs4942486,0.5116,,,,,,,,,,,,,+,T,C,32953388,32953388,97C65B85894EB489F1BFA65897685241,,,,,,,-1,BRCA2-  32953388,0,126190,22,,,,EMPTY,,D,,0,18,48,347826,493217,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5257,21,1,0.7826087,0.58536583,0.70521903,GRCh38/hg38,13,32379251,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,82
7,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244936,290,99.66,10,c.2612C>T,p.(Pro871Leu),G,A,0,289,CCG,CTG,P,L,NM_007294.3,NM_007294,41244936,within,.,,rs799917,0.5439,0.4932,,4.247,0.0,0.0,0.999,1.0,5.04,,,,,-,G,A,41244936,41244936,A19EA255CA888CE1FE48D08CAD633F1F,,,,,,,1,BRCA1- 458755064,-1485,41812,11,,,,EMPTY,,D,,1,11,40,290862,492662,126000,(eval),,0,0,,"1:4,2:1",,0.41,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.4127,9,3,0.47826087,0.4878049,0.59038854,GRCh38/hg38,17,43092919,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,83
4,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41234470,118,100.0,12,c.4308T>C,p.(Ser1436=),A,G,0,118,TCT,TCC,S,S,NM_007294.3,NM_007294,41234470,within,.,,rs1060915,0.3363,0.2796,,,,,,,,,,,,-,A,G,41234470,41234470,B7237055CF1D42F022A050C072B7583B,,,,,,,-1,BRCA1- 458765530,-50,125703,13,,,,EMPTY,,D,,0,11,40,270833,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3433,11,1,0.47826087,0.4878049,0.5497339,GRCh38/hg38,17,43082453,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,83
19,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41215825,63,100.0,17,c.5152+66G>A,p.(=),C,T,0,63,,,,,NM_007294.3,NM_007294,41215825,within,.,,rs3092994,0.3425,,,,,,,,,,,,,-,C,T,41215825,41215825,5BCA8D2E1E3875817F84A3EB582CDFAB,,,,,,,-1,BRCA1- 458784175,0,55428,18,,,,EMPTY,,D,,0,8,32,241843,492662,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3139,16,1,0.3478261,0.3902439,0.4908903,GRCh38/hg38,17,43063808,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,83
6,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244435,319,100.0,10,c.3113A>G,p.(Glu1038Gly),T,C,0,319,GAA,GGA,E,G,NM_007294.3,NM_007294,41244435,within,.,,rs16941,0.3357,0.279,,-0.149,0.972,0.606,0.922,0.0,-0.974,,,,,-,T,C,41244435,41244435,5D0FF1321BAC3C76DD352C33CC33B93E,,,,,,,-1,BRCA1- 458755565,-984,41815,11,,,,EMPTY,,D,,0,11,40,270861,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,0.936,113705,-1,,,,,,,,,,,3,0.343,9,1,0.47826087,0.4878049,0.54979074,GRCh38/hg38,17,43092418,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,83
20,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219780,138,100.0,16,c.4987-68A>G,p.(=),T,C,0,138,,,,,NM_007294.3,NM_007294,41219780,within,.,,rs8176234,0.3546,,,,,,,,,,,,,-,T,C,41219780,41219780,5995ECC305C33150BF3BB2B0C22FCC2A,,,,,,,-1,BRCA1- 458780220,0,125746,17,,,,EMPTY,,D,,0,11,40,234031,492662,126000,,,0,0,,,,,68,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3148,15,1,0.47826087,0.4878049,0.47503358,GRCh38/hg38,17,43067763,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,83
2,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41223094,254,99.21,15,c.4837A>G,p.(Ser1613Gly),T,C,1,252,AGT,GGT,S,G,NM_007294.3,NM_007294,41223094,within,.,,rs1799966,0.3558,0.2982,,-0.194,0.968,0.038,0.814,0.0,1.5,,,,,-,T,C,41223094,41223094,E3C52286D31F229973DB3595B052645F,,,,,,,-1,BRCA1- 458776906,-150,41827,16,,,,EMPTY,,D,,0,11,40,273625,492662,126000,,,0,0,,1:1,,0.349,0,,,,,,,,,,,,,,Benign,Benign,0.255,113705,-1,,,,,,,,,,,3,0.35,14,1,0.47826087,0.4878049,0.5554011,GRCh38/hg38,17,43071077,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,83
9,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245466,463,100.0,10,c.2082C>T,p.(Ser694=),G,A,0,463,AGC,AGT,S,S,NM_007294.3,NM_007294,41245466,within,.,,rs1799949,0.3365,0.2957,,,,,,,,,,,,-,G,A,41245466,41245466,3364E3D252EFEDF917C74D44FBC6A381,,,,,,,-1,BRCA1- 458754534,1412,125536,11,,,,EMPTY,,D,,0,11,40,269442,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.47826087,0.4878049,0.54691046,GRCh38/hg38,17,43093449,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,83
3,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41231516,120,100.0,13,c.4358-2885G>A,p.(=),C,T,0,120,,,,,NM_007294.3,NM_007294,41231516,within,.,,rs8176193,0.3534,,,,,,,,,,,,,-,C,T,41231516,41231516,7F4F80D2D005D34CEA47E4A2C561B172,,,,,,,-1,BRCA1- 458768484,0,209399,14,,,,EMPTY,,D,,0,11,40,190200,492662,126000,,,0,0,,,,,2885,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.317,12,1,0.47826087,0.4878049,0.3860659,GRCh38/hg38,17,43079499,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,83
21,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219804,139,100.0,16,c.4987-92A>G,p.(=),T,C,0,139,,,,,NM_007294.3,NM_007294,41219804,within,.,,rs8176233,0.3546,,,,,,,,,,,,,-,T,C,41219804,41219804,7341B20C52FFD4B9355840FB9CB56CDA,,,,,,,-1,BRCA1- 458780196,0,125749,17,,,,EMPTY,,D,,0,11,40,225491,492662,126000,,,0,0,,,,,92,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3128,15,1,0.47826087,0.4878049,0.45769918,GRCh38/hg38,17,43067787,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,83
8,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245237,146,100.0,10,c.2311T>C,p.(Leu771=),A,G,0,146,TTG,CTG,L,L,NM_007294.3,NM_007294,41245237,within,.,,rs16940,0.3353,0.2776,,,,,,,,,,,,-,A,G,41245237,41245237,711AF22D84A49E875C2B2A9597A95EE6,,,,,,,-1,BRCA1- 458754763,1641,125554,11,,,,EMPTY,,D,,0,11,39,269517,492662,126000,,,0,0,,1:1,,0.342,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3422,9,1,0.47826087,0.47560975,0.5470627,GRCh38/hg38,17,43093220,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,83
5,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244000,396,100.0,10,c.3548A>G,p.(Lys1183Arg),T,C,0,396,AAA,AGA,K,R,NM_007294.3,NM_007294,41244000,within,.,,rs16942,0.3526,0.2952,,-0.319,0.0,0.001,0.924,0.0,-2.35,,,,,-,T,C,41244000,41244000,37A54117EA353BDA677332A1F61FA173,,,,,,,-1,BRCA1- 458756000,-549,41818,11,,,,EMPTY,,D,,0,11,40,272437,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.47826087,0.4878049,0.55298966,GRCh38/hg38,17,43091983,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,83
18,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32972884,122,52.46,27,c.10234A>G,p.(Ile3412Val),A,G,58,64,ATT,GTT,I,V,NM_000059.3,NM_000059,32972884,within,.,,rs1801426,0.0449,0.0373,,0.556,0.077,,0.019,0.0,-0.286,,,,,+,A,G,32972884,32972884,FD2873D8FA6A6E3D4D35F2ACC4046DA1,,,,,,,-1,BRCA2-  32972884,586,41540,27,,,,EMPTY,,D,,0,2,2,10858,493217,126000,,,0,0,,"1:5,2:2",,0.022,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0248,26,2,0.08695652,0.024390243,0.022014651,GRCh38/hg38,13,32398747,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,83
16,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,306,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,306,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,23,63,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,0.76829267,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,83
12,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32912299,170,55.88,11,c.3807T>C,p.(Val1269=),T,C,75,95,GTT,GTC,V,V,NM_000059.3,NM_000059,32912299,within,.,,rs543304,0.1681,0.1911,,,,,,,,,,,,+,T,C,32912299,32912299,F2D3E8FFB3CEE8C1ACEA66738E41BC1E,,,,,,,-1,BRCA2-  32912299,1898,126022,11,,,,EMPTY,,D,,0,5,15,173719,493217,126000,,,0,0,,1:3,,0.176,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.1754,10,1,0.2173913,0.18292683,0.35221615,GRCh38/hg38,13,32338162,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,83
15,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,164,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,164,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,23,63,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,0.76829267,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,83
17,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,129,99.22,14,c.7397T>C,p.(Val2466Ala),T,C,1,128,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,23,62,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.75609756,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,83
1,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906729,179,48.04,10,c.1114A>C,p.(Asn372His),A,C,93,86,AAT,CAT,N,H,NM_000059.3,NM_000059,32906729,within,.,,rs144848,0.2494,0.2332,,0.32,0.861,,0.269,0.0,0.396,,,,,+,A,C,32906729,32906729,D514F785F1344AF9F6975E589D47BDF6,,,,,,,-1,BRCA2-  32906729,321,9329,10,,,,EMPTY,,D,,0,14,39,233635,493217,126000,,,0,0,,"1:1,2:1",,0.277,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2733,9,1,0.6086956,0.47560975,0.47369617,GRCh38/hg38,13,32332592,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,83
9,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244936,278,100.0,10,c.2612C>T,p.(Pro871Leu),G,A,0,278,CCG,CTG,P,L,NM_007294.3,NM_007294,41244936,within,.,,rs799917,0.5439,0.4932,,4.247,0.0,0.0,0.999,1.0,5.04,,,,,-,G,A,41244936,41244936,A19EA255CA888CE1FE48D08CAD633F1F,,,,,,,1,BRCA1- 458755064,-1485,41812,11,,,,EMPTY,,D,,1,11,40,290862,492662,126000,(eval),,0,0,,"1:4,2:1",,0.41,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.4127,9,3,0.47826087,0.4878049,0.59038854,GRCh38/hg38,17,43092919,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,84
4,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41223094,278,53.96,15,c.4837A>G,p.(Ser1613Gly),T,C,128,150,AGT,GGT,S,G,NM_007294.3,NM_007294,41223094,within,.,,rs1799966,0.3558,0.2982,,-0.194,0.968,0.038,0.814,0.0,1.5,,,,,-,T,C,41223094,41223094,E3C52286D31F229973DB3595B052645F,,,,,,,-1,BRCA1- 458776906,-150,41827,16,,,,EMPTY,,D,,0,11,40,273625,492662,126000,,,0,0,,1:1,,0.349,0,,,,,,,,,,,,,,Benign,Benign,0.255,113705,-1,,,,,,,,,,,3,0.35,14,1,0.47826087,0.4878049,0.5554011,GRCh38/hg38,17,43071077,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,84
11,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245466,452,48.45,10,c.2082C>T,p.(Ser694=),G,A,233,219,AGC,AGT,S,S,NM_007294.3,NM_007294,41245466,within,.,,rs1799949,0.3365,0.2957,,,,,,,,,,,,-,G,A,41245466,41245466,3364E3D252EFEDF917C74D44FBC6A381,,,,,,,-1,BRCA1- 458754534,1412,125536,11,,,,EMPTY,,D,,0,11,40,269442,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.47826087,0.4878049,0.54691046,GRCh38/hg38,17,43093449,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,84
8,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244435,288,48.96,10,c.3113A>G,p.(Glu1038Gly),T,C,147,141,GAA,GGA,E,G,NM_007294.3,NM_007294,41244435,within,.,,rs16941,0.3357,0.279,,-0.149,0.972,0.606,0.922,0.0,-0.974,,,,,-,T,C,41244435,41244435,5D0FF1321BAC3C76DD352C33CC33B93E,,,,,,,-1,BRCA1- 458755565,-984,41815,11,,,,EMPTY,,D,,0,11,40,270861,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,0.936,113705,-1,,,,,,,,,,,3,0.343,9,1,0.47826087,0.4878049,0.54979074,GRCh38/hg38,17,43092418,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,84
2,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219804,140,39.29,16,c.4987-92A>G,p.(=),T,C,85,55,,,,,NM_007294.3,NM_007294,41219804,within,.,,rs8176233,0.3546,,,,,,,,,,,,,-,T,C,41219804,41219804,7341B20C52FFD4B9355840FB9CB56CDA,,,,,,,-1,BRCA1- 458780196,0,125749,17,,,,EMPTY,,D,,0,11,40,225491,492662,126000,,,0,0,,,,,92,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3128,15,1,0.47826087,0.4878049,0.45769918,GRCh38/hg38,17,43067787,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,84
7,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244000,341,47.21,10,c.3548A>G,p.(Lys1183Arg),T,C,180,161,AAA,AGA,K,R,NM_007294.3,NM_007294,41244000,within,.,,rs16942,0.3526,0.2952,,-0.319,0.0,0.001,0.924,0.0,-2.35,,,,,-,T,C,41244000,41244000,37A54117EA353BDA677332A1F61FA173,,,,,,,-1,BRCA1- 458756000,-549,41818,11,,,,EMPTY,,D,,0,11,40,272437,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.47826087,0.4878049,0.55298966,GRCh38/hg38,17,43091983,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,84
10,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245237,154,43.51,10,c.2311T>C,p.(Leu771=),A,G,87,67,TTG,CTG,L,L,NM_007294.3,NM_007294,41245237,within,.,,rs16940,0.3353,0.2776,,,,,,,,,,,,-,A,G,41245237,41245237,711AF22D84A49E875C2B2A9597A95EE6,,,,,,,-1,BRCA1- 458754763,1641,125554,11,,,,EMPTY,,D,,0,11,39,269517,492662,126000,,,0,0,,1:1,,0.342,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3422,9,1,0.47826087,0.47560975,0.5470627,GRCh38/hg38,17,43093220,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,84
21,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41215825,57,52.63,17,c.5152+66G>A,p.(=),C,T,27,30,,,,,NM_007294.3,NM_007294,41215825,within,.,,rs3092994,0.3425,,,,,,,,,,,,,-,C,T,41215825,41215825,5BCA8D2E1E3875817F84A3EB582CDFAB,,,,,,,-1,BRCA1- 458784175,0,55428,18,,,,EMPTY,,D,,0,8,32,241843,492662,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3139,16,1,0.3478261,0.3902439,0.4908903,GRCh38/hg38,17,43063808,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,84
22,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219780,140,39.29,16,c.4987-68A>G,p.(=),T,C,85,55,,,,,NM_007294.3,NM_007294,41219780,within,.,,rs8176234,0.3546,,,,,,,,,,,,,-,T,C,41219780,41219780,5995ECC305C33150BF3BB2B0C22FCC2A,,,,,,,-1,BRCA1- 458780220,0,125746,17,,,,EMPTY,,D,,0,11,40,234031,492662,126000,,,0,0,,,,,68,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3148,15,1,0.47826087,0.4878049,0.47503358,GRCh38/hg38,17,43067763,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,84
6,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41234470,124,49.19,12,c.4308T>C,p.(Ser1436=),A,G,63,61,TCT,TCC,S,S,NM_007294.3,NM_007294,41234470,within,.,,rs1060915,0.3363,0.2796,,,,,,,,,,,,-,A,G,41234470,41234470,B7237055CF1D42F022A050C072B7583B,,,,,,,-1,BRCA1- 458765530,-50,125703,13,,,,EMPTY,,D,,0,11,40,270833,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3433,11,1,0.47826087,0.4878049,0.5497339,GRCh38/hg38,17,43082453,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,84
5,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41231516,111,57.66,13,c.4358-2885G>A,p.(=),C,T,47,64,,,,,NM_007294.3,NM_007294,41231516,within,.,,rs8176193,0.3534,,,,,,,,,,,,,-,C,T,41231516,41231516,7F4F80D2D005D34CEA47E4A2C561B172,,,,,,,-1,BRCA1- 458768484,0,209399,14,,,,EMPTY,,D,,0,11,40,190200,492662,126000,,,0,0,,,,,2885,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.317,12,1,0.47826087,0.4878049,0.3860659,GRCh38/hg38,17,43079499,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,84
16,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,191,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,191,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,23,63,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,0.76829267,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,84
20,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32953388,139,47.48,22,c.8755-66T>C,p.(=),T,C,73,66,,,,,NM_000059.3,NM_000059,32953388,within,.,,rs4942486,0.5116,,,,,,,,,,,,,+,T,C,32953388,32953388,97C65B85894EB489F1BFA65897685241,,,,,,,-1,BRCA2-  32953388,0,126190,22,,,,EMPTY,,D,,0,18,48,347826,493217,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5257,21,1,0.7826087,0.58536583,0.70521903,GRCh38/hg38,13,32379251,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,84
12,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32912299,153,43.79,11,c.3807T>C,p.(Val1269=),T,C,86,67,GTT,GTC,V,V,NM_000059.3,NM_000059,32912299,within,.,,rs543304,0.1681,0.1911,,,,,,,,,,,,+,T,C,32912299,32912299,F2D3E8FFB3CEE8C1ACEA66738E41BC1E,,,,,,,-1,BRCA2-  32912299,1898,126022,11,,,,EMPTY,,D,,0,5,15,173719,493217,126000,,,0,0,,1:3,,0.176,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.1754,10,1,0.2173913,0.18292683,0.35221615,GRCh38/hg38,13,32338162,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,84
1,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32903685,279,51.25,8,c.681+56C>T,p.(=),C,T,136,143,,,,,NM_000059.3,NM_000059,32903685,within,.,,rs2126042,0.1859,,,,,,,,,,,,,+,C,T,32903685,32903685,E9AEF840574909F4761D4EF7950E02CB,,,,,,,-1,BRCA2-  32903685,0,126192,8,,,,EMPTY,,D,,0,6,18,145186,493217,126000,,,0,0,,4:1,,,56,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2163,7,1,0.26086956,0.2195122,0.29436535,GRCh38/hg38,13,32329548,C,T,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,84
17,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,277,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,277,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,23,63,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,0.76829267,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,84
18,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,149,100.0,14,c.7397T>C,p.(Val2466Ala),T,C,0,149,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,23,62,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.75609756,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,84
19,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32936646,149,54.36,17,c.7806-14T>C,p.(=),T,C,68,81,,,,,NM_000059.3,NM_000059,32936646,within,.,,rs9534262,0.5316,0.5202,,,,,,,,,,,,+,T,C,32936646,32936646,5803939D8FBB75B042260991F0A62436,,,,,,,-1,BRCA2-  32936646,0,126158,17,,,,EMPTY,,D,,0,19,48,361616,493217,126000,,,0,0,,1:3,,0.52,14,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5255,16,1,0.82608694,0.58536583,0.7331783,GRCh38/hg38,13,32362509,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,84
9,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244936,287,58.89,10,c.2612C>T,p.(Pro871Leu),G,A,118,169,CCG,CTG,P,L,NM_007294.3,NM_007294,41244936,within,.,,rs799917,0.5439,0.4932,,4.247,0.0,0.0,0.999,1.0,5.04,,,,,-,G,A,41244936,41244936,A19EA255CA888CE1FE48D08CAD633F1F,,,,,,,1,BRCA1- 458755064,-1485,41812,11,,,,EMPTY,,D,,1,11,40,290862,492662,126000,(eval),,0,0,,"1:4,2:1",,0.41,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.4127,9,3,0.47826087,0.4878049,0.59038854,GRCh38/hg38,17,43092919,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,85
20,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41215825,67,46.27,17,c.5152+66G>A,p.(=),C,T,36,31,,,,,NM_007294.3,NM_007294,41215825,within,.,,rs3092994,0.3425,,,,,,,,,,,,,-,C,T,41215825,41215825,5BCA8D2E1E3875817F84A3EB582CDFAB,,,,,,,-1,BRCA1- 458784175,0,55428,18,,,,EMPTY,,D,,0,8,32,241843,492662,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3139,16,1,0.3478261,0.3902439,0.4908903,GRCh38/hg38,17,43063808,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,85
4,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41223094,276,51.45,15,c.4837A>G,p.(Ser1613Gly),T,C,134,142,AGT,GGT,S,G,NM_007294.3,NM_007294,41223094,within,.,,rs1799966,0.3558,0.2982,,-0.194,0.968,0.038,0.814,0.0,1.5,,,,,-,T,C,41223094,41223094,E3C52286D31F229973DB3595B052645F,,,,,,,-1,BRCA1- 458776906,-150,41827,16,,,,EMPTY,,D,,0,11,40,273625,492662,126000,,,0,0,,1:1,,0.349,0,,,,,,,,,,,,,,Benign,Benign,0.255,113705,-1,,,,,,,,,,,3,0.35,14,1,0.47826087,0.4878049,0.5554011,GRCh38/hg38,17,43071077,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,85
21,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219602,90,46.67,16,c.5074+23A>G,p.(=),T,C,48,42,,,,,NM_007294.3,NM_007294,41219602,within,.,,rs778115859,,,,,,,,,,,,,,-,T,C,41219602,41219602,955DF450385E3C74869B305FD5736664,,,,,,,-1,BRCA1- 458780398,0,371973,17,,,,EMPTY,,D,,0,1,1,76,492662,126000,,,0,0,,2:1,,1.0E-4,23,,,,,,,,,,,,,,Likely_benign,Likely benign,,113705,-1,,,,,,,,,,,3,1.0E-4,15,3,0.04347826,0.0121951215,1.5426398E-4,GRCh38/hg38,17,43067585,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,85
11,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245466,420,51.67,10,c.2082C>T,p.(Ser694=),G,A,203,217,AGC,AGT,S,S,NM_007294.3,NM_007294,41245466,within,.,,rs1799949,0.3365,0.2957,,,,,,,,,,,,-,G,A,41245466,41245466,3364E3D252EFEDF917C74D44FBC6A381,,,,,,,-1,BRCA1- 458754534,1412,125536,11,,,,EMPTY,,D,,0,11,40,269442,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.47826087,0.4878049,0.54691046,GRCh38/hg38,17,43093449,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,85
8,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244435,310,54.84,10,c.3113A>G,p.(Glu1038Gly),T,C,140,170,GAA,GGA,E,G,NM_007294.3,NM_007294,41244435,within,.,,rs16941,0.3357,0.279,,-0.149,0.972,0.606,0.922,0.0,-0.974,,,,,-,T,C,41244435,41244435,5D0FF1321BAC3C76DD352C33CC33B93E,,,,,,,-1,BRCA1- 458755565,-984,41815,11,,,,EMPTY,,D,,0,11,40,270861,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,0.936,113705,-1,,,,,,,,,,,3,0.343,9,1,0.47826087,0.4878049,0.54979074,GRCh38/hg38,17,43092418,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,85
2,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219804,120,45.83,16,c.4987-92A>G,p.(=),T,C,65,55,,,,,NM_007294.3,NM_007294,41219804,within,.,,rs8176233,0.3546,,,,,,,,,,,,,-,T,C,41219804,41219804,7341B20C52FFD4B9355840FB9CB56CDA,,,,,,,-1,BRCA1- 458780196,0,125749,17,,,,EMPTY,,D,,0,11,40,225491,492662,126000,,,0,0,,,,,92,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3128,15,1,0.47826087,0.4878049,0.45769918,GRCh38/hg38,17,43067787,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,85
7,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244000,358,50.84,10,c.3548A>G,p.(Lys1183Arg),T,C,176,182,AAA,AGA,K,R,NM_007294.3,NM_007294,41244000,within,.,,rs16942,0.3526,0.2952,,-0.319,0.0,0.001,0.924,0.0,-2.35,,,,,-,T,C,41244000,41244000,37A54117EA353BDA677332A1F61FA173,,,,,,,-1,BRCA1- 458756000,-549,41818,11,,,,EMPTY,,D,,0,11,40,272437,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.47826087,0.4878049,0.55298966,GRCh38/hg38,17,43091983,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,85
10,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245237,143,54.55,10,c.2311T>C,p.(Leu771=),A,G,65,78,TTG,CTG,L,L,NM_007294.3,NM_007294,41245237,within,.,,rs16940,0.3353,0.2776,,,,,,,,,,,,-,A,G,41245237,41245237,711AF22D84A49E875C2B2A9597A95EE6,,,,,,,-1,BRCA1- 458754763,1641,125554,11,,,,EMPTY,,D,,0,11,39,269517,492662,126000,,,0,0,,1:1,,0.342,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3422,9,1,0.47826087,0.47560975,0.5470627,GRCh38/hg38,17,43093220,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,85
22,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219780,121,46.28,16,c.4987-68A>G,p.(=),T,C,65,56,,,,,NM_007294.3,NM_007294,41219780,within,.,,rs8176234,0.3546,,,,,,,,,,,,,-,T,C,41219780,41219780,5995ECC305C33150BF3BB2B0C22FCC2A,,,,,,,-1,BRCA1- 458780220,0,125746,17,,,,EMPTY,,D,,0,11,40,234031,492662,126000,,,0,0,,,,,68,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3148,15,1,0.47826087,0.4878049,0.47503358,GRCh38/hg38,17,43067763,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,85
6,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41234470,105,50.48,12,c.4308T>C,p.(Ser1436=),A,G,52,53,TCT,TCC,S,S,NM_007294.3,NM_007294,41234470,within,.,,rs1060915,0.3363,0.2796,,,,,,,,,,,,-,A,G,41234470,41234470,B7237055CF1D42F022A050C072B7583B,,,,,,,-1,BRCA1- 458765530,-50,125703,13,,,,EMPTY,,D,,0,11,40,270833,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3433,11,1,0.47826087,0.4878049,0.5497339,GRCh38/hg38,17,43082453,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,85
5,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41231516,108,42.59,13,c.4358-2885G>A,p.(=),C,T,62,46,,,,,NM_007294.3,NM_007294,41231516,within,.,,rs8176193,0.3534,,,,,,,,,,,,,-,C,T,41231516,41231516,7F4F80D2D005D34CEA47E4A2C561B172,,,,,,,-1,BRCA1- 458768484,0,209399,14,,,,EMPTY,,D,,0,11,40,190200,492662,126000,,,0,0,,,,,2885,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.317,12,1,0.47826087,0.4878049,0.3860659,GRCh38/hg38,17,43079499,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,85
12,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,168,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,168,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,23,63,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,0.76829267,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,85
18,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32936646,115,100.0,17,c.7806-14T>C,p.(=),T,C,0,115,,,,,NM_000059.3,NM_000059,32936646,within,.,,rs9534262,0.5316,0.5202,,,,,,,,,,,,+,T,C,32936646,32936646,5803939D8FBB75B042260991F0A62436,,,,,,,-1,BRCA2-  32936646,0,126158,17,,,,EMPTY,,D,,0,19,48,361616,493217,126000,,,0,0,,1:3,,0.52,14,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5255,16,1,0.82608694,0.58536583,0.7331783,GRCh38/hg38,13,32362509,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,85
16,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,253,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,253,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,23,63,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,0.76829267,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,85
1,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32903685,265,100.0,8,c.681+56C>T,p.(=),C,T,0,265,,,,,NM_000059.3,NM_000059,32903685,within,.,,rs2126042,0.1859,,,,,,,,,,,,,+,C,T,32903685,32903685,E9AEF840574909F4761D4EF7950E02CB,,,,,,,-1,BRCA2-  32903685,0,126192,8,,,,EMPTY,,D,,0,6,18,145186,493217,126000,,,0,0,,4:1,,,56,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2163,7,1,0.26086956,0.2195122,0.29436535,GRCh38/hg38,13,32329548,C,T,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,85
17,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,136,100.0,14,c.7397T>C,p.(Val2466Ala),T,C,0,136,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,23,62,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.75609756,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,85
19,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32953388,192,100.0,22,c.8755-66T>C,p.(=),T,C,0,192,,,,,NM_000059.3,NM_000059,32953388,within,.,,rs4942486,0.5116,,,,,,,,,,,,,+,T,C,32953388,32953388,97C65B85894EB489F1BFA65897685241,,,,,,,-1,BRCA2-  32953388,0,126190,22,,,,EMPTY,,D,,0,18,48,347826,493217,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5257,21,1,0.7826087,0.58536583,0.70521903,GRCh38/hg38,13,32379251,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,85
3,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41251931,262,49.62,7,c.442-34C>T,p.(=),G,A,132,130,,,,,NM_007294.3,NM_007294,41251931,within,.,,rs799923,0.0986,0.1757,,,,,,,,,,,,-,G,A,41251931,41251931,A5CCEFE1E7B19A106A59AB89C8776C53,,,,,,,-1,BRCA1- 458748069,0,125864,8,,,,EMPTY,,D,,0,5,14,181678,492662,126000,,,0,0,,,,0.174,34,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.1711,6,1,0.2173913,0.17073171,0.36876804,GRCh38/hg38,17,43099914,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,86
2,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41246481,474,48.95,10,c.1067A>G,p.(Gln356Arg),T,C,241,232,CAG,CGG,Q,R,NM_007294.3,NM_007294,41246481,within,.,,rs1799950,0.0218,0.0459,,2.371,0.995,0.988,0.992,0.0218,3.71,,,,,-,T,C,41246481,41246481,DE7889D7BF4EEED5C3D165470529DA1E,,,,,,,-1,BRCA1- 458753519,397,41803,11,,,,EMPTY,,D,,0,1,2,61808,492662,126000,,,0,0,,"1:6,2:1",,0.044,0,,,,,,,,,,,,,,Benign,Benign,0.998,113705,-1,,,,,,,,,,,3,0.0471,9,3,0.04347826,0.024390243,0.12545721,GRCh38/hg38,17,43094464,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,86
1,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32903685,222,49.55,8,c.681+56C>T,p.(=),C,T,112,110,,,,,NM_000059.3,NM_000059,32903685,within,.,,rs2126042,0.1859,,,,,,,,,,,,,+,C,T,32903685,32903685,E9AEF840574909F4761D4EF7950E02CB,,,,,,,-1,BRCA2-  32903685,0,126192,8,,,,EMPTY,,D,,0,6,18,145186,493217,126000,,,0,0,,4:1,,,56,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2163,7,1,0.26086956,0.2195122,0.29436535,GRCh38/hg38,13,32329548,C,T,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,86
9,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32936646,151,43.05,17,c.7806-14T>C,p.(=),T,C,86,65,,,,,NM_000059.3,NM_000059,32936646,within,.,,rs9534262,0.5316,0.5202,,,,,,,,,,,,+,T,C,32936646,32936646,5803939D8FBB75B042260991F0A62436,,,,,,,-1,BRCA2-  32936646,0,126158,17,,,,EMPTY,,D,,0,19,48,361616,493217,126000,,,0,0,,1:3,,0.52,14,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5255,16,1,0.82608694,0.58536583,0.7331783,GRCh38/hg38,13,32362509,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,86
7,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,174,100.0,14,c.7397T>C,p.(Val2466Ala),T,C,0,174,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,23,62,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.75609756,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,86
4,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906729,190,55.26,10,c.1114A>C,p.(Asn372His),A,C,85,105,AAT,CAT,N,H,NM_000059.3,NM_000059,32906729,within,.,,rs144848,0.2494,0.2332,,0.32,0.861,,0.269,0.0,0.396,,,,,+,A,C,32906729,32906729,D514F785F1344AF9F6975E589D47BDF6,,,,,,,-1,BRCA2-  32906729,321,9329,10,,,,EMPTY,,D,,0,14,39,233635,493217,126000,,,0,0,,"1:1,2:1",,0.277,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2733,9,1,0.6086956,0.47560975,0.47369617,GRCh38/hg38,13,32332592,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,86
10,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32953388,202,49.01,22,c.8755-66T>C,p.(=),T,C,103,99,,,,,NM_000059.3,NM_000059,32953388,within,.,,rs4942486,0.5116,,,,,,,,,,,,,+,T,C,32953388,32953388,97C65B85894EB489F1BFA65897685241,,,,,,,-1,BRCA2-  32953388,0,126190,22,,,,EMPTY,,D,,0,18,48,347826,493217,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5257,21,1,0.7826087,0.58536583,0.70521903,GRCh38/hg38,13,32379251,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,86
8,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32930598,118,55.08,15,c.7469T>C,p.(Ile2490Thr),T,C,53,65,ATA,ACA,I,T,NM_000059.3,NM_000059,32930598,within,.,,rs11571707,0.016,0.0016,,0.406,0.895,,0.837,0.0,-5.83,,,,,+,T,C,32930598,32930598,D7CAF30A58440FCA5E8E7BACD8E1EDE4,,,,,,,-1,BRCA2-  32930598,34,96852,15,,,,EMPTY,,D,,0,6,17,6837,493217,126000,,,0,0,,"1:5,2:2",,0.014,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0176,14,2,0.26086956,0.20731707,0.013862053,GRCh38/hg38,13,32356461,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,86
5,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,225,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,225,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,23,63,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,0.76829267,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,86
6,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,346,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,346,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,23,63,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,0.76829267,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,86
5,C,BRCA2,,SNP,missense,GRCh37/hg19,13,32937492,148,45.27,18,c.8153T>C,p.(Ile2718Thr),T,C,80,67,ATT,ACT,I,T,NM_000059.3,NM_000059,32937492,within,.,,rs80359060,,,,2.634,0.497,,0.755,0.0,0.238,,,,,+,T,C,32937492,32937492,03A9A85637E6B0CA77A5C2BBC542C1F4,,,,,,,-1,BRCA2-  32937492,177,38140,18,,,,EMPTY,,C,,0,2,2,9,493217,126000,,,0,0,,3:1,,0.0,0,,,,,,,,,,,,,,Conflicting_interpretations_of_pathogenicity,Conflicting interpretations of pathogenicity,,600185,-1,,,,,,,,,,,3,0.0,17,3,0.08695652,0.024390243,1.8247547E-5,GRCh38/hg38,13,32363355,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,87
19,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244936,359,48.47,10,c.2612C>T,p.(Pro871Leu),G,A,185,174,CCG,CTG,P,L,NM_007294.3,NM_007294,41244936,within,.,,rs799917,0.5439,0.4932,,4.247,0.0,0.0,0.999,1.0,5.04,,,,,-,G,A,41244936,41244936,A19EA255CA888CE1FE48D08CAD633F1F,,,,,,,1,BRCA1- 458755064,-1485,41812,11,,,,EMPTY,,D,,1,11,40,290862,492662,126000,(eval),,0,0,,"1:4,2:1",,0.41,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.4127,9,3,0.47826087,0.4878049,0.59038854,GRCh38/hg38,17,43092919,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,87
14,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41223094,402,46.77,15,c.4837A>G,p.(Ser1613Gly),T,C,214,188,AGT,GGT,S,G,NM_007294.3,NM_007294,41223094,within,.,,rs1799966,0.3558,0.2982,,-0.194,0.968,0.038,0.814,0.0,1.5,,,,,-,T,C,41223094,41223094,E3C52286D31F229973DB3595B052645F,,,,,,,-1,BRCA1- 458776906,-150,41827,16,,,,EMPTY,,D,,0,11,40,273625,492662,126000,,,0,0,,1:1,,0.349,0,,,,,,,,,,,,,,Benign,Benign,0.255,113705,-1,,,,,,,,,,,3,0.35,14,1,0.47826087,0.4878049,0.5554011,GRCh38/hg38,17,43071077,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,87
15,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41231516,144,41.67,13,c.4358-2885G>A,p.(=),C,T,84,60,,,,,NM_007294.3,NM_007294,41231516,within,.,,rs8176193,0.3534,,,,,,,,,,,,,-,C,T,41231516,41231516,7F4F80D2D005D34CEA47E4A2C561B172,,,,,,,-1,BRCA1- 458768484,0,209399,14,,,,EMPTY,,D,,0,11,40,190200,492662,126000,,,0,0,,,,,2885,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.317,12,1,0.47826087,0.4878049,0.3860659,GRCh38/hg38,17,43079499,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,87
10,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41215825,129,54.26,17,c.5152+66G>A,p.(=),C,T,59,70,,,,,NM_007294.3,NM_007294,41215825,within,.,,rs3092994,0.3425,,,,,,,,,,,,,-,C,T,41215825,41215825,5BCA8D2E1E3875817F84A3EB582CDFAB,,,,,,,-1,BRCA1- 458784175,0,55428,18,,,,EMPTY,,D,,0,8,32,241843,492662,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3139,16,1,0.3478261,0.3902439,0.4908903,GRCh38/hg38,17,43063808,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,87
18,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244435,479,45.93,10,c.3113A>G,p.(Glu1038Gly),T,C,259,220,GAA,GGA,E,G,NM_007294.3,NM_007294,41244435,within,.,,rs16941,0.3357,0.279,,-0.149,0.972,0.606,0.922,0.0,-0.974,,,,,-,T,C,41244435,41244435,5D0FF1321BAC3C76DD352C33CC33B93E,,,,,,,-1,BRCA1- 458755565,-984,41815,11,,,,EMPTY,,D,,0,11,40,270861,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,0.936,113705,-1,,,,,,,,,,,3,0.343,9,1,0.47826087,0.4878049,0.54979074,GRCh38/hg38,17,43092418,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,87
11,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219780,196,46.94,16,c.4987-68A>G,p.(=),T,C,104,92,,,,,NM_007294.3,NM_007294,41219780,within,.,,rs8176234,0.3546,,,,,,,,,,,,,-,T,C,41219780,41219780,5995ECC305C33150BF3BB2B0C22FCC2A,,,,,,,-1,BRCA1- 458780220,0,125746,17,,,,EMPTY,,D,,0,11,40,234031,492662,126000,,,0,0,,,,,68,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3148,15,1,0.47826087,0.4878049,0.47503358,GRCh38/hg38,17,43067763,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,87
17,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244000,490,49.39,10,c.3548A>G,p.(Lys1183Arg),T,C,248,242,AAA,AGA,K,R,NM_007294.3,NM_007294,41244000,within,.,,rs16942,0.3526,0.2952,,-0.319,0.0,0.001,0.924,0.0,-2.35,,,,,-,T,C,41244000,41244000,37A54117EA353BDA677332A1F61FA173,,,,,,,-1,BRCA1- 458756000,-549,41818,11,,,,EMPTY,,D,,0,11,40,272437,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.47826087,0.4878049,0.55298966,GRCh38/hg38,17,43091983,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,87
13,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219804,196,46.43,16,c.4987-92A>G,p.(=),T,C,105,91,,,,,NM_007294.3,NM_007294,41219804,within,.,,rs8176233,0.3546,,,,,,,,,,,,,-,T,C,41219804,41219804,7341B20C52FFD4B9355840FB9CB56CDA,,,,,,,-1,BRCA1- 458780196,0,125749,17,,,,EMPTY,,D,,0,11,40,225491,492662,126000,,,0,0,,,,,92,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3128,15,1,0.47826087,0.4878049,0.45769918,GRCh38/hg38,17,43067787,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,87
21,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245466,734,53.81,10,c.2082C>T,p.(Ser694=),G,A,339,395,AGC,AGT,S,S,NM_007294.3,NM_007294,41245466,within,.,,rs1799949,0.3365,0.2957,,,,,,,,,,,,-,G,A,41245466,41245466,3364E3D252EFEDF917C74D44FBC6A381,,,,,,,-1,BRCA1- 458754534,1412,125536,11,,,,EMPTY,,D,,0,11,40,269442,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.47826087,0.4878049,0.54691046,GRCh38/hg38,17,43093449,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,87
16,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41234470,184,47.83,12,c.4308T>C,p.(Ser1436=),A,G,96,88,TCT,TCC,S,S,NM_007294.3,NM_007294,41234470,within,.,,rs1060915,0.3363,0.2796,,,,,,,,,,,,-,A,G,41234470,41234470,B7237055CF1D42F022A050C072B7583B,,,,,,,-1,BRCA1- 458765530,-50,125703,13,,,,EMPTY,,D,,0,11,40,270833,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3433,11,1,0.47826087,0.4878049,0.5497339,GRCh38/hg38,17,43082453,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,87
20,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245237,274,50.73,10,c.2311T>C,p.(Leu771=),A,G,135,139,TTG,CTG,L,L,NM_007294.3,NM_007294,41245237,within,.,,rs16940,0.3353,0.2776,,,,,,,,,,,,-,A,G,41245237,41245237,711AF22D84A49E875C2B2A9597A95EE6,,,,,,,-1,BRCA1- 458754763,1641,125554,11,,,,EMPTY,,D,,0,11,39,269517,492662,126000,,,0,0,,1:1,,0.342,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3422,9,1,0.47826087,0.47560975,0.5470627,GRCh38/hg38,17,43093220,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,87
27,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32906980,495,51.72,10,c.1365A>G,p.(Ser455=),A,G,239,256,TCA,TCG,S,S,NM_000059.3,NM_000059,32906980,within,.,,rs1801439,0.0737,0.031,,,,,,,,,,,,+,A,G,32906980,32906980,C76C22E555E869928B452D866988AB4F,,,,,,,-1,BRCA2-  32906980,-545,125943,10,,,,EMPTY,,D,,0,5,13,41480,493217,126000,,,0,0,,"1:4,2:1",,0.051,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0499,9,2,0.2173913,0.15853658,0.08410091,GRCh38/hg38,13,32332843,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,87
29,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32911463,152,47.37,11,c.2971A>G,p.(Asn991Asp),A,G,80,72,AAC,GAC,N,D,NM_000059.3,NM_000059,32911463,within,.,,rs1799944,0.0801,0.0373,,-0.04,0.0,,0.959,0.0,3.08,,,,,+,A,G,32911463,32911463,36F4F7E6CD788E45B30EA486775D07D6,,,,,,,-1,BRCA2-  32911463,1062,41545,11,,,,EMPTY,,D,,0,5,13,42142,493217,126000,,,0,0,,1:2,,0.053,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0522,10,1,0.2173913,0.15853658,0.085443124,GRCh38/hg38,13,32337326,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,87
6,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32953388,243,41.56,22,c.8755-66T>C,p.(=),T,C,142,101,,,,,NM_000059.3,NM_000059,32953388,within,.,,rs4942486,0.5116,,,,,,,,,,,,,+,T,C,32953388,32953388,97C65B85894EB489F1BFA65897685241,,,,,,,-1,BRCA2-  32953388,0,126190,22,,,,EMPTY,,D,,0,18,48,347826,493217,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5257,21,1,0.7826087,0.58536583,0.70521903,GRCh38/hg38,13,32379251,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,87
12,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906480,218,48.17,10,c.865A>C,p.(Asn289His),A,C,113,105,AAT,CAT,N,H,NM_000059.3,NM_000059,32906480,within,.,,rs766173,0.0737,0.0312,,0.498,0.998,,0.803,0.0,1.73,,,,,+,A,C,32906480,32906480,EE0CD2A1633CE9FEF0978528634002FE,,,,,,,-1,BRCA2-  32906480,72,41567,10,,,,EMPTY,,D,,0,5,13,41272,493217,126000,,,0,0,,"1:4,2:1",,0.051,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0496,9,2,0.2173913,0.15853658,0.08367919,GRCh38/hg38,13,32332343,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,87
30,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,243,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,243,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,23,63,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,0.76829267,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,87
1,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32899388,225,50.67,4,c.425+67A>C,p.(=),A,C,111,114,,,,,NM_000059.3,NM_000059,32899388,within,.,,rs11571610,0.0743,,,,,,,,,,,,,+,A,C,32899388,32899388,1AF346DE380A738371905EBFBCED20E1,,,,,,,-1,BRCA2-  32899388,0,126095,4,,,,EMPTY,,D,,0,5,13,39349,493217,126000,,,0,0,,2:1,,,67,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0306,3,3,0.2173913,0.15853658,0.0797803,GRCh38/hg38,13,32325251,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,87
31,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,353,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,353,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,23,63,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,0.76829267,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,87
3,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32930598,214,56.54,15,c.7469T>C,p.(Ile2490Thr),T,C,93,121,ATA,ACA,I,T,NM_000059.3,NM_000059,32930598,within,.,,rs11571707,0.016,0.0016,,0.406,0.895,,0.837,0.0,-5.83,,,,,+,T,C,32930598,32930598,D7CAF30A58440FCA5E8E7BACD8E1EDE4,,,,,,,-1,BRCA2-  32930598,34,96852,15,,,,EMPTY,,D,,0,6,17,6837,493217,126000,,,0,0,,"1:5,2:2",,0.014,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0176,14,2,0.26086956,0.20731707,0.013862053,GRCh38/hg38,13,32356461,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,87
28,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32910721,444,52.48,11,c.2229T>C,p.(His743=),T,C,211,233,CAT,CAC,H,H,NM_000059.3,NM_000059,32910721,within,.,,rs1801499,0.0735,0.0313,,,,,,,,,,,,+,T,C,32910721,32910721,D39471F16FE6D1F6752C2D4D179996AF,,,,,,,-1,BRCA2-  32910721,320,125979,11,,,,EMPTY,,D,,0,5,13,41536,493217,126000,,,0,0,,1:1,,0.052,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0503,10,1,0.2173913,0.15853658,0.08421446,GRCh38/hg38,13,32336584,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,87
23,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906729,171,50.88,10,c.1114A>C,p.(Asn372His),A,C,84,87,AAT,CAT,N,H,NM_000059.3,NM_000059,32906729,within,.,,rs144848,0.2494,0.2332,,0.32,0.861,,0.269,0.0,0.396,,,,,+,A,C,32906729,32906729,D514F785F1344AF9F6975E589D47BDF6,,,,,,,-1,BRCA2-  32906729,321,9329,10,,,,EMPTY,,D,,0,14,39,233635,493217,126000,,,0,0,,"1:1,2:1",,0.277,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2733,9,1,0.6086956,0.47560975,0.47369617,GRCh38/hg38,13,32332592,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,87
32,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,248,100.0,14,c.7397T>C,p.(Val2466Ala),T,C,0,248,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,23,62,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.75609756,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,87
4,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32936646,217,53.0,17,c.7806-14T>C,p.(=),T,C,102,115,,,,,NM_000059.3,NM_000059,32936646,within,.,,rs9534262,0.5316,0.5202,,,,,,,,,,,,+,T,C,32936646,32936646,5803939D8FBB75B042260991F0A62436,,,,,,,-1,BRCA2-  32936646,0,126158,17,,,,EMPTY,,D,,0,19,48,361616,493217,126000,,,0,0,,1:3,,0.52,14,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5255,16,1,0.82608694,0.58536583,0.7331783,GRCh38/hg38,13,32362509,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,87
2,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32929478,80,43.75,14,c.7435+53C>T,p.(=),C,T,45,35,,,,,NM_000059.3,NM_000059,32929478,within,.,,rs11147489,0.0725,,,,,,,,,,,,,+,C,T,32929478,32929478,F692B4BE5DCD39FA887FE8D63D296720,,,,,,,-1,BRCA2-  32929478,0,126136,14,,,,EMPTY,,D,,0,5,13,36369,493217,126000,,,0,0,,,,,53,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0301,13,3,0.2173913,0.15853658,0.07373834,GRCh38/hg38,13,32355341,C,T,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,87
7,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32953550,271,52.03,22,c.8851G>A,p.(Ala2951Thr),G,A,130,141,GCC,ACC,A,T,NM_000059.3,NM_000059,32953550,within,.,,rs11571769,0.01,0.0044,,7.914,1.0,,1.0,1.0,5.6,,,,,+,G,A,32953550,32953550,D3D6E2E00CDC932E43B7A97E2FA9A9A6,,,,,,,-1,BRCA2-  32953550,97,41570,22,,,,EMPTY,,D,,0,1,4,7101,493217,126000,,,0,0,,"1:8,2:1",,0.0078,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0089,21,3,0.04347826,0.048780486,0.014397314,GRCh38/hg38,13,32379413,G,A,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,87
15,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244936,1064,48.4,10,c.2612C>T,p.(Pro871Leu),G,A,549,515,CCG,CTG,P,L,NM_007294.3,NM_007294,41244936,within,.,,rs799917,0.5439,0.4932,,4.247,0.0,0.0,0.999,1.0,5.04,,,,,-,G,A,41244936,41244936,A19EA255CA888CE1FE48D08CAD633F1F,,,,,,,1,BRCA1- 458755064,-1485,41812,11,,,,EMPTY,,D,,1,13,13,290862,492662,126000,(eval),,0,0,,"1:4,2:1",,0.41,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.4127,9,3,0.8125,0.15853658,0.59038854,GRCh38/hg38,17,43092919,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,AL
17,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245466,1632,49.69,10,c.2082C>T,p.(Ser694=),G,A,820,811,AGC,AGT,S,S,NM_007294.3,NM_007294,41245466,within,.,,rs1799949,0.3365,0.2957,,,,,,,,,,,,-,G,A,41245466,41245466,3364E3D252EFEDF917C74D44FBC6A381,,,,,,,-1,BRCA1- 458754534,1412,125536,11,,,,EMPTY,,D,,0,13,13,269442,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.8125,0.15853658,0.54691046,GRCh38/hg38,17,43093449,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,AL
13,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244000,1378,50.36,10,c.3548A>G,p.(Lys1183Arg),T,C,683,694,AAA,AGA,K,R,NM_007294.3,NM_007294,41244000,within,.,,rs16942,0.3526,0.2952,,-0.319,0.0,0.001,0.924,0.0,-2.35,,,,,-,T,C,41244000,41244000,37A54117EA353BDA677332A1F61FA173,,,,,,,-1,BRCA1- 458756000,-549,41818,11,,,,EMPTY,,D,,0,13,13,272437,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.8125,0.15853658,0.55298966,GRCh38/hg38,17,43091983,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,AL
9,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41231516,500,51.8,13,c.4358-2885G>A,,C,T,241,259,,,,,NM_007294.3,NM_007294,41231516,within,.,,rs8176193,0.3534,,,,,,,,,,,,,-,C,T,41231516,41231516,7F4F80D2D005D34CEA47E4A2C561B172,,,,,,,-1,BRCA1- 458768484,0,209399,14,,,,EMPTY,,D,,0,13,13,190200,492662,126000,,,0,0,,,,,2885,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.317,12,1,0.8125,0.15853658,0.3860659,GRCh38/hg38,17,43079499,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,AL
5,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219780,682,44.43,16,c.4987-68A>G,,T,C,379,303,,,,,NM_007294.3,NM_007294,41219780,within,.,,rs8176234,0.3546,,,,,,,,,,,,,-,T,C,41219780,41219780,5995ECC305C33150BF3BB2B0C22FCC2A,,,,,,,-1,BRCA1- 458780220,0,125746,17,,,,EMPTY,,D,,0,13,13,234031,492662,126000,,,0,0,,,,,68,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3148,15,1,0.8125,0.15853658,0.47503358,GRCh38/hg38,17,43067763,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,AL
10,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41234470,504,56.94,12,c.4308T>C,p.(Ser1436=),A,G,217,287,TCT,TCC,S,S,NM_007294.3,NM_007294,41234470,within,.,,rs1060915,0.3363,0.2796,,,,,,,,,,,,-,A,G,41234470,41234470,B7237055CF1D42F022A050C072B7583B,,,,,,,-1,BRCA1- 458765530,-50,125703,13,,,,EMPTY,,D,,0,13,13,270833,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3433,11,1,0.8125,0.15853658,0.5497339,GRCh38/hg38,17,43082453,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,AL
6,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219804,682,44.57,16,c.4987-92A>G,,T,C,378,304,,,,,NM_007294.3,NM_007294,41219804,within,.,,rs8176233,0.3546,,,,,,,,,,,,,-,T,C,41219804,41219804,7341B20C52FFD4B9355840FB9CB56CDA,,,,,,,-1,BRCA1- 458780196,0,125749,17,,,,EMPTY,,D,,0,13,13,225491,492662,126000,,,0,0,,,,,92,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3128,15,1,0.8125,0.15853658,0.45769918,GRCh38/hg38,17,43067787,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,AL
8,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41223094,1027,53.85,15,c.4837A>G,p.(Ser1613Gly),T,C,474,553,AGT,GGT,S,G,NM_007294.3,NM_007294,41223094,within,.,,rs1799966,0.3558,0.2982,,-0.194,0.968,0.038,0.814,0.0,1.5,,,,,-,T,C,41223094,41223094,E3C52286D31F229973DB3595B052645F,,,,,,,-1,BRCA1- 458776906,-150,41827,16,,,,EMPTY,,D,,0,13,13,273625,492662,126000,,,0,0,,1:1,,0.349,0,,,,,,,,,,,,,,Benign,Benign,0.255,113705,-1,,,,,,,,,,,3,0.35,14,1,0.8125,0.15853658,0.5554011,GRCh38/hg38,17,43071077,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,AL
16,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245237,525,49.14,10,c.2311T>C,p.(Leu771=),A,G,267,258,TTG,CTG,L,L,NM_007294.3,NM_007294,41245237,within,.,,rs16940,0.3353,0.2776,,,,,,,,,,,,-,A,G,41245237,41245237,711AF22D84A49E875C2B2A9597A95EE6,,,,,,,-1,BRCA1- 458754763,1641,125554,11,,,,EMPTY,,D,,0,13,13,269517,492662,126000,,,0,0,,1:1,,0.342,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3422,9,1,0.8125,0.15853658,0.5470627,GRCh38/hg38,17,43093220,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,AL
14,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244435,1233,49.88,10,c.3113A>G,p.(Glu1038Gly),T,C,618,615,GAA,GGA,E,G,NM_007294.3,NM_007294,41244435,within,.,,rs16941,0.3357,0.279,,-0.149,0.972,0.606,0.922,0.0,-0.974,,,,,-,T,C,41244435,41244435,5D0FF1321BAC3C76DD352C33CC33B93E,,,,,,,-1,BRCA1- 458755565,-984,41815,11,,,,EMPTY,,D,,0,13,13,270861,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,0.936,113705,-1,,,,,,,,,,,3,0.343,9,1,0.8125,0.15853658,0.54979074,GRCh38/hg38,17,43092418,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,AL
29,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,464,99.78,14,c.7397T>C,p.(Val2466Ala),T,C,1,463,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,16,16,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.19512194,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,AL
2,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32953388,788,100.0,22,c.8755-66T>C,,T,C,0,788,,,,,NM_000059.3,NM_000059,32953388,within,.,,rs4942486,0.5116,,,,,,,,,,,,,+,T,C,32953388,32953388,97C65B85894EB489F1BFA65897685241,,,,,,,-1,BRCA2-  32953388,0,126190,22,,,,EMPTY,,D,,0,13,13,347826,493217,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5257,21,1,0.8125,0.15853658,0.70521903,GRCh38/hg38,13,32379251,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,AL
28,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32929232,579,52.33,14,c.7242A>G,p.(Ser2414=),A,G,275,303,TCA,TCG,S,S,NM_000059.3,NM_000059,32929232,within,.,,rs1799955,0.2326,0.2114,,,,,,,,,,,,+,A,G,32929232,32929232,6F8D6FF8BC9027D6C0351ADCEF41FD20,,,,,,,-1,BRCA2-  32929232,-194,126133,14,,,,EMPTY,,D,,0,8,8,192923,493217,126000,,,0,0,,"1:3,2:1",,0.224,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2257,13,1,0.5,0.09756097,0.39115238,GRCh38/hg38,13,32355095,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,AL
1,D,BRCA2,,SNP,5'UTR,GRCh37/hg19,13,32890572,1310,52.06,2,c.-26G>A,,G,A,628,682,,,,,NM_000059.3,NM_000059,32890572,within,.,,rs1799943,0.2093,0.2088,,,,,,,,,,,,+,G,A,32890572,32890572,A9C2B39455EF056EDB097A5953EB72EE,,,,,,,-1,BRCA2-  32890572,14,125965,2,,,,EMPTY,,D,,0,8,8,205902,493217,126000,,,0,0,,,,0.243,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2427,1,1,0.5,0.09756097,0.41746736,GRCh38/hg38,13,32316435,G,A,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,AL
23,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32911888,885,50.28,11,c.3396A>G,p.(Lys1132=),A,G,440,445,AAA,AAG,K,K,NM_000059.3,NM_000059,32911888,within,.,,rs1801406,0.2668,0.2798,,,,,,,,,,,,+,A,G,32911888,32911888,94F2C0D328C28C466A38A430BBE75D52,,,,,,,-1,BRCA2-  32911888,1487,126010,11,,,,EMPTY,,D,,0,8,8,248687,493217,126000,,,0,0,,1:3,,0.293,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.295,10,1,0.5,0.09756097,0.50421417,GRCh38/hg38,13,32337751,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,AL
12,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32903685,984,48.78,8,c.681+56C>T,,C,T,504,480,,,,,NM_000059.3,NM_000059,32903685,within,.,,rs2126042,0.1859,,,,,,,,,,,,,+,C,T,32903685,32903685,E9AEF840574909F4761D4EF7950E02CB,,,,,,,-1,BRCA2-  32903685,0,126192,8,,,,EMPTY,,D,,0,3,3,145186,493217,126000,,,0,0,,4:1,,,56,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2163,7,1,0.1875,0.036585364,0.29436535,GRCh38/hg38,13,32329548,C,T,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,AL
25,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,631,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,631,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,16,16,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,0.19512194,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,AL
26,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,1151,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,1151,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,16,16,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,0.19512194,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,AL
30,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32936646,486,100.0,17,c.7806-14T>C,,T,C,0,486,,,,,NM_000059.3,NM_000059,32936646,within,.,,rs9534262,0.5316,0.5202,,,,,,,,,,,,+,T,C,32936646,32936646,5803939D8FBB75B042260991F0A62436,,,,,,,-1,BRCA2-  32936646,0,126158,17,,,,EMPTY,,D,,0,13,13,361616,493217,126000,,,0,0,,1:3,,0.52,14,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5255,16,1,0.8125,0.15853658,0.7331783,GRCh38/hg38,13,32362509,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,AL
13,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,903,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,903,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,16,16,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,0.19512194,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,DC
12,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32911888,1015,50.25,11,c.3396A>G,p.(Lys1132=),A,G,505,510,AAA,AAG,K,K,NM_000059.3,NM_000059,32911888,within,.,,rs1801406,0.2668,0.2798,,,,,,,,,,,,+,A,G,32911888,32911888,94F2C0D328C28C466A38A430BBE75D52,,,,,,,-1,BRCA2-  32911888,1487,126010,11,,,,EMPTY,,D,,0,8,8,248687,493217,126000,,,0,0,,1:3,,0.293,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.295,10,1,0.5,0.09756097,0.50421417,GRCh38/hg38,13,32337751,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,DC
17,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32936646,683,47.88,17,c.7806-14T>C,,T,C,356,327,,,,,NM_000059.3,NM_000059,32936646,within,.,,rs9534262,0.5316,0.5202,,,,,,,,,,,,+,T,C,32936646,32936646,5803939D8FBB75B042260991F0A62436,,,,,,,-1,BRCA2-  32936646,0,126158,17,,,,EMPTY,,D,,0,13,13,361616,493217,126000,,,0,0,,1:3,,0.52,14,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5255,16,1,0.8125,0.15853658,0.7331783,GRCh38/hg38,13,32362509,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,DC
1,D,BRCA2,,SNP,5'UTR,GRCh37/hg19,13,32890572,1725,53.1,2,c.-26G>A,,G,A,809,916,,,,,NM_000059.3,NM_000059,32890572,within,.,,rs1799943,0.2093,0.2088,,,,,,,,,,,,+,G,A,32890572,32890572,A9C2B39455EF056EDB097A5953EB72EE,,,,,,,-1,BRCA2-  32890572,14,125965,2,,,,EMPTY,,D,,0,8,8,205902,493217,126000,,,0,0,,,,0.243,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2427,1,1,0.5,0.09756097,0.41746736,GRCh38/hg38,13,32316435,G,A,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,DC
14,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,1776,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,1776,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,16,16,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,0.19512194,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,DC
15,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32929232,852,52.46,14,c.7242A>G,p.(Ser2414=),A,G,405,447,TCA,TCG,S,S,NM_000059.3,NM_000059,32929232,within,.,,rs1799955,0.2326,0.2114,,,,,,,,,,,,+,A,G,32929232,32929232,6F8D6FF8BC9027D6C0351ADCEF41FD20,,,,,,,-1,BRCA2-  32929232,-194,126133,14,,,,EMPTY,,D,,0,8,8,192923,493217,126000,,,0,0,,"1:3,2:1",,0.224,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2257,13,1,0.5,0.09756097,0.39115238,GRCh38/hg38,13,32355095,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,DC
16,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,647,99.69,14,c.7397T>C,p.(Val2466Ala),T,C,2,645,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,16,16,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.19512194,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,DC
11,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906729,1034,49.52,10,c.1114A>C,p.(Asn372His),A,C,520,512,AAT,CAT,N,H,NM_000059.3,NM_000059,32906729,within,.,,rs144848,0.2494,0.2332,,0.32,0.861,,0.269,0.0,0.396,,,,,+,A,C,32906729,32906729,D514F785F1344AF9F6975E589D47BDF6,,,,,,,-1,BRCA2-  32906729,321,9329,10,,,,EMPTY,,D,,0,9,9,233635,493217,126000,,,0,0,,"1:1,2:1",,0.277,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2733,9,1,0.5625,0.1097561,0.47369617,GRCh38/hg38,13,32332592,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,DC
18,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32953388,1175,48.77,22,c.8755-66T>C,,T,C,602,573,,,,,NM_000059.3,NM_000059,32953388,within,.,,rs4942486,0.5116,,,,,,,,,,,,,+,T,C,32953388,32953388,97C65B85894EB489F1BFA65897685241,,,,,,,-1,BRCA2-  32953388,0,126190,22,,,,EMPTY,,D,,0,13,13,347826,493217,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5257,21,1,0.8125,0.15853658,0.70521903,GRCh38/hg38,13,32379251,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,DC
13,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244936,1668,99.82,10,c.2612C>T,p.(Pro871Leu),G,A,3,1665,CCG,CTG,P,L,NM_007294.3,NM_007294,41244936,within,.,,rs799917,0.5439,0.4932,,4.247,0.0,0.0,0.999,1.0,5.04,,,,,-,G,A,41244936,41244936,A19EA255CA888CE1FE48D08CAD633F1F,,,,,,,1,BRCA1- 458755064,-1485,41812,11,,,,EMPTY,,D,,1,13,13,290862,492662,126000,(eval),,0,0,,"1:4,2:1",,0.41,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.4127,9,3,0.8125,0.15853658,0.59038854,GRCh38/hg38,17,43092919,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,JC
10,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244000,2117,99.72,10,c.3548A>G,p.(Lys1183Arg),T,C,6,2111,AAA,AGA,K,R,NM_007294.3,NM_007294,41244000,within,.,,rs16942,0.3526,0.2952,,-0.319,0.0,0.001,0.924,0.0,-2.35,,,,,-,T,C,41244000,41244000,37A54117EA353BDA677332A1F61FA173,,,,,,,-1,BRCA1- 458756000,-549,41818,11,,,,EMPTY,,D,,0,13,13,272437,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.8125,0.15853658,0.55298966,GRCh38/hg38,17,43091983,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,JC
8,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41234470,578,100.0,12,c.4308T>C,p.(Ser1436=),A,G,0,578,TCT,TCC,S,S,NM_007294.3,NM_007294,41234470,within,.,,rs1060915,0.3363,0.2796,,,,,,,,,,,,-,A,G,41234470,41234470,B7237055CF1D42F022A050C072B7583B,,,,,,,-1,BRCA1- 458765530,-50,125703,13,,,,EMPTY,,D,,0,13,13,270833,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3433,11,1,0.8125,0.15853658,0.5497339,GRCh38/hg38,17,43082453,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,JC
7,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41231516,634,100.0,13,c.4358-2885G>A,,C,T,0,634,,,,,NM_007294.3,NM_007294,41231516,within,.,,rs8176193,0.3534,,,,,,,,,,,,,-,C,T,41231516,41231516,7F4F80D2D005D34CEA47E4A2C561B172,,,,,,,-1,BRCA1- 458768484,0,209399,14,,,,EMPTY,,D,,0,13,13,190200,492662,126000,,,0,0,,,,,2885,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.317,12,1,0.8125,0.15853658,0.3860659,GRCh38/hg38,17,43079499,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,JC
11,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244435,1653,100.0,10,c.3113A>G,p.(Glu1038Gly),T,C,0,1653,GAA,GGA,E,G,NM_007294.3,NM_007294,41244435,within,.,,rs16941,0.3357,0.279,,-0.149,0.972,0.606,0.922,0.0,-0.974,,,,,-,T,C,41244435,41244435,5D0FF1321BAC3C76DD352C33CC33B93E,,,,,,,-1,BRCA1- 458755565,-984,41815,11,,,,EMPTY,,D,,0,13,13,270861,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,0.936,113705,-1,,,,,,,,,,,3,0.343,9,1,0.8125,0.15853658,0.54979074,GRCh38/hg38,17,43092418,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,JC
14,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245237,724,100.0,10,c.2311T>C,p.(Leu771=),A,G,0,724,TTG,CTG,L,L,NM_007294.3,NM_007294,41245237,within,.,,rs16940,0.3353,0.2776,,,,,,,,,,,,-,A,G,41245237,41245237,711AF22D84A49E875C2B2A9597A95EE6,,,,,,,-1,BRCA1- 458754763,1641,125554,11,,,,EMPTY,,D,,0,13,13,269517,492662,126000,,,0,0,,1:1,,0.342,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3422,9,1,0.8125,0.15853658,0.5470627,GRCh38/hg38,17,43093220,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,JC
2,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41215825,287,100.0,17,c.5152+66G>A,,C,T,0,287,,,,,NM_007294.3,NM_007294,41215825,within,.,,rs3092994,0.3425,,,,,,,,,,,,,-,C,T,41215825,41215825,5BCA8D2E1E3875817F84A3EB582CDFAB,,,,,,,-1,BRCA1- 458784175,0,55428,18,,,,EMPTY,,D,,0,12,12,241843,492662,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3139,16,1,0.75,0.14634146,0.4908903,GRCh38/hg38,17,43063808,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,JC
4,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219804,856,99.77,16,c.4987-92A>G,,T,C,2,854,,,,,NM_007294.3,NM_007294,41219804,within,.,,rs8176233,0.3546,,,,,,,,,,,,,-,T,C,41219804,41219804,7341B20C52FFD4B9355840FB9CB56CDA,,,,,,,-1,BRCA1- 458780196,0,125749,17,,,,EMPTY,,D,,0,13,13,225491,492662,126000,,,0,0,,,,,92,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3128,15,1,0.8125,0.15853658,0.45769918,GRCh38/hg38,17,43067787,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,JC
3,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219780,854,99.88,16,c.4987-68A>G,,T,C,1,853,,,,,NM_007294.3,NM_007294,41219780,within,.,,rs8176234,0.3546,,,,,,,,,,,,,-,T,C,41219780,41219780,5995ECC305C33150BF3BB2B0C22FCC2A,,,,,,,-1,BRCA1- 458780220,0,125746,17,,,,EMPTY,,D,,0,13,13,234031,492662,126000,,,0,0,,,,,68,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3148,15,1,0.8125,0.15853658,0.47503358,GRCh38/hg38,17,43067763,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,JC
6,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41223094,1360,100.0,15,c.4837A>G,p.(Ser1613Gly),T,C,0,1360,AGT,GGT,S,G,NM_007294.3,NM_007294,41223094,within,.,,rs1799966,0.3558,0.2982,,-0.194,0.968,0.038,0.814,0.0,1.5,,,,,-,T,C,41223094,41223094,E3C52286D31F229973DB3595B052645F,,,,,,,-1,BRCA1- 458776906,-150,41827,16,,,,EMPTY,,D,,0,13,13,273625,492662,126000,,,0,0,,1:1,,0.349,0,,,,,,,,,,,,,,Benign,Benign,0.255,113705,-1,,,,,,,,,,,3,0.35,14,1,0.8125,0.15853658,0.5554011,GRCh38/hg38,17,43071077,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,JC
15,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245466,2458,99.92,10,c.2082C>T,p.(Ser694=),G,A,2,2456,AGC,AGT,S,S,NM_007294.3,NM_007294,41245466,within,.,,rs1799949,0.3365,0.2957,,,,,,,,,,,,-,G,A,41245466,41245466,3364E3D252EFEDF917C74D44FBC6A381,,,,,,,-1,BRCA1- 458754534,1412,125536,11,,,,EMPTY,,D,,0,13,13,269442,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.8125,0.15853658,0.54691046,GRCh38/hg38,17,43093449,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,JC
23,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,672,100.0,14,c.7397T>C,p.(Val2466Ala),T,C,0,672,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,16,16,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.19512194,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,JC
21,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,936,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,936,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,16,16,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,0.19512194,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,JC
12,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32912299,903,49.72,11,c.3807T>C,p.(Val1269=),T,C,454,449,GTT,GTC,V,V,NM_000059.3,NM_000059,32912299,within,.,,rs543304,0.1681,0.1911,,,,,,,,,,,,+,T,C,32912299,32912299,F2D3E8FFB3CEE8C1ACEA66738E41BC1E,,,,,,,-1,BRCA2-  32912299,1898,126022,11,,,,EMPTY,,D,,0,6,6,173719,493217,126000,,,0,0,,1:3,,0.176,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.1754,10,1,0.375,0.07317073,0.35221615,GRCh38/hg38,13,32338162,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,JC
1,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32903685,1623,48.92,8,c.681+56C>T,,C,T,828,794,,,,,NM_000059.3,NM_000059,32903685,within,.,,rs2126042,0.1859,,,,,,,,,,,,,+,C,T,32903685,32903685,E9AEF840574909F4761D4EF7950E02CB,,,,,,,-1,BRCA2-  32903685,0,126192,8,,,,EMPTY,,D,,0,3,3,145186,493217,126000,,,0,0,,4:1,,,56,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2163,7,1,0.1875,0.036585364,0.29436535,GRCh38/hg38,13,32329548,C,T,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,JC
22,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,1693,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,1693,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,16,16,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,0.19512194,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,JC
24,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32936646,857,48.89,17,c.7806-14T>C,,T,C,438,419,,,,,NM_000059.3,NM_000059,32936646,within,.,,rs9534262,0.5316,0.5202,,,,,,,,,,,,+,T,C,32936646,32936646,5803939D8FBB75B042260991F0A62436,,,,,,,-1,BRCA2-  32936646,0,126158,17,,,,EMPTY,,D,,0,13,13,361616,493217,126000,,,0,0,,1:3,,0.52,14,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5255,16,1,0.8125,0.15853658,0.7331783,GRCh38/hg38,13,32362509,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,JC
25,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32953388,1013,47.98,22,c.8755-66T>C,,T,C,527,486,,,,,NM_000059.3,NM_000059,32953388,within,.,,rs4942486,0.5116,,,,,,,,,,,,,+,T,C,32953388,32953388,97C65B85894EB489F1BFA65897685241,,,,,,,-1,BRCA2-  32953388,0,126190,22,,,,EMPTY,,D,,0,13,13,347826,493217,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5257,21,1,0.8125,0.15853658,0.70521903,GRCh38/hg38,13,32379251,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,JC
17,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244936,1711,50.73,10,c.2612C>T,p.(Pro871Leu),G,A,843,868,CCG,CTG,P,L,NM_007294.3,NM_007294,41244936,within,.,,rs799917,0.5439,0.4932,,4.247,0.0,0.0,0.999,1.0,5.04,,,,,-,G,A,41244936,41244936,A19EA255CA888CE1FE48D08CAD633F1F,,,,,,,1,BRCA1- 458755064,-1485,41812,11,,,,EMPTY,,D,,1,13,13,290862,492662,126000,(eval),,0,0,,"1:4,2:1",,0.41,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.4127,9,3,0.8125,0.15853658,0.59038854,GRCh38/hg38,17,43092919,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,JM
10,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41223094,1488,48.05,15,c.4837A>G,p.(Ser1613Gly),T,C,772,715,AGT,GGT,S,G,NM_007294.3,NM_007294,41223094,within,.,,rs1799966,0.3558,0.2982,,-0.194,0.968,0.038,0.814,0.0,1.5,,,,,-,T,C,41223094,41223094,E3C52286D31F229973DB3595B052645F,,,,,,,-1,BRCA1- 458776906,-150,41827,16,,,,EMPTY,,D,,0,13,13,273625,492662,126000,,,0,0,,1:1,,0.349,0,,,,,,,,,,,,,,Benign,Benign,0.255,113705,-1,,,,,,,,,,,3,0.35,14,1,0.8125,0.15853658,0.5554011,GRCh38/hg38,17,43071077,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,JM
16,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244435,1828,48.3,10,c.3113A>G,p.(Glu1038Gly),T,C,945,883,GAA,GGA,E,G,NM_007294.3,NM_007294,41244435,within,.,,rs16941,0.3357,0.279,,-0.149,0.972,0.606,0.922,0.0,-0.974,,,,,-,T,C,41244435,41244435,5D0FF1321BAC3C76DD352C33CC33B93E,,,,,,,-1,BRCA1- 458755565,-984,41815,11,,,,EMPTY,,D,,0,13,13,270861,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,0.936,113705,-1,,,,,,,,,,,3,0.343,9,1,0.8125,0.15853658,0.54979074,GRCh38/hg38,17,43092418,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,JM
11,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41231516,689,49.64,13,c.4358-2885G>A,,C,T,347,342,,,,,NM_007294.3,NM_007294,41231516,within,.,,rs8176193,0.3534,,,,,,,,,,,,,-,C,T,41231516,41231516,7F4F80D2D005D34CEA47E4A2C561B172,,,,,,,-1,BRCA1- 458768484,0,209399,14,,,,EMPTY,,D,,0,13,13,190200,492662,126000,,,0,0,,,,,2885,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.317,12,1,0.8125,0.15853658,0.3860659,GRCh38/hg38,17,43079499,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,JM
19,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245466,2481,51.03,10,c.2082C>T,p.(Ser694=),G,A,1215,1266,AGC,AGT,S,S,NM_007294.3,NM_007294,41245466,within,.,,rs1799949,0.3365,0.2957,,,,,,,,,,,,-,G,A,41245466,41245466,3364E3D252EFEDF917C74D44FBC6A381,,,,,,,-1,BRCA1- 458754534,1412,125536,11,,,,EMPTY,,D,,0,13,13,269442,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.8125,0.15853658,0.54691046,GRCh38/hg38,17,43093449,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,JM
7,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219780,819,50.06,16,c.4987-68A>G,,T,C,409,410,,,,,NM_007294.3,NM_007294,41219780,within,.,,rs8176234,0.3546,,,,,,,,,,,,,-,T,C,41219780,41219780,5995ECC305C33150BF3BB2B0C22FCC2A,,,,,,,-1,BRCA1- 458780220,0,125746,17,,,,EMPTY,,D,,0,13,13,234031,492662,126000,,,0,0,,,,,68,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3148,15,1,0.8125,0.15853658,0.47503358,GRCh38/hg38,17,43067763,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,JM
13,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41234470,689,49.35,12,c.4308T>C,p.(Ser1436=),A,G,349,340,TCT,TCC,S,S,NM_007294.3,NM_007294,41234470,within,.,,rs1060915,0.3363,0.2796,,,,,,,,,,,,-,A,G,41234470,41234470,B7237055CF1D42F022A050C072B7583B,,,,,,,-1,BRCA1- 458765530,-50,125703,13,,,,EMPTY,,D,,0,13,13,270833,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3433,11,1,0.8125,0.15853658,0.5497339,GRCh38/hg38,17,43082453,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,JM
8,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219804,820,50.37,16,c.4987-92A>G,,T,C,407,413,,,,,NM_007294.3,NM_007294,41219804,within,.,,rs8176233,0.3546,,,,,,,,,,,,,-,T,C,41219804,41219804,7341B20C52FFD4B9355840FB9CB56CDA,,,,,,,-1,BRCA1- 458780196,0,125749,17,,,,EMPTY,,D,,0,13,13,225491,492662,126000,,,0,0,,,,,92,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3128,15,1,0.8125,0.15853658,0.45769918,GRCh38/hg38,17,43067787,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,JM
6,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41215825,342,50.58,17,c.5152+66G>A,,C,T,169,173,,,,,NM_007294.3,NM_007294,41215825,within,.,,rs3092994,0.3425,,,,,,,,,,,,,-,C,T,41215825,41215825,5BCA8D2E1E3875817F84A3EB582CDFAB,,,,,,,-1,BRCA1- 458784175,0,55428,18,,,,EMPTY,,D,,0,12,12,241843,492662,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3139,16,1,0.75,0.14634146,0.4908903,GRCh38/hg38,17,43063808,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,JM
18,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245237,832,50.72,10,c.2311T>C,p.(Leu771=),A,G,410,422,TTG,CTG,L,L,NM_007294.3,NM_007294,41245237,within,.,,rs16940,0.3353,0.2776,,,,,,,,,,,,-,A,G,41245237,41245237,711AF22D84A49E875C2B2A9597A95EE6,,,,,,,-1,BRCA1- 458754763,1641,125554,11,,,,EMPTY,,D,,0,13,13,269517,492662,126000,,,0,0,,1:1,,0.342,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3422,9,1,0.8125,0.15853658,0.5470627,GRCh38/hg38,17,43093220,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,JM
15,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244000,2131,51.9,10,c.3548A>G,p.(Lys1183Arg),T,C,1025,1106,AAA,AGA,K,R,NM_007294.3,NM_007294,41244000,within,.,,rs16942,0.3526,0.2952,,-0.319,0.0,0.001,0.924,0.0,-2.35,,,,,-,T,C,41244000,41244000,37A54117EA353BDA677332A1F61FA173,,,,,,,-1,BRCA1- 458756000,-549,41818,11,,,,EMPTY,,D,,0,13,13,272437,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.8125,0.15853658,0.55298966,GRCh38/hg38,17,43091983,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,JM
12,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906729,938,52.88,10,c.1114A>C,p.(Asn372His),A,C,442,496,AAT,CAT,N,H,NM_000059.3,NM_000059,32906729,within,.,,rs144848,0.2494,0.2332,,0.32,0.861,,0.269,0.0,0.396,,,,,+,A,C,32906729,32906729,D514F785F1344AF9F6975E589D47BDF6,,,,,,,-1,BRCA2-  32906729,321,9329,10,,,,EMPTY,,D,,0,9,9,233635,493217,126000,,,0,0,,"1:1,2:1",,0.277,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2733,9,1,0.5625,0.1097561,0.47369617,GRCh38/hg38,13,32332592,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,JM
27,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,1703,99.94,11,c.6513G>C,p.(Val2171=),G,C,0,1702,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,16,16,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,0.19512194,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,JM
30,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,708,100.0,14,c.7397T>C,p.(Val2466Ala),T,C,0,708,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,16,16,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.19512194,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,JM
2,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32936646,797,51.19,17,c.7806-14T>C,,T,C,389,408,,,,,NM_000059.3,NM_000059,32936646,within,.,,rs9534262,0.5316,0.5202,,,,,,,,,,,,+,T,C,32936646,32936646,5803939D8FBB75B042260991F0A62436,,,,,,,-1,BRCA2-  32936646,0,126158,17,,,,EMPTY,,D,,0,13,13,361616,493217,126000,,,0,0,,1:3,,0.52,14,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5255,16,1,0.8125,0.15853658,0.7331783,GRCh38/hg38,13,32362509,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,JM
3,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32953388,1098,51.18,22,c.8755-66T>C,,T,C,536,562,,,,,NM_000059.3,NM_000059,32953388,within,.,,rs4942486,0.5116,,,,,,,,,,,,,+,T,C,32953388,32953388,97C65B85894EB489F1BFA65897685241,,,,,,,-1,BRCA2-  32953388,0,126190,22,,,,EMPTY,,D,,0,13,13,347826,493217,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5257,21,1,0.8125,0.15853658,0.70521903,GRCh38/hg38,13,32379251,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,JM
29,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32929232,947,51.53,14,c.7242A>G,p.(Ser2414=),A,G,459,488,TCA,TCG,S,S,NM_000059.3,NM_000059,32929232,within,.,,rs1799955,0.2326,0.2114,,,,,,,,,,,,+,A,G,32929232,32929232,6F8D6FF8BC9027D6C0351ADCEF41FD20,,,,,,,-1,BRCA2-  32929232,-194,126133,14,,,,EMPTY,,D,,0,8,8,192923,493217,126000,,,0,0,,"1:3,2:1",,0.224,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2257,13,1,0.5,0.09756097,0.39115238,GRCh38/hg38,13,32355095,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,JM
1,D,BRCA2,,SNP,5'UTR,GRCh37/hg19,13,32890572,1993,50.53,2,c.-26G>A,,G,A,986,1007,,,,,NM_000059.3,NM_000059,32890572,within,.,,rs1799943,0.2093,0.2088,,,,,,,,,,,,+,G,A,32890572,32890572,A9C2B39455EF056EDB097A5953EB72EE,,,,,,,-1,BRCA2-  32890572,14,125965,2,,,,EMPTY,,D,,0,8,8,205902,493217,126000,,,0,0,,,,0.243,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2427,1,1,0.5,0.09756097,0.41746736,GRCh38/hg38,13,32316435,G,A,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,JM
23,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32911888,1235,52.47,11,c.3396A>G,p.(Lys1132=),A,G,586,648,AAA,AAG,K,K,NM_000059.3,NM_000059,32911888,within,.,,rs1801406,0.2668,0.2798,,,,,,,,,,,,+,A,G,32911888,32911888,94F2C0D328C28C466A38A430BBE75D52,,,,,,,-1,BRCA2-  32911888,1487,126010,11,,,,EMPTY,,D,,0,8,8,248687,493217,126000,,,0,0,,1:3,,0.293,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.295,10,1,0.5,0.09756097,0.50421417,GRCh38/hg38,13,32337751,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,JM
26,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,961,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,961,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,16,16,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,0.19512194,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,JM
31,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32930598,773,51.23,15,c.7469T>C,p.(Ile2490Thr),T,C,377,396,ATA,ACA,I,T,NM_000059.3,NM_000059,32930598,within,.,,rs11571707,0.016,0.0016,,0.406,0.895,,0.837,0.0,-5.83,,,,,+,T,C,32930598,32930598,D7CAF30A58440FCA5E8E7BACD8E1EDE4,,,,,,,-1,BRCA2-  32930598,34,96852,15,,,,EMPTY,,D,,0,5,5,6837,493217,126000,,,0,0,,"1:5,2:2",,0.014,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0176,14,2,0.3125,0.06097561,0.013862053,GRCh38/hg38,13,32356461,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,JM
15,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244936,965,50.88,10,c.2612C>T,p.(Pro871Leu),G,A,473,491,CCG,CTG,P,L,NM_007294.3,NM_007294,41244936,within,.,,rs799917,0.5439,0.4932,,4.247,0.0,0.0,0.999,1.0,5.04,,,,,-,G,A,41244936,41244936,A19EA255CA888CE1FE48D08CAD633F1F,,,,,,,1,BRCA1- 458755064,-1485,41812,11,,,,EMPTY,,D,,1,13,13,290862,492662,126000,(eval),,0,0,,"1:4,2:1",,0.41,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.4127,9,3,0.8125,0.15853658,0.59038854,GRCh38/hg38,17,43092919,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,KV
17,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245466,1393,49.96,10,c.2082C>T,p.(Ser694=),G,A,697,696,AGC,AGT,S,S,NM_007294.3,NM_007294,41245466,within,.,,rs1799949,0.3365,0.2957,,,,,,,,,,,,-,G,A,41245466,41245466,3364E3D252EFEDF917C74D44FBC6A381,,,,,,,-1,BRCA1- 458754534,1412,125536,11,,,,EMPTY,,D,,0,13,13,269442,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.8125,0.15853658,0.54691046,GRCh38/hg38,17,43093449,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,KV
13,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244000,1041,49.86,10,c.3548A>G,p.(Lys1183Arg),T,C,522,519,AAA,AGA,K,R,NM_007294.3,NM_007294,41244000,within,.,,rs16942,0.3526,0.2952,,-0.319,0.0,0.001,0.924,0.0,-2.35,,,,,-,T,C,41244000,41244000,37A54117EA353BDA677332A1F61FA173,,,,,,,-1,BRCA1- 458756000,-549,41818,11,,,,EMPTY,,D,,0,13,13,272437,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.8125,0.15853658,0.55298966,GRCh38/hg38,17,43091983,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,KV
9,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41231516,363,52.34,13,c.4358-2885G>A,,C,T,173,190,,,,,NM_007294.3,NM_007294,41231516,within,.,,rs8176193,0.3534,,,,,,,,,,,,,-,C,T,41231516,41231516,7F4F80D2D005D34CEA47E4A2C561B172,,,,,,,-1,BRCA1- 458768484,0,209399,14,,,,EMPTY,,D,,0,13,13,190200,492662,126000,,,0,0,,,,,2885,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.317,12,1,0.8125,0.15853658,0.3860659,GRCh38/hg38,17,43079499,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,KV
5,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219780,417,49.64,16,c.4987-68A>G,,T,C,210,207,,,,,NM_007294.3,NM_007294,41219780,within,.,,rs8176234,0.3546,,,,,,,,,,,,,-,T,C,41219780,41219780,5995ECC305C33150BF3BB2B0C22FCC2A,,,,,,,-1,BRCA1- 458780220,0,125746,17,,,,EMPTY,,D,,0,13,13,234031,492662,126000,,,0,0,,,,,68,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3148,15,1,0.8125,0.15853658,0.47503358,GRCh38/hg38,17,43067763,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,KV
6,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219804,417,49.64,16,c.4987-92A>G,,T,C,210,207,,,,,NM_007294.3,NM_007294,41219804,within,.,,rs8176233,0.3546,,,,,,,,,,,,,-,T,C,41219804,41219804,7341B20C52FFD4B9355840FB9CB56CDA,,,,,,,-1,BRCA1- 458780196,0,125749,17,,,,EMPTY,,D,,0,13,13,225491,492662,126000,,,0,0,,,,,92,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3128,15,1,0.8125,0.15853658,0.45769918,GRCh38/hg38,17,43067787,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,KV
10,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41234470,307,47.23,12,c.4308T>C,p.(Ser1436=),A,G,162,145,TCT,TCC,S,S,NM_007294.3,NM_007294,41234470,within,.,,rs1060915,0.3363,0.2796,,,,,,,,,,,,-,A,G,41234470,41234470,B7237055CF1D42F022A050C072B7583B,,,,,,,-1,BRCA1- 458765530,-50,125703,13,,,,EMPTY,,D,,0,13,13,270833,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3433,11,1,0.8125,0.15853658,0.5497339,GRCh38/hg38,17,43082453,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,KV
18,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41245471,1392,49.71,10,c.2077G>A,p.(Asp693Asn),C,T,700,692,GAC,AAC,D,N,NM_007294.3,NM_007294,41245471,within,.,,rs4986850,0.0335,0.0543,,0.205,0.989,0.01,0.597,0.0,1.23,,,,,-,C,T,41245471,41245471,1EA9438AD2460C6CC594B844CD8DC7F6,,,,,,,-1,BRCA1- 458754529,1407,41808,11,,,,EMPTY,,D,,0,4,4,63951,492662,126000,,,0,0,,1:2,,0.057,0,,,,,,,,,,,,,,Benign,Benign,0.001,113705,-1,,,,,,,,,,,3,0.058,9,1,0.25,0.048780486,0.12980705,GRCh38/hg38,17,43093454,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,KV
19,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41251931,685,47.88,7,c.442-34C>T,,G,A,357,328,,,,,NM_007294.3,NM_007294,41251931,within,.,,rs799923,0.0986,0.1757,,,,,,,,,,,,-,G,A,41251931,41251931,A5CCEFE1E7B19A106A59AB89C8776C53,,,,,,,-1,BRCA1- 458748069,0,125864,8,,,,EMPTY,,D,,0,5,5,181678,492662,126000,,,0,0,,,,0.174,34,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.1711,6,1,0.3125,0.06097561,0.36876804,GRCh38/hg38,17,43099914,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,KV
4,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41215825,288,52.78,17,c.5152+66G>A,,C,T,136,152,,,,,NM_007294.3,NM_007294,41215825,within,.,,rs3092994,0.3425,,,,,,,,,,,,,-,C,T,41215825,41215825,5BCA8D2E1E3875817F84A3EB582CDFAB,,,,,,,-1,BRCA1- 458784175,0,55428,18,,,,EMPTY,,D,,0,12,12,241843,492662,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3139,16,1,0.75,0.14634146,0.4908903,GRCh38/hg38,17,43063808,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,KV
8,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41223094,942,52.02,15,c.4837A>G,p.(Ser1613Gly),T,C,452,490,AGT,GGT,S,G,NM_007294.3,NM_007294,41223094,within,.,,rs1799966,0.3558,0.2982,,-0.194,0.968,0.038,0.814,0.0,1.5,,,,,-,T,C,41223094,41223094,E3C52286D31F229973DB3595B052645F,,,,,,,-1,BRCA1- 458776906,-150,41827,16,,,,EMPTY,,D,,0,13,13,273625,492662,126000,,,0,0,,1:1,,0.349,0,,,,,,,,,,,,,,Benign,Benign,0.255,113705,-1,,,,,,,,,,,3,0.35,14,1,0.8125,0.15853658,0.5554011,GRCh38/hg38,17,43071077,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,KV
16,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245237,525,51.81,10,c.2311T>C,p.(Leu771=),A,G,253,272,TTG,CTG,L,L,NM_007294.3,NM_007294,41245237,within,.,,rs16940,0.3353,0.2776,,,,,,,,,,,,-,A,G,41245237,41245237,711AF22D84A49E875C2B2A9597A95EE6,,,,,,,-1,BRCA1- 458754763,1641,125554,11,,,,EMPTY,,D,,0,13,13,269517,492662,126000,,,0,0,,1:1,,0.342,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3422,9,1,0.8125,0.15853658,0.5470627,GRCh38/hg38,17,43093220,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,KV
14,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244435,1040,47.69,10,c.3113A>G,p.(Glu1038Gly),T,C,544,496,GAA,GGA,E,G,NM_007294.3,NM_007294,41244435,within,.,,rs16941,0.3357,0.279,,-0.149,0.972,0.606,0.922,0.0,-0.974,,,,,-,T,C,41244435,41244435,5D0FF1321BAC3C76DD352C33CC33B93E,,,,,,,-1,BRCA1- 458755565,-984,41815,11,,,,EMPTY,,D,,0,13,13,270861,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,0.936,113705,-1,,,,,,,,,,,3,0.343,9,1,0.8125,0.15853658,0.54979074,GRCh38/hg38,17,43092418,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,KV
23,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32912299,524,50.76,11,c.3807T>C,p.(Val1269=),T,C,258,266,GTT,GTC,V,V,NM_000059.3,NM_000059,32912299,within,.,,rs543304,0.1681,0.1911,,,,,,,,,,,,+,T,C,32912299,32912299,F2D3E8FFB3CEE8C1ACEA66738E41BC1E,,,,,,,-1,BRCA2-  32912299,1898,126022,11,,,,EMPTY,,D,,0,6,6,173719,493217,126000,,,0,0,,1:3,,0.176,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.1754,10,1,0.375,0.07317073,0.35221615,GRCh38/hg38,13,32338162,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,KV
12,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32911888,863,48.9,11,c.3396A>G,p.(Lys1132=),A,G,440,422,AAA,AAG,K,K,NM_000059.3,NM_000059,32911888,within,.,,rs1801406,0.2668,0.2798,,,,,,,,,,,,+,A,G,32911888,32911888,94F2C0D328C28C466A38A430BBE75D52,,,,,,,-1,BRCA2-  32911888,1487,126010,11,,,,EMPTY,,D,,0,8,8,248687,493217,126000,,,0,0,,1:3,,0.293,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.295,10,1,0.5,0.09756097,0.50421417,GRCh38/hg38,13,32337751,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,KV
29,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32936646,442,45.25,17,c.7806-14T>C,,T,C,242,200,,,,,NM_000059.3,NM_000059,32936646,within,.,,rs9534262,0.5316,0.5202,,,,,,,,,,,,+,T,C,32936646,32936646,5803939D8FBB75B042260991F0A62436,,,,,,,-1,BRCA2-  32936646,0,126158,17,,,,EMPTY,,D,,0,13,13,361616,493217,126000,,,0,0,,1:3,,0.52,14,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5255,16,1,0.8125,0.15853658,0.7331783,GRCh38/hg38,13,32362509,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,KV
1,D,BRCA2,,SNP,5'UTR,GRCh37/hg19,13,32890572,1196,53.68,2,c.-26G>A,,G,A,554,642,,,,,NM_000059.3,NM_000059,32890572,within,.,,rs1799943,0.2093,0.2088,,,,,,,,,,,,+,G,A,32890572,32890572,A9C2B39455EF056EDB097A5953EB72EE,,,,,,,-1,BRCA2-  32890572,14,125965,2,,,,EMPTY,,D,,0,8,8,205902,493217,126000,,,0,0,,,,0.243,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2427,1,1,0.5,0.09756097,0.41746736,GRCh38/hg38,13,32316435,G,A,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,KV
25,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,702,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,702,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,16,16,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,0.19512194,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,KV
26,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,1020,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,1020,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,16,16,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,0.19512194,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,KV
27,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32929232,609,51.07,14,c.7242A>G,p.(Ser2414=),A,G,298,311,TCA,TCG,S,S,NM_000059.3,NM_000059,32929232,within,.,,rs1799955,0.2326,0.2114,,,,,,,,,,,,+,A,G,32929232,32929232,6F8D6FF8BC9027D6C0351ADCEF41FD20,,,,,,,-1,BRCA2-  32929232,-194,126133,14,,,,EMPTY,,D,,0,8,8,192923,493217,126000,,,0,0,,"1:3,2:1",,0.224,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2257,13,1,0.5,0.09756097,0.39115238,GRCh38/hg38,13,32355095,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,KV
28,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,481,99.79,14,c.7397T>C,p.(Val2466Ala),T,C,1,480,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,16,16,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.19512194,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,KV
30,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32953388,514,47.28,22,c.8755-66T>C,,T,C,271,243,,,,,NM_000059.3,NM_000059,32953388,within,.,,rs4942486,0.5116,,,,,,,,,,,,,+,T,C,32953388,32953388,97C65B85894EB489F1BFA65897685241,,,,,,,-1,BRCA2-  32953388,0,126190,22,,,,EMPTY,,D,,0,13,13,347826,493217,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5257,21,1,0.8125,0.15853658,0.70521903,GRCh38/hg38,13,32379251,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,KV
21,A,BRCA1,37445,INDEL,frameshift,GRCh37/hg19,17,41245442,1719,46.66,10,c.2105dup,p.(Leu702Phefs*10),TAA,TAAA,906,802,TTA,TTT,L,F,NM_007294.3,NM_007294,41245442,within,.,,rs80357880,,,,,,,,,,,,,,-,-,A,41245442,41245443,86A74A5E0379B7B5A9A8D8798254ED0C,,1,,,,,5,BRCA1- 458754558,1436,37445,11,,,,EMPTY,,A,,4,1,1,10,492662,126000,"""Patogenica en clinvar  Interpretation:     Pathogenic  Review status:     reviewed by expert panel  Submissions:     12  First in ClinVar:     Apr 1, 2014 Most recent Submission:     Mar 11, 2023 Last evaluated:     Sep 8, 2016 Accession:     VCV000037445.20 Variation ID:     37445 Description:     1bp duplication  """,,0,0,,,,,0,,,,,,,,,,,,,,Pathogenic,Pathogenic,,113705,-1,,,,,,,,,,,3,,9,5,0.0625,0.0121951215,2.0297892E-5,GRCh38/hg38,17,43093425,TAA,TAAA,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,LV
19,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244936,1921,50.6,10,c.2612C>T,p.(Pro871Leu),G,A,949,972,CCG,CTG,P,L,NM_007294.3,NM_007294,41244936,within,.,,rs799917,0.5439,0.4932,,4.247,0.0,0.0,0.999,1.0,5.04,,,,,-,G,A,41244936,41244936,A19EA255CA888CE1FE48D08CAD633F1F,,,,,,,1,BRCA1- 458755064,-1485,41812,11,,,,EMPTY,,D,,1,13,13,290862,492662,126000,(eval),,0,0,,"1:4,2:1",,0.41,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.4127,9,3,0.8125,0.15853658,0.59038854,GRCh38/hg38,17,43092919,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,LV
22,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245466,2694,47.18,10,c.2082C>T,p.(Ser694=),G,A,1423,1271,AGC,AGT,S,S,NM_007294.3,NM_007294,41245466,within,.,,rs1799949,0.3365,0.2957,,,,,,,,,,,,-,G,A,41245466,41245466,3364E3D252EFEDF917C74D44FBC6A381,,,,,,,-1,BRCA1- 458754534,1412,125536,11,,,,EMPTY,,D,,0,13,13,269442,492662,126000,,,0,0,,1:2,5,0.348,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.8125,0.15853658,0.54691046,GRCh38/hg38,17,43093449,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,LV
15,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41234470,720,49.17,12,c.4308T>C,p.(Ser1436=),A,G,364,354,TCT,TCC,S,S,NM_007294.3,NM_007294,41234470,within,.,,rs1060915,0.3363,0.2796,,,,,,,,,,,,-,A,G,41234470,41234470,B7237055CF1D42F022A050C072B7583B,,,,,,,-1,BRCA1- 458765530,-50,125703,13,,,,EMPTY,,D,,0,13,13,270833,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3433,11,1,0.8125,0.15853658,0.5497339,GRCh38/hg38,17,43082453,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,LV
18,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244435,2026,48.67,10,c.3113A>G,p.(Glu1038Gly),T,C,1040,986,GAA,GGA,E,G,NM_007294.3,NM_007294,41244435,within,.,,rs16941,0.3357,0.279,,-0.149,0.972,0.606,0.922,0.0,-0.974,,,,,-,T,C,41244435,41244435,5D0FF1321BAC3C76DD352C33CC33B93E,,,,,,,-1,BRCA1- 458755565,-984,41815,11,,,,EMPTY,,D,,0,13,13,270861,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,0.936,113705,-1,,,,,,,,,,,3,0.343,9,1,0.8125,0.15853658,0.54979074,GRCh38/hg38,17,43092418,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,LV
8,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41215825,316,50.32,17,c.5152+66G>A,,C,T,157,159,,,,,NM_007294.3,NM_007294,41215825,within,.,,rs3092994,0.3425,,,,,,,,,,,,,-,C,T,41215825,41215825,5BCA8D2E1E3875817F84A3EB582CDFAB,,,,,,,-1,BRCA1- 458784175,0,55428,18,,,,EMPTY,,D,,0,12,12,241843,492662,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3139,16,1,0.75,0.14634146,0.4908903,GRCh38/hg38,17,43063808,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,LV
10,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219804,949,47.84,16,c.4987-92A>G,,T,C,495,454,,,,,NM_007294.3,NM_007294,41219804,within,.,,rs8176233,0.3546,,,,,,,,,,,,,-,T,C,41219804,41219804,7341B20C52FFD4B9355840FB9CB56CDA,,,,,,,-1,BRCA1- 458780196,0,125749,17,,,,EMPTY,,D,,0,13,13,225491,492662,126000,,,0,0,,,,,92,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3128,15,1,0.8125,0.15853658,0.45769918,GRCh38/hg38,17,43067787,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,LV
17,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244000,2312,49.7,10,c.3548A>G,p.(Lys1183Arg),T,C,1163,1149,AAA,AGA,K,R,NM_007294.3,NM_007294,41244000,within,.,,rs16942,0.3526,0.2952,,-0.319,0.0,0.001,0.924,0.0,-2.35,,,,,-,T,C,41244000,41244000,37A54117EA353BDA677332A1F61FA173,,,,,,,-1,BRCA1- 458756000,-549,41818,11,,,,EMPTY,,D,,0,13,13,272437,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.8125,0.15853658,0.55298966,GRCh38/hg38,17,43091983,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,LV
14,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41231516,738,49.46,13,c.4358-2885G>A,,C,T,373,365,,,,,NM_007294.3,NM_007294,41231516,within,.,,rs8176193,0.3534,,,,,,,,,,,,,-,C,T,41231516,41231516,7F4F80D2D005D34CEA47E4A2C561B172,,,,,,,-1,BRCA1- 458768484,0,209399,14,,,,EMPTY,,D,,0,13,13,190200,492662,126000,,,0,0,,,,,2885,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.317,12,1,0.8125,0.15853658,0.3860659,GRCh38/hg38,17,43079499,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,LV
20,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245237,831,50.54,10,c.2311T>C,p.(Leu771=),A,G,411,420,TTG,CTG,L,L,NM_007294.3,NM_007294,41245237,within,.,,rs16940,0.3353,0.2776,,,,,,,,,,,,-,A,G,41245237,41245237,711AF22D84A49E875C2B2A9597A95EE6,,,,,,,-1,BRCA1- 458754763,1641,125554,11,,,,EMPTY,,D,,0,13,13,269517,492662,126000,,,0,0,,1:1,,0.342,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3422,9,1,0.8125,0.15853658,0.5470627,GRCh38/hg38,17,43093220,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,LV
9,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219780,952,48.0,16,c.4987-68A>G,,T,C,495,457,,,,,NM_007294.3,NM_007294,41219780,within,.,,rs8176234,0.3546,,,,,,,,,,,,,-,T,C,41219780,41219780,5995ECC305C33150BF3BB2B0C22FCC2A,,,,,,,-1,BRCA1- 458780220,0,125746,17,,,,EMPTY,,D,,0,13,13,234031,492662,126000,,,0,0,,,,,68,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3148,15,1,0.8125,0.15853658,0.47503358,GRCh38/hg38,17,43067763,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,LV
13,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41223094,1474,50.88,15,c.4837A>G,p.(Ser1613Gly),T,C,724,750,AGT,GGT,S,G,NM_007294.3,NM_007294,41223094,within,.,,rs1799966,0.3558,0.2982,,-0.194,0.968,0.038,0.814,0.0,1.5,,,,,-,T,C,41223094,41223094,E3C52286D31F229973DB3595B052645F,,,,,,,-1,BRCA1- 458776906,-150,41827,16,,,,EMPTY,,D,,0,13,13,273625,492662,126000,,,0,0,,1:1,,0.349,0,,,,,,,,,,,,,,Benign,Benign,0.255,113705,-1,,,,,,,,,,,3,0.35,14,1,0.8125,0.15853658,0.5554011,GRCh38/hg38,17,43071077,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,LV
32,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32911463,556,51.8,11,c.2971A>G,p.(Asn991Asp),A,G,268,288,AAC,GAC,N,D,NM_000059.3,NM_000059,32911463,within,.,,rs1799944,0.0801,0.0373,,-0.04,0.0,,0.959,0.0,3.08,,,,,+,A,G,32911463,32911463,36F4F7E6CD788E45B30EA486775D07D6,,,,,,,-1,BRCA2-  32911463,1062,41545,11,,,,EMPTY,,D,,0,3,3,42142,493217,126000,,,0,0,,1:2,,0.053,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0522,10,1,0.1875,0.036585364,0.085443124,GRCh38/hg38,13,32337326,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,LV
3,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32936646,820,47.8,17,c.7806-14T>C,,T,C,428,392,,,,,NM_000059.3,NM_000059,32936646,within,.,,rs9534262,0.5316,0.5202,,,,,,,,,,,,+,T,C,32936646,32936646,5803939D8FBB75B042260991F0A62436,,,,,,,-1,BRCA2-  32936646,0,126158,17,,,,EMPTY,,D,,0,13,13,361616,493217,126000,,,0,0,,1:3,,0.52,14,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5255,16,1,0.8125,0.15853658,0.7331783,GRCh38/hg38,13,32362509,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,LV
35,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,1869,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,1869,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,16,16,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,0.19512194,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,LV
5,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32953550,1283,48.48,22,c.8851G>A,p.(Ala2951Thr),G,A,661,622,GCC,ACC,A,T,NM_000059.3,NM_000059,32953550,within,.,,rs11571769,0.01,0.0044,,7.914,1.0,,1.0,1.0,5.6,,,,,+,G,A,32953550,32953550,D3D6E2E00CDC932E43B7A97E2FA9A9A6,,,,,,,-1,BRCA2-  32953550,97,41570,22,,,,EMPTY,,D,,0,1,1,7101,493217,126000,,,0,0,,"1:8,2:1",,0.0078,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0089,21,3,0.0625,0.0121951215,0.014397314,GRCh38/hg38,13,32379413,G,A,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,LV
12,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906480,1026,49.12,10,c.865A>C,p.(Asn289His),A,C,522,504,AAT,CAT,N,H,NM_000059.3,NM_000059,32906480,within,.,,rs766173,0.0737,0.0312,,0.498,0.998,,0.803,0.0,1.73,,,,,+,A,C,32906480,32906480,EE0CD2A1633CE9FEF0978528634002FE,,,,,,,-1,BRCA2-  32906480,72,41567,10,,,,EMPTY,,D,,0,3,3,41272,493217,126000,,,0,0,,"1:4,2:1",,0.051,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0496,9,2,0.1875,0.036585364,0.08367919,GRCh38/hg38,13,32332343,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,LV
1,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32899388,827,51.51,4,c.425+67A>C,,A,C,401,426,,,,,NM_000059.3,NM_000059,32899388,within,.,,rs11571610,0.0743,,,,,,,,,,,,,+,A,C,32899388,32899388,1AF346DE380A738371905EBFBCED20E1,,,,,,,-1,BRCA2-  32899388,0,126095,4,,,,EMPTY,,D,,0,3,3,39349,493217,126000,,,0,0,,2:1,,,67,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0306,3,3,0.1875,0.036585364,0.0797803,GRCh38/hg38,13,32325251,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,LV
34,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,985,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,985,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,16,16,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,0.19512194,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,LV
33,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32912299,1028,50.1,11,c.3807T>C,p.(Val1269=),T,C,513,515,GTT,GTC,V,V,NM_000059.3,NM_000059,32912299,within,.,,rs543304,0.1681,0.1911,,,,,,,,,,,,+,T,C,32912299,32912299,F2D3E8FFB3CEE8C1ACEA66738E41BC1E,,,,,,,-1,BRCA2-  32912299,1898,126022,11,,,,EMPTY,,D,,0,6,6,173719,493217,126000,,,0,0,,1:3,,0.176,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.1754,10,1,0.375,0.07317073,0.35221615,GRCh38/hg38,13,32338162,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,LV
31,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32910721,2158,48.93,11,c.2229T>C,p.(His743=),T,C,1101,1056,CAT,CAC,H,H,NM_000059.3,NM_000059,32910721,within,.,,rs1801499,0.0735,0.0313,,,,,,,,,,,,+,T,C,32910721,32910721,D39471F16FE6D1F6752C2D4D179996AF,,,,,,,-1,BRCA2-  32910721,320,125979,11,,,,EMPTY,,D,,0,3,3,41536,493217,126000,,,0,0,,1:1,,0.052,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0503,10,1,0.1875,0.036585364,0.08421446,GRCh38/hg38,13,32336584,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,LV
2,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32929478,629,50.87,14,c.7435+53C>T,,C,T,308,320,,,,,NM_000059.3,NM_000059,32929478,within,.,,rs11147489,0.0725,,,,,,,,,,,,,+,C,T,32929478,32929478,F692B4BE5DCD39FA887FE8D63D296720,,,,,,,-1,BRCA2-  32929478,0,126136,14,,,,EMPTY,,D,,0,3,3,36369,493217,126000,,,0,0,,,,,53,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0301,13,3,0.1875,0.036585364,0.07373834,GRCh38/hg38,13,32355341,C,T,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,LV
4,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32953388,1200,45.42,22,c.8755-66T>C,,T,C,655,545,,,,,NM_000059.3,NM_000059,32953388,within,.,,rs4942486,0.5116,,,,,,,,,,,,,+,T,C,32953388,32953388,97C65B85894EB489F1BFA65897685241,,,,,,,-1,BRCA2-  32953388,0,126190,22,,,,EMPTY,,D,,0,13,13,347826,493217,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5257,21,1,0.8125,0.15853658,0.70521903,GRCh38/hg38,13,32379251,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,LV
23,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32906980,1976,51.37,10,c.1365A>G,p.(Ser455=),A,G,960,1015,TCA,TCG,S,S,NM_000059.3,NM_000059,32906980,within,.,,rs1801439,0.0737,0.031,,,,,,,,,,,,+,A,G,32906980,32906980,C76C22E555E869928B452D866988AB4F,,,,,,,-1,BRCA2-  32906980,-545,125943,10,,,,EMPTY,,D,,0,3,3,41480,493217,126000,,,0,0,,"1:4,2:1",,0.051,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0499,9,2,0.1875,0.036585364,0.08410091,GRCh38/hg38,13,32332843,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,LV
36,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,762,100.0,14,c.7397T>C,p.(Val2466Ala),T,C,0,762,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,16,16,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.19512194,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,LV
13,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244936,1224,99.84,10,c.2612C>T,p.(Pro871Leu),G,A,2,1222,CCG,CTG,P,L,NM_007294.3,NM_007294,41244936,within,.,,rs799917,0.5439,0.4932,,4.247,0.0,0.0,0.999,1.0,5.04,,,,,-,G,A,41244936,41244936,A19EA255CA888CE1FE48D08CAD633F1F,,,,,,,1,BRCA1- 458755064,-1485,41812,11,,,,EMPTY,,D,,1,13,13,290862,492662,126000,(eval),,0,0,,"1:4,2:1",,0.41,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.4127,9,3,0.8125,0.15853658,0.59038854,GRCh38/hg38,17,43092919,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,MC
10,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244000,1486,99.87,10,c.3548A>G,p.(Lys1183Arg),T,C,2,1484,AAA,AGA,K,R,NM_007294.3,NM_007294,41244000,within,.,,rs16942,0.3526,0.2952,,-0.319,0.0,0.001,0.924,0.0,-2.35,,,,,-,T,C,41244000,41244000,37A54117EA353BDA677332A1F61FA173,,,,,,,-1,BRCA1- 458756000,-549,41818,11,,,,EMPTY,,D,,0,13,13,272437,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.8125,0.15853658,0.55298966,GRCh38/hg38,17,43091983,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,MC
8,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41234470,429,99.77,12,c.4308T>C,p.(Ser1436=),A,G,1,428,TCT,TCC,S,S,NM_007294.3,NM_007294,41234470,within,.,,rs1060915,0.3363,0.2796,,,,,,,,,,,,-,A,G,41234470,41234470,B7237055CF1D42F022A050C072B7583B,,,,,,,-1,BRCA1- 458765530,-50,125703,13,,,,EMPTY,,D,,0,13,13,270833,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3433,11,1,0.8125,0.15853658,0.5497339,GRCh38/hg38,17,43082453,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,MC
7,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41231516,460,100.0,13,c.4358-2885G>A,,C,T,0,460,,,,,NM_007294.3,NM_007294,41231516,within,.,,rs8176193,0.3534,,,,,,,,,,,,,-,C,T,41231516,41231516,7F4F80D2D005D34CEA47E4A2C561B172,,,,,,,-1,BRCA1- 458768484,0,209399,14,,,,EMPTY,,D,,0,13,13,190200,492662,126000,,,0,0,,,,,2885,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.317,12,1,0.8125,0.15853658,0.3860659,GRCh38/hg38,17,43079499,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,MC
11,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244435,1316,100.0,10,c.3113A>G,p.(Glu1038Gly),T,C,0,1316,GAA,GGA,E,G,NM_007294.3,NM_007294,41244435,within,.,,rs16941,0.3357,0.279,,-0.149,0.972,0.606,0.922,0.0,-0.974,,,,,-,T,C,41244435,41244435,5D0FF1321BAC3C76DD352C33CC33B93E,,,,,,,-1,BRCA1- 458755565,-984,41815,11,,,,EMPTY,,D,,0,13,13,270861,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,0.936,113705,-1,,,,,,,,,,,3,0.343,9,1,0.8125,0.15853658,0.54979074,GRCh38/hg38,17,43092418,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,MC
14,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245237,573,100.0,10,c.2311T>C,p.(Leu771=),A,G,0,573,TTG,CTG,L,L,NM_007294.3,NM_007294,41245237,within,.,,rs16940,0.3353,0.2776,,,,,,,,,,,,-,A,G,41245237,41245237,711AF22D84A49E875C2B2A9597A95EE6,,,,,,,-1,BRCA1- 458754763,1641,125554,11,,,,EMPTY,,D,,0,13,13,269517,492662,126000,,,0,0,,1:1,,0.342,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3422,9,1,0.8125,0.15853658,0.5470627,GRCh38/hg38,17,43093220,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,MC
2,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41215825,316,99.68,17,c.5152+66G>A,,C,T,1,315,,,,,NM_007294.3,NM_007294,41215825,within,.,,rs3092994,0.3425,,,,,,,,,,,,,-,C,T,41215825,41215825,5BCA8D2E1E3875817F84A3EB582CDFAB,,,,,,,-1,BRCA1- 458784175,0,55428,18,,,,EMPTY,,D,,0,12,12,241843,492662,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3139,16,1,0.75,0.14634146,0.4908903,GRCh38/hg38,17,43063808,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,MC
4,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219804,702,100.0,16,c.4987-92A>G,,T,C,0,702,,,,,NM_007294.3,NM_007294,41219804,within,.,,rs8176233,0.3546,,,,,,,,,,,,,-,T,C,41219804,41219804,7341B20C52FFD4B9355840FB9CB56CDA,,,,,,,-1,BRCA1- 458780196,0,125749,17,,,,EMPTY,,D,,0,13,13,225491,492662,126000,,,0,0,,,,,92,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3128,15,1,0.8125,0.15853658,0.45769918,GRCh38/hg38,17,43067787,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,MC
3,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219780,706,100.0,16,c.4987-68A>G,,T,C,0,706,,,,,NM_007294.3,NM_007294,41219780,within,.,,rs8176234,0.3546,,,,,,,,,,,,,-,T,C,41219780,41219780,5995ECC305C33150BF3BB2B0C22FCC2A,,,,,,,-1,BRCA1- 458780220,0,125746,17,,,,EMPTY,,D,,0,13,13,234031,492662,126000,,,0,0,,,,,68,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3148,15,1,0.8125,0.15853658,0.47503358,GRCh38/hg38,17,43067763,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,MC
6,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41223094,1213,99.92,15,c.4837A>G,p.(Ser1613Gly),T,C,1,1212,AGT,GGT,S,G,NM_007294.3,NM_007294,41223094,within,.,,rs1799966,0.3558,0.2982,,-0.194,0.968,0.038,0.814,0.0,1.5,,,,,-,T,C,41223094,41223094,E3C52286D31F229973DB3595B052645F,,,,,,,-1,BRCA1- 458776906,-150,41827,16,,,,EMPTY,,D,,0,13,13,273625,492662,126000,,,0,0,,1:1,,0.349,0,,,,,,,,,,,,,,Benign,Benign,0.255,113705,-1,,,,,,,,,,,3,0.35,14,1,0.8125,0.15853658,0.5554011,GRCh38/hg38,17,43071077,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,MC
16,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41245471,1656,50.12,10,c.2077G>A,p.(Asp693Asn),C,T,826,830,GAC,AAC,D,N,NM_007294.3,NM_007294,41245471,within,.,,rs4986850,0.0335,0.0543,,0.205,0.989,0.01,0.597,0.0,1.23,,,,,-,C,T,41245471,41245471,1EA9438AD2460C6CC594B844CD8DC7F6,,,,,,,-1,BRCA1- 458754529,1407,41808,11,,,,EMPTY,,D,,0,4,4,63951,492662,126000,,,0,0,,1:2,,0.057,0,,,,,,,,,,,,,,Benign,Benign,0.001,113705,-1,,,,,,,,,,,3,0.058,9,1,0.25,0.048780486,0.12980705,GRCh38/hg38,17,43093454,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,MC
15,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245466,1658,99.94,10,c.2082C>T,p.(Ser694=),G,A,1,1657,AGC,AGT,S,S,NM_007294.3,NM_007294,41245466,within,.,,rs1799949,0.3365,0.2957,,,,,,,,,,,,-,G,A,41245466,41245466,3364E3D252EFEDF917C74D44FBC6A381,,,,,,,-1,BRCA1- 458754534,1412,125536,11,,,,EMPTY,,D,,0,13,13,269442,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.8125,0.15853658,0.54691046,GRCh38/hg38,17,43093449,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,MC
25,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32929232,660,50.91,14,c.7242A>G,p.(Ser2414=),A,G,324,336,TCA,TCG,S,S,NM_000059.3,NM_000059,32929232,within,.,,rs1799955,0.2326,0.2114,,,,,,,,,,,,+,A,G,32929232,32929232,6F8D6FF8BC9027D6C0351ADCEF41FD20,,,,,,,-1,BRCA2-  32929232,-194,126133,14,,,,EMPTY,,D,,0,8,8,192923,493217,126000,,,0,0,,"1:3,2:1",,0.224,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2257,13,1,0.5,0.09756097,0.39115238,GRCh38/hg38,13,32355095,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,MC
12,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32911888,769,100.0,11,c.3396A>G,p.(Lys1132=),A,G,0,769,AAA,AAG,K,K,NM_000059.3,NM_000059,32911888,within,.,,rs1801406,0.2668,0.2798,,,,,,,,,,,,+,A,G,32911888,32911888,94F2C0D328C28C466A38A430BBE75D52,,,,,,,-1,BRCA2-  32911888,1487,126010,11,,,,EMPTY,,D,,0,8,8,248687,493217,126000,,,0,0,,1:3,,0.293,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.295,10,1,0.5,0.09756097,0.50421417,GRCh38/hg38,13,32337751,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,MC
26,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,487,100.0,14,c.7397T>C,p.(Val2466Ala),T,C,0,487,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,16,16,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.19512194,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,MC
1,D,BRCA2,,SNP,5'UTR,GRCh37/hg19,13,32890572,1428,99.72,2,c.-26G>A,,G,A,3,1424,,,,,NM_000059.3,NM_000059,32890572,within,.,,rs1799943,0.2093,0.2088,,,,,,,,,,,,+,G,A,32890572,32890572,A9C2B39455EF056EDB097A5953EB72EE,,,,,,,-1,BRCA2-  32890572,14,125965,2,,,,EMPTY,,D,,0,8,8,205902,493217,126000,,,0,0,,,,0.243,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2427,1,1,0.5,0.09756097,0.41746736,GRCh38/hg38,13,32316435,G,A,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,MC
24,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,1316,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,1316,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,16,16,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,0.19512194,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,MC
23,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,748,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,748,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,16,16,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,0.19512194,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,MC
28,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32953388,723,50.21,22,c.8755-66T>C,,T,C,360,363,,,,,NM_000059.3,NM_000059,32953388,within,.,,rs4942486,0.5116,,,,,,,,,,,,,+,T,C,32953388,32953388,97C65B85894EB489F1BFA65897685241,,,,,,,-1,BRCA2-  32953388,0,126190,22,,,,EMPTY,,D,,0,13,13,347826,493217,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5257,21,1,0.8125,0.15853658,0.70521903,GRCh38/hg38,13,32379251,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,MC
27,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32936646,500,48.8,17,c.7806-14T>C,,T,C,256,244,,,,,NM_000059.3,NM_000059,32936646,within,.,,rs9534262,0.5316,0.5202,,,,,,,,,,,,+,T,C,32936646,32936646,5803939D8FBB75B042260991F0A62436,,,,,,,-1,BRCA2-  32936646,0,126158,17,,,,EMPTY,,D,,0,13,13,361616,493217,126000,,,0,0,,1:3,,0.52,14,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5255,16,1,0.8125,0.15853658,0.7331783,GRCh38/hg38,13,32362509,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,MC
11,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41251931,1014,47.93,7,c.442-34C>T,,G,A,528,486,,,,,NM_007294.3,NM_007294,41251931,within,.,,rs799923,0.0986,0.1757,,,,,,,,,,,,-,G,A,41251931,41251931,A5CCEFE1E7B19A106A59AB89C8776C53,,,,,,,-1,BRCA1- 458748069,0,125864,8,,,,EMPTY,,D,,0,5,5,181678,492662,126000,,,0,0,,,,0.174,34,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.1711,6,1,0.3125,0.06097561,0.36876804,GRCh38/hg38,17,43099914,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,ML
3,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,733,100.0,14,c.7397T>C,p.(Val2466Ala),T,C,0,733,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,16,16,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.19512194,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,ML
24,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,1876,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,1876,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,16,16,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,0.19512194,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,ML
5,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32936646,806,49.01,17,c.7806-14T>C,,T,C,411,395,,,,,NM_000059.3,NM_000059,32936646,within,.,,rs9534262,0.5316,0.5202,,,,,,,,,,,,+,T,C,32936646,32936646,5803939D8FBB75B042260991F0A62436,,,,,,,-1,BRCA2-  32936646,0,126158,17,,,,EMPTY,,D,,0,13,13,361616,493217,126000,,,0,0,,1:3,,0.52,14,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5255,16,1,0.8125,0.15853658,0.7331783,GRCh38/hg38,13,32362509,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,ML
18,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32906980,2051,48.85,10,c.1365A>G,p.(Ser455=),A,G,1049,1002,TCA,TCG,S,S,NM_000059.3,NM_000059,32906980,within,.,,rs1801439,0.0737,0.031,,,,,,,,,,,,+,A,G,32906980,32906980,C76C22E555E869928B452D866988AB4F,,,,,,,-1,BRCA2-  32906980,-545,125943,10,,,,EMPTY,,D,,0,3,3,41480,493217,126000,,,0,0,,"1:4,2:1",,0.051,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0499,9,2,0.1875,0.036585364,0.08410091,GRCh38/hg38,13,32332843,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,ML
22,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,916,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,916,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,16,16,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,0.19512194,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,ML
19,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32910721,2171,51.82,11,c.2229T>C,p.(His743=),T,C,1046,1125,CAT,CAC,H,H,NM_000059.3,NM_000059,32910721,within,.,,rs1801499,0.0735,0.0313,,,,,,,,,,,,+,T,C,32910721,32910721,D39471F16FE6D1F6752C2D4D179996AF,,,,,,,-1,BRCA2-  32910721,320,125979,11,,,,EMPTY,,D,,0,3,3,41536,493217,126000,,,0,0,,1:1,,0.052,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0503,10,1,0.1875,0.036585364,0.08421446,GRCh38/hg38,13,32336584,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,ML
20,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32911463,664,48.8,11,c.2971A>G,p.(Asn991Asp),A,G,340,324,AAC,GAC,N,D,NM_000059.3,NM_000059,32911463,within,.,,rs1799944,0.0801,0.0373,,-0.04,0.0,,0.959,0.0,3.08,,,,,+,A,G,32911463,32911463,36F4F7E6CD788E45B30EA486775D07D6,,,,,,,-1,BRCA2-  32911463,1062,41545,11,,,,EMPTY,,D,,0,3,3,42142,493217,126000,,,0,0,,1:2,,0.053,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0522,10,1,0.1875,0.036585364,0.085443124,GRCh38/hg38,13,32337326,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,ML
23,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32914815,818,51.22,11,c.6323G>A,p.(Arg2108His),G,A,399,419,CGT,CAT,R,H,NM_000059.3,NM_000059,32914815,within,.,,rs35029074,0.0038,0.0033,,0.072,0.853,,0.557,0.0,2.76,,,,,+,G,A,32914815,32914815,0F43B205542C45ED1D3D73FBB43CB228,,,,,,,-1,BRCA2-  32914815,-519,38037,11,,,,EMPTY,,D,,0,1,1,1134,493217,126000,,,0,0,,"1:3,2:3",,0.0013,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0013,10,3,0.0625,0.0121951215,0.0022991907,GRCh38/hg38,13,32340678,G,A,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,ML
6,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32953388,1142,50.35,22,c.8755-66T>C,,T,C,567,575,,,,,NM_000059.3,NM_000059,32953388,within,.,,rs4942486,0.5116,,,,,,,,,,,,,+,T,C,32953388,32953388,97C65B85894EB489F1BFA65897685241,,,,,,,-1,BRCA2-  32953388,0,126190,22,,,,EMPTY,,D,,0,13,13,347826,493217,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5257,21,1,0.8125,0.15853658,0.70521903,GRCh38/hg38,13,32379251,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,ML
12,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906480,1039,50.82,10,c.865A>C,p.(Asn289His),A,C,510,528,AAT,CAT,N,H,NM_000059.3,NM_000059,32906480,within,.,,rs766173,0.0737,0.0312,,0.498,0.998,,0.803,0.0,1.73,,,,,+,A,C,32906480,32906480,EE0CD2A1633CE9FEF0978528634002FE,,,,,,,-1,BRCA2-  32906480,72,41567,10,,,,EMPTY,,D,,0,3,3,41272,493217,126000,,,0,0,,"1:4,2:1",,0.051,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0496,9,2,0.1875,0.036585364,0.08367919,GRCh38/hg38,13,32332343,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,ML
21,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32912299,777,49.16,11,c.3807T>C,p.(Val1269=),T,C,395,382,GTT,GTC,V,V,NM_000059.3,NM_000059,32912299,within,.,,rs543304,0.1681,0.1911,,,,,,,,,,,,+,T,C,32912299,32912299,F2D3E8FFB3CEE8C1ACEA66738E41BC1E,,,,,,,-1,BRCA2-  32912299,1898,126022,11,,,,EMPTY,,D,,0,6,6,173719,493217,126000,,,0,0,,1:3,,0.176,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.1754,10,1,0.375,0.07317073,0.35221615,GRCh38/hg38,13,32338162,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,ML
1,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32899388,703,50.5,4,c.425+67A>C,,A,C,348,355,,,,,NM_000059.3,NM_000059,32899388,within,.,,rs11571610,0.0743,,,,,,,,,,,,,+,A,C,32899388,32899388,1AF346DE380A738371905EBFBCED20E1,,,,,,,-1,BRCA2-  32899388,0,126095,4,,,,EMPTY,,D,,0,3,3,39349,493217,126000,,,0,0,,2:1,,,67,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0306,3,3,0.1875,0.036585364,0.0797803,GRCh38/hg38,13,32325251,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,ML
4,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32929478,811,45.5,14,c.7435+53C>T,,C,T,442,369,,,,,NM_000059.3,NM_000059,32929478,within,.,,rs11147489,0.0725,,,,,,,,,,,,,+,C,T,32929478,32929478,F692B4BE5DCD39FA887FE8D63D296720,,,,,,,-1,BRCA2-  32929478,0,126136,14,,,,EMPTY,,D,,0,3,3,36369,493217,126000,,,0,0,,,,,53,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0301,13,3,0.1875,0.036585364,0.07373834,GRCh38/hg38,13,32355341,C,T,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,ML
19,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244936,1598,49.5,10,c.2612C>T,p.(Pro871Leu),G,A,807,791,CCG,CTG,P,L,NM_007294.3,NM_007294,41244936,within,.,,rs799917,0.5439,0.4932,,4.247,0.0,0.0,0.999,1.0,5.04,,,,,-,G,A,41244936,41244936,A19EA255CA888CE1FE48D08CAD633F1F,,,,,,,1,BRCA1- 458755064,-1485,41812,11,,,,EMPTY,,D,,1,13,13,290862,492662,126000,(eval),,0,0,,"1:4,2:1",,0.41,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.4127,9,3,0.8125,0.15853658,0.59038854,GRCh38/hg38,17,43092919,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,NS
17,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244000,1634,47.31,10,c.3548A>G,p.(Lys1183Arg),T,C,861,773,AAA,AGA,K,R,NM_007294.3,NM_007294,41244000,within,.,,rs16942,0.3526,0.2952,,-0.319,0.0,0.001,0.924,0.0,-2.35,,,,,-,T,C,41244000,41244000,37A54117EA353BDA677332A1F61FA173,,,,,,,-1,BRCA1- 458756000,-549,41818,11,,,,EMPTY,,D,,0,13,13,272437,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.8125,0.15853658,0.55298966,GRCh38/hg38,17,43091983,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,NS
21,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245466,2161,49.1,10,c.2082C>T,p.(Ser694=),G,A,1100,1061,AGC,AGT,S,S,NM_007294.3,NM_007294,41245466,within,.,,rs1799949,0.3365,0.2957,,,,,,,,,,,,-,G,A,41245466,41245466,3364E3D252EFEDF917C74D44FBC6A381,,,,,,,-1,BRCA1- 458754534,1412,125536,11,,,,EMPTY,,D,,0,13,13,269442,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.8125,0.15853658,0.54691046,GRCh38/hg38,17,43093449,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,NS
14,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41231516,497,50.1,13,c.4358-2885G>A,,C,T,248,249,,,,,NM_007294.3,NM_007294,41231516,within,.,,rs8176193,0.3534,,,,,,,,,,,,,-,C,T,41231516,41231516,7F4F80D2D005D34CEA47E4A2C561B172,,,,,,,-1,BRCA1- 458768484,0,209399,14,,,,EMPTY,,D,,0,13,13,190200,492662,126000,,,0,0,,,,,2885,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.317,12,1,0.8125,0.15853658,0.3860659,GRCh38/hg38,17,43079499,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,NS
15,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41234470,436,49.31,12,c.4308T>C,p.(Ser1436=),A,G,221,215,TCT,TCC,S,S,NM_007294.3,NM_007294,41234470,within,.,,rs1060915,0.3363,0.2796,,,,,,,,,,,,-,A,G,41234470,41234470,B7237055CF1D42F022A050C072B7583B,,,,,,,-1,BRCA1- 458765530,-50,125703,13,,,,EMPTY,,D,,0,13,13,270833,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3433,11,1,0.8125,0.15853658,0.5497339,GRCh38/hg38,17,43082453,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,NS
18,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244435,1661,48.89,10,c.3113A>G,p.(Glu1038Gly),T,C,849,812,GAA,GGA,E,G,NM_007294.3,NM_007294,41244435,within,.,,rs16941,0.3357,0.279,,-0.149,0.972,0.606,0.922,0.0,-0.974,,,,,-,T,C,41244435,41244435,5D0FF1321BAC3C76DD352C33CC33B93E,,,,,,,-1,BRCA1- 458755565,-984,41815,11,,,,EMPTY,,D,,0,13,13,270861,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,0.936,113705,-1,,,,,,,,,,,3,0.343,9,1,0.8125,0.15853658,0.54979074,GRCh38/hg38,17,43092418,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,NS
20,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245237,763,45.61,10,c.2311T>C,p.(Leu771=),A,G,415,348,TTG,CTG,L,L,NM_007294.3,NM_007294,41245237,within,.,,rs16940,0.3353,0.2776,,,,,,,,,,,,-,A,G,41245237,41245237,711AF22D84A49E875C2B2A9597A95EE6,,,,,,,-1,BRCA1- 458754763,1641,125554,11,,,,EMPTY,,D,,0,13,13,269517,492662,126000,,,0,0,,1:1,,0.342,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3422,9,1,0.8125,0.15853658,0.5470627,GRCh38/hg38,17,43093220,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,NS
8,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41215825,483,48.65,17,c.5152+66G>A,,C,T,248,235,,,,,NM_007294.3,NM_007294,41215825,within,.,,rs3092994,0.3425,,,,,,,,,,,,,-,C,T,41215825,41215825,5BCA8D2E1E3875817F84A3EB582CDFAB,,,,,,,-1,BRCA1- 458784175,0,55428,18,,,,EMPTY,,D,,0,12,12,241843,492662,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3139,16,1,0.75,0.14634146,0.4908903,GRCh38/hg38,17,43063808,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,NS
9,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219780,582,47.25,16,c.4987-68A>G,,T,C,307,275,,,,,NM_007294.3,NM_007294,41219780,within,.,,rs8176234,0.3546,,,,,,,,,,,,,-,T,C,41219780,41219780,5995ECC305C33150BF3BB2B0C22FCC2A,,,,,,,-1,BRCA1- 458780220,0,125746,17,,,,EMPTY,,D,,0,13,13,234031,492662,126000,,,0,0,,,,,68,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3148,15,1,0.8125,0.15853658,0.47503358,GRCh38/hg38,17,43067763,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,NS
13,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41223094,1399,47.61,15,c.4837A>G,p.(Ser1613Gly),T,C,733,666,AGT,GGT,S,G,NM_007294.3,NM_007294,41223094,within,.,,rs1799966,0.3558,0.2982,,-0.194,0.968,0.038,0.814,0.0,1.5,,,,,-,T,C,41223094,41223094,E3C52286D31F229973DB3595B052645F,,,,,,,-1,BRCA1- 458776906,-150,41827,16,,,,EMPTY,,D,,0,13,13,273625,492662,126000,,,0,0,,1:1,,0.349,0,,,,,,,,,,,,,,Benign,Benign,0.255,113705,-1,,,,,,,,,,,3,0.35,14,1,0.8125,0.15853658,0.5554011,GRCh38/hg38,17,43071077,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,NS
10,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219804,581,47.85,16,c.4987-92A>G,,T,C,303,278,,,,,NM_007294.3,NM_007294,41219804,within,.,,rs8176233,0.3546,,,,,,,,,,,,,-,T,C,41219804,41219804,7341B20C52FFD4B9355840FB9CB56CDA,,,,,,,-1,BRCA1- 458780196,0,125749,17,,,,EMPTY,,D,,0,13,13,225491,492662,126000,,,0,0,,,,,92,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3128,15,1,0.8125,0.15853658,0.45769918,GRCh38/hg38,17,43067787,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,NS
3,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32929478,457,47.7,14,c.7435+53C>T,,C,T,239,218,,,,,NM_000059.3,NM_000059,32929478,within,.,,rs11147489,0.0725,,,,,,,,,,,,,+,C,T,32929478,32929478,F692B4BE5DCD39FA887FE8D63D296720,,,,,,,-1,BRCA2-  32929478,0,126136,14,,,,EMPTY,,D,,0,3,3,36369,493217,126000,,,0,0,,,,,53,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0301,13,3,0.1875,0.036585364,0.07373834,GRCh38/hg38,13,32355341,C,T,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,NS
31,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32912299,810,52.35,11,c.3807T>C,p.(Val1269=),T,C,386,424,GTT,GTC,V,V,NM_000059.3,NM_000059,32912299,within,.,,rs543304,0.1681,0.1911,,,,,,,,,,,,+,T,C,32912299,32912299,F2D3E8FFB3CEE8C1ACEA66738E41BC1E,,,,,,,-1,BRCA2-  32912299,1898,126022,11,,,,EMPTY,,D,,0,6,6,173719,493217,126000,,,0,0,,1:3,,0.176,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.1754,10,1,0.375,0.07317073,0.35221615,GRCh38/hg38,13,32338162,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,NS
29,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32910721,1623,51.26,11,c.2229T>C,p.(His743=),T,C,791,832,CAT,CAC,H,H,NM_000059.3,NM_000059,32910721,within,.,,rs1801499,0.0735,0.0313,,,,,,,,,,,,+,T,C,32910721,32910721,D39471F16FE6D1F6752C2D4D179996AF,,,,,,,-1,BRCA2-  32910721,320,125979,11,,,,EMPTY,,D,,0,3,3,41536,493217,126000,,,0,0,,1:1,,0.052,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0503,10,1,0.1875,0.036585364,0.08421446,GRCh38/hg38,13,32336584,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,NS
5,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32953388,835,45.27,22,c.8755-66T>C,,T,C,457,378,,,,,NM_000059.3,NM_000059,32953388,within,.,,rs4942486,0.5116,,,,,,,,,,,,,+,T,C,32953388,32953388,97C65B85894EB489F1BFA65897685241,,,,,,,-1,BRCA2-  32953388,0,126190,22,,,,EMPTY,,D,,0,13,13,347826,493217,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5257,21,1,0.8125,0.15853658,0.70521903,GRCh38/hg38,13,32379251,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,NS
30,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32911463,343,48.4,11,c.2971A>G,p.(Asn991Asp),A,G,177,166,AAC,GAC,N,D,NM_000059.3,NM_000059,32911463,within,.,,rs1799944,0.0801,0.0373,,-0.04,0.0,,0.959,0.0,3.08,,,,,+,A,G,32911463,32911463,36F4F7E6CD788E45B30EA486775D07D6,,,,,,,-1,BRCA2-  32911463,1062,41545,11,,,,EMPTY,,D,,0,3,3,42142,493217,126000,,,0,0,,1:2,,0.053,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0522,10,1,0.1875,0.036585364,0.085443124,GRCh38/hg38,13,32337326,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,NS
4,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32936646,732,51.91,17,c.7806-14T>C,,T,C,352,380,,,,,NM_000059.3,NM_000059,32936646,within,.,,rs9534262,0.5316,0.5202,,,,,,,,,,,,+,T,C,32936646,32936646,5803939D8FBB75B042260991F0A62436,,,,,,,-1,BRCA2-  32936646,0,126158,17,,,,EMPTY,,D,,0,13,13,361616,493217,126000,,,0,0,,1:3,,0.52,14,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5255,16,1,0.8125,0.15853658,0.7331783,GRCh38/hg38,13,32362509,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,NS
33,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,1699,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,1699,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,16,16,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,0.19512194,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,NS
12,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906480,1013,46.69,10,c.865A>C,p.(Asn289His),A,C,539,473,AAT,CAT,N,H,NM_000059.3,NM_000059,32906480,within,.,,rs766173,0.0737,0.0312,,0.498,0.998,,0.803,0.0,1.73,,,,,+,A,C,32906480,32906480,EE0CD2A1633CE9FEF0978528634002FE,,,,,,,-1,BRCA2-  32906480,72,41567,10,,,,EMPTY,,D,,0,3,3,41272,493217,126000,,,0,0,,"1:4,2:1",,0.051,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0496,9,2,0.1875,0.036585364,0.08367919,GRCh38/hg38,13,32332343,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,NS
32,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,1082,99.91,11,c.4563A>G,p.(Leu1521=),A,G,1,1081,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,16,16,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,0.19512194,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,NS
1,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32899388,724,53.73,4,c.425+67A>C,,A,C,335,389,,,,,NM_000059.3,NM_000059,32899388,within,.,,rs11571610,0.0743,,,,,,,,,,,,,+,A,C,32899388,32899388,1AF346DE380A738371905EBFBCED20E1,,,,,,,-1,BRCA2-  32899388,0,126095,4,,,,EMPTY,,D,,0,3,3,39349,493217,126000,,,0,0,,2:1,,,67,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0306,3,3,0.1875,0.036585364,0.0797803,GRCh38/hg38,13,32325251,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,NS
23,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32906980,1604,48.07,10,c.1365A>G,p.(Ser455=),A,G,833,771,TCA,TCG,S,S,NM_000059.3,NM_000059,32906980,within,.,,rs1801439,0.0737,0.031,,,,,,,,,,,,+,A,G,32906980,32906980,C76C22E555E869928B452D866988AB4F,,,,,,,-1,BRCA2-  32906980,-545,125943,10,,,,EMPTY,,D,,0,3,3,41480,493217,126000,,,0,0,,"1:4,2:1",,0.051,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0499,9,2,0.1875,0.036585364,0.08410091,GRCh38/hg38,13,32332843,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,NS
2,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,803,99.63,14,c.7397T>C,p.(Val2466Ala),T,C,3,800,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,16,16,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.19512194,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,NS
23,C,BRCA2,,SNP,missense,GRCh37/hg19,13,32910881,503,47.91,11,c.2389A>C,p.(Lys797Gln),A,C,261,241,AAG,CAG,K,Q,NM_000059.3,NM_000059,32910881,within,.,,rs587782737,,,,-0.112,0.996,,0.965,0.0,-1.64,,,,,+,A,C,32910881,32910881,FCE36A419FDD924E5C700EFC02E78270,,,,,,,-1,BRCA2-  32910881,480,142813,11,,,,EMPTY,,C,,0,1,1,21,493217,126000,,,0,0,,3:1,,,0,,,,,,,,,,,,,,Uncertain_significance,Uncertain significance,,600185,-1,,,,,,,,,,,3,,10,3,0.0625,0.0121951215,4.257761E-5,GRCh38/hg38,13,32336744,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,PM
14,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244936,827,100.0,10,c.2612C>T,p.(Pro871Leu),G,A,0,827,CCG,CTG,P,L,NM_007294.3,NM_007294,41244936,within,.,,rs799917,0.5439,0.4932,,4.247,0.0,0.0,0.999,1.0,5.04,,,,,-,G,A,41244936,41244936,A19EA255CA888CE1FE48D08CAD633F1F,,,,,,,1,BRCA1- 458755064,-1485,41812,11,,,,EMPTY,,D,,1,13,13,290862,492662,126000,(eval),,0,0,,"1:4,2:1",,0.41,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.4127,9,3,0.8125,0.15853658,0.59038854,GRCh38/hg38,17,43092919,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,PM
7,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41223094,703,100.0,15,c.4837A>G,p.(Ser1613Gly),T,C,0,703,AGT,GGT,S,G,NM_007294.3,NM_007294,41223094,within,.,,rs1799966,0.3558,0.2982,,-0.194,0.968,0.038,0.814,0.0,1.5,,,,,-,T,C,41223094,41223094,E3C52286D31F229973DB3595B052645F,,,,,,,-1,BRCA1- 458776906,-150,41827,16,,,,EMPTY,,D,,0,13,13,273625,492662,126000,,,0,0,,1:1,,0.349,0,,,,,,,,,,,,,,Benign,Benign,0.255,113705,-1,,,,,,,,,,,3,0.35,14,1,0.8125,0.15853658,0.5554011,GRCh38/hg38,17,43071077,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,PM
8,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41231516,457,100.0,13,c.4358-2885G>A,,C,T,0,457,,,,,NM_007294.3,NM_007294,41231516,within,.,,rs8176193,0.3534,,,,,,,,,,,,,-,C,T,41231516,41231516,7F4F80D2D005D34CEA47E4A2C561B172,,,,,,,-1,BRCA1- 458768484,0,209399,14,,,,EMPTY,,D,,0,13,13,190200,492662,126000,,,0,0,,,,,2885,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.317,12,1,0.8125,0.15853658,0.3860659,GRCh38/hg38,17,43079499,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,PM
17,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41245471,1080,99.91,10,c.2077G>A,p.(Asp693Asn),C,T,1,1079,GAC,AAC,D,N,NM_007294.3,NM_007294,41245471,within,.,,rs4986850,0.0335,0.0543,,0.205,0.989,0.01,0.597,0.0,1.23,,,,,-,C,T,41245471,41245471,1EA9438AD2460C6CC594B844CD8DC7F6,,,,,,,-1,BRCA1- 458754529,1407,41808,11,,,,EMPTY,,D,,0,4,4,63951,492662,126000,,,0,0,,1:2,,0.057,0,,,,,,,,,,,,,,Benign,Benign,0.001,113705,-1,,,,,,,,,,,3,0.058,9,1,0.25,0.048780486,0.12980705,GRCh38/hg38,17,43093454,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,PM
11,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244000,851,99.88,10,c.3548A>G,p.(Lys1183Arg),T,C,1,850,AAA,AGA,K,R,NM_007294.3,NM_007294,41244000,within,.,,rs16942,0.3526,0.2952,,-0.319,0.0,0.001,0.924,0.0,-2.35,,,,,-,T,C,41244000,41244000,37A54117EA353BDA677332A1F61FA173,,,,,,,-1,BRCA1- 458756000,-549,41818,11,,,,EMPTY,,D,,0,13,13,272437,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.8125,0.15853658,0.55298966,GRCh38/hg38,17,43091983,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,PM
16,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245466,1083,99.72,10,c.2082C>T,p.(Ser694=),G,A,3,1080,AGC,AGT,S,S,NM_007294.3,NM_007294,41245466,within,.,,rs1799949,0.3365,0.2957,,,,,,,,,,,,-,G,A,41245466,41245466,3364E3D252EFEDF917C74D44FBC6A381,,,,,,,-1,BRCA1- 458754534,1412,125536,11,,,,EMPTY,,D,,0,13,13,269442,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.8125,0.15853658,0.54691046,GRCh38/hg38,17,43093449,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,PM
13,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244435,792,99.87,10,c.3113A>G,p.(Glu1038Gly),T,C,1,791,GAA,GGA,E,G,NM_007294.3,NM_007294,41244435,within,.,,rs16941,0.3357,0.279,,-0.149,0.972,0.606,0.922,0.0,-0.974,,,,,-,T,C,41244435,41244435,5D0FF1321BAC3C76DD352C33CC33B93E,,,,,,,-1,BRCA1- 458755565,-984,41815,11,,,,EMPTY,,D,,0,13,13,270861,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,0.936,113705,-1,,,,,,,,,,,3,0.343,9,1,0.8125,0.15853658,0.54979074,GRCh38/hg38,17,43092418,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,PM
2,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41215825,176,100.0,17,c.5152+66G>A,,C,T,0,176,,,,,NM_007294.3,NM_007294,41215825,within,.,,rs3092994,0.3425,,,,,,,,,,,,,-,C,T,41215825,41215825,5BCA8D2E1E3875817F84A3EB582CDFAB,,,,,,,-1,BRCA1- 458784175,0,55428,18,,,,EMPTY,,D,,0,12,12,241843,492662,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3139,16,1,0.75,0.14634146,0.4908903,GRCh38/hg38,17,43063808,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,PM
4,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219780,513,99.42,16,c.4987-68A>G,,T,C,3,510,,,,,NM_007294.3,NM_007294,41219780,within,.,,rs8176234,0.3546,,,,,,,,,,,,,-,T,C,41219780,41219780,5995ECC305C33150BF3BB2B0C22FCC2A,,,,,,,-1,BRCA1- 458780220,0,125746,17,,,,EMPTY,,D,,0,13,13,234031,492662,126000,,,0,0,,,,,68,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3148,15,1,0.8125,0.15853658,0.47503358,GRCh38/hg38,17,43067763,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,PM
15,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245237,232,100.0,10,c.2311T>C,p.(Leu771=),A,G,0,232,TTG,CTG,L,L,NM_007294.3,NM_007294,41245237,within,.,,rs16940,0.3353,0.2776,,,,,,,,,,,,-,A,G,41245237,41245237,711AF22D84A49E875C2B2A9597A95EE6,,,,,,,-1,BRCA1- 458754763,1641,125554,11,,,,EMPTY,,D,,0,13,13,269517,492662,126000,,,0,0,,1:1,,0.342,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3422,9,1,0.8125,0.15853658,0.5470627,GRCh38/hg38,17,43093220,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,PM
3,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41216021,378,47.62,17,c.5075-53C>T,,G,A,198,180,,,,,NM_007294.3,NM_007294,41216021,within,.,,rs8176258,0.011,0.0171,,,,,,,,,,,,-,G,A,41216021,41216021,572E590682CF9457EB082CC2055935DB,,,,,,,-1,BRCA1- 458783979,0,125760,18,,,,EMPTY,,D,,0,1,1,18649,492662,126000,,,0,0,,2:1,,,53,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.0183,16,3,0.0625,0.0121951215,0.03785354,GRCh38/hg38,17,43064004,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,PM
5,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219804,510,99.61,16,c.4987-92A>G,,T,C,2,508,,,,,NM_007294.3,NM_007294,41219804,within,.,,rs8176233,0.3546,,,,,,,,,,,,,-,T,C,41219804,41219804,7341B20C52FFD4B9355840FB9CB56CDA,,,,,,,-1,BRCA1- 458780196,0,125749,17,,,,EMPTY,,D,,0,13,13,225491,492662,126000,,,0,0,,,,,92,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3128,15,1,0.8125,0.15853658,0.45769918,GRCh38/hg38,17,43067787,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,PM
9,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41234470,357,99.72,12,c.4308T>C,p.(Ser1436=),A,G,1,356,TCT,TCC,S,S,NM_007294.3,NM_007294,41234470,within,.,,rs1060915,0.3363,0.2796,,,,,,,,,,,,-,A,G,41234470,41234470,B7237055CF1D42F022A050C072B7583B,,,,,,,-1,BRCA1- 458765530,-50,125703,13,,,,EMPTY,,D,,0,13,13,270833,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3433,11,1,0.8125,0.15853658,0.5497339,GRCh38/hg38,17,43082453,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,PM
12,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906729,578,44.81,10,c.1114A>C,p.(Asn372His),A,C,319,259,AAT,CAT,N,H,NM_000059.3,NM_000059,32906729,within,.,,rs144848,0.2494,0.2332,,0.32,0.861,,0.269,0.0,0.396,,,,,+,A,C,32906729,32906729,D514F785F1344AF9F6975E589D47BDF6,,,,,,,-1,BRCA2-  32906729,321,9329,10,,,,EMPTY,,D,,0,9,9,233635,493217,126000,,,0,0,,"1:1,2:1",,0.277,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2733,9,1,0.5625,0.1097561,0.47369617,GRCh38/hg38,13,32332592,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,PM
27,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,886,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,886,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,16,16,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,0.19512194,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,PM
29,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32936646,240,59.17,17,c.7806-14T>C,,T,C,98,142,,,,,NM_000059.3,NM_000059,32936646,within,.,,rs9534262,0.5316,0.5202,,,,,,,,,,,,+,T,C,32936646,32936646,5803939D8FBB75B042260991F0A62436,,,,,,,-1,BRCA2-  32936646,0,126158,17,,,,EMPTY,,D,,0,13,13,361616,493217,126000,,,0,0,,1:3,,0.52,14,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5255,16,1,0.8125,0.15853658,0.7331783,GRCh38/hg38,13,32362509,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,PM
26,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,397,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,397,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,16,16,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,0.19512194,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,PM
1,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32903685,776,46.13,8,c.681+56C>T,,C,T,418,358,,,,,NM_000059.3,NM_000059,32903685,within,.,,rs2126042,0.1859,,,,,,,,,,,,,+,C,T,32903685,32903685,E9AEF840574909F4761D4EF7950E02CB,,,,,,,-1,BRCA2-  32903685,0,126192,8,,,,EMPTY,,D,,0,3,3,145186,493217,126000,,,0,0,,4:1,,,56,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2163,7,1,0.1875,0.036585364,0.29436535,GRCh38/hg38,13,32329548,C,T,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,PM
28,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,241,100.0,14,c.7397T>C,p.(Val2466Ala),T,C,0,241,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,16,16,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.19512194,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,PM
30,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32953388,678,46.76,22,c.8755-66T>C,,T,C,361,317,,,,,NM_000059.3,NM_000059,32953388,within,.,,rs4942486,0.5116,,,,,,,,,,,,,+,T,C,32953388,32953388,97C65B85894EB489F1BFA65897685241,,,,,,,-1,BRCA2-  32953388,0,126190,22,,,,EMPTY,,D,,0,13,13,347826,493217,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5257,21,1,0.8125,0.15853658,0.70521903,GRCh38/hg38,13,32379251,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,PM
10,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244936,1096,49.82,10,c.2612C>T,p.(Pro871Leu),G,A,548,546,CCG,CTG,P,L,NM_007294.3,NM_007294,41244936,within,.,,rs799917,0.5439,0.4932,,4.247,0.0,0.0,0.999,1.0,5.04,,,,,-,G,A,41244936,41244936,A19EA255CA888CE1FE48D08CAD633F1F,,,,,,,1,BRCA1- 458755064,-1485,41812,11,,,,EMPTY,,D,,1,13,13,290862,492662,126000,(eval),,0,0,,"1:4,2:1",,0.41,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.4127,9,3,0.8125,0.15853658,0.59038854,GRCh38/hg38,17,43092919,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,PP
4,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41223094,800,49.75,15,c.4837A>G,p.(Ser1613Gly),T,C,402,398,AGT,GGT,S,G,NM_007294.3,NM_007294,41223094,within,.,,rs1799966,0.3558,0.2982,,-0.194,0.968,0.038,0.814,0.0,1.5,,,,,-,T,C,41223094,41223094,E3C52286D31F229973DB3595B052645F,,,,,,,-1,BRCA1- 458776906,-150,41827,16,,,,EMPTY,,D,,0,13,13,273625,492662,126000,,,0,0,,1:1,,0.349,0,,,,,,,,,,,,,,Benign,Benign,0.255,113705,-1,,,,,,,,,,,3,0.35,14,1,0.8125,0.15853658,0.5554011,GRCh38/hg38,17,43071077,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,PP
23,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41215825,168,44.64,17,c.5152+66G>A,,C,T,93,75,,,,,NM_007294.3,NM_007294,41215825,within,.,,rs3092994,0.3425,,,,,,,,,,,,,-,C,T,41215825,41215825,5BCA8D2E1E3875817F84A3EB582CDFAB,,,,,,,-1,BRCA1- 458784175,0,55428,18,,,,EMPTY,,D,,0,12,12,241843,492662,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3139,16,1,0.75,0.14634146,0.4908903,GRCh38/hg38,17,43063808,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,PP
11,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245237,406,52.71,10,c.2311T>C,p.(Leu771=),A,G,192,214,TTG,CTG,L,L,NM_007294.3,NM_007294,41245237,within,.,,rs16940,0.3353,0.2776,,,,,,,,,,,,-,A,G,41245237,41245237,711AF22D84A49E875C2B2A9597A95EE6,,,,,,,-1,BRCA1- 458754763,1641,125554,11,,,,EMPTY,,D,,0,13,13,269517,492662,126000,,,0,0,,1:1,,0.342,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3422,9,1,0.8125,0.15853658,0.5470627,GRCh38/hg38,17,43093220,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,PP
8,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244000,1234,51.46,10,c.3548A>G,p.(Lys1183Arg),T,C,598,635,AAA,AGA,K,R,NM_007294.3,NM_007294,41244000,within,.,,rs16942,0.3526,0.2952,,-0.319,0.0,0.001,0.924,0.0,-2.35,,,,,-,T,C,41244000,41244000,37A54117EA353BDA677332A1F61FA173,,,,,,,-1,BRCA1- 458756000,-549,41818,11,,,,EMPTY,,D,,0,13,13,272437,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.8125,0.15853658,0.55298966,GRCh38/hg38,17,43091983,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,PP
24,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219780,552,50.54,16,c.4987-68A>G,,T,C,273,279,,,,,NM_007294.3,NM_007294,41219780,within,.,,rs8176234,0.3546,,,,,,,,,,,,,-,T,C,41219780,41219780,5995ECC305C33150BF3BB2B0C22FCC2A,,,,,,,-1,BRCA1- 458780220,0,125746,17,,,,EMPTY,,D,,0,13,13,234031,492662,126000,,,0,0,,,,,68,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3148,15,1,0.8125,0.15853658,0.47503358,GRCh38/hg38,17,43067763,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,PP
13,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245466,1535,47.69,10,c.2082C>T,p.(Ser694=),G,A,803,732,AGC,AGT,S,S,NM_007294.3,NM_007294,41245466,within,.,,rs1799949,0.3365,0.2957,,,,,,,,,,,,-,G,A,41245466,41245466,3364E3D252EFEDF917C74D44FBC6A381,,,,,,,-1,BRCA1- 458754534,1412,125536,11,,,,EMPTY,,D,,0,13,13,269442,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.8125,0.15853658,0.54691046,GRCh38/hg38,17,43093449,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,PP
9,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244435,996,49.2,10,c.3113A>G,p.(Glu1038Gly),T,C,506,490,GAA,GGA,E,G,NM_007294.3,NM_007294,41244435,within,.,,rs16941,0.3357,0.279,,-0.149,0.972,0.606,0.922,0.0,-0.974,,,,,-,T,C,41244435,41244435,5D0FF1321BAC3C76DD352C33CC33B93E,,,,,,,-1,BRCA1- 458755565,-984,41815,11,,,,EMPTY,,D,,0,13,13,270861,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,0.936,113705,-1,,,,,,,,,,,3,0.343,9,1,0.8125,0.15853658,0.54979074,GRCh38/hg38,17,43092418,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,PP
2,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219804,551,50.45,16,c.4987-92A>G,,T,C,273,278,,,,,NM_007294.3,NM_007294,41219804,within,.,,rs8176233,0.3546,,,,,,,,,,,,,-,T,C,41219804,41219804,7341B20C52FFD4B9355840FB9CB56CDA,,,,,,,-1,BRCA1- 458780196,0,125749,17,,,,EMPTY,,D,,0,13,13,225491,492662,126000,,,0,0,,,,,92,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3128,15,1,0.8125,0.15853658,0.45769918,GRCh38/hg38,17,43067787,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,PP
6,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41234470,328,46.65,12,c.4308T>C,p.(Ser1436=),A,G,174,153,TCT,TCC,S,S,NM_007294.3,NM_007294,41234470,within,.,,rs1060915,0.3363,0.2796,,,,,,,,,,,,-,A,G,41234470,41234470,B7237055CF1D42F022A050C072B7583B,,,,,,,-1,BRCA1- 458765530,-50,125703,13,,,,EMPTY,,D,,0,13,13,270833,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3433,11,1,0.8125,0.15853658,0.5497339,GRCh38/hg38,17,43082453,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,PP
5,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41231516,412,50.73,13,c.4358-2885G>A,,C,T,203,209,,,,,NM_007294.3,NM_007294,41231516,within,.,,rs8176193,0.3534,,,,,,,,,,,,,-,C,T,41231516,41231516,7F4F80D2D005D34CEA47E4A2C561B172,,,,,,,-1,BRCA1- 458768484,0,209399,14,,,,EMPTY,,D,,0,13,13,190200,492662,126000,,,0,0,,,,,2885,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.317,12,1,0.8125,0.15853658,0.3860659,GRCh38/hg38,17,43079499,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,PP
20,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32930598,477,51.57,15,c.7469T>C,p.(Ile2490Thr),T,C,231,246,ATA,ACA,I,T,NM_000059.3,NM_000059,32930598,within,.,,rs11571707,0.016,0.0016,,0.406,0.895,,0.837,0.0,-5.83,,,,,+,T,C,32930598,32930598,D7CAF30A58440FCA5E8E7BACD8E1EDE4,,,,,,,-1,BRCA2-  32930598,34,96852,15,,,,EMPTY,,D,,0,5,5,6837,493217,126000,,,0,0,,"1:5,2:2",,0.014,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0176,14,2,0.3125,0.06097561,0.013862053,GRCh38/hg38,13,32356461,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,PP
19,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,389,100.0,14,c.7397T>C,p.(Val2466Ala),T,C,0,389,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,16,16,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.19512194,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,PP
12,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,525,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,525,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,16,16,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,0.19512194,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,PP
18,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,1123,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,1123,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,16,16,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,0.19512194,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,PP
1,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906729,549,99.82,10,c.1114A>C,p.(Asn372His),A,C,1,548,AAT,CAT,N,H,NM_000059.3,NM_000059,32906729,within,.,,rs144848,0.2494,0.2332,,0.32,0.861,,0.269,0.0,0.396,,,,,+,A,C,32906729,32906729,D514F785F1344AF9F6975E589D47BDF6,,,,,,,-1,BRCA2-  32906729,321,9329,10,,,,EMPTY,,D,,0,9,9,233635,493217,126000,,,0,0,,"1:1,2:1",,0.277,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2733,9,1,0.5625,0.1097561,0.47369617,GRCh38/hg38,13,32332592,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,PP
17,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244936,1835,47.36,10,c.2612C>T,p.(Pro871Leu),G,A,966,869,CCG,CTG,P,L,NM_007294.3,NM_007294,41244936,within,.,,rs799917,0.5439,0.4932,,4.247,0.0,0.0,0.999,1.0,5.04,,,,,-,G,A,41244936,41244936,A19EA255CA888CE1FE48D08CAD633F1F,,,,,,,1,BRCA1- 458755064,-1485,41812,11,,,,EMPTY,,D,,1,13,13,290862,492662,126000,(eval),,0,0,,"1:4,2:1",,0.41,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.4127,9,3,0.8125,0.15853658,0.59038854,GRCh38/hg38,17,43092919,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,PV
20,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41245471,2464,46.96,10,c.2077G>A,p.(Asp693Asn),C,T,1307,1157,GAC,AAC,D,N,NM_007294.3,NM_007294,41245471,within,.,,rs4986850,0.0335,0.0543,,0.205,0.989,0.01,0.597,0.0,1.23,,,,,-,C,T,41245471,41245471,1EA9438AD2460C6CC594B844CD8DC7F6,,,,,,,-1,BRCA1- 458754529,1407,41808,11,,,,EMPTY,,D,,0,4,4,63951,492662,126000,,,0,0,,1:2,,0.057,0,,,,,,,,,,,,,,Benign,Benign,0.001,113705,-1,,,,,,,,,,,3,0.058,9,1,0.25,0.048780486,0.12980705,GRCh38/hg38,17,43093454,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,PV
7,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219780,807,47.21,16,c.4987-68A>G,,T,C,426,381,,,,,NM_007294.3,NM_007294,41219780,within,.,,rs8176234,0.3546,,,,,,,,,,,,,-,T,C,41219780,41219780,5995ECC305C33150BF3BB2B0C22FCC2A,,,,,,,-1,BRCA1- 458780220,0,125746,17,,,,EMPTY,,D,,0,13,13,234031,492662,126000,,,0,0,,,,,68,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3148,15,1,0.8125,0.15853658,0.47503358,GRCh38/hg38,17,43067763,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,PV
22,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41251931,1166,51.11,7,c.442-34C>T,,G,A,570,596,,,,,NM_007294.3,NM_007294,41251931,within,.,,rs799923,0.0986,0.1757,,,,,,,,,,,,-,G,A,41251931,41251931,A5CCEFE1E7B19A106A59AB89C8776C53,,,,,,,-1,BRCA1- 458748069,0,125864,8,,,,EMPTY,,D,,0,5,5,181678,492662,126000,,,0,0,,,,0.174,34,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.1711,6,1,0.3125,0.06097561,0.36876804,GRCh38/hg38,17,43099914,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,PV
15,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244000,2043,48.9,10,c.3548A>G,p.(Lys1183Arg),T,C,1044,999,AAA,AGA,K,R,NM_007294.3,NM_007294,41244000,within,.,,rs16942,0.3526,0.2952,,-0.319,0.0,0.001,0.924,0.0,-2.35,,,,,-,T,C,41244000,41244000,37A54117EA353BDA677332A1F61FA173,,,,,,,-1,BRCA1- 458756000,-549,41818,11,,,,EMPTY,,D,,0,13,13,272437,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.8125,0.15853658,0.55298966,GRCh38/hg38,17,43091983,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,PV
10,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41223094,1382,45.66,15,c.4837A>G,p.(Ser1613Gly),T,C,751,631,AGT,GGT,S,G,NM_007294.3,NM_007294,41223094,within,.,,rs1799966,0.3558,0.2982,,-0.194,0.968,0.038,0.814,0.0,1.5,,,,,-,T,C,41223094,41223094,E3C52286D31F229973DB3595B052645F,,,,,,,-1,BRCA1- 458776906,-150,41827,16,,,,EMPTY,,D,,0,13,13,273625,492662,126000,,,0,0,,1:1,,0.349,0,,,,,,,,,,,,,,Benign,Benign,0.255,113705,-1,,,,,,,,,,,3,0.35,14,1,0.8125,0.15853658,0.5554011,GRCh38/hg38,17,43071077,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,PV
16,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244435,1627,48.56,10,c.3113A>G,p.(Glu1038Gly),T,C,837,790,GAA,GGA,E,G,NM_007294.3,NM_007294,41244435,within,.,,rs16941,0.3357,0.279,,-0.149,0.972,0.606,0.922,0.0,-0.974,,,,,-,T,C,41244435,41244435,5D0FF1321BAC3C76DD352C33CC33B93E,,,,,,,-1,BRCA1- 458755565,-984,41815,11,,,,EMPTY,,D,,0,13,13,270861,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,0.936,113705,-1,,,,,,,,,,,3,0.343,9,1,0.8125,0.15853658,0.54979074,GRCh38/hg38,17,43092418,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,PV
11,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41231516,725,46.21,13,c.4358-2885G>A,,C,T,390,335,,,,,NM_007294.3,NM_007294,41231516,within,.,,rs8176193,0.3534,,,,,,,,,,,,,-,C,T,41231516,41231516,7F4F80D2D005D34CEA47E4A2C561B172,,,,,,,-1,BRCA1- 458768484,0,209399,14,,,,EMPTY,,D,,0,13,13,190200,492662,126000,,,0,0,,,,,2885,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.317,12,1,0.8125,0.15853658,0.3860659,GRCh38/hg38,17,43079499,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,PV
19,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245466,2486,46.86,10,c.2082C>T,p.(Ser694=),G,A,1321,1165,AGC,AGT,S,S,NM_007294.3,NM_007294,41245466,within,.,,rs1799949,0.3365,0.2957,,,,,,,,,,,,-,G,A,41245466,41245466,3364E3D252EFEDF917C74D44FBC6A381,,,,,,,-1,BRCA1- 458754534,1412,125536,11,,,,EMPTY,,D,,0,13,13,269442,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.8125,0.15853658,0.54691046,GRCh38/hg38,17,43093449,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,PV
13,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41234470,486,49.79,12,c.4308T>C,p.(Ser1436=),A,G,244,242,TCT,TCC,S,S,NM_007294.3,NM_007294,41234470,within,.,,rs1060915,0.3363,0.2796,,,,,,,,,,,,-,A,G,41234470,41234470,B7237055CF1D42F022A050C072B7583B,,,,,,,-1,BRCA1- 458765530,-50,125703,13,,,,EMPTY,,D,,0,13,13,270833,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3433,11,1,0.8125,0.15853658,0.5497339,GRCh38/hg38,17,43082453,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,PV
8,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219804,810,47.41,16,c.4987-92A>G,,T,C,426,384,,,,,NM_007294.3,NM_007294,41219804,within,.,,rs8176233,0.3546,,,,,,,,,,,,,-,T,C,41219804,41219804,7341B20C52FFD4B9355840FB9CB56CDA,,,,,,,-1,BRCA1- 458780196,0,125749,17,,,,EMPTY,,D,,0,13,13,225491,492662,126000,,,0,0,,,,,92,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3128,15,1,0.8125,0.15853658,0.45769918,GRCh38/hg38,17,43067787,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,PV
6,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41215825,343,50.15,17,c.5152+66G>A,,C,T,171,172,,,,,NM_007294.3,NM_007294,41215825,within,.,,rs3092994,0.3425,,,,,,,,,,,,,-,C,T,41215825,41215825,5BCA8D2E1E3875817F84A3EB582CDFAB,,,,,,,-1,BRCA1- 458784175,0,55428,18,,,,EMPTY,,D,,0,12,12,241843,492662,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3139,16,1,0.75,0.14634146,0.4908903,GRCh38/hg38,17,43063808,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,PV
18,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245237,731,49.11,10,c.2311T>C,p.(Leu771=),A,G,372,359,TTG,CTG,L,L,NM_007294.3,NM_007294,41245237,within,.,,rs16940,0.3353,0.2776,,,,,,,,,,,,-,A,G,41245237,41245237,711AF22D84A49E875C2B2A9597A95EE6,,,,,,,-1,BRCA1- 458754763,1641,125554,11,,,,EMPTY,,D,,0,13,13,269517,492662,126000,,,0,0,,1:1,,0.342,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3422,9,1,0.8125,0.15853658,0.5470627,GRCh38/hg38,17,43093220,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,PV
1,D,BRCA2,,SNP,5'UTR,GRCh37/hg19,13,32890572,1974,52.23,2,c.-26G>A,,G,A,942,1031,,,,,NM_000059.3,NM_000059,32890572,within,.,,rs1799943,0.2093,0.2088,,,,,,,,,,,,+,G,A,32890572,32890572,A9C2B39455EF056EDB097A5953EB72EE,,,,,,,-1,BRCA2-  32890572,14,125965,2,,,,EMPTY,,D,,0,8,8,205902,493217,126000,,,0,0,,,,0.243,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2427,1,1,0.5,0.09756097,0.41746736,GRCh38/hg38,13,32316435,G,A,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,PV
23,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32911888,1588,50.06,11,c.3396A>G,p.(Lys1132=),A,G,793,795,AAA,AAG,K,K,NM_000059.3,NM_000059,32911888,within,.,,rs1801406,0.2668,0.2798,,,,,,,,,,,,+,A,G,32911888,32911888,94F2C0D328C28C466A38A430BBE75D52,,,,,,,-1,BRCA2-  32911888,1487,126010,11,,,,EMPTY,,D,,0,8,8,248687,493217,126000,,,0,0,,1:3,,0.293,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.295,10,1,0.5,0.09756097,0.50421417,GRCh38/hg38,13,32337751,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,PV
32,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,1893,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,1893,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,16,16,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,0.19512194,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,PV
30,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,1086,99.91,11,c.4563A>G,p.(Leu1521=),A,G,1,1085,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,16,16,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,0.19512194,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,PV
35,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32930598,750,47.33,15,c.7469T>C,p.(Ile2490Thr),T,C,395,355,ATA,ACA,I,T,NM_000059.3,NM_000059,32930598,within,.,,rs11571707,0.016,0.0016,,0.406,0.895,,0.837,0.0,-5.83,,,,,+,T,C,32930598,32930598,D7CAF30A58440FCA5E8E7BACD8E1EDE4,,,,,,,-1,BRCA2-  32930598,34,96852,15,,,,EMPTY,,D,,0,5,5,6837,493217,126000,,,0,0,,"1:5,2:2",,0.014,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0176,14,2,0.3125,0.06097561,0.013862053,GRCh38/hg38,13,32356461,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,PV
31,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32914236,1246,47.59,11,c.5744C>T,p.(Thr1915Met),C,T,653,593,ACG,ATG,T,M,NM_000059.3,NM_000059,32914236,within,.,,rs4987117,0.0086,0.0211,,-1.105,0.674,,0.286,0.0,0.623,,,,,+,C,T,32914236,32914236,9B18380606AE96F8022F8AB5893BFD77,,,,,,,-1,BRCA2-  32914236,-1098,41556,11,,,,EMPTY,,D,,0,1,1,22222,493217,126000,,,0,0,,"1:4,2:1",,0.018,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0179,10,2,0.0625,0.0121951215,0.045055218,GRCh38/hg38,13,32340099,C,T,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,PV
12,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906729,769,49.54,10,c.1114A>C,p.(Asn372His),A,C,388,381,AAT,CAT,N,H,NM_000059.3,NM_000059,32906729,within,.,,rs144848,0.2494,0.2332,,0.32,0.861,,0.269,0.0,0.396,,,,,+,A,C,32906729,32906729,D514F785F1344AF9F6975E589D47BDF6,,,,,,,-1,BRCA2-  32906729,321,9329,10,,,,EMPTY,,D,,0,9,9,233635,493217,126000,,,0,0,,"1:1,2:1",,0.277,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2733,9,1,0.5625,0.1097561,0.47369617,GRCh38/hg38,13,32332592,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,PV
34,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,677,100.0,14,c.7397T>C,p.(Val2466Ala),T,C,0,677,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,16,16,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.19512194,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,PV
3,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32953388,1038,49.13,22,c.8755-66T>C,,T,C,528,510,,,,,NM_000059.3,NM_000059,32953388,within,.,,rs4942486,0.5116,,,,,,,,,,,,,+,T,C,32953388,32953388,97C65B85894EB489F1BFA65897685241,,,,,,,-1,BRCA2-  32953388,0,126190,22,,,,EMPTY,,D,,0,13,13,347826,493217,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5257,21,1,0.8125,0.15853658,0.70521903,GRCh38/hg38,13,32379251,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,PV
2,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32936646,716,49.3,17,c.7806-14T>C,,T,C,363,353,,,,,NM_000059.3,NM_000059,32936646,within,.,,rs9534262,0.5316,0.5202,,,,,,,,,,,,+,T,C,32936646,32936646,5803939D8FBB75B042260991F0A62436,,,,,,,-1,BRCA2-  32936646,0,126158,17,,,,EMPTY,,D,,0,13,13,361616,493217,126000,,,0,0,,1:3,,0.52,14,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5255,16,1,0.8125,0.15853658,0.7331783,GRCh38/hg38,13,32362509,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,PV
33,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32929232,1033,51.4,14,c.7242A>G,p.(Ser2414=),A,G,502,531,TCA,TCG,S,S,NM_000059.3,NM_000059,32929232,within,.,,rs1799955,0.2326,0.2114,,,,,,,,,,,,+,A,G,32929232,32929232,6F8D6FF8BC9027D6C0351ADCEF41FD20,,,,,,,-1,BRCA2-  32929232,-194,126133,14,,,,EMPTY,,D,,0,8,8,192923,493217,126000,,,0,0,,"1:3,2:1",,0.224,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2257,13,1,0.5,0.09756097,0.39115238,GRCh38/hg38,13,32355095,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,PV
10,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244936,1440,47.78,10,c.2612C>T,p.(Pro871Leu),G,A,752,688,CCG,CTG,P,L,NM_007294.3,NM_007294,41244936,within,.,,rs799917,0.5439,0.4932,,4.247,0.0,0.0,0.999,1.0,5.04,,,,,-,G,A,41244936,41244936,A19EA255CA888CE1FE48D08CAD633F1F,,,,,,,1,BRCA1- 458755064,-1485,41812,11,,,,EMPTY,,D,,1,13,13,290862,492662,126000,(eval),,0,0,,"1:4,2:1",,0.41,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.4127,9,3,0.8125,0.15853658,0.59038854,GRCh38/hg38,17,43092919,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,PZ
4,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41223094,1406,49.64,15,c.4837A>G,p.(Ser1613Gly),T,C,708,698,AGT,GGT,S,G,NM_007294.3,NM_007294,41223094,within,.,,rs1799966,0.3558,0.2982,,-0.194,0.968,0.038,0.814,0.0,1.5,,,,,-,T,C,41223094,41223094,E3C52286D31F229973DB3595B052645F,,,,,,,-1,BRCA1- 458776906,-150,41827,16,,,,EMPTY,,D,,0,13,13,273625,492662,126000,,,0,0,,1:1,,0.349,0,,,,,,,,,,,,,,Benign,Benign,0.255,113705,-1,,,,,,,,,,,3,0.35,14,1,0.8125,0.15853658,0.5554011,GRCh38/hg38,17,43071077,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,PZ
2,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219780,654,50.76,16,c.4987-68A>G,,T,C,322,332,,,,,NM_007294.3,NM_007294,41219780,within,.,,rs8176234,0.3546,,,,,,,,,,,,,-,T,C,41219780,41219780,5995ECC305C33150BF3BB2B0C22FCC2A,,,,,,,-1,BRCA1- 458780220,0,125746,17,,,,EMPTY,,D,,0,13,13,234031,492662,126000,,,0,0,,,,,68,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3148,15,1,0.8125,0.15853658,0.47503358,GRCh38/hg38,17,43067763,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,PZ
11,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245237,774,48.19,10,c.2311T>C,p.(Leu771=),A,G,400,373,TTG,CTG,L,L,NM_007294.3,NM_007294,41245237,within,.,,rs16940,0.3353,0.2776,,,,,,,,,,,,-,A,G,41245237,41245237,711AF22D84A49E875C2B2A9597A95EE6,,,,,,,-1,BRCA1- 458754763,1641,125554,11,,,,EMPTY,,D,,0,13,13,269517,492662,126000,,,0,0,,1:1,,0.342,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3422,9,1,0.8125,0.15853658,0.5470627,GRCh38/hg38,17,43093220,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,PZ
3,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219804,652,50.77,16,c.4987-92A>G,,T,C,321,331,,,,,NM_007294.3,NM_007294,41219804,within,.,,rs8176233,0.3546,,,,,,,,,,,,,-,T,C,41219804,41219804,7341B20C52FFD4B9355840FB9CB56CDA,,,,,,,-1,BRCA1- 458780196,0,125749,17,,,,EMPTY,,D,,0,13,13,225491,492662,126000,,,0,0,,,,,92,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3128,15,1,0.8125,0.15853658,0.45769918,GRCh38/hg38,17,43067787,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,PZ
8,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244000,1773,52.62,10,c.3548A>G,p.(Lys1183Arg),T,C,840,933,AAA,AGA,K,R,NM_007294.3,NM_007294,41244000,within,.,,rs16942,0.3526,0.2952,,-0.319,0.0,0.001,0.924,0.0,-2.35,,,,,-,T,C,41244000,41244000,37A54117EA353BDA677332A1F61FA173,,,,,,,-1,BRCA1- 458756000,-549,41818,11,,,,EMPTY,,D,,0,13,13,272437,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.8125,0.15853658,0.55298966,GRCh38/hg38,17,43091983,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,PZ
13,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245466,1926,49.9,10,c.2082C>T,p.(Ser694=),G,A,964,961,AGC,AGT,S,S,NM_007294.3,NM_007294,41245466,within,.,,rs1799949,0.3365,0.2957,,,,,,,,,,,,-,G,A,41245466,41245466,3364E3D252EFEDF917C74D44FBC6A381,,,,,,,-1,BRCA1- 458754534,1412,125536,11,,,,EMPTY,,D,,0,13,13,269442,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.8125,0.15853658,0.54691046,GRCh38/hg38,17,43093449,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,PZ
9,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244435,1594,46.17,10,c.3113A>G,p.(Glu1038Gly),T,C,857,736,GAA,GGA,E,G,NM_007294.3,NM_007294,41244435,within,.,,rs16941,0.3357,0.279,,-0.149,0.972,0.606,0.922,0.0,-0.974,,,,,-,T,C,41244435,41244435,5D0FF1321BAC3C76DD352C33CC33B93E,,,,,,,-1,BRCA1- 458755565,-984,41815,11,,,,EMPTY,,D,,0,13,13,270861,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,0.936,113705,-1,,,,,,,,,,,3,0.343,9,1,0.8125,0.15853658,0.54979074,GRCh38/hg38,17,43092418,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,PZ
27,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41215825,373,55.23,17,c.5152+66G>A,,C,T,167,206,,,,,NM_007294.3,NM_007294,41215825,within,.,,rs3092994,0.3425,,,,,,,,,,,,,-,C,T,41215825,41215825,5BCA8D2E1E3875817F84A3EB582CDFAB,,,,,,,-1,BRCA1- 458784175,0,55428,18,,,,EMPTY,,D,,0,12,12,241843,492662,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3139,16,1,0.75,0.14634146,0.4908903,GRCh38/hg38,17,43063808,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,PZ
6,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41234470,497,48.69,12,c.4308T>C,p.(Ser1436=),A,G,255,242,TCT,TCC,S,S,NM_007294.3,NM_007294,41234470,within,.,,rs1060915,0.3363,0.2796,,,,,,,,,,,,-,A,G,41234470,41234470,B7237055CF1D42F022A050C072B7583B,,,,,,,-1,BRCA1- 458765530,-50,125703,13,,,,EMPTY,,D,,0,13,13,270833,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3433,11,1,0.8125,0.15853658,0.5497339,GRCh38/hg38,17,43082453,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,PZ
5,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41231516,552,52.54,13,c.4358-2885G>A,,C,T,262,290,,,,,NM_007294.3,NM_007294,41231516,within,.,,rs8176193,0.3534,,,,,,,,,,,,,-,C,T,41231516,41231516,7F4F80D2D005D34CEA47E4A2C561B172,,,,,,,-1,BRCA1- 458768484,0,209399,14,,,,EMPTY,,D,,0,13,13,190200,492662,126000,,,0,0,,,,,2885,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.317,12,1,0.8125,0.15853658,0.3860659,GRCh38/hg38,17,43079499,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,PZ
23,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,707,99.72,14,c.7397T>C,p.(Val2466Ala),T,C,2,705,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,16,16,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.19512194,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,PZ
21,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,1485,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,1485,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,16,16,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,0.19512194,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,PZ
12,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,854,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,854,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,16,16,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,0.19512194,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,PZ
24,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32930598,671,50.67,15,c.7469T>C,p.(Ile2490Thr),T,C,331,340,ATA,ACA,I,T,NM_000059.3,NM_000059,32930598,within,.,,rs11571707,0.016,0.0016,,0.406,0.895,,0.837,0.0,-5.83,,,,,+,T,C,32930598,32930598,D7CAF30A58440FCA5E8E7BACD8E1EDE4,,,,,,,-1,BRCA2-  32930598,34,96852,15,,,,EMPTY,,D,,0,5,5,6837,493217,126000,,,0,0,,"1:5,2:2",,0.014,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0176,14,2,0.3125,0.06097561,0.013862053,GRCh38/hg38,13,32356461,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,PZ
1,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906729,674,100.0,10,c.1114A>C,p.(Asn372His),A,C,0,674,AAT,CAT,N,H,NM_000059.3,NM_000059,32906729,within,.,,rs144848,0.2494,0.2332,,0.32,0.861,,0.269,0.0,0.396,,,,,+,A,C,32906729,32906729,D514F785F1344AF9F6975E589D47BDF6,,,,,,,-1,BRCA2-  32906729,321,9329,10,,,,EMPTY,,D,,0,9,9,233635,493217,126000,,,0,0,,"1:1,2:1",,0.277,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2733,9,1,0.5625,0.1097561,0.47369617,GRCh38/hg38,13,32332592,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,PZ
12,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906729,655,47.79,10,c.1114A>C,p.(Asn372His),A,C,341,313,AAT,CAT,N,H,NM_000059.3,NM_000059,32906729,within,.,,rs144848,0.2494,0.2332,,0.32,0.861,,0.269,0.0,0.396,,,,,+,A,C,32906729,32906729,D514F785F1344AF9F6975E589D47BDF6,,,,,,,-1,BRCA2-  32906729,321,9329,10,,,,EMPTY,,D,,0,9,9,233635,493217,126000,,,0,0,,"1:1,2:1",,0.277,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2733,9,1,0.5625,0.1097561,0.47369617,GRCh38/hg38,13,32332592,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,RQ
19,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32930598,374,54.55,15,c.7469T>C,p.(Ile2490Thr),T,C,170,204,ATA,ACA,I,T,NM_000059.3,NM_000059,32930598,within,.,,rs11571707,0.016,0.0016,,0.406,0.895,,0.837,0.0,-5.83,,,,,+,T,C,32930598,32930598,D7CAF30A58440FCA5E8E7BACD8E1EDE4,,,,,,,-1,BRCA2-  32930598,34,96852,15,,,,EMPTY,,D,,0,5,5,6837,493217,126000,,,0,0,,"1:5,2:2",,0.014,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.0176,14,2,0.3125,0.06097561,0.013862053,GRCh38/hg38,13,32356461,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,RQ
2,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32936646,372,51.08,17,c.7806-14T>C,,T,C,182,190,,,,,NM_000059.3,NM_000059,32936646,within,.,,rs9534262,0.5316,0.5202,,,,,,,,,,,,+,T,C,32936646,32936646,5803939D8FBB75B042260991F0A62436,,,,,,,-1,BRCA2-  32936646,0,126158,17,,,,EMPTY,,D,,0,13,13,361616,493217,126000,,,0,0,,1:3,,0.52,14,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5255,16,1,0.8125,0.15853658,0.7331783,GRCh38/hg38,13,32362509,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,RQ
3,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32953388,674,47.33,22,c.8755-66T>C,,T,C,355,319,,,,,NM_000059.3,NM_000059,32953388,within,.,,rs4942486,0.5116,,,,,,,,,,,,,+,T,C,32953388,32953388,97C65B85894EB489F1BFA65897685241,,,,,,,-1,BRCA2-  32953388,0,126190,22,,,,EMPTY,,D,,0,13,13,347826,493217,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5257,21,1,0.8125,0.15853658,0.70521903,GRCh38/hg38,13,32379251,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,RQ
1,D,BRCA2,,SNP,5'UTR,GRCh37/hg19,13,32890572,1157,49.96,2,c.-26G>A,,G,A,579,578,,,,,NM_000059.3,NM_000059,32890572,within,.,,rs1799943,0.2093,0.2088,,,,,,,,,,,,+,G,A,32890572,32890572,A9C2B39455EF056EDB097A5953EB72EE,,,,,,,-1,BRCA2-  32890572,14,125965,2,,,,EMPTY,,D,,0,8,8,205902,493217,126000,,,0,0,,,,0.243,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2427,1,1,0.5,0.09756097,0.41746736,GRCh38/hg38,13,32316435,G,A,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,RQ
18,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,383,99.74,14,c.7397T>C,p.(Val2466Ala),T,C,1,382,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,16,16,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.19512194,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,RQ
14,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,537,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,537,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,16,16,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,0.19512194,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,RQ
17,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32929232,486,48.97,14,c.7242A>G,p.(Ser2414=),A,G,248,238,TCA,TCG,S,S,NM_000059.3,NM_000059,32929232,within,.,,rs1799955,0.2326,0.2114,,,,,,,,,,,,+,A,G,32929232,32929232,6F8D6FF8BC9027D6C0351ADCEF41FD20,,,,,,,-1,BRCA2-  32929232,-194,126133,14,,,,EMPTY,,D,,0,8,8,192923,493217,126000,,,0,0,,"1:3,2:1",,0.224,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2257,13,1,0.5,0.09756097,0.39115238,GRCh38/hg38,13,32355095,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,RQ
13,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32911888,792,51.64,11,c.3396A>G,p.(Lys1132=),A,G,382,409,AAA,AAG,K,K,NM_000059.3,NM_000059,32911888,within,.,,rs1801406,0.2668,0.2798,,,,,,,,,,,,+,A,G,32911888,32911888,94F2C0D328C28C466A38A430BBE75D52,,,,,,,-1,BRCA2-  32911888,1487,126010,11,,,,EMPTY,,D,,0,8,8,248687,493217,126000,,,0,0,,1:3,,0.293,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.295,10,1,0.5,0.09756097,0.50421417,GRCh38/hg38,13,32337751,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,RQ
15,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,1157,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,1157,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,16,16,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,0.19512194,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,RQ
15,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244936,2036,49.17,10,c.2612C>T,p.(Pro871Leu),G,A,1035,1001,CCG,CTG,P,L,NM_007294.3,NM_007294,41244936,within,.,,rs799917,0.5439,0.4932,,4.247,0.0,0.0,0.999,1.0,5.04,,,,,-,G,A,41244936,41244936,A19EA255CA888CE1FE48D08CAD633F1F,,,,,,,1,BRCA1- 458755064,-1485,41812,11,,,,EMPTY,,D,,1,13,13,290862,492662,126000,(eval),,0,0,,"1:4,2:1",,0.41,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.4127,9,3,0.8125,0.15853658,0.59038854,GRCh38/hg38,17,43092919,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,VM
17,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245466,3121,49.79,10,c.2082C>T,p.(Ser694=),G,A,1567,1554,AGC,AGT,S,S,NM_007294.3,NM_007294,41245466,within,.,,rs1799949,0.3365,0.2957,,,,,,,,,,,,-,G,A,41245466,41245466,3364E3D252EFEDF917C74D44FBC6A381,,,,,,,-1,BRCA1- 458754534,1412,125536,11,,,,EMPTY,,D,,0,13,13,269442,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.8125,0.15853658,0.54691046,GRCh38/hg38,17,43093449,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,VM
13,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244000,2607,51.17,10,c.3548A>G,p.(Lys1183Arg),T,C,1273,1334,AAA,AGA,K,R,NM_007294.3,NM_007294,41244000,within,.,,rs16942,0.3526,0.2952,,-0.319,0.0,0.001,0.924,0.0,-2.35,,,,,-,T,C,41244000,41244000,37A54117EA353BDA677332A1F61FA173,,,,,,,-1,BRCA1- 458756000,-549,41818,11,,,,EMPTY,,D,,0,13,13,272437,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.8125,0.15853658,0.55298966,GRCh38/hg38,17,43091983,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,VM
9,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41231516,844,49.05,13,c.4358-2885G>A,,C,T,430,414,,,,,NM_007294.3,NM_007294,41231516,within,.,,rs8176193,0.3534,,,,,,,,,,,,,-,C,T,41231516,41231516,7F4F80D2D005D34CEA47E4A2C561B172,,,,,,,-1,BRCA1- 458768484,0,209399,14,,,,EMPTY,,D,,0,13,13,190200,492662,126000,,,0,0,,,,,2885,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.317,12,1,0.8125,0.15853658,0.3860659,GRCh38/hg38,17,43079499,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,VM
5,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219780,1014,51.38,16,c.4987-68A>G,,T,C,493,521,,,,,NM_007294.3,NM_007294,41219780,within,.,,rs8176234,0.3546,,,,,,,,,,,,,-,T,C,41219780,41219780,5995ECC305C33150BF3BB2B0C22FCC2A,,,,,,,-1,BRCA1- 458780220,0,125746,17,,,,EMPTY,,D,,0,13,13,234031,492662,126000,,,0,0,,,,,68,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3148,15,1,0.8125,0.15853658,0.47503358,GRCh38/hg38,17,43067763,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,VM
6,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219804,1015,51.43,16,c.4987-92A>G,,T,C,493,522,,,,,NM_007294.3,NM_007294,41219804,within,.,,rs8176233,0.3546,,,,,,,,,,,,,-,T,C,41219804,41219804,7341B20C52FFD4B9355840FB9CB56CDA,,,,,,,-1,BRCA1- 458780196,0,125749,17,,,,EMPTY,,D,,0,13,13,225491,492662,126000,,,0,0,,,,,92,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3128,15,1,0.8125,0.15853658,0.45769918,GRCh38/hg38,17,43067787,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,VM
10,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41234470,728,47.94,12,c.4308T>C,p.(Ser1436=),A,G,379,349,TCT,TCC,S,S,NM_007294.3,NM_007294,41234470,within,.,,rs1060915,0.3363,0.2796,,,,,,,,,,,,-,A,G,41234470,41234470,B7237055CF1D42F022A050C072B7583B,,,,,,,-1,BRCA1- 458765530,-50,125703,13,,,,EMPTY,,D,,0,13,13,270833,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3433,11,1,0.8125,0.15853658,0.5497339,GRCh38/hg38,17,43082453,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,VM
19,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41251931,1445,50.52,7,c.442-34C>T,,G,A,715,730,,,,,NM_007294.3,NM_007294,41251931,within,.,,rs799923,0.0986,0.1757,,,,,,,,,,,,-,G,A,41251931,41251931,A5CCEFE1E7B19A106A59AB89C8776C53,,,,,,,-1,BRCA1- 458748069,0,125864,8,,,,EMPTY,,D,,0,5,5,181678,492662,126000,,,0,0,,,,0.174,34,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.1711,6,1,0.3125,0.06097561,0.36876804,GRCh38/hg38,17,43099914,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,VM
4,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41215825,433,51.5,17,c.5152+66G>A,,C,T,210,223,,,,,NM_007294.3,NM_007294,41215825,within,.,,rs3092994,0.3425,,,,,,,,,,,,,-,C,T,41215825,41215825,5BCA8D2E1E3875817F84A3EB582CDFAB,,,,,,,-1,BRCA1- 458784175,0,55428,18,,,,EMPTY,,D,,0,12,12,241843,492662,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3139,16,1,0.75,0.14634146,0.4908903,GRCh38/hg38,17,43063808,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,VM
8,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41223094,1946,49.49,15,c.4837A>G,p.(Ser1613Gly),T,C,983,963,AGT,GGT,S,G,NM_007294.3,NM_007294,41223094,within,.,,rs1799966,0.3558,0.2982,,-0.194,0.968,0.038,0.814,0.0,1.5,,,,,-,T,C,41223094,41223094,E3C52286D31F229973DB3595B052645F,,,,,,,-1,BRCA1- 458776906,-150,41827,16,,,,EMPTY,,D,,0,13,13,273625,492662,126000,,,0,0,,1:1,,0.349,0,,,,,,,,,,,,,,Benign,Benign,0.255,113705,-1,,,,,,,,,,,3,0.35,14,1,0.8125,0.15853658,0.5554011,GRCh38/hg38,17,43071077,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,VM
16,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245237,1099,51.14,10,c.2311T>C,p.(Leu771=),A,G,537,562,TTG,CTG,L,L,NM_007294.3,NM_007294,41245237,within,.,,rs16940,0.3353,0.2776,,,,,,,,,,,,-,A,G,41245237,41245237,711AF22D84A49E875C2B2A9597A95EE6,,,,,,,-1,BRCA1- 458754763,1641,125554,11,,,,EMPTY,,D,,0,13,13,269517,492662,126000,,,0,0,,1:1,,0.342,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3422,9,1,0.8125,0.15853658,0.5470627,GRCh38/hg38,17,43093220,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,VM
14,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244435,2213,47.85,10,c.3113A>G,p.(Glu1038Gly),T,C,1154,1059,GAA,GGA,E,G,NM_007294.3,NM_007294,41244435,within,.,,rs16941,0.3357,0.279,,-0.149,0.972,0.606,0.922,0.0,-0.974,,,,,-,T,C,41244435,41244435,5D0FF1321BAC3C76DD352C33CC33B93E,,,,,,,-1,BRCA1- 458755565,-984,41815,11,,,,EMPTY,,D,,0,13,13,270861,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,0.936,113705,-1,,,,,,,,,,,3,0.343,9,1,0.8125,0.15853658,0.54979074,GRCh38/hg38,17,43092418,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,VM
12,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906729,1103,51.13,10,c.1114A>C,p.(Asn372His),A,C,539,564,AAT,CAT,N,H,NM_000059.3,NM_000059,32906729,within,.,,rs144848,0.2494,0.2332,,0.32,0.861,,0.269,0.0,0.396,,,,,+,A,C,32906729,32906729,D514F785F1344AF9F6975E589D47BDF6,,,,,,,-1,BRCA2-  32906729,321,9329,10,,,,EMPTY,,D,,0,9,9,233635,493217,126000,,,0,0,,"1:1,2:1",,0.277,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2733,9,1,0.5625,0.1097561,0.47369617,GRCh38/hg38,13,32332592,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,VM
29,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32936646,978,100.0,17,c.7806-14T>C,,T,C,0,978,,,,,NM_000059.3,NM_000059,32936646,within,.,,rs9534262,0.5316,0.5202,,,,,,,,,,,,+,T,C,32936646,32936646,5803939D8FBB75B042260991F0A62436,,,,,,,-1,BRCA2-  32936646,0,126158,17,,,,EMPTY,,D,,0,13,13,361616,493217,126000,,,0,0,,1:3,,0.52,14,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5255,16,1,0.8125,0.15853658,0.7331783,GRCh38/hg38,13,32362509,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,VM
1,D,BRCA2,,SNP,5'UTR,GRCh37/hg19,13,32890572,2316,51.34,2,c.-26G>A,,G,A,1126,1189,,,,,NM_000059.3,NM_000059,32890572,within,.,,rs1799943,0.2093,0.2088,,,,,,,,,,,,+,G,A,32890572,32890572,A9C2B39455EF056EDB097A5953EB72EE,,,,,,,-1,BRCA2-  32890572,14,125965,2,,,,EMPTY,,D,,0,8,8,205902,493217,126000,,,0,0,,,,0.243,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2427,1,1,0.5,0.09756097,0.41746736,GRCh38/hg38,13,32316435,G,A,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,VM
23,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32911888,1883,50.19,11,c.3396A>G,p.(Lys1132=),A,G,936,945,AAA,AAG,K,K,NM_000059.3,NM_000059,32911888,within,.,,rs1801406,0.2668,0.2798,,,,,,,,,,,,+,A,G,32911888,32911888,94F2C0D328C28C466A38A430BBE75D52,,,,,,,-1,BRCA2-  32911888,1487,126010,11,,,,EMPTY,,D,,0,8,8,248687,493217,126000,,,0,0,,1:3,,0.293,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.295,10,1,0.5,0.09756097,0.50421417,GRCh38/hg38,13,32337751,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,VM
25,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,1435,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,1435,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,16,16,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,0.19512194,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,VM
26,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,2254,100.0,11,c.6513G>C,p.(Val2171=),G,C,0,2254,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,16,16,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,0.19512194,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,VM
27,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32929232,1307,48.66,14,c.7242A>G,p.(Ser2414=),A,G,671,636,TCA,TCG,S,S,NM_000059.3,NM_000059,32929232,within,.,,rs1799955,0.2326,0.2114,,,,,,,,,,,,+,A,G,32929232,32929232,6F8D6FF8BC9027D6C0351ADCEF41FD20,,,,,,,-1,BRCA2-  32929232,-194,126133,14,,,,EMPTY,,D,,0,8,8,192923,493217,126000,,,0,0,,"1:3,2:1",,0.224,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2257,13,1,0.5,0.09756097,0.39115238,GRCh38/hg38,13,32355095,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,VM
28,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,931,99.79,14,c.7397T>C,p.(Val2466Ala),T,C,1,929,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,16,16,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.19512194,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,VM
30,D,BRCA2,,SNP,intronic,GRCh37/hg19,13,32953388,1184,100.0,22,c.8755-66T>C,,T,C,0,1184,,,,,NM_000059.3,NM_000059,32953388,within,.,,rs4942486,0.5116,,,,,,,,,,,,,+,T,C,32953388,32953388,97C65B85894EB489F1BFA65897685241,,,,,,,-1,BRCA2-  32953388,0,126190,22,,,,EMPTY,,D,,0,13,13,347826,493217,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.5257,21,1,0.8125,0.15853658,0.70521903,GRCh38/hg38,13,32379251,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,VM
13,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244936,1496,51.87,10,c.2612C>T,p.(Pro871Leu),G,A,719,776,CCG,CTG,P,L,NM_007294.3,NM_007294,41244936,within,.,,rs799917,0.5439,0.4932,,4.247,0.0,0.0,0.999,1.0,5.04,,,,,-,G,A,41244936,41244936,A19EA255CA888CE1FE48D08CAD633F1F,,,,,,,1,BRCA1- 458755064,-1485,41812,11,,,,EMPTY,,D,,1,13,13,290862,492662,126000,(eval),,0,0,,"1:4,2:1",,0.41,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.4127,9,3,0.8125,0.15853658,0.59038854,GRCh38/hg38,17,43092919,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,YA
17,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41251931,834,51.8,7,c.442-34C>T,,G,A,402,432,,,,,NM_007294.3,NM_007294,41251931,within,.,,rs799923,0.0986,0.1757,,,,,,,,,,,,-,G,A,41251931,41251931,A5CCEFE1E7B19A106A59AB89C8776C53,,,,,,,-1,BRCA1- 458748069,0,125864,8,,,,EMPTY,,D,,0,5,5,181678,492662,126000,,,0,0,,,,0.174,34,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.1711,6,1,0.3125,0.06097561,0.36876804,GRCh38/hg38,17,43099914,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,YA
2,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219780,895,46.48,16,c.4987-68A>G,,T,C,479,416,,,,,NM_007294.3,NM_007294,41219780,within,.,,rs8176234,0.3546,,,,,,,,,,,,,-,T,C,41219780,41219780,5995ECC305C33150BF3BB2B0C22FCC2A,,,,,,,-1,BRCA1- 458780220,0,125746,17,,,,EMPTY,,D,,0,13,13,234031,492662,126000,,,0,0,,,,,68,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3148,15,1,0.8125,0.15853658,0.47503358,GRCh38/hg38,17,43067763,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,YA
3,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41219804,892,46.19,16,c.4987-92A>G,,T,C,480,412,,,,,NM_007294.3,NM_007294,41219804,within,.,,rs8176233,0.3546,,,,,,,,,,,,,-,T,C,41219804,41219804,7341B20C52FFD4B9355840FB9CB56CDA,,,,,,,-1,BRCA1- 458780196,0,125749,17,,,,EMPTY,,D,,0,13,13,225491,492662,126000,,,0,0,,,,,92,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3128,15,1,0.8125,0.15853658,0.45769918,GRCh38/hg38,17,43067787,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,YA
7,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41234470,620,51.29,12,c.4308T>C,p.(Ser1436=),A,G,302,318,TCT,TCC,S,S,NM_007294.3,NM_007294,41234470,within,.,,rs1060915,0.3363,0.2796,,,,,,,,,,,,-,A,G,41234470,41234470,B7237055CF1D42F022A050C072B7583B,,,,,,,-1,BRCA1- 458765530,-50,125703,13,,,,EMPTY,,D,,0,13,13,270833,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3433,11,1,0.8125,0.15853658,0.5497339,GRCh38/hg38,17,43082453,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,YA
30,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41215825,318,53.77,17,c.5152+66G>A,,C,T,147,171,,,,,NM_007294.3,NM_007294,41215825,within,.,,rs3092994,0.3425,,,,,,,,,,,,,-,C,T,41215825,41215825,5BCA8D2E1E3875817F84A3EB582CDFAB,,,,,,,-1,BRCA1- 458784175,0,55428,18,,,,EMPTY,,D,,0,12,12,241843,492662,126000,,,0,0,,,,,66,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3139,16,1,0.75,0.14634146,0.4908903,GRCh38/hg38,17,43063808,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,YA
11,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244435,1587,49.21,10,c.3113A>G,p.(Glu1038Gly),T,C,806,781,GAA,GGA,E,G,NM_007294.3,NM_007294,41244435,within,.,,rs16941,0.3357,0.279,,-0.149,0.972,0.606,0.922,0.0,-0.974,,,,,-,T,C,41244435,41244435,5D0FF1321BAC3C76DD352C33CC33B93E,,,,,,,-1,BRCA1- 458755565,-984,41815,11,,,,EMPTY,,D,,0,13,13,270861,492662,126000,,,0,0,,1:1,,0.343,0,,,,,,,,,,,,,,Benign,Benign,0.936,113705,-1,,,,,,,,,,,3,0.343,9,1,0.8125,0.15853658,0.54979074,GRCh38/hg38,17,43092418,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,YA
5,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41223094,1256,50.48,15,c.4837A>G,p.(Ser1613Gly),T,C,622,634,AGT,GGT,S,G,NM_007294.3,NM_007294,41223094,within,.,,rs1799966,0.3558,0.2982,,-0.194,0.968,0.038,0.814,0.0,1.5,,,,,-,T,C,41223094,41223094,E3C52286D31F229973DB3595B052645F,,,,,,,-1,BRCA1- 458776906,-150,41827,16,,,,EMPTY,,D,,0,13,13,273625,492662,126000,,,0,0,,1:1,,0.349,0,,,,,,,,,,,,,,Benign,Benign,0.255,113705,-1,,,,,,,,,,,3,0.35,14,1,0.8125,0.15853658,0.5554011,GRCh38/hg38,17,43071077,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,YA
10,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244429,1574,50.76,10,c.3119G>A,p.(Ser1040Asn),C,T,775,799,AGC,AAC,S,N,NM_007294.3,NM_007294,41244429,within,.,,rs4986852,0.0098,0.0165,,-0.025,0.93,0.831,0.882,0.003,2.01,,,,,-,C,T,41244429,41244429,B78957833778EAA9E7BE3A4ED1B331FB,,,,,,,-1,BRCA1- 458755571,-978,17670,11,,,,EMPTY,,D,,0,1,1,21060,492662,126000,,,0,0,,"1:4,2:3,4:1",,0.013,0,,,,,,,,,,,,,,Benign,Benign,0.974,113705,-1,,,,,,,,,,,3,0.0129,9,3,0.0625,0.0121951215,0.04274736,GRCh38/hg38,17,43092412,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,YA
14,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245237,620,49.68,10,c.2311T>C,p.(Leu771=),A,G,312,308,TTG,CTG,L,L,NM_007294.3,NM_007294,41245237,within,.,,rs16940,0.3353,0.2776,,,,,,,,,,,,-,A,G,41245237,41245237,711AF22D84A49E875C2B2A9597A95EE6,,,,,,,-1,BRCA1- 458754763,1641,125554,11,,,,EMPTY,,D,,0,13,13,269517,492662,126000,,,0,0,,1:1,,0.342,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3422,9,1,0.8125,0.15853658,0.5470627,GRCh38/hg38,17,43093220,A,G,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,YA
9,D,BRCA1,,SNP,missense,GRCh37/hg19,17,41244000,1750,47.31,10,c.3548A>G,p.(Lys1183Arg),T,C,922,828,AAA,AGA,K,R,NM_007294.3,NM_007294,41244000,within,.,,rs16942,0.3526,0.2952,,-0.319,0.0,0.001,0.924,0.0,-2.35,,,,,-,T,C,41244000,41244000,37A54117EA353BDA677332A1F61FA173,,,,,,,-1,BRCA1- 458756000,-549,41818,11,,,,EMPTY,,D,,0,13,13,272437,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,0.0,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.8125,0.15853658,0.55298966,GRCh38/hg38,17,43091983,T,C,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,YA
6,D,BRCA1,,SNP,intronic,GRCh37/hg19,17,41231516,742,52.29,13,c.4358-2885G>A,,C,T,354,388,,,,,NM_007294.3,NM_007294,41231516,within,.,,rs8176193,0.3534,,,,,,,,,,,,,-,C,T,41231516,41231516,7F4F80D2D005D34CEA47E4A2C561B172,,,,,,,-1,BRCA1- 458768484,0,209399,14,,,,EMPTY,,D,,0,13,13,190200,492662,126000,,,0,0,,,,,2885,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.317,12,1,0.8125,0.15853658,0.3860659,GRCh38/hg38,17,43079499,C,T,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,YA
15,D,BRCA1,,SNP,synonymous,GRCh37/hg19,17,41245466,2050,48.68,10,c.2082C>T,p.(Ser694=),G,A,1052,998,AGC,AGT,S,S,NM_007294.3,NM_007294,41245466,within,.,,rs1799949,0.3365,0.2957,,,,,,,,,,,,-,G,A,41245466,41245466,3364E3D252EFEDF917C74D44FBC6A381,,,,,,,-1,BRCA1- 458754534,1412,125536,11,,,,EMPTY,,D,,0,13,13,269442,492662,126000,,,0,0,,1:2,,0.348,0,,,,,,,,,,,,,,Benign,Benign,,113705,-1,,,,,,,,,,,3,0.3486,9,1,0.8125,0.15853658,0.54691046,GRCh38/hg38,17,43093449,G,A,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1|PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4|FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS","Mu, AD|N/A|AR",604370|614320|617883,,,,,,,,,,,,,,,,,YA
27,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32929387,485,100.0,14,c.7397T>C,p.(Val2466Ala),T,C,0,485,GTA,GCA,V,A,NM_000059.3,NM_000059,32929387,within,.,,rs169547,0.9758,0.9777,,2.491,0.0,,0.903,0.0,5.07,,,,,+,T,C,32929387,32929387,68A5190E726F2E4EA09C54D6EFA9DFDA,,,,,,,-1,BRCA2-  32929387,-39,133738,14,,,,EMPTY,,D,,0,16,16,486625,493217,126000,,,0,0,,1:4,,0.994,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9934,13,1,1.0,0.19512194,0.9866347,GRCh38/hg38,13,32355250,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,YA
12,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32912299,554,47.47,11,c.3807T>C,p.(Val1269=),T,C,291,263,GTT,GTC,V,V,NM_000059.3,NM_000059,32912299,within,.,,rs543304,0.1681,0.1911,,,,,,,,,,,,+,T,C,32912299,32912299,F2D3E8FFB3CEE8C1ACEA66738E41BC1E,,,,,,,-1,BRCA2-  32912299,1898,126022,11,,,,EMPTY,,D,,0,6,6,173719,493217,126000,,,0,0,,1:3,,0.176,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.1754,10,1,0.375,0.07317073,0.35221615,GRCh38/hg38,13,32338162,T,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,YA
23,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32913055,793,100.0,11,c.4563A>G,p.(Leu1521=),A,G,0,793,CTA,CTG,L,L,NM_000059.3,NM_000059,32913055,within,.,,rs206075,0.974,0.9758,,,,,,,,,,,,+,A,G,32913055,32913055,4DE8AA3A7B0E08EBA7BE0799C7137F3C,,,,,,,-1,BRCA2-  32913055,-2279,132779,11,,,,EMPTY,,D,,0,16,16,487213,493217,126000,,,0,0,,1:3,,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9927,10,1,1.0,0.19512194,0.9878269,GRCh38/hg38,13,32338918,A,G,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,YA
25,D,BRCA2,,SNP,synonymous,GRCh37/hg19,13,32915005,1584,99.94,11,c.6513G>C,p.(Val2171=),G,C,0,1583,GTG,GTC,V,V,NM_000059.3,NM_000059,32915005,within,.,,rs206076,0.9736,0.9755,,,,,,,,,,,,+,G,C,32915005,32915005,6D100C77725F6F2478A2CE895458D8A9,,,,,,,-1,BRCA2-  32915005,-329,132780,11,,,,EMPTY,,D,,0,16,16,486661,493217,126000,,,0,0,,"1:3,2:1",,0.993,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.9925,10,1,1.0,0.19512194,0.9867077,GRCh38/hg38,13,32340868,G,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,YA
1,D,BRCA2,,SNP,missense,GRCh37/hg19,13,32906729,861,46.92,10,c.1114A>C,p.(Asn372His),A,C,457,404,AAT,CAT,N,H,NM_000059.3,NM_000059,32906729,within,.,,rs144848,0.2494,0.2332,,0.32,0.861,,0.269,0.0,0.396,,,,,+,A,C,32906729,32906729,D514F785F1344AF9F6975E589D47BDF6,,,,,,,-1,BRCA2-  32906729,321,9329,10,,,,EMPTY,,D,,0,9,9,233635,493217,126000,,,0,0,,"1:1,2:1",,0.277,0,,,,,,,,,,,,,,Benign,Benign,,600185,-1,,,,,,,,,,,3,0.2733,9,1,0.5625,0.1097561,0.47369617,GRCh38/hg38,13,32332592,A,C,"BREAST CANCER|MEDULLOBLASTOMA; MDB|PROSTATE CANCER|WILMS TUMOR 1; WT1|FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1|BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2|GLIOMA SUSCEPTIBILITY 3; GLM3|PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","SMu, AD|SMu, AR, AD|SMu, AD|SMu, AD|AR|AD|AR|N/A",114480|155255|176807|194070|605724|612555|613029|613347,,,,,,,,,,,,,,,,,YA
